uric acid has been researched along with Metabolic Syndrome in 648 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study aimed to examine the impact of liraglutide plus dapagliflozin on high uric acid (UA) and microalbuminuria (MAU) in patients with diabetes mellitus (DM) complicated with metabolic syndrome (MS)." | 9.51 | Liraglutide Plus Dapagliflozin for High Uric Acid and Microalbuminuria in Diabetes Mellitus Complicated With Metabolic Syndrome. ( Dai, X; Hao, H; Li, Y; Ou, T; Wang, D; Wang, R; Wang, W; Yong, H, 2022) |
| "The study showed that in patients with hypertension and metabolic syndrome, both losartan and eprosartan have a neutral effect on fasting and postfructose load serum uric acid concentration and its urinary excretion." | 9.41 | Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome. ( Majer, J; Masajtis-Zagajewska, A; Nowicki, M, 2021) |
| "The relationship between Serum Uric Acid (UA) and Cardiovascular (CV) diseases has already been extensively evaluated, and it was found to be an independent predictor of all-cause and cardiovascular mortality but also acute coronary syndrome, stroke and heart failure." | 9.41 | The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation. ( Agabiti Rosei, E; Angeli, F; Barbagallo, CM; Bernardino, B; Bombelli, M; Borghi, C; Cappelli, F; Casiglia, E; Cianci, R; Ciccarelli, M; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Dell'Oro, R; Desideri, G; Facchetti, R; Ferri, C; Galletti, F; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Masulli, M; Mazza, A; Mengozzi, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pauletto, P; Pontremoli, R; Pugliese, NR; Quarti-Trevano, F; Rattazzi, M; Reboldi, G; Rivasi, G; Russo, E; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2023) |
| "The role of uric acid on metabolic syndrome (MetS) has always been controversial." | 9.34 | Association of Serum Uric Acid with Metabolic Syndrome and Its Components: A Mendelian Randomization Analysis. ( Liu, Y; Tang, F; Wang, L; Xue, F; Zhang, T, 2020) |
| "Increased blood lactate or uric acid (UA) levels are associated with an increased risk of metabolic syndrome (MS)." | 9.30 | Interaction Between Lactate and Uric Acid is Associated With a Higher Prevalence of Metabolic Syndrome: A Community-Based Study. ( Li, F; Pan, H; Ren, M; Wu, M; Xu, M; Yan, D; Zhang, J, 2019) |
| "Increased serum uric acid (SUA) levels are commonly seen in patients with metabolic syndrome and are widely accepted as risk factors for hypertension, gout, non-alcoholic fatty liver disease, chronic kidney disease (CKD), and cardiovascular diseases." | 9.22 | Uric acid in metabolic syndrome: Does uric acid have a definitive role? ( Copur, S; Demiray, A; Kanbay, M, 2022) |
| "This systematic review and meta-analysis aim to provide the best evidence on the association between metabolic syndrome (MetS) and uric acid (UA) by determining the size of the effect of this biomarker on MetS." | 9.22 | Association between metabolic syndrome and uric acid: a systematic review and meta-analysis. ( De Pedro-Jiménez, D; Molina-Luque, R; Molina-Recio, G; Raya-Cano, E; Romero-Saldaña, M; Vaquero-Abellán, M, 2022) |
| "Intravenous L-carnitine can ameliorate fasting-induced hunger, fatigue, cholesterol abnormalities and hepatic metabolic changes and facilitate fasting-induced weight loss in MetS patients." | 9.19 | L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. ( Cai, YJ; Huang, YJ; Ke, B; Qin, J; Qiu, CP; Shi, LY; Wu, ZB; Yang, YB; Zhang, JJ, 2014) |
| "Excessive fructose intake causes metabolic syndrome in animals and can be partially prevented by lowering the uric acid level." | 9.14 | Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. ( Johnson, RJ; Lillo, JL; Nakagawa, T; Perez-Pozo, SE; Sánchez-Lozada, LG; Schold, J, 2010) |
| " Of 2,963 patients with coronary artery disease enrolled in the Bezafibrate Infarction Prevention study, 1,410 had MS, as established by the presence of ≥3 of the following 5 criteria: serum fasting glucose >110 mg/dl, triglycerides >150 mg/dl, high-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women, systolic and diastolic blood pressures >130 and 80 mm Hg, respectively, and body mass index >28 kg/m²." | 9.14 | Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P, 2010) |
| " Elevated uric acid levels are risk factors for gout, hypertension, and chronic kidney diseases." | 9.12 | Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis. ( Kimura, Y; Kono, H; Tsukui, D, 2021) |
| "The aim of our investigation was to study the peculiarities of serum uric acid (UA) levels in patients with metabolic syndrome (MS) during 6 month therapy with metformin (MF), Rosiglitazone (RG) and their combination." | 9.12 | [Relation of serum uric acid levels with basic metabolic parameters in patients with metabolic syndrome during insulin-sensitizing therapy]. ( Javashvili, L; Kilasonia, L; Tananashvili, D; Tetradze, L; Virsaladze, D, 2007) |
| " The Mesh Terms considered were: uric acid, antioxidant, oxidant, metabolic syndrome, diabetes, cerebrovascular diseases, stroke, haemorrhagic stroke, neurocognitive disorders, and their combinations." | 9.05 | Uric Acid in Metabolic and Cerebrovascular Disorders: A Review. ( Andriani, A; Calculli, G; Ciccone, MM; Cortese, AM; Cortese, F; Giordano, P; Meliota, G; Scicchitano, P; Truncellito, L, 2020) |
| " For many years, hyperuricemia was attributed to the effects of insulin resistance to reduce urinary excretion of uric acid, and it was believed that uric acid may not have any causal role in the metabolic syndrome." | 8.98 | Uric Acid as a Cause of the Metabolic Syndrome. ( Jensen, T; Johnson, RJ; King, C; Lanaspa, MA; Sánchez-Lozada, LG; Tolan, DR, 2018) |
| "Uric acid nephrolithiasis (UAN) is an increasingly common disease in ethnically diverse populations and constitutes about 10% of all kidney stones." | 8.98 | Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus. ( Badalamenti, S; Dauriz, M; Ferraro, PM; Gambaro, G; Spatola, L, 2018) |
| "Xanthine oxidoreductase (XOR) could contribute to the pathogenesis of metabolic syndrome through the oxidative stress and the inflammatory response induced by XOR-derived reactive oxygen species and uric acid." | 8.98 | The role of xanthine oxidoreductase and uric acid in metabolic syndrome. ( Battelli, MG; Bolognesi, A; Bortolotti, M; Polito, L, 2018) |
| "Uric acid, once viewed as an inert metabolic end-product of purine metabolism, has been recently incriminated in a number of chronic disease states, including hypertension, metabolic syndrome, diabetes, non-alcoholic fatty liver disease, and chronic kidney disease." | 8.93 | Uric acid in metabolic syndrome: From an innocent bystander to a central player. ( Jensen, T; Johnson, RJ; Kanbay, M; Lanaspa, MA; Le, M; Nakagawa, T; Rivard, C; Roncal-Jimenez, C; Solak, Y, 2016) |
| "An excess circulating uric acid level, even within the normal range, is always comorbid with metabolic syndrome (MS), several of its components, and nonalcoholic fatty liver disease (NAFLD), which was regarded as hepatic manifestation of MS; however, these associations remain controversial." | 8.91 | Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. ( Li, X; Sun, L; Yang, Z; Yu, C; Yuan, H; Zhang, Z; Zhao, C; Zhu, X, 2015) |
| "Emerging evidence has shown that serum uric acid (SUA) elevation might cause metabolic derangements, including metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD); however, magnitude of the risk has not been quantified." | 8.91 | Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies. ( Liu, Z; Que, S; Zheng, S; Zhou, L, 2015) |
| "The relationship between elevated serum uric acid level and metabolic syndrome (MS) has been debated." | 8.90 | Association of serum uric acid and metabolic syndrome in type 2 diabetes. ( Bonakdaran, S; Kharaqani, B, 2014) |
| "Elevated serum uric acid concentration is a common laboratory finding in subjects with metabolic syndrome/obesity, hypertension, kidney disease and cardiovascular events." | 8.89 | Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? ( Kapusta, DR; Rasheed, K; Reisin, E; Soltani, Z, 2013) |
| "Elevated uric acid levels are a common finding in patients with metabolic syndrome and in those with cardiovascular and renal disease, but the meaning of this elevation is still unclear." | 8.88 | Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage? ( Di Giorgio, C; Gesualdo, L; Morrone, LF; Stellato, D, 2012) |
| "Uric acid (UA) increase is considered an important risk factor for the development of cardiovascular disease (CVD) favoring oxidative stress and endothelial dysfunction and is also involved in metabolic syndrome (MS) pathophysiology." | 8.88 | The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome. ( Dichi, I; Lozovoy, MA; Simão, AN, 2012) |
| "Uric acid stones are significantly more common among nephrolithiasis patients with type 2 diabetes, obesity, and/or the metabolic syndrome." | 8.87 | Metabolic syndrome and the genesis of uric acid stones. ( Maalouf, NM, 2011) |
| " The prevalence of uric acid nephrolithiasis is higher among stone-forming patients with features of the metabolic syndrome such as obesity and/or type 2 diabetes mellitus." | 8.84 | Metabolic syndrome and uric acid nephrolithiasis. ( Maalouf, NM; Sakhaee, K, 2008) |
| "Elevated serum uric acid (SUA) levels are commonly seen in patients with the metabolic syndrome (MetS)." | 8.83 | Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? ( Athyros, VG; Elisaf, MS; Liberopoulos, EN; Mikhailidis, DP; Tsouli, SG, 2006) |
| " Measurements of anthropometric parameters, blood pressure, fasting blood glucose, insulin concentration, insulin resistance (HOMA-IR), lipid profile, C reactive protein, uric acid, resistin and prevalence of Metabolic Syndrome were determined." | 8.31 | Resistin/uric acid index as a marker of metabolic syndrome in females with obesity. ( de Luis, D; Izaola, O; Primo, D, 2023) |
| "Serum uric acid to creatinine ratio (SUA/Cr) may be associated with metabolic syndrome (MS)." | 8.31 | Serum uric acid to creatinine ratio and metabolic syndrome in middle-aged and elderly population: Based on the 2015 CHARLS. ( Cao, T; Guo, X; Halengbieke, A; Ni, X; Tang, J; Tong, C; Yang, X; Zheng, D, 2023) |
| "Uric acid excretion after 6 months of therapy in patients with urolithiasis and meta-bolic syndrome decreased from 9." | 8.31 | [Prevention of urolithiasis using febuxostat in patients with metabolic syndrome]. ( Babkin, PA; Paronnikov, MV; Protoshchak, VV; Sleptsov, AV, 2023) |
| "We investigated the association of serum uric acid to high-density lipoprotein ratio (UHR) with the presence and severity of metabolic syndrome (MetS) among MASHAD cohort participants." | 8.31 | Serum uric acid to high-density lipoprotein ratio as a novel indicator of inflammation is correlated with the presence and severity of metabolic syndrome: A large-scale study. ( Esmaily, H; Feizi, S; Ghayour-Mobarhan, M; Kolahi Ahari, R; Mansoori, A; Miri, MS; Sahranavard, T, 2023) |
| "To explore the relationship between serum uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) ratio (UHR) and metabolic syndrome (MetS) in nondiabetic individuals." | 8.31 | Serum uric acid to high-density lipoprotein cholesterol ratio is a promising marker for identifying metabolic syndrome in nondiabetic Chinese men. ( Gao, B; Ji, Q; Li, Q; Liang, S; Ming, J; Shi, L; Sun, F; Wang, L; Xu, Q; Yu, X; Zhang, W, 2023) |
| " Subjects were divided into two groups with and without metabolic syndrome, and the relevant factors such as the ratios of uric acid to high-density lipoprotein (HDL) (UHR) in these two groups were compared, and the best cut-off point was determined." | 8.12 | Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. ( Baghaei, MH; Baniasad, A; Gozashti, MH; Naghibzadeh-Tahami, A; Najafipour, H; Yazdi, F, 2022) |
| "The above study shows that serum uric acid levels are significantly elevated in patients with metabolic syndrome." | 8.12 | Study of Serum Uric Acid Levels in Patients of Metabolic Syndrome in a Tertiary Care Centre in South India. ( Kulkarni, A; N, R; Subhash, N; T, AK, 2022) |
| "The association of the metabolic syndrome with lithogenesis has been described, especially in uric acid stones." | 8.12 | Metabolic syndrome in calcium oxalate stones: Is it so important in this type of lithiasis? ( Arias Fúnez, F; Burgos Revilla, FJ; Duque Ruiz, G; Gomez Dos Santos, V; Hevia Palacios, M; Laso García, I; Sánchez Herranz, A, 2022) |
| "Serum uric acid (SUA) is associated with many cardiovascular risk factors, such as metabolic syndrome (MetS) and subclinical atherosclerosis." | 8.12 | Association Between Serum Uric Acid Level and Carotid Atherosclerosis and Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus. ( Li, M; Li, T; Li, W; Liu, R; Liu, S; Liu, X; Ouyang, S; Wang, Y; Zhang, Y, 2022) |
| "To investigate whether serum uric acid (SUA) levels and hyperuricemia can be predictive biomarkers of incident metabolic syndrome(MS) among different body mass index(BMI) categories, and to investigate SUA cutoffs that best discriminate individuals with incident MS." | 8.12 | Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA - Brasil). ( B Duncan, B; Haueisen Sander Diniz, MF; Inês Schmidt, M; Isabel Rodrigues Galvão, A; Luiz P Ribeiro, A; M Benseñor, I; M R Beleigoli, A; Maria Barreto, S; Vidigal, PG; Weiss Telles, R, 2022) |
| "Associations of alanine aminotransferase (ALT) and serum uric acid (SUA) with metabolic syndrome (MetS) remain controversial." | 8.12 | Individual and combined relationship of serum uric acid and alanine aminotransferase on metabolic syndrome in adults in Qingdao, China. ( Li, X; Liu, L; Shao, Y; Sun, J; Xing, D, 2022) |
| "Little research has been conducted into the effects of the combined manifestation of hyperuricemia and hyperhomocysteinemia on cardiometabolic risk factors and markers in young subjects." | 8.12 | The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study. ( Gurecká, R; Koborová, I; Podracká, Ľ; Repiská, G; Šebeková, K, 2022) |
| " Anthropometric measurements, fasting glucose, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), HOMA- β (%), lipids profile, monocyte to lymphocyte ratio (MLR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), uric acid, gamma glutamyl transpeptidase (GGT), AST/ALT ratio and total bilirubin were assessed." | 8.12 | Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity. ( Asar, M; El-Eshmawy, MM; Elsehely, I; Mahsoub, N, 2022) |
| "Elevated serum uric acid (SUA) levels, body shape index (BSI) and body roundness index (BRI) were associated with incident metabolic syndrome (MetS)." | 8.02 | Serum uric acid is associated with incident metabolic syndrome independent of body shape index and body roundness index in healthy individuals. ( Chen, CC; Liu, CW; Tseng, GS; Tu, CM; Wei, TE, 2021) |
| "We conducted a study to examine the association of endothelial dysfunction and oxidative stress with uric acid levels in patients of metabolic syndrome." | 8.02 | Uric acid as a predictor of endothelial dysfunction in patients with metabolic syndrome. ( Dhawan, V; Jain, S; Kalra, N; Kumari, S; Singh, C, 2021) |
| "Although high serum uric acid (SUA) at baseline has been linked to increased risk for metabolic syndrome (MetS), the association of longitudinal SUA changes with MetS risk is unclear." | 8.02 | Dose-response relationship between distinct serum uric acid trajectories and metabolic syndrome risk: A 5-year prospective cohort study. ( Guo, X; Han, Y; Li, Q; Liu, J; Ma, Z; Tao, L; Yang, X; Zhang, J; Zhang, S, 2021) |
| " This study investigated the effects of two neutral CB1 receptor antagonists, AM6545 and AM4113, on nephropathy associated with metabolic syndrome (MetS)." | 8.02 | Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. ( Aldawsari, HM; Binmahfouz, L; Eid, BG; El-Aziz, GA; El-Bassossy, HM; Hanafy, A; Hasan, A; Makriyannis, A; Neamatallah, T; Vemuri, K, 2021) |
| "Serum uric acid (SUA) has been depicted as a contributory causal factor in metabolic syndrome (MS), which in turn, portends unfavourable prognosis." | 8.02 | The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk. ( Barbagallo, CM; Bombelli, M; Borghi, C; Bruno, B; Casiglia, E; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Dell'Oro, R; Desideri, G; Ferri, C; Galletti, F; Georgiopoulos, G; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Mazza, A; Mengozzi, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pontremoli, R; Pugliese, NR; Rattazzi, M; Rivasi, G; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2021) |
| "Recently, studies have shown a positive association between serum uric acid (UA) and metabolic syndrome (MS)." | 8.02 | Uric acid: A new marker for metabolic syndrome? Results of a population-based study with adults. ( da Silva, DCG; de Magalhães, ELG; Ferreira, FG; Hinnig, PF; Juvanhol, LL; Longo, GZ; Roberto, DMT, 2021) |
| "BACKGROUND Serum uric acid (SUA) and alanine aminotransferase (ALT) levels are increased in patients with metabolic syndrome." | 7.96 | Measurement of the Combined Levels of Serum Uric Acid and Alanine Aminotransferase and the Risk of Metabolic Syndrome in a Population Aged 60 Years or More in Northeastern China. ( Chen, F; Ma, G; Wang, D; Wang, J; Wang, Y, 2020) |
| "Although the level of uric acid (UA) is higher in males, increased UA level in females was reported to be closely associated with prevalence of metabolic syndrome (Mets) leading to atherosclerotic cardiovascular disease (ASCVD)." | 7.96 | The serum uric acid level in females may be a better indicator of metabolic syndrome and its components than in males in a Japanese population . ( Imatake, K; Matsumoto, N; Matsuo, R; Okumura, Y; Suzuki, Y; Takahashi, A; Tani, S; Yagi, T, 2020) |
| "There is still controversy over the clinical interpretation of the association between metabolic syndrome (MetS) and serum uric acid (SUA) levels." | 7.96 | Association of Serum Uric Acid with cardio-metabolic risk factors and metabolic syndrome in seafarers working on tankers. ( Ahmadvand, A; Baygi, F; Herttua, K; Jensen, OC; Sheidaei, A, 2020) |
| "This study aimed to investigate the association between Serum Uric Acid (UA) to Creatinine (Cr) Ratio (UA/Cr) and metabolic syndrome (MetS) in postmenopausal women." | 7.96 | Serum uric acid to creatinine ratio and metabolic syndrome in postmenopausal Chinese women. ( Cha, E; Gu, PP; He, LL; Li, GQ; Li, J; Liu, J; Shen, X; Tao, J; Wang, Z; Zhu, W, 2020) |
| "Elevated levels of serum uric acid (SUA) have been suggested to associate with cardiovascular disease, diabetes and metabolic syndrome (MetS)." | 7.96 | Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. ( Ali, N; Barman, Z; Hafsa, JM; Hasan, A; Hasan, M; Islam, F; Miah, R; Mou, AD; Trisha, AD, 2020) |
| "We aimed to investigate resistin expression in penile tissue in the presence of insulin resistance (IR) and the effect of Boldine treatment on erectile functions in the metabolic syndrome (MetS) rat model." | 7.96 | The role of resistin on metabolic syndrome-induced erectile dysfunction and the possible therapeutic effect of Boldine. ( Atabey, N; Dayar, E; Demir, O; Durmus, N; Gidener, S; Kahraman, E; Kara, E; Yetik Anacak, G, 2020) |
| "Many studies have demonstrated that elevated serum uric acid (SUA) level is linked with metabolic syndrome (MetS)." | 7.96 | Sex-specific association of serum uric acid dynamics with the incidence of metabolic syndrome in a health check-up Chinese population: a prospective cohort study. ( Chen, F; Fan, Y; Hu, D; Li, G; Liu, K; Liu, Q; Liu, Y; Song, G; Tang, X, 2020) |
| "To investigate the relationship between serum uric acid/creatinine(SUA/Cr) ratio and metabolic syndrome(MS) and its components in population, whose thyroid function were normal." | 7.96 | [Association of serum uric acid/creatinine ratio and metabolic syndrome in euthyroid population]. ( Liu, S; Peng, J; Song, J; Tang, Z; Zhang, J; Zhang, L, 2020) |
| "Body mass index and blood uric acid level were found to be the two independent factors to distinguish between different types of metabolic syndrome." | 7.96 | Distinguish different Chinese medicine types of metabolic syndrome by combining body mass index and uric acid. ( Chen, Q; Li, S; Lian, T; Liu, M; Peng, B; Wang, X; Zhao, X, 2020) |
| "Serum uric acid (UA) levels are one of the determinants of the cardiovascular disease and metabolic syndrome but none of criteria for that syndrome include serum UA." | 7.96 | Uric acid alterations by consumption of gluten-free bakery products in relation to cardiovascular and metabolic syndrome risk factors. ( Gažarová, M; Mečiarová, L, 2020) |
| "To assess the association between the consumption of non-soy legumes and different subtypes of non-soy legumes and serum uric acid (SUA) or hyperuricemia in elderly individuals with overweight or obesity and metabolic syndrome." | 7.96 | Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study. ( Abellán Cano, I; Alonso-Gómez, ÁM; Babio, N; Becerra-Tomás, N; Bernal-Lopez, MR; Bueno-Cavanillas, A; Casas, R; Cenoz, JC; Corbella, E; Corella, D; Crespo-Oliva, E; Daimiel, L; Del Mar Bibiloni, M; Díaz-López, A; Estruch, R; Fernandez-Brufal, N; Fernández-Carrión, R; Fernández-García, JC; Freixer, G; Gaforio, JJ; Lapetra, J; Llimona, R; López-Miranda, J; Martín-Sánchez, V; Martínez, JA; Martínez-González, MÁ; Matía-Martín, P; Mena-Sánchez, G; Morey, M; Navarrete-Muñoz, EM; Pintó, X; Prieto, RM; Quifer, M; Razquin, C; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Salaverria Lete, I; Sanchez-Villegas, A; Santos-Lozano, JM; Serra-Majem, L; Sorli, JV; Tojal Sierra, L; Torres, L; Tur, JA; Vázquez, C; Vidal, J; Vioque, J; Wärnberg, J; Zulet, MÁ, 2020) |
| "This study aims to investigate the prevalence of metabolic syndrome (MetS) in familial Mediterranean fever (FMF) and the relationship between serum uric acid (SUA) concentrations and MetS status by sex in patients with FMF." | 7.91 | Relationship between Metabolic Syndrome and Uric Acid Levels in Patients with Familial Mediterranean Fever. ( Akkececi, NS; Cetin, GY; Gögebakan, H, 2019) |
| "Although previous studies have highlighted the importance of serum uric acid as a risk factor of metabolic syndrome, no study has previously used a national Korean survey to examine the association between serum uric acid level and metabolic syndrome." | 7.91 | Association between Serum Uric Acid and Metabolic Syndrome in Koreans. ( Jeong, J; Suh, YJ, 2019) |
| " However, the dose-response effects of serum uric acid (SUA) on the prevalence of MetS and electrocardiographic left ventricular hypertrophy (LVH) are unclear." | 7.91 | The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals. ( Chang, WC; Chen, KH; Hwang, JJ; Liu, CW; Tseng, CK; Wu, YW, 2019) |
| "The aim of this study was to assess the association between serum uric acid concentration (SUAC) and the parameters of the metabolic syndrome (MetS) and insulin resistance (IR)." | 7.91 | Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children ( Ersoy, B; Özalp Kızılay, D; Şen, S, 2019) |
| "It has not been determined whether changes in serum uric acid (SUA) level are associated with incident metabolic syndrome (MetS)." | 7.91 | The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome. ( Bae, JC; Jee, JH; Jin, SM; Kim, JH; Lee, MK; Yu, TY, 2019) |
| "Insulin and uric acid were shown affect the prevalence of Metabolic Syndrome (MetS), but no studies examine their interaction." | 7.88 | Low serum uric acid concentration augments insulin effects on the prevalence of metabolic syndrome. ( Gonzalez-Mejia, ME; Pérez-Fuentes, R; Porchia, LM; Ruiz-Vivanco, G; Torres-Rasgado, E, 2018) |
| " The associations among metabolic syndrome (MetS), serum uric acid and CKD are also unclear." | 7.88 | Chronic kidney disease associated with decreased bone mineral density, uric acid and metabolic syndrome. ( Loke, SS; Pan, BL, 2018) |
| "We explored the association between serum uric acid (SUA) and metabolic syndrome (MetS) in Chinese rural adults." | 7.88 | Sex-specific associations of serum uric acid with metabolic syndrome in Chinese rural population: The RuralDiab study. ( Jiang, J; Li, Y; Liu, R; Liu, X; Mao, Z; Qian, X; Wang, C; Yang, K; Zhang, G; Zhang, H; Zhang, X, 2018) |
| "The study aimed to determine the relationship among serum uric acid and metabolic syndrome and atherosclerosis, by means of carotid intima media-thickness, in a cohort of 811 otherwise healthy overweight/obese subjects, without overt atherosclerosis not using any kind of drug." | 7.88 | Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First? ( Caccavo, D; Carbonara, R; Ciccone, MM; Cortese, AM; Cortese, F; De Pergola, G; Masiello, M; Meliota, G; Silvestris, F; Termine, G, 2018) |
| " Patients with metabolic syndrome (MS) have higher values of homocysteine." | 7.88 | Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score. ( Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M, 2018) |
| " Both Diosmin and Crocin improved insulin resistance, decreased blood pressure, uric acid, lipoproteins and blocked diabetic nephropathy as indicated by reduction of albumin excretion rate and albumin/creatinine ratio." | 7.88 | Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: Effect on oxidative stress and low grade inflammation. ( El Fayoumi, HM; El-Fawal, R; Mahmoud, MF, 2018) |
| "The longitudinal associations between serum uric acid (UA) levels and metabolic syndrome (MetS) and its components, as well as the shared genetic and environmental correlations between these traits, were evaluated." | 7.88 | Genetic and Environmental Influences on the Associations Between Uric Acid Levels and Metabolic Syndrome Over Time. ( Lee, K; Song, YM, 2018) |
| "Metabolic syndrome (MS) consists of a cluster of metabolic diseases, and the association between serum uric acid (SUA) and MS has recently been reported in several studies; however, whether SUA is a susceptibility or risk biomarker for the development of MS among Chinese adults is unclear." | 7.88 | Association Between Metabolic Syndrome and the Serum Uric Acid: a Cohort Study. ( Gao, M; Ren, P, 2018) |
| "Metabolic Syndrome (Mets) and increased serum uric acid (SUA), are well known renal risk predictors and often coexist in patients with type 2 diabetes (T2D)." | 7.85 | Metabolic syndrome, serum uric acid and renal risk in patients with T2D. ( Ceriello, A; De Cosmo, S; Fioretto, P; Genovese, S; Giorda, C; Guida, P; Piscitelli, P; Pontremoli, R; Russo, G; Viazzi, F, 2017) |
| "Serum uric acid levels of psoriasis patients were significantly higher than those of controls." | 7.85 | Evaluation of serum uric acid levels in psoriasis vulgaris. ( Artüz, F; Köktürk, F; Külcü Çakmak, S; Tamer, E; Yilmaz, E, 2017) |
| "Since the association between serum uric acid (SUA) and metabolic syndrome (MetS) has been reported extensively, it remains unclear whether SUA is associated with MetS and its components in a Chinese Yi population." | 7.85 | Sex difference in the association of serum uric acid with metabolic syndrome and its components: a cross-sectional study in a Chinese Yi population. ( Huang, S; Jia, H; Li, H; Liu, X; Xu, W, 2017) |
| "Aims of this study were 1) to evaluate early cardiovascular abnormalities in a large population of obese children and adolescents compared with a normal weight counterpart, 2) to investigate their potential association with insulin resistance (IR), serum uric acid (sUA) and metabolic syndrome (MetS)." | 7.85 | Insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity. ( Aronici, M; Bellone, S; Bona, G; Castagno, M; Di Mario, C; Genoni, G; Grossini, E; Martelli, M; Menegon, V; Monzani, A; Prodam, F; Ricotti, R; Secco, GG; Sonzini, M, 2017) |
| "This study aimed to investigate whether uric acid to creatinine (UA/Cr) ratio is associated with higher risk of metabolic syndrome (MetS) and its components." | 7.85 | Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. ( Al-Attas, OS; Al-Daghri, NM; Alokail, MS; Sabico, S; Wani, K, 2017) |
| "Hyperuricemia leads to insulin resistance, whereas insulin resistance decreases renal excretion of uric acid, both mechanisms link elevated serum uric acid with metabolic syndrome." | 7.85 | Circulating Levels of Uric Acid and Risk for Metabolic Syndrome. ( Durán-Salgado, MB; Garro-Almendaro, AK; Huerta-Ramírez, S; Lozano-Nuevo, JJ; Morales-López, H; Rubio-Guerra, AF; Vargas-Ayala, G, 2017) |
| "The aim of the study was to explore the association between serum uric acid (SUA) and metabolic syndrome (MetS) in premenopausal and postmenopausal women in the Jinchang Cohort." | 7.85 | The relationship between serum uric acid and metabolic syndrome in premenopausal and postmenopausal women in the Jinchang Cohort. ( Bai, YN; Chan, C; He, SJ; Hu, XB; Li, HY; Shi, D; Wang, D; Wang, MZ; Xie, ZD, 2017) |
| "This study aimed to investigate effects of curcumin on high fructose diet (HFD)-induced metabolic syndrome (MetS) in rats and the possible mechanisms involved." | 7.85 | Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. ( Hakami, TM; Kelany, ME; Omar, AH, 2017) |
| "Although it is known that high uric acid (UA) level is associated with type 2 diabetes (T2DM) and metabolic syndrome (MetS), most of the previous studies were focused on adults." | 7.85 | The Role of Uric Acid for Predicting Future Metabolic Syndrome and Type 2 Diabetes in Older People. ( Chang, JB; Chen, YL; Hsieh, CH; Hung, YJ; Lee, CH; Liang, YJ; Lin, CM; Lin, JD; Pei, D; Wu, CZ, 2017) |
| "The objective was to determine whether serum uric acid concentrations were associated with metabolic syndrome in a population from Wuhan." | 7.85 | Positive association between metabolic syndrome and serum uric acid in Wuhan. ( Chen, M; Fan, ZF; Fu, YQ; Li, D; Wang, L; Yang, H; Zeng, W; Zeng, XY; Zheng, JS, 2017) |
| "Hyperuricemia has been described as associated with the risk of development metabolic syndrome; however the relationship between the uric acid level and particular parameters of metabolic syndrome remained unclear." | 7.85 | Correlation of uric acid levels and parameters of metabolic syndrome. ( Cibičková, Ľ; Karásek, D; Kubíčková, V; Langová, K; Vaverková, H, 2017) |
| "Associations between high serum uric acid (SUA) levels and high blood pressure (BP), as well as between SUA levels and metabolic syndrome (MetS) have already been reported." | 7.83 | Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients. ( Kalogeropoulos, P; Karamanou, AG; Moustakas, G; Papavasileiou, MV; Patsianis, S; Pittaras, A, 2016) |
| "Elevated serum uric acid levels and increased arginase activity are risk factors for cardiovascular diseases (CVD)." | 7.83 | Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome. ( Demirci, F; Demirustu, C; Ergun, B; Kebapci, N; Ozcelik, E; Temel, HE; Uslu, S, 2016) |
| "This study examined the relationship between serum levels of uric acid and insulin resistance and metabolic syndrome in nondiabetic patients with schizophrenia." | 7.83 | Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. ( Cimpeanu, C; Fan, X; Harrington, A; Rajan, S; Song, X; Zalpuri, I, 2016) |
| "Serum uric acid (SUA) is the end-product of purine metabolism in humans, and its levels often increase in subjects with metabolic syndrome (MetS)." | 7.83 | High serum uric acid levels increase the risk of metabolic syndrome in elderly women: The PRO.V.A study. ( Crepaldi, G; Giantin, V; Maggi, S; Manzato, E; Maselli, M; Musacchio, E; Perissinotto, E; Sartori, L; Sergi, G; Toffanello, ED; Veronese, N; Zambon, S; Zurlo, A, 2016) |
| "Psoriasis has been reported to be associated with raised serum uric acid levels and gout, and uric acid has been demonstrated to mediate inflammatory pathways via secretion of pro-inflammatory chemokines." | 7.83 | Psoriasis and uric acid: a population-based cross-sectional study. ( Lai, YC; Yew, YW, 2016) |
| "Elevated serum uric acid (SUA) level is strongly associated with prevalence of metabolic syndrome (MS), elevated parathyroid hormone (PTH) levels, and 25-hydroxyvitamin D [25(OH)D] insufficiency in adults." | 7.83 | Uric Acid-Induced Inflammation Is Mediated by the Parathyroid Hormone:25-Hydroxyvitamin D Ratio in Obese Adolescents. ( Alemzadeh, R; Kichler, J, 2016) |
| "Some observational studies have suggested that serum uric acid (SUA) levels are one of the determinants of the metabolic syndrome (MetS)." | 7.83 | Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. ( Bae, JC; Baek, JH; Jee, JH; Jin, SM; Kim, JH; Lee, MK; Yu, TY, 2016) |
| "To investigate the association between serum direct bilirubin (DBIL) with metabolic syndrome (MS) and its components." | 7.83 | [Association between serum direct bilirubin with metabolic syndrome and its components based on a longitudinal health check-up study]. ( Chen, L; Chen, Q; Chen, X; Wang, S; Xiao, J; Zhang, P, 2016) |
| " Bipolar disorder was the only diagnostic subgroup significantly associated with increased uric acid levels." | 7.83 | Exploring the association between bipolar disorder and uric acid: A mediation analysis. ( Bartoli, F; Carrà, G; Castagna, G; Clerici, M; Crocamo, C; Gennaro, GM; Trotta, G, 2016) |
| "Elevated uric acid (UA) is associated with the presence of the metabolic syndrome (MetS)." | 7.83 | Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. ( Eriksen, BO; Jenssen, TG; Norvik, JV; Solbu, MD; Storhaug, HM; Ytrehus, K; Zykova, SN, 2016) |
| " To help understand the pathogenesis and early prevention of progressive CKD, this large-scale study is designed to determine the complex association between serum uric acid (SUA), metabolic syndrome and the prevalence of CKD in hypertensive patients." | 7.83 | Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients. ( Chen, R; Chen, Z; Dai, H; Liu, C; Lu, M; Lu, S; Lu, Y; Tang, X; Yang, P; Yuan, H; Zhou, H, 2016) |
| " We evaluated the association between serum uric acid and uACR in persons with 0, and 1-2 metabolic syndrome (MetS) components and determined the modification effects of visceral adiposity index (VAI), mean arterial pressure (MAP), and fasting glucose on this association." | 7.83 | The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome. ( Bruthans, J; Cifkova, R; Hamet, P; Krajcoviechova, A; Tahir, MR; Tremblay, J; Wohlfahrt, P, 2016) |
| "Although serum uric acid (sUA) is not a criterion for diagnosing metabolic syndrome (MetS), many studies have identified a positive association between sUA and MetS in patients of various ages and ethnicities." | 7.83 | The Power of Serum Uric Acid in Predicting Metabolic Syndrome Diminishes With Age in an Elderly Chinese Population. ( Chang, HW; Chen, JH; Chen, YL; Chuang, TJ; Hsieh, CH; Huang, CL; Li, PF; Liu, JS; Pei, D, 2016) |
| "The purpose of this study was to examine the associations between serum uric acid (SUA) levels and the incidences of hypertension and metabolic syndrome (MetS) in a large screened cohort of Japanese men and women." | 7.81 | Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. ( Inoue, T; Kinjo, K; Kohagura, K; Nagahama, K; Ohya, Y, 2015) |
| "Serum uric acid (SUA) is associated with many cardiovascular risk factors such as hypertension (HTN) and metabolic syndrome (MetS)." | 7.81 | Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. ( Bao, YQ; Dong, XH; Jia, WP; Li, LX; Li, MF; Li, TT; Shen, J; Zhang, R, 2015) |
| "Several studies have demonstrated a relationship between increased serum uric acid (SUA) concentrations and the prevalence of metabolic syndrome (MetS) in the oriental population." | 7.81 | Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study. ( Babio, N; Basora, J; Becerra-Tomás, N; Corella, D; Estruch, R; Fitó, M; Martínez-González, MA; Ortega-Calvo, M; Recondo, J; Ros, E; Salas-Salvadó, J; Serra-Majem, L; Wärnberg, J, 2015) |
| "It is controversial whether serum uric acid (SUA) is a risk factor for the prevalence of metabolic syndrome (MetS)." | 7.81 | Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome: Results from Fangchenggang Area Male Health and Examination Survey in China. ( Chen, D; Gao, Y; Jiang, Y; Lin, X; Lu, Z; Mo, Z; Tan, A; Wu, C; Yang, X; Yao, Z; Zhang, H, 2015) |
| "Recent studies have demonstrated an association between serum uric acid (SUA) levels and metabolic syndrome (MetS)." | 7.81 | Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. ( Ahn, SV; Choi, E; Chung, CH; Kim, HM; Koh, SB; Lee, ES; Lee, EY; Lim, JS; Yadav, D, 2015) |
| " Linear regression was used to evaluate associations between uric acid and clinical and laboratory findings associated with metabolic syndrome." | 7.81 | [Metabolic complications of obesity during adolescence, particularly regarding elevated uric acid levels]. ( Almási, A; Barkai, L; Fehér, V; Kiss-Tóth, E; Ságodi, L, 2015) |
| "To explore the association between serum uric acid (SUA) levels, metabolic syndrome (MetS) and cardiovascular disease (CVD) in patients treated with lipid-lowering agents from multiple centers in China." | 7.81 | The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study. ( Chen, K; Fang, Y; Hu, D; Mu, Y; Nie, Y; Tian, Y; Wang, H; Xie, Z, 2015) |
| " The association between serum uric acid and prevalence of colorectal adenoma was estimated from the results of a logistic regression analysis." | 7.81 | Uric Acid Is a Risk Indicator for Metabolic Syndrome-related Colorectal Adenoma: Results in a Korean Population Receiving Screening Colonoscopy. ( Chang, DK; Hong, SN; Jung, JH; Kim, ER; Kim, HJ; Kim, JE; Kim, JJ; Kim, YH; Rhee, PL; Son, HJ, 2015) |
| "The relationships between uric acid and chronic disease risk factors such as metabolic syndrome, type 2 diabetes mellitus, and hypertension have been studied in adults." | 7.81 | Uric Acid Levels Can Predict Metabolic Syndrome and Hypertension in Adolescents: A 10-Year Longitudinal Study. ( Chen, YL; Lue, KH; Pei, D; Sun, HL, 2015) |
| "Serum uric acid levels have been reported to be associated with metabolic syndrome (MetS)." | 7.80 | Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women. ( Chen, Y; Liu, PJ; Lou, HP; Ma, F; Zhu, YN, 2014) |
| "Serum levels of uric acid (UA) are associated with metabolic syndrome (MetS)." | 7.80 | Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. ( Oda, E, 2014) |
| "Serum uric acid (SUA) levels correlate with many recognized cardiovascular risk factors, including age, male sex, hypertension, diabetes mellitus, hypertriglyceridemia, obesity, and insulin resistance." | 7.80 | Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. ( Borghi, C; Cicero, AF; D'Addato, S; Rosticci, M; Salvi, P, 2014) |
| "Serum uric acid (SUA) has been suggested as a potentially modifiable mediator associated with the metabolic syndrome." | 7.80 | Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes. ( Esteghamati, A; Fotouhi, A; Hafezi-Nejad, N; Nakhjavani, M; Sheikhbahaei, S, 2014) |
| "To explore the relationship between serum uric acid (SUA) and metabolic syndrome (MS) in men, premenopausal women and postmenopausal women." | 7.80 | Association of uric acid with metabolic syndrome in men, premenopausal women and postmenopausal women. ( Chen, S; Deng, K; Guo, J; Holthöfer, H; Li, B; Li, Y; Liu, A; Liu, Q; Liu, X; Shao, X; Wang, H; Zhang, Y; Zou, H, 2014) |
| "To investigate the relationship between serum uric acid (UA) level and abdominal obesity or metabolic syndrome (MS)." | 7.80 | [The correlation between serum uric acid level and abdominal obesity or metabolic syndrome]. ( Dong, X; Li, H; Pan, Q; Yin, X; Yu, D; Zheng, F; Zhou, J, 2014) |
| " We studied the associations between the serum uric acid concentration and the following: (i) demographic, anthropometric and other variables previously reported to be associated with serum uric acid concentrations; (ii) the presence of metabolic syndrome and the levels of metabolic syndrome components; and (iii) selected genetic variants of the MTHFR (c." | 7.80 | Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. ( Kožich, V; Pavlíková, M; Sokolová, J; Stibůrková, B, 2014) |
| "To investigate the relationship among serum uric acid levels and metabolic syndrome." | 7.80 | Serum uric acid levels and metabolic syndrome. ( Ciarla, S; Ferri, C; Giorgini, P; Necozione, S; Properzi, G; Striuli, R; Struglia, M, 2014) |
| "To evaluate whether uric acid (UA) predicts 4-yr incidence of metabolic syndrome (MetS) in non-diabetic participants of the Strong Heart Study (SHS) cohort." | 7.80 | Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity. ( de Simone, G; Devereux, RB; Ferrara, LA; Franceschini, N; Howard, BV; Jolly, S; Lee, ET; Umans, JG; Wang, H; Yeh, J, 2014) |
| "Excess circulating uric acid, a product of hepatic glycolysis and purine metabolism, often accompanies metabolic syndrome." | 7.80 | Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. ( DeBosch, BJ; Fujiwara, H; Kluth, O; Moley, K; Schürmann, A, 2014) |
| " Fructose administration resulted in significant increase in body weight, elevations of blood glucose, serum insulin, cholesterol, triglycerides, advanced glycation end products (AGEs), uric acid levels, insulin resistance index and blood pressure compared to control rats." | 7.80 | Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. ( Elshazly, SM; Mahmoud, AA, 2014) |
| "The association between serum uric acid (SUA) levels and metabolic syndrome (MetS) has recently been reported in several cross-sectional and longitudinal studies." | 7.80 | A possible role of serum uric acid as a marker of metabolic syndrome. ( Cho, S; Kim, SR; Lee, YJ, 2014) |
| "To study the relationship between serum uric acid (SUA) level and metabolic syndrome (MS) in Uygur children and adolescents with overweight or obesity." | 7.80 | [Relationship between serum uric acid level and metabolic syndrome in Uygur children and adolescents with overweight or obesity]. ( Li, M; Mao, JF; Yi, LD; Zhang, MC, 2014) |
| "Hyperuricemia is related to Metabolic Syndrome (MetS) and cardiovascular diseases, but the use of serum uric acid (UA) to diagnose MetS is currently ignored in clinical practices." | 7.80 | The impact of serum uric acid on the diagnostic of metabolic syndrome in apparently healthy brazilian middle-aged men. ( Azevedo Novello, A; Bressan, J; Cardoso dos Santos, E; de Oliveira, A; Guedes Cocate, P; Hermsdorff, HHM; José Natali, A, 2014) |
| " Of note, diabetic subjects with glycosuria, who represented 24% of the diabetic participants, had a null prevalence of hyperuricemia, and statistically higher values for fractional excretion of uric acid, Na excretion index, and prevalence of microalbuminuria than those without glycosuria." | 7.80 | Serum uric acid and disorders of glucose metabolism: the role of glycosuria. ( Andrade, JA; Garcia Rosa, ML; Greffin, S; Kang, HC; Lugon, JR, 2014) |
| "Elevated serum uric acid (UA) is commonly found in subjects with metabolic syndrome (MetS)." | 7.80 | Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study. ( Berenson, GS; Chen, W; Fernandez, C; Li, S; Srinivasan, SR; Sun, D; Zhang, X, 2014) |
| "Elevated serum uric acid (UA) has been known to be associated with the prevalence of metabolic syndrome (MetS)." | 7.80 | Serum uric acid level and the incidence of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study. ( Choi, JM; Lee, JK; Park, SK; Ryoo, JH, 2014) |
| "We aimed to assess the extent to which metabolic syndrome (MetS) and serum uric acid (UA) and its interaction impact on diastolic heart failure (DHF)." | 7.79 | Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure. ( Fang, Z; Li, Z; Tang, ZH; Zeng, F; Zhou, L, 2013) |
| "Our aim was to study whether there is causal association between serum uric acid and metabolic syndrome (MetS)." | 7.79 | Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. ( Chen, W; Dai, X; Fang, W; Gui, L; Guo, H; He, M; Hu, FB; Li, X; Liang, Y; Miao, X; Min, X; Wang, Y; Wei, S; Wu, T; Yang, B; Yang, H; Yao, P; Yuan, J; Zhang, X, 2013) |
| "Increased serum uric acid (SUA) levels may be involved in the development of non-alcoholic fatty liver disease (NAFLD) in men presenting with metabolic syndrome (MetS) and/or insulin resistance." | 7.79 | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. ( Gao, Y; Hu, Y; Huang, Z; Li, L; Li, Z; Liang, Z; Liao, M; Lu, Z; Mo, Z; Peng, T; Qin, X; Shi, D; Sun, Y; Tan, A; Wang, M; Wu, C; Xie, Y; Yang, X; Zhang, H; Zhang, S; Zhang, Y, 2013) |
| "High uric acid (UA) levels and metabolic syndrome (MS) are risk factors for atherosclerotic diseases." | 7.79 | Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components. ( Sun, N; Tian, JL; Wang, H; Zhang, Y, 2013) |
| "The aim of this study was to compare serum uric acid values in two ethnically distinct Chinese populations: Uyghur, with a high prevalence of nonalcoholic fatty liver disease, and Han, with a lower prevalence." | 7.79 | Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. ( Cai, W; Miao, L; Sun, YP; Wu, X; Yao, H; Zhang, B; Zou, Y, 2013) |
| "To explore the levels of uric acid, blood pressure, serum lipid metabolic disorders and the distribution of obesity and metabolic syndrome (MS) among Uygur, Han and Kazak pre-diabetic groups in Xinjiang." | 7.79 | [A cross-sectional study on serum uric acid level and the distribution of metabolic syndrome among Uigur, Han and Kazak prediabetic groups in Xinjiang]. ( Jiang, S; Xu, YC; Zhang, HW, 2013) |
| "Experimental and observational studies suggest a role for uric acid in non-alcoholic fatty liver disease (NAFLD)." | 7.79 | Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. ( Chonchol, M; Jalal, DI; Johnson, RJ; McFann, K; Sirota, JC; Targher, G, 2013) |
| "The objective of this study was to examine the association between uric acid, GGT, obesity and the individual components of metabolic syndrome in children and adolescents." | 7.79 | Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents. ( Chan, CW; Chan, JC; Chan, MH; Choi, KC; Ho, CS; Kong, AP; Ozaki, R, 2013) |
| " This study sought to determine the association between the novel G109T polymorphism in SLC22A12 with serum uric acid and the development of metabolic syndrome in Korean male subjects." | 7.78 | G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome. ( Ahn, YC; Choe, JY; Her, M; Jang, WC; Kim, SK; Nam, YH; Park, SH; Park, SM; Yoon, IK, 2012) |
| " Since low urine pH is the main risk factor for uric acid urolithiasis (UAU), UAU may be regarded as a renal manifestation of the MS." | 7.78 | Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis. ( Schubert, G; Strohmaier, WL; Wrobel, BM, 2012) |
| "Among adolescents, uric acid is associated with insulin resistance, hypertension, and the metabolic syndrome (MetS); and in adults, high uric acid levels are an independent risk factor for cardiovascular disease and diabetes." | 7.78 | Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. ( DeBoer, MD; Dong, L; Gurka, MJ, 2012) |
| "Serum uric acid (SUA) is a potential risk factor for atherosclerosis." | 7.78 | Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. ( Bian, L; Choi, Y; Zhang, Z, 2012) |
| "Despite some epidemiologic research demonstrating a positive relationship between serum uric acid (SUA) levels and the prevalence of metabolic syndrome (MetS), prospective data on SUA as a predictor of MetS incidence are limited." | 7.78 | Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. ( Bai, CH; Chien, KL; Chou, WY; Chou, YC; Chu, CH; Hwang, LC; Su, TC; Sun, CA; Tseng, CH; Yang, T; You, SL, 2012) |
| "In this study, we examined whether melatonin improves metabolic syndrome induced by high fructose intake in male Wistar rats." | 7.78 | Melatonin improves metabolic syndrome induced by high fructose intake in rats. ( Kitagawa, A; Ohashi, K; Ohta, Y, 2012) |
| " Associations between uric acid (UA), metabolic syndrome (MetS) and carotid IMT have been reported, but findings regarding the relationship have been inconsistent." | 7.78 | Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. ( Abe, M; Kawamoto, R; Kusunoki, T; Onji, M; Takayama, S, 2012) |
| "For more than 200 years initially seen as a cause of gout, speaking in a politically correct 21st century term, a disease of the rich and very well nourished people, many experimental and epidemiological studies have associated increased levels of serum uric acid (UA) with the classical components of the metabolic syndrome (MS), type 2 diabetes, and cardiovascular disease [1]." | 7.78 | Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander? ( Santos, RD, 2012) |
| "To evaluate the cause-effect relationships between serum levels of uric acid (UA) and metabolic syndrome (MetS) in an adolescent-male cohort that was followed for 2." | 7.78 | Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents. ( Chen, YL; Hsu, CH; Pei, D; Tang, SH; Wang, JY; Wu, CZ, 2012) |
| " At the end of the feeding schedule, Dia group had insulin resistance along with increased blood glucose, triglyceride, uric acid and nitric oxide (NO) levels." | 7.78 | Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. ( Bagul, PK; Banerjee, SK; Bastia, T; Chakravarty, S; Madhusudana, K; Matapally, S; Middela, H; Padiya, R; Reddy, BR, 2012) |
| "It has been recently demonstrated that serum uric acid (UA) is associated with metabolic syndrome (MetS) or its related clinical indications based on cross-sectional or prospective cohort studies." | 7.78 | A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. ( Lin, H; Liu, L; Meng, W; Song, X; Tang, F; Xue, F; Yang, X; Zhang, C; Zhang, D; Zhang, Q; Zhang, Y; Zhu, Z, 2012) |
| "Uric acid, the levels of which have been shown to increase after menopause, has been associated with metabolic syndrome." | 7.77 | Relationship between uric acid and metabolic syndrome according to menopausal status. ( Ahn, KH; Cho, GJ; Hur, JY; Kim, SH; Kim, T; Kim, YT; Lee, HJ; Park, HT; Shin, JH; Yi, KW, 2011) |
| " Studies on the association between serum uric acid (sUA) and metabolic syndrome (MetS) in juvenile obesity are scant." | 7.77 | Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity. ( Chrzanowska, J; Gamian, A; Krzystek-Korpacka, M; Kustrzeba-Wojcicka, I; Noczynska, A; Patryn, E, 2011) |
| "Elevated serum uric acid (SUA) concentrations have been suggested to associate with metabolic syndrome (MetS) and its components." | 7.77 | The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. ( Larijani, B; Meshkani, R; Zargari, M, 2011) |
| "To examine the association between renal function, serum uric acid and markers of both pro-inflammatory and prothrombotic state in patients with diabetes mellitus (DM), metabolic syndrome and coronary artery disease." | 7.77 | Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. ( Buraczyńska, MJ; Kondracki, B; Rychta, E; Waciński, P; Wysokiński, A; Zapolski, T, 2011) |
| "We aimed to investigate whether elevated serum uric acid concentrations are associated with higher risk of metabolic syndrome (MetS) and carotid atherosclerosis in patients with type 2 diabetes." | 7.77 | Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. ( Chen, L; He, M; Hu, R; Huang, Y; Li, Q; Lu, B; Qu, S; Tao, X; Wen, J; Yang, Z; Ye, Z; Zhang, W; Zhang, Z, 2011) |
| "A positive association between serum uric acid and metabolic syndrome has been reported, but little information is available about the association between serum uric acid and metabolic syndrome in Taiwanese adults." | 7.76 | Serum uric acid and metabolic syndrome in Taiwanese adults. ( Chang, TY; Chen, JD; Liu, PW, 2010) |
| " Resistin and uric acid, surrogate plasma markers of metabolic syndrome, were decreased." | 7.76 | Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. ( Alfredo Martinez, J; Bour, S; Carpéné, C; Iffiú-Soltész, Z; Lomba, A; Milagro, FI; Pellati, F; Portillo, MP; Szöko, E; Valet, P; Wanecq, E; Woodley, J, 2010) |
| " We examined the association between uric acid levels and various clinical parameters, including the components of metabolic syndrome, in essential hypertension." | 7.76 | Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension. ( Anzawa, R; Fujii, T; Seki, S; Tsutsui, K; Yamazaki, K; Yoshimura, M, 2010) |
| "Uric acid (UA) is considered to be a powerful predictor of cardiovascular risk and hyperuricemia might be involved in the metabolic syndrome (MS)." | 7.76 | Relation of uric acid levels to aortic root dilatation in hypertensive patients with and without metabolic syndrome. ( Chen, XF; Du, YX; Fang, CF; Jiang, JJ; Lin, XF; Pu, ZX; Tang, LJ; Wang, JA, 2010) |
| " The objective of this study was to analyze the relationships of leptin, C-reactive protein (CRP), adiponectin, insulin, and uric acid to the metabolic syndrome components in lean, overweight, and obese young females." | 7.75 | Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. ( Abdullah, AR; Hasan, HA; Raigangar, VL, 2009) |
| "The aim of the study was to assess the association of serum uric acid levels with microalbuminuria -urinary albumin excretion (UAE)> or = 30mg/24h-." | 7.75 | Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients. ( Costa, JA; González, C; Miralles, A; Moral, D; Pascual, JM; Pérez-Lahiguera, F; Rodilla, E, 2009) |
| "Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome." | 7.75 | Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2009) |
| "The relationship among serum uric acid (SUA), metabolic syndrome, and chronic kidney disease (CKD) is unclear." | 7.75 | Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. ( Chen, HW; Chen, YM; Chuang, FH; Kuo, CF; Li, HY; See, LC; Yu, KH, 2009) |
| "Allopurinol was administered to end-stage renal disease (ESRD) patients with elevated uric acid levels presenting with symptoms of gout and also had risk factors of metabolic syndrome." | 7.75 | The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. ( Beavers, D; Bowden, RG; Hartman, J; Shelmadine, B; Wilson, RL, 2009) |
| "The relationships between uric acid and metabolic syndrome (MetS) and diabetes, as well as the gender differences in these relationships are controversial." | 7.75 | Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. ( Kawai, R; Oda, E; Sukumaran, V; Watanabe, K, 2009) |
| "Serum uric acid (SUA) level is often elevated in participants with metabolic syndrome (MS), and hyperuricemia appears linked inextricably to the presence of MS." | 7.75 | The relationship between serum uric acid concentration and metabolic syndrome in university freshmen. ( Lin, KP, 2009) |
| "The effects of exercise and serum uric acid on the metabolic syndrome (MetS) were evaluated." | 7.74 | Effects of exercise and serum uric acid on the metabolic syndrome for Japanese workers. ( Amezawa, M; Kawada, T, 2008) |
| "The aim of this study is to investigate the respective associations of alanine aminotransferase (ALT), white blood cell (WBC) count, and uric acid with metabolic syndrome and compare the magnitude in their association with metabolic syndrome, using modified Adult Treatment Panel III (ATP III) and its components." | 7.74 | Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults. ( Kang, YH; Kim, IJ; Kim, YK; Min, HG; Son, SM, 2008) |
| "Information on plasma homocysteine concentrations and their associated factors in Brazilian subjects with metabolic syndrome (MS) is nonexistent." | 7.74 | Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene. ( Rosa, G; Uehara, SK, 2008) |
| "This post hoc analysis of the GREek Atorvastatin and Coronary heart disease (CHD)." | 7.74 | Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluati ( Athyros, VG; Elisaf, M; Ganotakis, ES; Kakafika, AI; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Papageorgiou, AA; Tziomalos, K, 2007) |
| " Several substances (such as leptin and adiponectin) are secreted from adipocytes, which may contribute to regulate energy homeostasis and the development of cardiovascular diseases." | 7.74 | Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. ( Caliumi, C; Cavallaro, G; Cotesta, D; D' Erasmo, E; De Toma, G; Delfini, E; Diacinti, D; Letizia, C; Mazzuoli, GF; Minisola, S; Panzironi, G; Petramala, L, 2007) |
| "We examined the associations of serum uric acid (UA) with indices of coronary heart disease (CHD) risk, including the 10-year probability of CHD (10y-CHDr), metabolic syndrome (MS), inflammation (C-reactive protein [CRP] and fibrinogen), and the presence and quantity of coronary artery calcium (CAC)." | 7.74 | Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. ( Bielak, LF; Coutinho, Tde A; Kullo, IJ; Peyser, PA; Sheedy, PF; Turner, ST, 2007) |
| "The association between concentrations of uric acid and the metabolic syndrome in children and adolescents remains incompletely understood." | 7.74 | Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. ( Choi, HK; Cook, S; Ford, ES; Li, C, 2007) |
| "This study investigates the impact of uric acid (UA) on the risk factors associated with metabolic syndrome." | 7.74 | Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. ( Chang, HY; Chiou, WK; Lin, JD; Liu, FH; Weng, HF, 2007) |
| "The aim of our investigation was to study the peculiarities of serum uric acid (UA) levels in patients with metabolic syndrome (MS) and without it, also correlations between UA and parameters of MS features." | 7.74 | [Levels of uric acid in serum in patients with metabolic syndrome]. ( Dzhavashvili, LV; Esaliia, NG; Tananashvili, DE; Tetradze, LO; Virsaladze, DK, 2007) |
| "Gout and increased serum uric acid (SUA) levels are often seen in patients with components of the metabolic syndrome." | 7.74 | Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. ( Algra, A; Hjortnaes, J; Huisman, M; Jacobs, J; Olijhoek, J; van der Graaf, Y; Visseren, F, 2007) |
| "The aim of this study was to examine whether serum uric acid (SUA) concentration was related to the metabolic syndrome (MS)." | 7.74 | Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen. ( Katsumata, M; Kawada, T; Otsuka, T; Suzuki, H, 2007) |
| "The link between uric acid levels and metabolic syndrome was investigated." | 7.74 | Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. ( Makino, H; Miyatake, N; Numata, T; Wada, J, 2008) |
| "To assess the association of serum uric acid (UA) with components of metabolic syndrome (MetS) in different ethnic groups." | 7.74 | Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. ( Alberti, G; Chitson, P; Dong, Y; Gao, W; Nan, H; Pauvaday, V; Qiao, Q; Shaw, J; Söderberg, S; Tuomilehto, J; Uusitalo, U; Zimmet, P, 2008) |
| "To assess the correlation between serum uric acid and insulin resistance in natural population of Beijing." | 7.74 | [Correlation between serum uric acid and insulin resistance]. ( Li, GW; Liu, J; Liu, S; Qin, LP; Wang, M; Wang, W; Zhao, D; Zhou, GH, 2007) |
| "Cross-sectional studies indicate metabolic syndrome is a risk factor for elevated serum uric acid." | 7.74 | Impact of childhood metabolic syndrome components on the risk of elevated uric acid in adulthood: the Bogalusa Heart Study. ( Berenson, G; Chen, W; Menke, A; Muntner, P; Patel, DA; Srinivasan, S, 2008) |
| "Associations between serum uric acid (UA) levels and metabolic syndrome (MetS) have been reported in cross-sectional studies." | 7.74 | Uric acid and the development of metabolic syndrome in women and men. ( Blair, SN; Church, TS; Lobelo, F; Meriwether, RA; Sui, X, 2008) |
| " After adjusting for age, total cholesterol, and smoking status, the odds ratios (95% CI) of sex-specific quartiles of serum uric acid for metabolic syndrome were 1." | 7.73 | Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. ( Ishizaka, N; Ishizaka, Y; Nagai, R; Toda, E; Yamakado, M, 2005) |
| "The levels of the liporegulatory hormone leptin are increased in obesity, which contributes to the metabolic syndrome; the latter is associated with elevated cardiovascular risk and morbidity." | 7.73 | Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans. ( Chraibi, A; Israili, ZH; Lyoussi, B; Mguil, M; Ragala, MA, 2005) |
| " The present study examined a Korean adult population with respect to the relationships between serum uric acid concentrations and hypertension, insulin resistance, and the risk factors of metabolic syndrome." | 7.73 | Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. ( Kang, JH; Keum, DG; Kim, BJ; Kim, BS; Kim, H; Kim, SW; Lee, MH; Lee, WY; Park, JR; Rhee, EJ; Ryu, SH; Shin, HS; Sung, KC; Yoo, TW, 2005) |
| "The worldwide epidemic of metabolic syndrome correlates with an elevation in serum uric acid as well as a marked increase in total fructose intake (in the form of table sugar and high-fructose corn syrup)." | 7.73 | A causal role for uric acid in fructose-induced metabolic syndrome. ( Block, ER; Feig, DI; Glushakova, O; Herrera-Acosta, J; Hu, H; Johnson, RJ; Nakagawa, T; Ouyang, X; Patel, JM; Short, RA; Tuttle, KR; Zharikov, S, 2006) |
| "Hyperuricemia is considered a feature of the metabolic syndrome (MS) despite serum uric acid (SUA) is not considered a diagnostic criterion." | 7.73 | [Serum urate levels and urinary uric acid excretion in subjects with metabolic syndrome]. ( Bascuñana-Quirell, A; Benítez-Rodríguez, E; Elvira-González, J; Escribano-Serrano, J; López-Suárez, A; Michán-Doña, A; Rosal-Obrador, J, 2006) |
| "To study effects of uric acid disbolism in combination with other metabolic disturbances on prevalence and clinical symptoms of arterial hypertension; contribution of uric acid nephropathy to its development." | 7.73 | [Relationships between arterial hypertension, metabolic disturbances and uric acid nephropathy]. ( Balkarov, IM; Britov, AN; Deev, AD; Eliseeva, NA, 2006) |
| "Abdominal obesity is the main determinant of uric acid variance." | 7.73 | Serum uric acid is a determinant of metabolic syndrome in a population-based study. ( Albayrak, S; Hergenç, G; Karabulut, A; Keleş, I; Onat, A; Sari, I; Uyarel, H; Yazici, M, 2006) |
| "Serum uric acid (UA) level has been suggested to be associated with factors that contribute to the metabolic syndrome." | 7.73 | Association between serum uric acid level and components of the metabolic syndrome. ( Hsu, SR; Lin, SD; Tsai, DH, 2006) |
| " Besides alcohol consumption and the use of antihypertensive therapy, mainly diuretics, serum uric acid is markedly associated with parameters of the metabolic syndrome, in particular serum triglycerides." | 7.72 | Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. ( Bovet, P; Burnier, M; Conen, D; Paccaud, F; Riesen, W; Shamlaye, C; Wietlisbach, V, 2004) |
| " The aim of this study was to analyse the role of different variables of metabolic syndrome, including leptin, in 74 non-obese children and 68 children with non-syndromal obesity." | 7.71 | Leptin and metabolic syndrome in obese and non-obese children. ( Bueno, M; Fleta, J; Giner, A; Juste, MG; Moreno, LA; Pineda, I; Rodríguez, G; Sarría, A, 2002) |
| "The serum uric acid level has been said to be an independent predictor of cardiovascular disease death, mainly for women, and to be linked with the metabolic Syndrome X of insulin resistance, obesity, hypertension, and dyslipidemia." | 7.71 | Elevated serum leptin concentrations in women with hyperuricemia. ( Chiba, H; Katayose, S; Maruoka, S; Matsubara, M, 2002) |
| "High uric acid concentration is a common finding in subjects with risk factors for cardiovascular disease (CVD), including some characteristics of the metabolic syndrome." | 7.71 | Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. ( Bedini, J; Conget, I; Costa, A; Igualá, I; Quintó, L, 2002) |
| "To examine the relation between fitness and fibrinogen, white blood cell count, uric acid and metabolic syndrome across levels of adiposity in apparently healthy, nonsmoking men." | 7.71 | Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. ( Blair, SN; Church, TS; Earnest, CP; Finley, CE; Gibbons, LW; Kampert, JB, 2002) |
| " Although blood levels of potassium, hemoglobin A1c and uric acid (UA) significantly increased after 3 months for all of the patients, none of the patients showed serious adverse effects." | 6.77 | Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension. ( Arimura, T; Fujisawa, K; Inoue, A; Kuwano, T; Matsunaga, E; Mitsutake, R; Miura, S; Morii, J; Nagata, I; Norimatsu, K; Saku, K; Shiga, Y; Shimizu, T; Shirotani, T; Uehara, Y, 2012) |
| "Atorvastatin was titrated from 10-80 mg/day aiming at a low density lipoprotein cholesterol (LDL-C) target of <100 mg/dl (group A) or an LDL-C target of <130 mg/dl (group B)." | 6.76 | Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. ( Alexandrides, T; Athyros, VG; Bacharoudis, G; Ganotakis, ES; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Nicolaou, V; Paletas, K; Tziomalos, K, 2011) |
| "Nonalcoholic fatty liver disease (NAFLD) is a major, worldwide public health problem." | 6.53 | Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. ( Braddock, M; Liu, WY; Lu, QD; Shi, KQ; Song, D; Sun, DQ; Wu, SJ; Zheng, MH; Zhu, GQ, 2016) |
| "Hyperuricemia is a prevalent finding in patients presenting metabolic syndrome, although its clinical meaning is still controversial and often underestimated." | 6.46 | Uric acid as a factor in the metabolic syndrome. ( Batista, MC; Borges, RL; Ribeiro, AB; Zanella, MT, 2010) |
| "Allopurinol is an inhibitor of xanthine oxidoreductase (XOR) and inhibits the generation of uric acid (UA) as the final product of purine catabolism, as well as the resulting generation of superoxide (O2(-)), in humans." | 6.45 | Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders? ( Nozaki, S; Onuma, M; Suzuki, I; Yamauchi, T, 2009) |
| "Hyperuricemia has long been known to be associated with cardiovascular disease, and it is particularly common in people with hypertension, metabolic syndrome, or kidney disease." | 6.43 | Role of uric acid in hypertension, renal disease, and metabolic syndrome. ( Heinig, M; Johnson, RJ, 2006) |
| "Hyperuricemia is perceived as one of the risk factors for developing and progressing cardiovascular disease and metabolic syndrome through various pathological mechanisms." | 5.91 | Effect of Alcohol Consumption Habits on Early Arterial Aging in Subjects with Metabolic Syndrome and Elevated Serum Uric Acid. ( Badarienė, J; Čypienė, A; Gimžauskaitė, S; Jasiūnas, E; Laucevičius, A; Rinkūnienė, E; Ryliškytė, L, 2023) |
| " The dose-response relationship of SUACr and MetS was further assessed by a restricted cubic spline model (RCS)." | 5.72 | Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China. ( Guo, Y; Huang, H; Huang, S; Li, L; Liu, D; Wu, F; Zhong, D, 2022) |
| "This study aimed to investigate the efficacy and safety of tart cherry supplementary citrate (TaCCi) mixture on urine pH, serum urate (sUA), C-reactive protein (CRP), and gout flares in gout patients initiating urate-lowering therapy (ULT), in comparison to citrate mixture and sodium bicarbonate." | 5.69 | Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study. ( Cui, L; Dalbeth, N; Han, L; He, Y; Ji, A; Ji, X; Li, C; Li, X; Liu, Z; Sun, M; Sun, W; Wang, C; Wang, X; Wang, Z; Xue, X, 2023) |
| "Uric acid wGRS was not associated with fasting serum glucose, HbA1C, waist circumference, or BMI." | 5.56 | The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components. ( Biradar, MI; Chiang, KM; Huang, YT; Pan, WH; Yang, HC, 2020) |
| "Rosacea is an inflammatory skin disease with a chronic course." | 5.56 | Evaluation of serum uric acid levels in patients with rosacea. ( Karaaslan, E; Karaosmanoglu, N; Ozdemir Cetinkaya, P, 2020) |
| "The study aimed to examine the impact of liraglutide plus dapagliflozin on high uric acid (UA) and microalbuminuria (MAU) in patients with diabetes mellitus (DM) complicated with metabolic syndrome (MS)." | 5.51 | Liraglutide Plus Dapagliflozin for High Uric Acid and Microalbuminuria in Diabetes Mellitus Complicated With Metabolic Syndrome. ( Dai, X; Hao, H; Li, Y; Ou, T; Wang, D; Wang, R; Wang, W; Yong, H, 2022) |
| " Compared with baseline, all 3-month treatments significantly reduce body weight and subcutaneous fat area, but only TRE and combination treatment reduce visceral fat area (VFA), fasting blood glucose, uric acid (UA), and dyslipidemia." | 5.51 | Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial. ( Chen, H; Chen, Z; Deji, C; Geng, H; Guo, H; Guo, X; He, M; Hui, CC; Li, M; Liang, Q; Liu, Y; Ma, M; Qian, B; Rensen, PCN; Shi, B; Su, S; Sui, J; Wang, J; Wang, Y; Wang, YW; Zhang, M; Zheng, Y; Zhou, WX; Zhu, WZ, 2022) |
| "The uric acid level was strongly associated with incident metabolic syndrome in the multivariable model (adjusted hazard ratio: 1." | 5.51 | Association of Uric Acid with Incident Metabolic Syndrome in a Japanese General Population. ( Imai, K; Kurabayashi, M; Nakamura, T; Ohyama, Y; Saito, Y; Sumiyoshi, H, 2019) |
| "Treatment with leflunomide was associated with increased levels of carbonyl protein, and lowered levels in TRAP and UA, while the NOx/TRAP ratio further increased." | 5.48 | Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis. ( Alfieri, DF; Costa, NT; de Medeiros, FA; de Sá, MC; Dichi, I; Iriyoda, TMV; Lozovoy, MAB; Maes, M; Micheletti, PL; Reiche, EMV; Scavuzzi, BM; Sekiguchi, BA; Simão, ANC, 2018) |
| "WIT and post-LT hyperuricemia are associated with the prevalence of PTMS." | 5.48 | Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death. ( Chai, YC; Hu, LS; Jia, A; Lv, Y; Shi, JH; Tian, M; Wang, B; Zhang, C; Zheng, J, 2018) |
| "Hyperuricemia is associated with metabolic syndrome (MetS), but the association is often confounded by the shared background of obesity." | 5.46 | Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. ( Du, T; Li, M; Lin, X; Lu, H; Yu, X; Zhang, S, 2017) |
| "Metabolic syndrome was defined according to the Adult Treatment Panel III criteria modified for children and adolescents." | 5.43 | Association of Serum Uric Acid With Cardiometabolic Risk Factors and Metabolic Syndrome in Iranian Adolescents: the CASPIAN-III Study. ( Asayesh, H; Djalalinia, S; Eslami Shahr Babaki, A; Heshmat, R; Kelishadi, R; Motlagh, ME; Qorbani, M; Safari, O; Safiri, S; Tajadini, MH; Tajbakhsh, R, 2016) |
| "In the present study, 841 NAFLD males (30-75 years) were recruited from a Chinese prospective cohort study (PMMJS) and followed up for five years." | 5.43 | Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males. ( Dong, C; Guo, Z; Liu, C; Qiu, J; Song, K; Wang, Y; Xu, Y; Zhang, B; Zhou, H; Zhou, Z, 2016) |
| "The prevalence rates of NAFLD were 71." | 5.43 | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. ( Chen, N; He, CM; Li, X; Li, Z; Liu, CQ; Liu, S; Liu, Y; Shi, X; Wang, D; Yan, B; Yang, S; Zeng, X, 2016) |
| "The study showed that in patients with hypertension and metabolic syndrome, both losartan and eprosartan have a neutral effect on fasting and postfructose load serum uric acid concentration and its urinary excretion." | 5.41 | Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome. ( Majer, J; Masajtis-Zagajewska, A; Nowicki, M, 2021) |
| "The relationship between Serum Uric Acid (UA) and Cardiovascular (CV) diseases has already been extensively evaluated, and it was found to be an independent predictor of all-cause and cardiovascular mortality but also acute coronary syndrome, stroke and heart failure." | 5.41 | The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation. ( Agabiti Rosei, E; Angeli, F; Barbagallo, CM; Bernardino, B; Bombelli, M; Borghi, C; Cappelli, F; Casiglia, E; Cianci, R; Ciccarelli, M; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Dell'Oro, R; Desideri, G; Facchetti, R; Ferri, C; Galletti, F; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Masulli, M; Mazza, A; Mengozzi, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pauletto, P; Pontremoli, R; Pugliese, NR; Quarti-Trevano, F; Rattazzi, M; Reboldi, G; Rivasi, G; Russo, E; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2023) |
| " This review article focuses on the relationship between uric acid and thirteen specific domains: transporters, genetic factors, diet, lifestyle, gout, diabetes mellitus, metabolic syndrome, atherosclerosis, hypertension, kidney diseases, cardiovascular diseases, neurological diseases, and malignancies." | 5.41 | Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases. ( Abe, K; Akashi, N; Aoki, Y; Fukuuchi, T; Hisatome, I; Ichida, K; Kurajoh, M; Kuwabara, M; Maruhashi, T; Miyata, H; Mizuta, E; Morikawa, N; Morita, M; Nishimiya, K; Ogino, K; Otani, N; Ouchi, M; Takada, T; Tanaka, A; Tanaka, Y; Tsutani, H, 2023) |
| "Hyperuricemia was defined as an SUA level of ≥7." | 5.40 | Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. ( Liu, A; Wang, P; Wu, H; Wuyun, G; You, L, 2014) |
| "Mild hyperuricemia is a strong, independent marker of MS and high cardio-renal risk profile in hypertensive patients under specialist care." | 5.40 | Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. ( Agabiti Rosei, E; Ambrosioni, E; Costa, FV; Deferrari, G; Garneri, D; Gonnella, A; Leoncini, G; Leonetti, G; Muiesan, ML; Pessina, AC; Pontremoli, R; Trimarco, B; Viazzi, F; Volpe, M, 2014) |
| "Nonalcoholic fatty liver disease (NAFLD) is an emerging health problem worldwide." | 5.39 | Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. ( Moon, SS, 2013) |
| "In conclusion, weight loss is effective in treating obese children with SDB." | 5.38 | Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. ( Aerts, P; De Backer, WA; Debode, P; Desager, KN; Franckx, H; Ramet, J; Van Gaal, LF; Van Hoorenbeeck, K; Verhulst, SL; Wouters, K, 2012) |
| "Hyperuricemia was defined as SUA ≥70 mg/L in men and ≥60 mg/L in women." | 5.38 | Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. ( Gonçalves, JP; Lopes, C; Oliveira, A; Santos, AC; Severo, M, 2012) |
| "Uric acid (UA) has been frequently reported to be associated with MetS in the general population." | 5.38 | The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder. ( Chen, CH; Chen, PY; Chiu, CC; Huang, MC; Lu, ML; Tsai, CJ, 2012) |
| "Hyperuricemia was defined as UA ≥ 7 mg/dL in men and UA ≥ 6 mg/dL in women." | 5.38 | Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. ( Asefzadeh, S; Esmailzadehha, N; Ghorbani, A; Ziaee, A, 2012) |
| "Hyperuricemia was more common in men than in women (51." | 5.37 | Relation of uric acid with components of metabolic syndrome before and after Roux-en-Y gastric bypass in morbidly obese subjects. ( Rossi, FM; Rossi, M; Serpa Neto, A; Teixeira, GK; Valle, LG, 2011) |
| "Hyperuricemia was defined as a serum UA value >7." | 5.36 | The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. ( Chiou, WK; Chiu, HT; Huang, DH; Lee, YJ; Lin, JD; Wang, MH, 2010) |
| "The metabolic syndrome was defined by the original ATP III criteria and the modified ATP III criteria that include a reduced waist circumference." | 5.35 | Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. ( Choi, SJ; Ji, JD; Lee, YH; Rho, YH; Song, GG; Woo, JH, 2008) |
| "Insulin resistance was determined by the homeostasis model assessment (HOMA-IR)." | 5.35 | Uric acid: a surrogate of insulin resistance in older women. ( Chen, LK; Chiou, ST; Hwang, SJ; Lai, HY; Lin, MH, 2008) |
| "Moreover, hyperuricemia is significantly correlated with hypertriglyceridemia, hypertension, and visceral obesity." | 5.35 | Serum uric acid levels and risk of metabolic syndrome in healthy adults. ( Bandarian, F; Ebrahimpour, P; Fakhrzadeh, H; Heshmat, R; Larijani, B, 2008) |
| "The role of uric acid on metabolic syndrome (MetS) has always been controversial." | 5.34 | Association of Serum Uric Acid with Metabolic Syndrome and Its Components: A Mendelian Randomization Analysis. ( Liu, Y; Tang, F; Wang, L; Xue, F; Zhang, T, 2020) |
| "Metabolic syndrome was diagnosed using the WHO criteria." | 5.34 | Serum uric acid level as an independent component of the metabolic syndrome in type 2 diabetic blacks. ( Akande, AA; Akinyinka, OA; Jimoh, AK; Olarinoye, GO, 2007) |
| "Hyperuricemia is part of the "metabolic syndrome"." | 5.32 | Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. ( Debatin, KM; Denzer, C; Heinze, E; Mayer, H; Muche, R; Wabitsch, M, 2003) |
| "Acute hyperinsulinemia was associated with higher urinary pH (6." | 5.32 | The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. ( Abate, N; Cabo-Chan, AV; Chandalia, M; Moe, OW; Sakhaee, K, 2004) |
| "Increased blood lactate or uric acid (UA) levels are associated with an increased risk of metabolic syndrome (MS)." | 5.30 | Interaction Between Lactate and Uric Acid is Associated With a Higher Prevalence of Metabolic Syndrome: A Community-Based Study. ( Li, F; Pan, H; Ren, M; Wu, M; Xu, M; Yan, D; Zhang, J, 2019) |
| " Nevertheless, it remains unclear whether lowering of serum uric acid (UA) alters any of the features of the metabolic syndrome." | 5.27 | Effects of pharmacological reversal of hyperuricemia on features of the metabolic syndrome in patients with gouty arthritis. ( Maalouf, NM; Marin, M, 2018) |
| "Increased serum uric acid (SUA) levels are commonly seen in patients with metabolic syndrome and are widely accepted as risk factors for hypertension, gout, non-alcoholic fatty liver disease, chronic kidney disease (CKD), and cardiovascular diseases." | 5.22 | Uric acid in metabolic syndrome: Does uric acid have a definitive role? ( Copur, S; Demiray, A; Kanbay, M, 2022) |
| "This systematic review and meta-analysis aim to provide the best evidence on the association between metabolic syndrome (MetS) and uric acid (UA) by determining the size of the effect of this biomarker on MetS." | 5.22 | Association between metabolic syndrome and uric acid: a systematic review and meta-analysis. ( De Pedro-Jiménez, D; Molina-Luque, R; Molina-Recio, G; Raya-Cano, E; Romero-Saldaña, M; Vaquero-Abellán, M, 2022) |
| "Fructose acutely raises serum uric acid in normal subjects, but the effect in subjects with metabolic syndrome or subjects with chronic kidney disease is unknown." | 5.20 | The fructose tolerance test in patients with chronic kidney disease and metabolic syndrome in comparison to healthy controls. ( Donderski, R; Grajewska, M; Johnson, RJ; Junik, R; Kamińska, A; Kretowicz, M; Lanaspa, M; Manitius, J; Miśkowiec-Wiśniewska, I; Odrowąż-Sypniewska, G; Pluta, A; Siódmiak, J; Stefańska, A, 2015) |
| "Intravenous L-carnitine can ameliorate fasting-induced hunger, fatigue, cholesterol abnormalities and hepatic metabolic changes and facilitate fasting-induced weight loss in MetS patients." | 5.19 | L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study. ( Cai, YJ; Huang, YJ; Ke, B; Qin, J; Qiu, CP; Shi, LY; Wu, ZB; Yang, YB; Zhang, JJ, 2014) |
| "Excessive fructose intake causes metabolic syndrome in animals and can be partially prevented by lowering the uric acid level." | 5.14 | Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. ( Johnson, RJ; Lillo, JL; Nakagawa, T; Perez-Pozo, SE; Sánchez-Lozada, LG; Schold, J, 2010) |
| " Of 2,963 patients with coronary artery disease enrolled in the Bezafibrate Infarction Prevention study, 1,410 had MS, as established by the presence of ≥3 of the following 5 criteria: serum fasting glucose >110 mg/dl, triglycerides >150 mg/dl, high-density lipoprotein cholesterol <40 mg/dl in men and <50 mg/dl in women, systolic and diastolic blood pressures >130 and 80 mm Hg, respectively, and body mass index >28 kg/m²." | 5.14 | Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). ( Behar, S; Boyko, V; Brodov, Y; Chouraqui, P, 2010) |
| " Elevated uric acid levels are risk factors for gout, hypertension, and chronic kidney diseases." | 5.12 | Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis. ( Kimura, Y; Kono, H; Tsukui, D, 2021) |
| "The aim of our investigation was to study the peculiarities of serum uric acid (UA) levels in patients with metabolic syndrome (MS) during 6 month therapy with metformin (MF), Rosiglitazone (RG) and their combination." | 5.12 | [Relation of serum uric acid levels with basic metabolic parameters in patients with metabolic syndrome during insulin-sensitizing therapy]. ( Javashvili, L; Kilasonia, L; Tananashvili, D; Tetradze, L; Virsaladze, D, 2007) |
| " The Mesh Terms considered were: uric acid, antioxidant, oxidant, metabolic syndrome, diabetes, cerebrovascular diseases, stroke, haemorrhagic stroke, neurocognitive disorders, and their combinations." | 5.05 | Uric Acid in Metabolic and Cerebrovascular Disorders: A Review. ( Andriani, A; Calculli, G; Ciccone, MM; Cortese, AM; Cortese, F; Giordano, P; Meliota, G; Scicchitano, P; Truncellito, L, 2020) |
| " In the present review, we summarize experimental data on the potential biological mechanisms linking fructose and uric acid in the development of insulin resistance, metabolic syndrome, obesity, diabetes, hypertension, non-alcoholic fatty liver disease and chronic renal disease, thereby contributing to an increase in cardiovascular risk at pediatric age." | 5.05 | Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age. ( Esposito, P; Garibotto, G; Leoncini, G; Pontremoli, R; Russo, E; Viazzi, F, 2020) |
| " While uric acid is usually discussed in the context of gout, hyperuricaemia is also associated with hypertension, chronic kidney disease, hypertriglyceridaemia, obesity, atherosclerotic heart disease, metabolic syndrome, and type 2 diabetes." | 5.05 | Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. ( Agabiti-Rosei, E; Borghi, C; Johnson, RJ; Kielstein, JT; Lurbe, E; Mancia, G; Redon, J; Stack, AG; Tsioufis, KP, 2020) |
| "Purine metabolism in the circulatory system yields uric acid as its final oxidation product, which is believed to be linked to the development of gout and kidney stones." | 5.01 | Hyperuricemia and Cardiovascular Disease. ( Cheng, J; Huangfu, N; Wang, Y; Xu, Z; Zhang, D; Zhang, F; Zhang, S; Zhao, R; Zheng, W, 2019) |
| " The current obesity epidemic has in fact made it relatively frequent even among children and adolescents to find some cardiovascular risk factors known in adults such as arterial hypertension, dyslipidemia, glucose metabolism disorders and increased of uric acid values." | 5.01 | Prevention of Cardiovascular Diseases in Children and Adolescents. ( Battaglino, MG; Genovesi, S; Giussani, M; Nava, E; Orlando, A; Parati, G, 2019) |
| " For many years, hyperuricemia was attributed to the effects of insulin resistance to reduce urinary excretion of uric acid, and it was believed that uric acid may not have any causal role in the metabolic syndrome." | 4.98 | Uric Acid as a Cause of the Metabolic Syndrome. ( Jensen, T; Johnson, RJ; King, C; Lanaspa, MA; Sánchez-Lozada, LG; Tolan, DR, 2018) |
| "Uric acid nephrolithiasis (UAN) is an increasingly common disease in ethnically diverse populations and constitutes about 10% of all kidney stones." | 4.98 | Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus. ( Badalamenti, S; Dauriz, M; Ferraro, PM; Gambaro, G; Spatola, L, 2018) |
| "Xanthine oxidoreductase (XOR) could contribute to the pathogenesis of metabolic syndrome through the oxidative stress and the inflammatory response induced by XOR-derived reactive oxygen species and uric acid." | 4.98 | The role of xanthine oxidoreductase and uric acid in metabolic syndrome. ( Battelli, MG; Bolognesi, A; Bortolotti, M; Polito, L, 2018) |
| "Diabetes and obesity are already recognized as potential risk factors for nephrolithiasis, especially for uric acid stones." | 4.95 | Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences. ( Angelini, C; Badalamenti, S; Gambaro, G; Maringhini, S; Spatola, L, 2017) |
| " In addition, various other abnormalities such as inflammation, oxidative stress, and elevated levels of uric acid are also part of this syndrome." | 4.95 | Excessive consumption of fructose causes cardiometabolic dysfunctions through oxidative stress and inflammation. ( Akolkar, G; Ayyappan, P; Bagchi, A; Belló-Klein, A; Bernardes, N; da Silva Dias, D; De Angelis, K; Singal, PK, 2017) |
| "Uric acid, once viewed as an inert metabolic end-product of purine metabolism, has been recently incriminated in a number of chronic disease states, including hypertension, metabolic syndrome, diabetes, non-alcoholic fatty liver disease, and chronic kidney disease." | 4.93 | Uric acid in metabolic syndrome: From an innocent bystander to a central player. ( Jensen, T; Johnson, RJ; Kanbay, M; Lanaspa, MA; Le, M; Nakagawa, T; Rivard, C; Roncal-Jimenez, C; Solak, Y, 2016) |
| "The hypothesis that dietary (poly)phenols promote well-being by improving chronic disease-risk biomarkers, such as endothelial dysfunction, chronic inflammation and plasma uric acid, is the subject of intense current research, involving human interventions studies, animal models and in vitro mechanistic work." | 4.93 | At the interface of antioxidant signalling and cellular function: Key polyphenol effects. ( Kerimi, A; Williamson, G, 2016) |
| "An excess circulating uric acid level, even within the normal range, is always comorbid with metabolic syndrome (MS), several of its components, and nonalcoholic fatty liver disease (NAFLD), which was regarded as hepatic manifestation of MS; however, these associations remain controversial." | 4.91 | Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. ( Li, X; Sun, L; Yang, Z; Yu, C; Yuan, H; Zhang, Z; Zhao, C; Zhu, X, 2015) |
| "Emerging evidence has shown that serum uric acid (SUA) elevation might cause metabolic derangements, including metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD); however, magnitude of the risk has not been quantified." | 4.91 | Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies. ( Liu, Z; Que, S; Zheng, S; Zhou, L, 2015) |
| "In gouty patients, urate lowering therapies (ULTs) are recommended to bring serum uric acid (SUA) levels below 6." | 4.91 | Why focus on uric acid? ( Johnson, RJ, 2015) |
| " Apart from the diagnostic criteria, MetS has also been associated with other risk factors including waist to hip ratio, high density lipoprotein dysfunction, small dense low density lipoprotein, postprandial hypertriglyceridaemia, lipoprotein (a), uric acid, liver function tests, prothrombotic factors, cytokines, adipokines, vitamin D, arterial stiffness, renal dysfunction, nephrolithiasis, polycystic ovary syndrome, obstructive sleep apnea." | 4.90 | Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. ( Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP, 2014) |
| "The relationship between elevated serum uric acid level and metabolic syndrome (MS) has been debated." | 4.90 | Association of serum uric acid and metabolic syndrome in type 2 diabetes. ( Bonakdaran, S; Kharaqani, B, 2014) |
| "Elevated serum uric acid concentration is a common laboratory finding in subjects with metabolic syndrome/obesity, hypertension, kidney disease and cardiovascular events." | 4.89 | Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? ( Kapusta, DR; Rasheed, K; Reisin, E; Soltani, Z, 2013) |
| "Elevated uric acid levels are a common finding in patients with metabolic syndrome and in those with cardiovascular and renal disease, but the meaning of this elevation is still unclear." | 4.88 | Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage? ( Di Giorgio, C; Gesualdo, L; Morrone, LF; Stellato, D, 2012) |
| "A number of epidemiological studies have reported an association between serum uric acid levels and a wide variety of high-risk conditions including hypertension, insulin resistance, and kidney and cerebro-cardiovascular disease." | 4.88 | Cardiovascular and renal effects of hyperuricaemia and gout. ( Leoncini, G; Pontremoli, R; Viazzi, F, 2012) |
| "With considering serum concentration of the uric acid in humans we are observing hyperuricemia and possible gout development." | 4.88 | Uric acid as one of the important factors in multifactorial disorders--facts and controversies. ( Feher-Turkovic, L; Marinkovic, N; Pasalic, D, 2012) |
| "Uric acid (UA) increase is considered an important risk factor for the development of cardiovascular disease (CVD) favoring oxidative stress and endothelial dysfunction and is also involved in metabolic syndrome (MS) pathophysiology." | 4.88 | The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome. ( Dichi, I; Lozovoy, MA; Simão, AN, 2012) |
| " Fructose induces systemic hypertension through several mechanisms mainly associated with deleterious effects on target organs (kidney, endothelium, heart) exerted by the byproducts of its metabolism, such as uric acid." | 4.87 | Dietary fructose and hypertension. ( Jalal, D; Johnson, RJ; Madero, M; Perez-Pozo, SE; Sánchez-Lozada, LG, 2011) |
| "Uric acid stones are significantly more common among nephrolithiasis patients with type 2 diabetes, obesity, and/or the metabolic syndrome." | 4.87 | Metabolic syndrome and the genesis of uric acid stones. ( Maalouf, NM, 2011) |
| " However, emerging data suggest that elevated uric acid (UA) is actually one of the most important factors for cardiovascular disease and that it also plays a significant role in the development of renal disease and metabolic syndrome." | 4.87 | Uric acid as a cardiometabolic risk factor: to be or not to be. ( Afsar, B; Covic, A; Kanbay, M, 2011) |
| "High uric acid (UA) levels can cause gout, urolithiasis and acute and chronic nephropathy, all of which are due to the deposit of urate crystals." | 4.87 | Is there anything good in uric acid? ( Alvarez-Lario, B; Macarrón-Vicente, J, 2011) |
| "During the past few decades, the mean serum uric acid levels and the prevalence of hyperuricemia in the general population appear to have increased." | 4.87 | The epidemiology of uric acid and fructose. ( Choi, HK; Rho, YH; Zhu, Y, 2011) |
| "Recently, much attention of medical professionals is directed to correlations between hyperuricemia, arterial hypertension, metabolic syndrome and renal affection because of the evidence that elevated blood level of uric acid raises the risk of cardiovascular complications not only in arterial hypertension and metabolic syndrome but also in diabetes mellitus type 2, coronary heart disease, congestive heart failure and renal dysfunction." | 4.87 | [Lozartan potential in hyperuricemia correction]. ( , 2011) |
| "Uric acid has historically been viewed as a purine metabolic waste product excreted by the kidney and gut that is relatively unimportant other than its penchant to crystallize in joints to cause the disease gout." | 4.85 | Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society? ( Benner, SA; Gabriela Sanchez-Lozada, L; Johnson, RJ; Mu, W; Nakagawa, T; Oliver, WJ; Rodriguez-Iturbe, B; Roncal, C; Sautin, YY, 2009) |
| " These advances have led to our further understanding of a pathogenetic link between uric acid nephrolithiasis and the metabolic syndrome, the role of Oxalobacter formigenes in calcium oxalate stone formation, oxalate transport in Slc26a6-null mice, the potential pathogenetic role of Randall's plaque as a precursor for calcium oxalate nephrolithiasis, and the role of renal tubular crystal retention." | 4.85 | Recent advances in the pathophysiology of nephrolithiasis. ( Sakhaee, K, 2009) |
| "Gout is a common rheumatic disease in humans which is characterized by elevation in serum uric acid levels, and deposition of uric acid crystals in the joint." | 4.85 | Recent insights into the pathogenesis of hyperuricaemia and gout. ( Ralston, SH; Riches, PL; Wright, AF, 2009) |
| "The level of serum uric acid in human has been increasing over the last decades, and correlates with an increase prevalence of renal disease and metabolic syndrome." | 4.84 | The conundrum of hyperuricemia, metabolic syndrome, and renal disease. ( Cirillo, P; Gersch, M; Johnson, RJ; Mu, W; Nakagawa, T; Roncal, C; Sánchez-Lozada, LG; Sato, W; Sautin, Y, 2008) |
| " The prevalence of uric acid nephrolithiasis is higher among stone-forming patients with features of the metabolic syndrome such as obesity and/or type 2 diabetes mellitus." | 4.84 | Metabolic syndrome and uric acid nephrolithiasis. ( Maalouf, NM; Sakhaee, K, 2008) |
| "Elevated serum uric acid (SUA) levels are commonly seen in patients with the metabolic syndrome (MetS)." | 4.83 | Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? ( Athyros, VG; Elisaf, MS; Liberopoulos, EN; Mikhailidis, DP; Tsouli, SG, 2006) |
| " First, after adjusting for the related variables, the hemoglobin [Hb] level in the hyperuricemia subgroup (uric acid [UA] ≥ 7." | 4.31 | The relationship between hyperuricemia and anemia and metabolic syndrome in Korean adults: The Korea National Health and Nutrition Examination Survey 2019. ( Bin Choi, S; Hwang, JH; Lee, JH; Mun, CY; Park, CY; Seo, HY; Yoon, H, 2023) |
| " In the stratified analysis by uric acid levels, the prevalence of NAFLD was significantly higher in participants with MHO, MUNW, and MUO in the hyperuricemia group than those in the normal uric acid group, and the interaction effect of metabolic phenotypes and uric acid on NAFLD was statistical significant (P < 0." | 4.31 | Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population. ( Li, X; Miao, Y; Zhang, Q; Zhang, Y; Zheng, J, 2023) |
| " Measurements of anthropometric parameters, blood pressure, fasting blood glucose, insulin concentration, insulin resistance (HOMA-IR), lipid profile, C reactive protein, uric acid, resistin and prevalence of Metabolic Syndrome were determined." | 4.31 | Resistin/uric acid index as a marker of metabolic syndrome in females with obesity. ( de Luis, D; Izaola, O; Primo, D, 2023) |
| " Our aim was to identify the frequency of MHO in obese subjects, to assess the potential associations of demographic characteristics, serum uric acid, alanine transaminase (ALT), pediatric nonalcoholic fatty liver disease fibsosis score probability (PNFS p) with MHO status and to evaluate the differences between MHO and metabolically unhealthy obesity (MUO) with regard to metabolic syndrome surrogates." | 4.31 | Comparative analyses of surrogates of metabolic syndrome in children and adolescents with metabolically healthy obesity vs. metabolically unhealthy obesity according to Damanhoury's criteria. ( Ada, Hİ; Cakir, AD; Mohamad, R; Uçar, A, 2023) |
| "According to our findings, higher mean uric acid levels were reported in recipients with metabolic syndrome (6." | 4.31 | Association of Metabolic Syndrome and Hyperuricemia in the Recipients of Kidney Transplants: A Single-Center Study. ( Hami, M; Mehrad-Majd, H; Miri, M; Salari, M; Yaghoubi, MA, 2023) |
| "Patients with metabolic syndrome We can observe that the Blood urea level showed positive correlation with uric acid level (p value 0." | 4.31 | Endocrinology. ( Konan, V; Swamy, N, 2023) |
| "Serum uric acid to creatinine ratio (SUA/Cr) may be associated with metabolic syndrome (MS)." | 4.31 | Serum uric acid to creatinine ratio and metabolic syndrome in middle-aged and elderly population: Based on the 2015 CHARLS. ( Cao, T; Guo, X; Halengbieke, A; Ni, X; Tang, J; Tong, C; Yang, X; Zheng, D, 2023) |
| " Compared to nonadenomatous polyps, older age, higher 25(OH) vitamin D and higher uric acid levels were at increased risk for adenomatous polyps." | 4.31 | Association of 25(OH)-Vitamin D and metabolic factors with colorectal polyps. ( Chang, YJ; Chao, JN; Chiang, CH; He, SR; Liu, YT; Yang, CH, 2023) |
| "Uric acid excretion after 6 months of therapy in patients with urolithiasis and meta-bolic syndrome decreased from 9." | 4.31 | [Prevention of urolithiasis using febuxostat in patients with metabolic syndrome]. ( Babkin, PA; Paronnikov, MV; Protoshchak, VV; Sleptsov, AV, 2023) |
| "We investigated the association of serum uric acid to high-density lipoprotein ratio (UHR) with the presence and severity of metabolic syndrome (MetS) among MASHAD cohort participants." | 4.31 | Serum uric acid to high-density lipoprotein ratio as a novel indicator of inflammation is correlated with the presence and severity of metabolic syndrome: A large-scale study. ( Esmaily, H; Feizi, S; Ghayour-Mobarhan, M; Kolahi Ahari, R; Mansoori, A; Miri, MS; Sahranavard, T, 2023) |
| "To explore the relationship between serum uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) ratio (UHR) and metabolic syndrome (MetS) in nondiabetic individuals." | 4.31 | Serum uric acid to high-density lipoprotein cholesterol ratio is a promising marker for identifying metabolic syndrome in nondiabetic Chinese men. ( Gao, B; Ji, Q; Li, Q; Liang, S; Ming, J; Shi, L; Sun, F; Wang, L; Xu, Q; Yu, X; Zhang, W, 2023) |
| " Subjects were divided into two groups with and without metabolic syndrome, and the relevant factors such as the ratios of uric acid to high-density lipoprotein (HDL) (UHR) in these two groups were compared, and the best cut-off point was determined." | 4.12 | Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. ( Baghaei, MH; Baniasad, A; Gozashti, MH; Naghibzadeh-Tahami, A; Najafipour, H; Yazdi, F, 2022) |
| " The clinical evaluation included lipid and glycid profile, platelets, leukocytes, lymphocytes, monocytes, uric acid and blood pressure, as well as the presence of metabolic syndrome (MS) and its components." | 4.12 | Cardiometabolic risk in adolescents with normal weight obesity. ( Cota, BC; de Faria, ER; de Faria, FR; Juvanhol, LL; Pereira, PF; Priore, SE; Ribeiro, SAV, 2022) |
| " Hyperuricemia was diagnosed as fasting serum uric acid > 420 µmol/L in men and women." | 4.12 | Association between circulating cystatin C and hyperuricemia: a cross-sectional study. ( Chen, Y; Guo, Y; Huang, H; Shen, C; Xu, C, 2022) |
| "The above study shows that serum uric acid levels are significantly elevated in patients with metabolic syndrome." | 4.12 | Study of Serum Uric Acid Levels in Patients of Metabolic Syndrome in a Tertiary Care Centre in South India. ( Kulkarni, A; N, R; Subhash, N; T, AK, 2022) |
| "The association of the metabolic syndrome with lithogenesis has been described, especially in uric acid stones." | 4.12 | Metabolic syndrome in calcium oxalate stones: Is it so important in this type of lithiasis? ( Arias Fúnez, F; Burgos Revilla, FJ; Duque Ruiz, G; Gomez Dos Santos, V; Hevia Palacios, M; Laso García, I; Sánchez Herranz, A, 2022) |
| " 113 patients fulfilled the criteria for central obesity with the mean uric acid level of 8." | 4.12 | A Clinical Profile of Patients with Hyperuricemia and the Relationship between Hyperuricemia and Metabolic Syndrome: A Cross-sectional Study at a Tertiary Hospital in the Indian Population. ( Ingawale, S; Raghorte, N; Rajadhyaksha, A; Sarate, N, 2022) |
| "Serum uric acid (SUA) is associated with many cardiovascular risk factors, such as metabolic syndrome (MetS) and subclinical atherosclerosis." | 4.12 | Association Between Serum Uric Acid Level and Carotid Atherosclerosis and Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus. ( Li, M; Li, T; Li, W; Liu, R; Liu, S; Liu, X; Ouyang, S; Wang, Y; Zhang, Y, 2022) |
| "To investigate whether serum uric acid (SUA) levels and hyperuricemia can be predictive biomarkers of incident metabolic syndrome(MS) among different body mass index(BMI) categories, and to investigate SUA cutoffs that best discriminate individuals with incident MS." | 4.12 | Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA - Brasil). ( B Duncan, B; Haueisen Sander Diniz, MF; Inês Schmidt, M; Isabel Rodrigues Galvão, A; Luiz P Ribeiro, A; M Benseñor, I; M R Beleigoli, A; Maria Barreto, S; Vidigal, PG; Weiss Telles, R, 2022) |
| "Associations of alanine aminotransferase (ALT) and serum uric acid (SUA) with metabolic syndrome (MetS) remain controversial." | 4.12 | Individual and combined relationship of serum uric acid and alanine aminotransferase on metabolic syndrome in adults in Qingdao, China. ( Li, X; Liu, L; Shao, Y; Sun, J; Xing, D, 2022) |
| " We also tested whether the addition of an insulin resistance index (HOMA-index >90th percentile by sex and age) and the presence of hyperuricemia (serum uric acid >90th percentile by sex and age) to the definition of MUO better identified obese children with early cardiac damage." | 4.12 | Association of obesity phenotypes with left ventricular mass index and left ventricular hypertrophy in children and adolescents. ( Antolini, L; Genovesi, S; Giussani, M; Lieti, G; Montemerlo, M; Orlando, A; Parati, G; Patti, I; Tassistro, E, 2022) |
| "Little research has been conducted into the effects of the combined manifestation of hyperuricemia and hyperhomocysteinemia on cardiometabolic risk factors and markers in young subjects." | 4.12 | The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study. ( Gurecká, R; Koborová, I; Podracká, Ľ; Repiská, G; Šebeková, K, 2022) |
| "This study aimed to assess the relationship of serum uric acid with metabolic syndrome and its components in Tibetan adults on the Tibetan plateau." | 4.12 | Association between hyperuricemia and metabolic syndrome: A cross-sectional study in Tibetan adults on the Tibetan plateau. ( Bao, S; Feng, H; Ge, W; Xu, L; Yao, S; Zhang, Q; Zhou, Y, 2022) |
| " Anthropometric measurements, fasting glucose, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), HOMA- β (%), lipids profile, monocyte to lymphocyte ratio (MLR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), uric acid, gamma glutamyl transpeptidase (GGT), AST/ALT ratio and total bilirubin were assessed." | 4.12 | Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity. ( Asar, M; El-Eshmawy, MM; Elsehely, I; Mahsoub, N, 2022) |
| "Elevated serum uric acid (SUA) levels, body shape index (BSI) and body roundness index (BRI) were associated with incident metabolic syndrome (MetS)." | 4.02 | Serum uric acid is associated with incident metabolic syndrome independent of body shape index and body roundness index in healthy individuals. ( Chen, CC; Liu, CW; Tseng, GS; Tu, CM; Wei, TE, 2021) |
| "Greater waist circumference, serum triglycerides, and serum uric acid were associated with higher localized stage II/III periodontitis risk [odds ratio (OR) and 95% confidence interval (CI): 1." | 4.02 | Associations between metabolic biomarkers and localized stage II/III periodontitis in young adults: The CHIEF Oral Health study. ( Cheng, WC; Huang, RY; Lin, GM; Lin, YP; Su, FY; Tsai, KZ, 2021) |
| "Serum uric acid (SUA) level has been suggested to be associated with cardiovascular disease, diabetes and metabolic syndrome." | 4.02 | Assessment of the relationship between serum uric acid levels and liver enzymes activity in Bangladeshi adults. ( Ali, N; Barman, Z; Fariha, KA; Hasan, A; Kathak, RR; Mahmud, F; Molla, NH; Mou, AD; Sumon, AH, 2021) |
| "We conducted a study to examine the association of endothelial dysfunction and oxidative stress with uric acid levels in patients of metabolic syndrome." | 4.02 | Uric acid as a predictor of endothelial dysfunction in patients with metabolic syndrome. ( Dhawan, V; Jain, S; Kalra, N; Kumari, S; Singh, C, 2021) |
| "Although high serum uric acid (SUA) at baseline has been linked to increased risk for metabolic syndrome (MetS), the association of longitudinal SUA changes with MetS risk is unclear." | 4.02 | Dose-response relationship between distinct serum uric acid trajectories and metabolic syndrome risk: A 5-year prospective cohort study. ( Guo, X; Han, Y; Li, Q; Liu, J; Ma, Z; Tao, L; Yang, X; Zhang, J; Zhang, S, 2021) |
| " This study investigated the effects of two neutral CB1 receptor antagonists, AM6545 and AM4113, on nephropathy associated with metabolic syndrome (MetS)." | 4.02 | Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. ( Aldawsari, HM; Binmahfouz, L; Eid, BG; El-Aziz, GA; El-Bassossy, HM; Hanafy, A; Hasan, A; Makriyannis, A; Neamatallah, T; Vemuri, K, 2021) |
| "Serum uric acid (SUA) has been depicted as a contributory causal factor in metabolic syndrome (MS), which in turn, portends unfavourable prognosis." | 4.02 | The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk. ( Barbagallo, CM; Bombelli, M; Borghi, C; Bruno, B; Casiglia, E; Cicero, AFG; Cirillo, M; Cirillo, P; D'Elia, L; Dell'Oro, R; Desideri, G; Ferri, C; Galletti, F; Georgiopoulos, G; Gesualdo, L; Giannattasio, C; Grassi, G; Iaccarino, G; Lippa, L; Mallamaci, F; Maloberti, A; Masi, S; Mazza, A; Mengozzi, A; Muiesan, ML; Nazzaro, P; Palatini, P; Parati, G; Pontremoli, R; Pugliese, NR; Rattazzi, M; Rivasi, G; Salvetti, M; Tikhonoff, V; Tocci, G; Ungar, A; Verdecchia, P; Viazzi, F; Virdis, A; Volpe, M, 2021) |
| " The metabolic profile comprised the following components: waist circumference, glucose, high-density lipoprotein cholesterol (HDL-C), non-HDL-C, triglycerides, C-reactive protein, homeostatic model assessment index-insulin resistance (HOMA-IR), serum uric acid, systolic blood pressure, and diastolic blood pressure." | 4.02 | Phase angle association with metabolic profile in adults: A population-based study. ( Gabiatti, MP; Hansen, F; Longo, GZ; Martins, PC; Silva, DAS, 2021) |
| "Recently, studies have shown a positive association between serum uric acid (UA) and metabolic syndrome (MS)." | 4.02 | Uric acid: A new marker for metabolic syndrome? Results of a population-based study with adults. ( da Silva, DCG; de Magalhães, ELG; Ferreira, FG; Hinnig, PF; Juvanhol, LL; Longo, GZ; Roberto, DMT, 2021) |
| "In a multi-center study (n=2495), we used unsupervised machine learning to cluster patients with obesity from Shanghai Tenth People's hospital (n=882, main cohort) based on three clinical variables (AUCs of glucose and of insulin during OGTT, and uric acid)." | 4.02 | Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study. ( Arefan, D; Cheng, X; Du, L; Feng, W; Gao, L; Lin, Z; Liu, Y; Ma, C; Qu, S; Wu, S; You, H; Yu, J; Zhou, D; Zhu, D; Zhu, J, 2021) |
| "BACKGROUND Serum uric acid (SUA) and alanine aminotransferase (ALT) levels are increased in patients with metabolic syndrome." | 3.96 | Measurement of the Combined Levels of Serum Uric Acid and Alanine Aminotransferase and the Risk of Metabolic Syndrome in a Population Aged 60 Years or More in Northeastern China. ( Chen, F; Ma, G; Wang, D; Wang, J; Wang, Y, 2020) |
| "Background Elevated serum uric acid concentrations have been associated with metabolic syndrome." | 3.96 | Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China. ( Du, Y; Lu, Y; Ma, ZF; Pan, B; Shao, J; Wang, L; Wei, H; Wu, Q; Zhao, Q; Zhou, H; Zhu, W, 2020) |
| "Although the level of uric acid (UA) is higher in males, increased UA level in females was reported to be closely associated with prevalence of metabolic syndrome (Mets) leading to atherosclerotic cardiovascular disease (ASCVD)." | 3.96 | The serum uric acid level in females may be a better indicator of metabolic syndrome and its components than in males in a Japanese population . ( Imatake, K; Matsumoto, N; Matsuo, R; Okumura, Y; Suzuki, Y; Takahashi, A; Tani, S; Yagi, T, 2020) |
| "There is still controversy over the clinical interpretation of the association between metabolic syndrome (MetS) and serum uric acid (SUA) levels." | 3.96 | Association of Serum Uric Acid with cardio-metabolic risk factors and metabolic syndrome in seafarers working on tankers. ( Ahmadvand, A; Baygi, F; Herttua, K; Jensen, OC; Sheidaei, A, 2020) |
| "This study aimed to investigate the association between Serum Uric Acid (UA) to Creatinine (Cr) Ratio (UA/Cr) and metabolic syndrome (MetS) in postmenopausal women." | 3.96 | Serum uric acid to creatinine ratio and metabolic syndrome in postmenopausal Chinese women. ( Cha, E; Gu, PP; He, LL; Li, GQ; Li, J; Liu, J; Shen, X; Tao, J; Wang, Z; Zhu, W, 2020) |
| "Elevated levels of serum uric acid (SUA) have been suggested to associate with cardiovascular disease, diabetes and metabolic syndrome (MetS)." | 3.96 | Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. ( Ali, N; Barman, Z; Hafsa, JM; Hasan, A; Hasan, M; Islam, F; Miah, R; Mou, AD; Trisha, AD, 2020) |
| "We aimed to investigate resistin expression in penile tissue in the presence of insulin resistance (IR) and the effect of Boldine treatment on erectile functions in the metabolic syndrome (MetS) rat model." | 3.96 | The role of resistin on metabolic syndrome-induced erectile dysfunction and the possible therapeutic effect of Boldine. ( Atabey, N; Dayar, E; Demir, O; Durmus, N; Gidener, S; Kahraman, E; Kara, E; Yetik Anacak, G, 2020) |
| "Many studies have demonstrated that elevated serum uric acid (SUA) level is linked with metabolic syndrome (MetS)." | 3.96 | Sex-specific association of serum uric acid dynamics with the incidence of metabolic syndrome in a health check-up Chinese population: a prospective cohort study. ( Chen, F; Fan, Y; Hu, D; Li, G; Liu, K; Liu, Q; Liu, Y; Song, G; Tang, X, 2020) |
| "To investigate the relationship between serum uric acid/creatinine(SUA/Cr) ratio and metabolic syndrome(MS) and its components in population, whose thyroid function were normal." | 3.96 | [Association of serum uric acid/creatinine ratio and metabolic syndrome in euthyroid population]. ( Liu, S; Peng, J; Song, J; Tang, Z; Zhang, J; Zhang, L, 2020) |
| "Body mass index and blood uric acid level were found to be the two independent factors to distinguish between different types of metabolic syndrome." | 3.96 | Distinguish different Chinese medicine types of metabolic syndrome by combining body mass index and uric acid. ( Chen, Q; Li, S; Lian, T; Liu, M; Peng, B; Wang, X; Zhao, X, 2020) |
| "Serum uric acid (UA) levels are one of the determinants of the cardiovascular disease and metabolic syndrome but none of criteria for that syndrome include serum UA." | 3.96 | Uric acid alterations by consumption of gluten-free bakery products in relation to cardiovascular and metabolic syndrome risk factors. ( Gažarová, M; Mečiarová, L, 2020) |
| "To assess the association between the consumption of non-soy legumes and different subtypes of non-soy legumes and serum uric acid (SUA) or hyperuricemia in elderly individuals with overweight or obesity and metabolic syndrome." | 3.96 | Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study. ( Abellán Cano, I; Alonso-Gómez, ÁM; Babio, N; Becerra-Tomás, N; Bernal-Lopez, MR; Bueno-Cavanillas, A; Casas, R; Cenoz, JC; Corbella, E; Corella, D; Crespo-Oliva, E; Daimiel, L; Del Mar Bibiloni, M; Díaz-López, A; Estruch, R; Fernandez-Brufal, N; Fernández-Carrión, R; Fernández-García, JC; Freixer, G; Gaforio, JJ; Lapetra, J; Llimona, R; López-Miranda, J; Martín-Sánchez, V; Martínez, JA; Martínez-González, MÁ; Matía-Martín, P; Mena-Sánchez, G; Morey, M; Navarrete-Muñoz, EM; Pintó, X; Prieto, RM; Quifer, M; Razquin, C; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Salaverria Lete, I; Sanchez-Villegas, A; Santos-Lozano, JM; Serra-Majem, L; Sorli, JV; Tojal Sierra, L; Torres, L; Tur, JA; Vázquez, C; Vidal, J; Vioque, J; Wärnberg, J; Zulet, MÁ, 2020) |
| "This study aims to investigate the prevalence of metabolic syndrome (MetS) in familial Mediterranean fever (FMF) and the relationship between serum uric acid (SUA) concentrations and MetS status by sex in patients with FMF." | 3.91 | Relationship between Metabolic Syndrome and Uric Acid Levels in Patients with Familial Mediterranean Fever. ( Akkececi, NS; Cetin, GY; Gögebakan, H, 2019) |
| "Although previous studies have highlighted the importance of serum uric acid as a risk factor of metabolic syndrome, no study has previously used a national Korean survey to examine the association between serum uric acid level and metabolic syndrome." | 3.91 | Association between Serum Uric Acid and Metabolic Syndrome in Koreans. ( Jeong, J; Suh, YJ, 2019) |
| "This is a medical records review study of 348 hyperuricemia patients identified in 2015, as having been followed with serial uric acid measurements." | 3.91 | Effect of Uric Acid Control on Serum Creatinine. ( Block, C; Field, C; Li, Z; Taylor, T; Xie, J; Yamamoto, T, 2019) |
| " Then serum urate (Sua), renal function, uric acid metabolism, and the prevalence of metabolic syndrome (Mets) were compared among these groups by the Tukey-Kramer test or Fisher's exact test." | 3.91 | Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography. ( Hori, H; Shimizu, K; Shimizu, T; Umeyama, M, 2019) |
| "To investigate the diagnostic role of combined salivary uric acid (UA), glucose and insulin levels to screen noninvasively for metabolic syndrome (MetS) and nonalcoholic fatty liver disease." | 3.91 | Salivary markers of hepato-metabolic comorbidities in pediatric obesity. ( Belmonte, F; Bisogno, A; Cavallo, P; Guercio Nuzio, S; Landolfi, A; Lausi, O; Marciano, F; Pierri, L; Troisi, J; Vajro, P, 2019) |
| " However, the dose-response effects of serum uric acid (SUA) on the prevalence of MetS and electrocardiographic left ventricular hypertrophy (LVH) are unclear." | 3.91 | The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals. ( Chang, WC; Chen, KH; Hwang, JJ; Liu, CW; Tseng, CK; Wu, YW, 2019) |
| "The aim of this study was to assess the association between serum uric acid concentration (SUAC) and the parameters of the metabolic syndrome (MetS) and insulin resistance (IR)." | 3.91 | Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children ( Ersoy, B; Özalp Kızılay, D; Şen, S, 2019) |
| "It has not been determined whether changes in serum uric acid (SUA) level are associated with incident metabolic syndrome (MetS)." | 3.91 | The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome. ( Bae, JC; Jee, JH; Jin, SM; Kim, JH; Lee, MK; Yu, TY, 2019) |
| " Glutamine (GLT) has been demonstrated to have a modulatory effect in MS and/or insulin resistance (IR)." | 3.91 | Glutamine confers renoprotection by normalizing lipid and glutathione content in insulin-resistant pregnant rats. ( Olaniyi, KS; Olatunji, LA, 2019) |
| "Insulin and uric acid were shown affect the prevalence of Metabolic Syndrome (MetS), but no studies examine their interaction." | 3.88 | Low serum uric acid concentration augments insulin effects on the prevalence of metabolic syndrome. ( Gonzalez-Mejia, ME; Pérez-Fuentes, R; Porchia, LM; Ruiz-Vivanco, G; Torres-Rasgado, E, 2018) |
| " The associations among metabolic syndrome (MetS), serum uric acid and CKD are also unclear." | 3.88 | Chronic kidney disease associated with decreased bone mineral density, uric acid and metabolic syndrome. ( Loke, SS; Pan, BL, 2018) |
| "We explored the association between serum uric acid (SUA) and metabolic syndrome (MetS) in Chinese rural adults." | 3.88 | Sex-specific associations of serum uric acid with metabolic syndrome in Chinese rural population: The RuralDiab study. ( Jiang, J; Li, Y; Liu, R; Liu, X; Mao, Z; Qian, X; Wang, C; Yang, K; Zhang, G; Zhang, H; Zhang, X, 2018) |
| "The study aimed to determine the relationship among serum uric acid and metabolic syndrome and atherosclerosis, by means of carotid intima media-thickness, in a cohort of 811 otherwise healthy overweight/obese subjects, without overt atherosclerosis not using any kind of drug." | 3.88 | Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First? ( Caccavo, D; Carbonara, R; Ciccone, MM; Cortese, AM; Cortese, F; De Pergola, G; Masiello, M; Meliota, G; Silvestris, F; Termine, G, 2018) |
| " Patients with metabolic syndrome (MS) have higher values of homocysteine." | 3.88 | Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score. ( Colak, E; Dimitrijevic-Sreckovic, V; Gacic, J; Janeski, H; Janeski, N; Mrdovic, I; Soldatovic, I; Srećković, B; Sumarac-Dumanovic, M, 2018) |
| " Both Diosmin and Crocin improved insulin resistance, decreased blood pressure, uric acid, lipoproteins and blocked diabetic nephropathy as indicated by reduction of albumin excretion rate and albumin/creatinine ratio." | 3.88 | Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: Effect on oxidative stress and low grade inflammation. ( El Fayoumi, HM; El-Fawal, R; Mahmoud, MF, 2018) |
| "The longitudinal associations between serum uric acid (UA) levels and metabolic syndrome (MetS) and its components, as well as the shared genetic and environmental correlations between these traits, were evaluated." | 3.88 | Genetic and Environmental Influences on the Associations Between Uric Acid Levels and Metabolic Syndrome Over Time. ( Lee, K; Song, YM, 2018) |
| "Metabolic syndrome (MS) consists of a cluster of metabolic diseases, and the association between serum uric acid (SUA) and MS has recently been reported in several studies; however, whether SUA is a susceptibility or risk biomarker for the development of MS among Chinese adults is unclear." | 3.88 | Association Between Metabolic Syndrome and the Serum Uric Acid: a Cohort Study. ( Gao, M; Ren, P, 2018) |
| " Hyperuricemia is defined as a serum uric acid level of 7 mg/dL or more in men or 6 mg/dL or more in women." | 3.88 | Hyperuricemia Is Associated With a Higher Prevalence of Metabolic Syndrome in Military Individuals. ( Chang, WC; Chen, KH; Hwang, JJ; Lee, CC; Liu, CW; Wu, YW, 2018) |
| " Classical (fasting glucose, TGL, HDL, blood pressure) and non classical (insulin resistance [HOMA-IR], creatinine, AST, ALT, uric acid, fibrinogen, liver US and 24h BP profile) risk factors were compared between groups with and without MS." | 3.88 | Shall we diagnose metabolic syndrome in adolescents? ( Janus, D; Ruszała, A; Starzyk, JB; Szczudlik, E; Sztefko, K; Wójcik, M, 2018) |
| " Hyperuricemia was determined as serum uric acid level above 420 μmol/L in men and 360 μmol/L in women (N Engl J Med 359(17):1811-1821, 2008)." | 3.88 | Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder. ( Chen, H; Chen, J; Feng, J; Huang, XF; Jones, A; Li, J; Li, R; Tan, Y; Wang, S; Wilson, I; Yang, F; Zhang, L, 2018) |
| "This study was aimed to evaluate the relationship between normal serum uric acid (SUA) level and metabolic syndrome (MetS) risk." | 3.85 | An Increase in Normal SUA Level Within the Normal Range Predicts Risk of Metabolic Syndrome, Especially in Women: A Cross-Sectional Study. ( Cao, X; Feng, JP; Li, Q; Lu, J; Shi, TT; Yang, JK, 2017) |
| "Metabolic Syndrome (Mets) and increased serum uric acid (SUA), are well known renal risk predictors and often coexist in patients with type 2 diabetes (T2D)." | 3.85 | Metabolic syndrome, serum uric acid and renal risk in patients with T2D. ( Ceriello, A; De Cosmo, S; Fioretto, P; Genovese, S; Giorda, C; Guida, P; Piscitelli, P; Pontremoli, R; Russo, G; Viazzi, F, 2017) |
| "Serum uric acid levels of psoriasis patients were significantly higher than those of controls." | 3.85 | Evaluation of serum uric acid levels in psoriasis vulgaris. ( Artüz, F; Köktürk, F; Külcü Çakmak, S; Tamer, E; Yilmaz, E, 2017) |
| " Uric acid concentration associated with metabolic health when abdominal obesity was excluded." | 3.85 | Impact of dietary intake, lifestyle and biochemical factors on metabolic health in obese adolescents. ( Aldhoon-Hainerová, I; Hainer, V; Zamrazilová, H, 2017) |
| "This study aimed to a) examine IR and β-cell function as measured by the homeostasis model assessment of insulin resistance (HOMA-IR) and insulin sensitivity and β cell function (HOMA-B) and glucotoxicity (conceptualized as increased glucose levels versus lowered HOMA-B values) in 74 participants with major depressive disorder (MDD) and bipolar disorder, with and or without MetS and TUD, versus 46 healthy controls, and b) whether IR is associated with IO&NS biomarkers, including nitric oxide metabolites (NOx), lipid hydroperoxides (LOOH), plasma advanced oxidation protein products (AOPP), C-reactive protein (CRP), haptoglobin (Hp) and uric acid." | 3.85 | Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers. ( Berk, M; Camargo, AEI; de Farias, CC; Dodd, S; Favaro Soares, J; Gastaldello Moreira, E; Higachi, L; Landucci Bonifácio, K; Maes, M; Nunes, SOV; Odebrecht Vargas, H; Sabbatini Barbosa, D, 2017) |
| "Since the association between serum uric acid (SUA) and metabolic syndrome (MetS) has been reported extensively, it remains unclear whether SUA is associated with MetS and its components in a Chinese Yi population." | 3.85 | Sex difference in the association of serum uric acid with metabolic syndrome and its components: a cross-sectional study in a Chinese Yi population. ( Huang, S; Jia, H; Li, H; Liu, X; Xu, W, 2017) |
| "Aims of this study were 1) to evaluate early cardiovascular abnormalities in a large population of obese children and adolescents compared with a normal weight counterpart, 2) to investigate their potential association with insulin resistance (IR), serum uric acid (sUA) and metabolic syndrome (MetS)." | 3.85 | Insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity. ( Aronici, M; Bellone, S; Bona, G; Castagno, M; Di Mario, C; Genoni, G; Grossini, E; Martelli, M; Menegon, V; Monzani, A; Prodam, F; Ricotti, R; Secco, GG; Sonzini, M, 2017) |
| "This study aimed to investigate whether uric acid to creatinine (UA/Cr) ratio is associated with higher risk of metabolic syndrome (MetS) and its components." | 3.85 | Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. ( Al-Attas, OS; Al-Daghri, NM; Alokail, MS; Sabico, S; Wani, K, 2017) |
| "Hyperuricemia leads to insulin resistance, whereas insulin resistance decreases renal excretion of uric acid, both mechanisms link elevated serum uric acid with metabolic syndrome." | 3.85 | Circulating Levels of Uric Acid and Risk for Metabolic Syndrome. ( Durán-Salgado, MB; Garro-Almendaro, AK; Huerta-Ramírez, S; Lozano-Nuevo, JJ; Morales-López, H; Rubio-Guerra, AF; Vargas-Ayala, G, 2017) |
| "The aim of the study was to explore the association between serum uric acid (SUA) and metabolic syndrome (MetS) in premenopausal and postmenopausal women in the Jinchang Cohort." | 3.85 | The relationship between serum uric acid and metabolic syndrome in premenopausal and postmenopausal women in the Jinchang Cohort. ( Bai, YN; Chan, C; He, SJ; Hu, XB; Li, HY; Shi, D; Wang, D; Wang, MZ; Xie, ZD, 2017) |
| "This study aimed to investigate effects of curcumin on high fructose diet (HFD)-induced metabolic syndrome (MetS) in rats and the possible mechanisms involved." | 3.85 | Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. ( Hakami, TM; Kelany, ME; Omar, AH, 2017) |
| "Although it is known that high uric acid (UA) level is associated with type 2 diabetes (T2DM) and metabolic syndrome (MetS), most of the previous studies were focused on adults." | 3.85 | The Role of Uric Acid for Predicting Future Metabolic Syndrome and Type 2 Diabetes in Older People. ( Chang, JB; Chen, YL; Hsieh, CH; Hung, YJ; Lee, CH; Liang, YJ; Lin, CM; Lin, JD; Pei, D; Wu, CZ, 2017) |
| "The objective was to determine whether serum uric acid concentrations were associated with metabolic syndrome in a population from Wuhan." | 3.85 | Positive association between metabolic syndrome and serum uric acid in Wuhan. ( Chen, M; Fan, ZF; Fu, YQ; Li, D; Wang, L; Yang, H; Zeng, W; Zeng, XY; Zheng, JS, 2017) |
| "Hyperuricemia has been described as associated with the risk of development metabolic syndrome; however the relationship between the uric acid level and particular parameters of metabolic syndrome remained unclear." | 3.85 | Correlation of uric acid levels and parameters of metabolic syndrome. ( Cibičková, Ľ; Karásek, D; Kubíčková, V; Langová, K; Vaverková, H, 2017) |
| "Associations between high serum uric acid (SUA) levels and high blood pressure (BP), as well as between SUA levels and metabolic syndrome (MetS) have already been reported." | 3.83 | Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients. ( Kalogeropoulos, P; Karamanou, AG; Moustakas, G; Papavasileiou, MV; Patsianis, S; Pittaras, A, 2016) |
| "Elevated serum uric acid levels and increased arginase activity are risk factors for cardiovascular diseases (CVD)." | 3.83 | Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome. ( Demirci, F; Demirustu, C; Ergun, B; Kebapci, N; Ozcelik, E; Temel, HE; Uslu, S, 2016) |
| "This study examined the relationship between serum levels of uric acid and insulin resistance and metabolic syndrome in nondiabetic patients with schizophrenia." | 3.83 | Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia. ( Cimpeanu, C; Fan, X; Harrington, A; Rajan, S; Song, X; Zalpuri, I, 2016) |
| "Serum uric acid (SUA) is the end-product of purine metabolism in humans, and its levels often increase in subjects with metabolic syndrome (MetS)." | 3.83 | High serum uric acid levels increase the risk of metabolic syndrome in elderly women: The PRO.V.A study. ( Crepaldi, G; Giantin, V; Maggi, S; Manzato, E; Maselli, M; Musacchio, E; Perissinotto, E; Sartori, L; Sergi, G; Toffanello, ED; Veronese, N; Zambon, S; Zurlo, A, 2016) |
| "Psoriasis has been reported to be associated with raised serum uric acid levels and gout, and uric acid has been demonstrated to mediate inflammatory pathways via secretion of pro-inflammatory chemokines." | 3.83 | Psoriasis and uric acid: a population-based cross-sectional study. ( Lai, YC; Yew, YW, 2016) |
| " Variables included were waist circumference (WC), glucose, high-density lipoprotein (HDL), triglycerides (TGL), blood pressure, insulin resistance (by homeostatic model assessment HOMA-index), acanthosis nigricans (AN), uric acid, serum glutamic oxaloacetic transaminase (GOT) and alanine transaminase, and hepatic sonogram." | 3.83 | Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients. ( Barrera-de Leon, JC; Colunga Rodríguez, C; Hurtado López, EF; López Beltrán, AL; Ortega-Cortes, R; Tlacuilo-Parra, A; Trujillo, X, 2016) |
| "Elevated serum uric acid (SUA) level is strongly associated with prevalence of metabolic syndrome (MS), elevated parathyroid hormone (PTH) levels, and 25-hydroxyvitamin D [25(OH)D] insufficiency in adults." | 3.83 | Uric Acid-Induced Inflammation Is Mediated by the Parathyroid Hormone:25-Hydroxyvitamin D Ratio in Obese Adolescents. ( Alemzadeh, R; Kichler, J, 2016) |
| "A metabolic syndrome (MetS) is accompanied by hyperuricemia, during which xanthine oxidoreductase (XOR) catalyzes the production of uric acid." | 3.83 | Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis. ( Aibibula, Z; Ailixiding, M; Asou, Y; Hara, Y; Iwata, M; Okawa, A; Piao, J, 2016) |
| "Some observational studies have suggested that serum uric acid (SUA) levels are one of the determinants of the metabolic syndrome (MetS)." | 3.83 | Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. ( Bae, JC; Baek, JH; Jee, JH; Jin, SM; Kim, JH; Lee, MK; Yu, TY, 2016) |
| "To investigate the association between serum direct bilirubin (DBIL) with metabolic syndrome (MS) and its components." | 3.83 | [Association between serum direct bilirubin with metabolic syndrome and its components based on a longitudinal health check-up study]. ( Chen, L; Chen, Q; Chen, X; Wang, S; Xiao, J; Zhang, P, 2016) |
| " Bipolar disorder was the only diagnostic subgroup significantly associated with increased uric acid levels." | 3.83 | Exploring the association between bipolar disorder and uric acid: A mediation analysis. ( Bartoli, F; Carrà, G; Castagna, G; Clerici, M; Crocamo, C; Gennaro, GM; Trotta, G, 2016) |
| "Elevated uric acid (UA) is associated with the presence of the metabolic syndrome (MetS)." | 3.83 | Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. ( Eriksen, BO; Jenssen, TG; Norvik, JV; Solbu, MD; Storhaug, HM; Ytrehus, K; Zykova, SN, 2016) |
| " To help understand the pathogenesis and early prevention of progressive CKD, this large-scale study is designed to determine the complex association between serum uric acid (SUA), metabolic syndrome and the prevalence of CKD in hypertensive patients." | 3.83 | Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients. ( Chen, R; Chen, Z; Dai, H; Liu, C; Lu, M; Lu, S; Lu, Y; Tang, X; Yang, P; Yuan, H; Zhou, H, 2016) |
| "Both the serum uric acid (SUA) level and elevated alanine aminotransferase (ALT) are related to metabolic syndrome." | 3.83 | Association between Serum Uric Acid and Elevated Alanine Aminotransferase in the General Population. ( Chen, S; Guo, X; Li, Z; Sun, G; Sun, Y; Yang, H; Yu, S, 2016) |
| " We evaluated the association between serum uric acid and uACR in persons with 0, and 1-2 metabolic syndrome (MetS) components and determined the modification effects of visceral adiposity index (VAI), mean arterial pressure (MAP), and fasting glucose on this association." | 3.83 | The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome. ( Bruthans, J; Cifkova, R; Hamet, P; Krajcoviechova, A; Tahir, MR; Tremblay, J; Wohlfahrt, P, 2016) |
| "Although serum uric acid (sUA) is not a criterion for diagnosing metabolic syndrome (MetS), many studies have identified a positive association between sUA and MetS in patients of various ages and ethnicities." | 3.83 | The Power of Serum Uric Acid in Predicting Metabolic Syndrome Diminishes With Age in an Elderly Chinese Population. ( Chang, HW; Chen, JH; Chen, YL; Chuang, TJ; Hsieh, CH; Huang, CL; Li, PF; Liu, JS; Pei, D, 2016) |
| "High serum uric acid (SUA) levels are present in patients with metabolic syndrome (MetS), when the latter is associated with endothelial dysfunction, inflammation, and hypertension." | 3.81 | Association of serum uric acid levels to inflammation biomarkers and endothelial dysfunction in obese prepubertal children. ( Bermudo, F; Cañete, MD; Cañete, R; Martos, R; Valle, M; Valle, R; van Donkelaar, EL, 2015) |
| "The purpose of this study was to examine the associations between serum uric acid (SUA) levels and the incidences of hypertension and metabolic syndrome (MetS) in a large screened cohort of Japanese men and women." | 3.81 | Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. ( Inoue, T; Kinjo, K; Kohagura, K; Nagahama, K; Ohya, Y, 2015) |
| "Serum uric acid (SUA) is associated with many cardiovascular risk factors such as hypertension (HTN) and metabolic syndrome (MetS)." | 3.81 | Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. ( Bao, YQ; Dong, XH; Jia, WP; Li, LX; Li, MF; Li, TT; Shen, J; Zhang, R, 2015) |
| "Several studies have demonstrated a relationship between increased serum uric acid (SUA) concentrations and the prevalence of metabolic syndrome (MetS) in the oriental population." | 3.81 | Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study. ( Babio, N; Basora, J; Becerra-Tomás, N; Corella, D; Estruch, R; Fitó, M; Martínez-González, MA; Ortega-Calvo, M; Recondo, J; Ros, E; Salas-Salvadó, J; Serra-Majem, L; Wärnberg, J, 2015) |
| "Elevated serum uric acid levels reflect and also cause both oxidative stress and insulin resistance and are frequently observed in patients with the metabolic syndrome." | 3.81 | The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort. ( Ben-Assuli, O; Chodick, G; Goldstein, A; Magid, A; Rabinowich, L; Shalev, V; Shibolet, O; Zelber-Sagi, S, 2015) |
| "This study examines the effects of malondialdehyde (MDA) and uric acid on insulin resistance and atherogenicity in subjects with and without mood disorders, the metabolic syndrome (MetS) and tobacco use disorder (TUD)." | 3.81 | Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder. ( Barbosa, DS; Berk, M; Bortolasci, CC; de Castro, MR; de Melo, LG; Dodd, S; Maes, M; Moreira, EG; Vargas Nunes, SO; Vargas, HO, 2015) |
| "It is controversial whether serum uric acid (SUA) is a risk factor for the prevalence of metabolic syndrome (MetS)." | 3.81 | Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome: Results from Fangchenggang Area Male Health and Examination Survey in China. ( Chen, D; Gao, Y; Jiang, Y; Lin, X; Lu, Z; Mo, Z; Tan, A; Wu, C; Yang, X; Yao, Z; Zhang, H, 2015) |
| "Recent studies have demonstrated an association between serum uric acid (SUA) levels and metabolic syndrome (MetS)." | 3.81 | Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. ( Ahn, SV; Choi, E; Chung, CH; Kim, HM; Koh, SB; Lee, ES; Lee, EY; Lim, JS; Yadav, D, 2015) |
| " Linear regression was used to evaluate associations between uric acid and clinical and laboratory findings associated with metabolic syndrome." | 3.81 | [Metabolic complications of obesity during adolescence, particularly regarding elevated uric acid levels]. ( Almási, A; Barkai, L; Fehér, V; Kiss-Tóth, E; Ságodi, L, 2015) |
| " Hyperuricemia was defined according to sex-specific serum uric acid levels (SUA): SUA≥7." | 3.81 | Combination of hyperuricemia and metabolic syndrome is an independent and powerful predictor for left ventricular hypertrophy in rural Chinese. ( Guo, X; Sun, Y; Yang, H; Yu, S, 2015) |
| "To explore the association between serum uric acid (SUA) levels, metabolic syndrome (MetS) and cardiovascular disease (CVD) in patients treated with lipid-lowering agents from multiple centers in China." | 3.81 | The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study. ( Chen, K; Fang, Y; Hu, D; Mu, Y; Nie, Y; Tian, Y; Wang, H; Xie, Z, 2015) |
| " The association between serum uric acid and prevalence of colorectal adenoma was estimated from the results of a logistic regression analysis." | 3.81 | Uric Acid Is a Risk Indicator for Metabolic Syndrome-related Colorectal Adenoma: Results in a Korean Population Receiving Screening Colonoscopy. ( Chang, DK; Hong, SN; Jung, JH; Kim, ER; Kim, HJ; Kim, JE; Kim, JJ; Kim, YH; Rhee, PL; Son, HJ, 2015) |
| "The relationships between uric acid and chronic disease risk factors such as metabolic syndrome, type 2 diabetes mellitus, and hypertension have been studied in adults." | 3.81 | Uric Acid Levels Can Predict Metabolic Syndrome and Hypertension in Adolescents: A 10-Year Longitudinal Study. ( Chen, YL; Lue, KH; Pei, D; Sun, HL, 2015) |
| "Serum uric acid levels have been reported to be associated with metabolic syndrome (MetS)." | 3.80 | Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women. ( Chen, Y; Liu, PJ; Lou, HP; Ma, F; Zhu, YN, 2014) |
| "Serum levels of uric acid (UA) are associated with metabolic syndrome (MetS)." | 3.80 | Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population. ( Oda, E, 2014) |
| " With the reduction of serum potassium quartiles, participants were tended to have higher level of triglycerides and uric acid, lower level of high-density lipoprotein cholesterol (HDL-C), larger waist circumference and more severe insulin resistance." | 3.80 | Serum potassium level is associated with metabolic syndrome: a population-based study. ( Bi, Y; Li, M; Liu, J; Lu, J; Ning, G; Su, T; Sun, K; Xu, B; Xu, M, 2014) |
| " The changes of BMI-SDS in the time period of 1-year were related to baseline fasting insulin resistance index HOMA, blood pressure, waist circumference, waist-to-height ratio, lipids, uric acid, and HbA1c." | 3.80 | Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention. ( Knop, C; Reinehr, T; Uysal, Y; Wolters, B, 2014) |
| "Few studies have examined the association between elevated serum uric acid (SUA) levels and psoriasis, and their results have been inconclusive because most of these studies did not take into account the confounding effects of coexisting features of the metabolic syndrome." | 3.80 | Hyperuricemia in patients with chronic plaque psoriasis. ( Cagalli, A; Girolomoni, G; Gisondi, P; Targher, G, 2014) |
| "Serum uric acid (SUA) levels correlate with many recognized cardiovascular risk factors, including age, male sex, hypertension, diabetes mellitus, hypertriglyceridemia, obesity, and insulin resistance." | 3.80 | Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. ( Borghi, C; Cicero, AF; D'Addato, S; Rosticci, M; Salvi, P, 2014) |
| "The prevalence of MetS is related to obesity and elevated serum uric acid." | 3.80 | Clinical investigation of metabolic syndrome in the female elderly occupational population. ( Chang, HT; Chen, YF; Hu, YC; Shen, HC; Tung, TH, 2014) |
| "Serum uric acid (SUA) has been suggested as a potentially modifiable mediator associated with the metabolic syndrome." | 3.80 | Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes. ( Esteghamati, A; Fotouhi, A; Hafezi-Nejad, N; Nakhjavani, M; Sheikhbahaei, S, 2014) |
| "The relationship between metabolic syndrome (MetS) and uric acid (UA) has been explored in many studies, but there is paucity of information on hypo-uricemia and MetS." | 3.80 | Is lower uric acid level better? A combined cross-sectional and longitudinal study in the elderly. ( Chen, YL; Hsieh, CH; Hsu, CH; Liang, YJ; Lin, JD; Pei, D; Wu, CZ, 2014) |
| "A link between uric acid (UA) levels and cardiovascular diseases has been previously reported." | 3.80 | Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals. ( Gu, H; Li, R; Li, X; Lu, S; Ning, G; Qin, L; Shi, Q; Su, Q; Xing, Y; Yang, Z, 2014) |
| "To explore the relationship between serum uric acid (SUA) and metabolic syndrome (MS) in men, premenopausal women and postmenopausal women." | 3.80 | Association of uric acid with metabolic syndrome in men, premenopausal women and postmenopausal women. ( Chen, S; Deng, K; Guo, J; Holthöfer, H; Li, B; Li, Y; Liu, A; Liu, Q; Liu, X; Shao, X; Wang, H; Zhang, Y; Zou, H, 2014) |
| "To investigate the relationship between serum uric acid (UA) level and abdominal obesity or metabolic syndrome (MS)." | 3.80 | [The correlation between serum uric acid level and abdominal obesity or metabolic syndrome]. ( Dong, X; Li, H; Pan, Q; Yin, X; Yu, D; Zheng, F; Zhou, J, 2014) |
| " We studied the associations between the serum uric acid concentration and the following: (i) demographic, anthropometric and other variables previously reported to be associated with serum uric acid concentrations; (ii) the presence of metabolic syndrome and the levels of metabolic syndrome components; and (iii) selected genetic variants of the MTHFR (c." | 3.80 | Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration. ( Kožich, V; Pavlíková, M; Sokolová, J; Stibůrková, B, 2014) |
| "Serum uric acid levels have been reported to be associated with non-alcoholic fatty liver disease (NAFLD)." | 3.80 | Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. ( Chen, Y; Liu, PJ; Lou, HP; Ma, F; Zhu, YN, 2014) |
| "To investigate the relationship among serum uric acid levels and metabolic syndrome." | 3.80 | Serum uric acid levels and metabolic syndrome. ( Ciarla, S; Ferri, C; Giorgini, P; Necozione, S; Properzi, G; Striuli, R; Struglia, M, 2014) |
| "To evaluate whether uric acid (UA) predicts 4-yr incidence of metabolic syndrome (MetS) in non-diabetic participants of the Strong Heart Study (SHS) cohort." | 3.80 | Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity. ( de Simone, G; Devereux, RB; Ferrara, LA; Franceschini, N; Howard, BV; Jolly, S; Lee, ET; Umans, JG; Wang, H; Yeh, J, 2014) |
| "Excess circulating uric acid, a product of hepatic glycolysis and purine metabolism, often accompanies metabolic syndrome." | 3.80 | Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9. ( DeBosch, BJ; Fujiwara, H; Kluth, O; Moley, K; Schürmann, A, 2014) |
| "Serum uric acid levels are significantly associated with nonalcoholic fatty liver disease (NAFLD)." | 3.80 | The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease. ( Chen, Y; Xu, C; Zhang, J; Zhao, Y, 2014) |
| " The relationship between uric acid levels and left ventricular mass in hypertension, however, is unclear." | 3.80 | Uricaemia and left ventricular mass in hypertensive patients. ( Brosolo, G; Capobianco, F; Catena, C; Colussi, G; Sechi, LA, 2014) |
| " Fructose administration resulted in significant increase in body weight, elevations of blood glucose, serum insulin, cholesterol, triglycerides, advanced glycation end products (AGEs), uric acid levels, insulin resistance index and blood pressure compared to control rats." | 3.80 | Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. ( Elshazly, SM; Mahmoud, AA, 2014) |
| "The association between serum uric acid (SUA) levels and metabolic syndrome (MetS) has recently been reported in several cross-sectional and longitudinal studies." | 3.80 | A possible role of serum uric acid as a marker of metabolic syndrome. ( Cho, S; Kim, SR; Lee, YJ, 2014) |
| "To study the relationship between serum uric acid (SUA) level and metabolic syndrome (MS) in Uygur children and adolescents with overweight or obesity." | 3.80 | [Relationship between serum uric acid level and metabolic syndrome in Uygur children and adolescents with overweight or obesity]. ( Li, M; Mao, JF; Yi, LD; Zhang, MC, 2014) |
| "Hyperuricemia is related to Metabolic Syndrome (MetS) and cardiovascular diseases, but the use of serum uric acid (UA) to diagnose MetS is currently ignored in clinical practices." | 3.80 | The impact of serum uric acid on the diagnostic of metabolic syndrome in apparently healthy brazilian middle-aged men. ( Azevedo Novello, A; Bressan, J; Cardoso dos Santos, E; de Oliveira, A; Guedes Cocate, P; Hermsdorff, HHM; José Natali, A, 2014) |
| " Of note, diabetic subjects with glycosuria, who represented 24% of the diabetic participants, had a null prevalence of hyperuricemia, and statistically higher values for fractional excretion of uric acid, Na excretion index, and prevalence of microalbuminuria than those without glycosuria." | 3.80 | Serum uric acid and disorders of glucose metabolism: the role of glycosuria. ( Andrade, JA; Garcia Rosa, ML; Greffin, S; Kang, HC; Lugon, JR, 2014) |
| "Elevated serum uric acid (UA) is commonly found in subjects with metabolic syndrome (MetS)." | 3.80 | Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study. ( Berenson, GS; Chen, W; Fernandez, C; Li, S; Srinivasan, SR; Sun, D; Zhang, X, 2014) |
| "Elevated serum uric acid (UA) has been known to be associated with the prevalence of metabolic syndrome (MetS)." | 3.80 | Serum uric acid level and the incidence of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study. ( Choi, JM; Lee, JK; Park, SK; Ryoo, JH, 2014) |
| "To examine the association between hematological indices and serum uric acid in adolescents with hyperuricemia." | 3.80 | Hematological parameters in adolescents with hyperuricemia. ( Protas, P; Stelmach, MJ; Szczerbinski, L; Wasilewska, A; Wasilewska, N, 2014) |
| "We aimed to assess the extent to which metabolic syndrome (MetS) and serum uric acid (UA) and its interaction impact on diastolic heart failure (DHF)." | 3.79 | Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure. ( Fang, Z; Li, Z; Tang, ZH; Zeng, F; Zhou, L, 2013) |
| "Metabolic syndrome trait clustering is associated with greater severity of kidney stone disease; increased urinary calcium, uric acid, and oxalate excretion; and decreased urinary citrate excretion." | 3.79 | Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. ( Hara, I; Iguchi, M; Inagaki, T; Kohjimoto, Y; Matsumura, N; Sasaki, Y, 2013) |
| " The AD group was older, had higher BMI, waist circumference, higher proportion of metabolic syndrome and stroke, higher levels of triglyceride, high sensitivity C-reactive protein (hsCRP), uric acid, and lower levels of total cholesterol, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) than the normal testosterone group." | 3.79 | The prevalence and predictors of androgen deficiency in Taiwanese men with type 2 diabetes. ( Chancellor, MB; Chen, CD; Chuang, YC; Chung, MS; Lee, JJ; Lee, WC; Liu, RT; Wang, PW; Yang, KD, 2013) |
| "Obesity is a risk factor for metabolic syndrome and urolithiasis, particularly uric acid stones." | 3.79 | Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy. ( Agalliu, I; DiVito, J; Hoenig, DM; Watts, K; Zhou, T, 2013) |
| " Total cholesterol, high- and low-density lipoprotein cholesterol, triglyceride, fasting blood glucose and uric acid were determined, and hepatitis B serum antigen (HBsAg) and anti-HCV antibodies were assayed using commercial kits." | 3.79 | Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. ( Chen, IC; Chiu, FH; Chuang, CH; Lee, YY; Li, WC; Sun, C, 2013) |
| "Our aim was to study whether there is causal association between serum uric acid and metabolic syndrome (MetS)." | 3.79 | Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. ( Chen, W; Dai, X; Fang, W; Gui, L; Guo, H; He, M; Hu, FB; Li, X; Liang, Y; Miao, X; Min, X; Wang, Y; Wei, S; Wu, T; Yang, B; Yang, H; Yao, P; Yuan, J; Zhang, X, 2013) |
| "Increased serum uric acid (SUA) levels may be involved in the development of non-alcoholic fatty liver disease (NAFLD) in men presenting with metabolic syndrome (MetS) and/or insulin resistance." | 3.79 | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. ( Gao, Y; Hu, Y; Huang, Z; Li, L; Li, Z; Liang, Z; Liao, M; Lu, Z; Mo, Z; Peng, T; Qin, X; Shi, D; Sun, Y; Tan, A; Wang, M; Wu, C; Xie, Y; Yang, X; Zhang, H; Zhang, S; Zhang, Y, 2013) |
| "High uric acid (UA) levels and metabolic syndrome (MS) are risk factors for atherosclerotic diseases." | 3.79 | Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components. ( Sun, N; Tian, JL; Wang, H; Zhang, Y, 2013) |
| "The aim of this study was to compare serum uric acid values in two ethnically distinct Chinese populations: Uyghur, with a high prevalence of nonalcoholic fatty liver disease, and Han, with a lower prevalence." | 3.79 | Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. ( Cai, W; Miao, L; Sun, YP; Wu, X; Yao, H; Zhang, B; Zou, Y, 2013) |
| "To explore the levels of uric acid, blood pressure, serum lipid metabolic disorders and the distribution of obesity and metabolic syndrome (MS) among Uygur, Han and Kazak pre-diabetic groups in Xinjiang." | 3.79 | [A cross-sectional study on serum uric acid level and the distribution of metabolic syndrome among Uigur, Han and Kazak prediabetic groups in Xinjiang]. ( Jiang, S; Xu, YC; Zhang, HW, 2013) |
| " In other rats, glucose, insulin, uric acid, and insulin sensitivity index, were determined before and after fructose or lipoic acid plus fructose." | 3.79 | A single oral dose of fructose induces some features of metabolic syndrome in rats: role of oxidative stress. ( Hong, E; Moreno, JA, 2013) |
| " The higher CRP group was discriminated by the above variables in addition to lower VO(2max), serum metabolic syndrome components (triglycerides, glucose, and HDL cholesterol), higher insulin, homeostasis assessment of insulin resistance, uric acid, gamma-GT, and homocysteine." | 3.79 | Pathological and behavioral risk factors for higher serum C-reactive protein concentrations in free-living adults--a Brazilian community-based study. ( Burini, RC; de Oliveira, EP; Manda, RM; Michelin, E; Moreto, F; Teixeira, O; Torezan, GA, 2013) |
| "Metabolic syndrome is associated with a significantly increased risk of uric acid calculi development, especially those with impaired fasting glucose and hypertriglyceridemia." | 3.79 | Correlation of metabolic syndrome with urinary stone composition. ( Cho, ST; Jung, SI; Kim, TH; Myung, SC, 2013) |
| "Experimental and observational studies suggest a role for uric acid in non-alcoholic fatty liver disease (NAFLD)." | 3.79 | Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. ( Chonchol, M; Jalal, DI; Johnson, RJ; McFann, K; Sirota, JC; Targher, G, 2013) |
| "The objective of this study was to examine the association between uric acid, GGT, obesity and the individual components of metabolic syndrome in children and adolescents." | 3.79 | Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents. ( Chan, CW; Chan, JC; Chan, MH; Choi, KC; Ho, CS; Kong, AP; Ozaki, R, 2013) |
| "High plasma uric acid (UA) is a prerequisite for gout and is also associated with the metabolic syndrome and its components and consequently risk factors for cardiovascular diseases." | 3.79 | Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults. ( Burini, RC; de Oliveira, EP; Moreto, F; Silveira, LV, 2013) |
| " This study sought to determine the association between the novel G109T polymorphism in SLC22A12 with serum uric acid and the development of metabolic syndrome in Korean male subjects." | 3.78 | G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome. ( Ahn, YC; Choe, JY; Her, M; Jang, WC; Kim, SK; Nam, YH; Park, SH; Park, SM; Yoon, IK, 2012) |
| " Since low urine pH is the main risk factor for uric acid urolithiasis (UAU), UAU may be regarded as a renal manifestation of the MS." | 3.78 | Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis. ( Schubert, G; Strohmaier, WL; Wrobel, BM, 2012) |
| "Among adolescents, uric acid is associated with insulin resistance, hypertension, and the metabolic syndrome (MetS); and in adults, high uric acid levels are an independent risk factor for cardiovascular disease and diabetes." | 3.78 | Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006. ( DeBoer, MD; Dong, L; Gurka, MJ, 2012) |
| "Serum uric acid (SUA) is a potential risk factor for atherosclerosis." | 3.78 | Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. ( Bian, L; Choi, Y; Zhang, Z, 2012) |
| "The objective of this study was to explore the relationships between circulating uric acid and lipid levels and components of the metabolic syndrome (MetS) in Arab dyslipidemic patients, a group already at high coronary artery disease risk." | 3.78 | Determinants of blood uric acid levels in a dyslipidemic Arab population. ( Akanji, AO; Al-Meshaweh, AF; Asem, M; Jafar, Y, 2012) |
| "Despite some epidemiologic research demonstrating a positive relationship between serum uric acid (SUA) levels and the prevalence of metabolic syndrome (MetS), prospective data on SUA as a predictor of MetS incidence are limited." | 3.78 | Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. ( Bai, CH; Chien, KL; Chou, WY; Chou, YC; Chu, CH; Hwang, LC; Su, TC; Sun, CA; Tseng, CH; Yang, T; You, SL, 2012) |
| "In this study, we examined whether melatonin improves metabolic syndrome induced by high fructose intake in male Wistar rats." | 3.78 | Melatonin improves metabolic syndrome induced by high fructose intake in rats. ( Kitagawa, A; Ohashi, K; Ohta, Y, 2012) |
| " Associations between uric acid (UA), metabolic syndrome (MetS) and carotid IMT have been reported, but findings regarding the relationship have been inconsistent." | 3.78 | Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. ( Abe, M; Kawamoto, R; Kusunoki, T; Onji, M; Takayama, S, 2012) |
| "Baseline levels of serum uric acid were negatively correlated with HbA1c, were higher in men and in the elderly and were independently associated with components of the metabolic syndrome." | 3.78 | Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study. ( Barutta, F; Bruno, G; Cavallo-Perin, P; Fornengo, P; Ghezzo, G; Greco, E; Gruden, G; Panero, F; Perotto, M; Runzo, C, 2012) |
| " The study measured the serum high sensitivity C-reactive protein (CRP) as an inflammatory marker, serum insulin as a marker of insulin resistance and serum high-molecular-weight adiponectin (HMW-adipo), in addition to the serum levels of liver enzymes and uric acid." | 3.78 | Predictive ability of serum high-molecular-weight adiponectin in combination with serum insulin and serum C-reactive protein for the presence of metabolic syndrome. ( Hasegawa, M; Kawada, T, 2012) |
| "For more than 200 years initially seen as a cause of gout, speaking in a politically correct 21st century term, a disease of the rich and very well nourished people, many experimental and epidemiological studies have associated increased levels of serum uric acid (UA) with the classical components of the metabolic syndrome (MS), type 2 diabetes, and cardiovascular disease [1]." | 3.78 | Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander? ( Santos, RD, 2012) |
| "To evaluate the cause-effect relationships between serum levels of uric acid (UA) and metabolic syndrome (MetS) in an adolescent-male cohort that was followed for 2." | 3.78 | Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents. ( Chen, YL; Hsu, CH; Pei, D; Tang, SH; Wang, JY; Wu, CZ, 2012) |
| " At the end of the feeding schedule, Dia group had insulin resistance along with increased blood glucose, triglyceride, uric acid and nitric oxide (NO) levels." | 3.78 | Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. ( Bagul, PK; Banerjee, SK; Bastia, T; Chakravarty, S; Madhusudana, K; Matapally, S; Middela, H; Padiya, R; Reddy, BR, 2012) |
| "It has been recently demonstrated that serum uric acid (UA) is associated with metabolic syndrome (MetS) or its related clinical indications based on cross-sectional or prospective cohort studies." | 3.78 | A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. ( Lin, H; Liu, L; Meng, W; Song, X; Tang, F; Xue, F; Yang, X; Zhang, C; Zhang, D; Zhang, Q; Zhang, Y; Zhu, Z, 2012) |
| " Obesity was not associated with differences in composition, although a secondary analysis of morbidly obese patients showed a higher proportion of uric acid stones and a lower proportion of calcium oxalate stones." | 3.78 | Metabolic syndrome and urinary stone composition: what factors matter most? ( Fridirici, ZC; Greco, K; Hart, ST; Kadlec, AO; Turk, TM; Vellos, T, 2012) |
| "Uric acid, the levels of which have been shown to increase after menopause, has been associated with metabolic syndrome." | 3.77 | Relationship between uric acid and metabolic syndrome according to menopausal status. ( Ahn, KH; Cho, GJ; Hur, JY; Kim, SH; Kim, T; Kim, YT; Lee, HJ; Park, HT; Shin, JH; Yi, KW, 2011) |
| " Studies on the association between serum uric acid (sUA) and metabolic syndrome (MetS) in juvenile obesity are scant." | 3.77 | Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity. ( Chrzanowska, J; Gamian, A; Krzystek-Korpacka, M; Kustrzeba-Wojcicka, I; Noczynska, A; Patryn, E, 2011) |
| "Elevated serum uric acid (SUA) concentrations have been suggested to associate with metabolic syndrome (MetS) and its components." | 3.77 | The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. ( Larijani, B; Meshkani, R; Zargari, M, 2011) |
| " A clinical study on 467 patients with nephrolithiasis at our institution revealed that clustering of MetS traits increased the risk of uric acid stone formation by decreasing urinary pH." | 3.77 | [Metabolic syndrome and nephrolithiasis]. ( Hara, I; Iba, A; Kohjimoto, Y; Sasaki, Y, 2011) |
| " MetS was defined according to Japanese criteria, and serum uric acid (UA) levels in the upper half of the fifth (highest) quintile range were defined as severe hyperuricemia, whereas those in the lower half of this quintile range were defined as mild hyperuricemia." | 3.77 | Relationships among hyperuricemia, metabolic syndrome, and endothelial function. ( Higashi, Y; Inoue, T; Ishibashi, Y; Node, K; Sata, M; Shimada, K; Takase, B; Tomiyama, H; Ueda, S; Yamashina, A, 2011) |
| "To examine the association between renal function, serum uric acid and markers of both pro-inflammatory and prothrombotic state in patients with diabetes mellitus (DM), metabolic syndrome and coronary artery disease." | 3.77 | Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. ( Buraczyńska, MJ; Kondracki, B; Rychta, E; Waciński, P; Wysokiński, A; Zapolski, T, 2011) |
| "We investigate whether the changing environment caused by rapid economic growth yielded differential effects for successive Taiwanese generations on 8 components of metabolic syndrome (MetS): body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting plasma glucose (FPG), triglycerides (TG), high-density lipoprotein (HDL), Low-density lipoproteins (LDL) and uric acid (UA)." | 3.77 | Unravelling the effects of age, period and cohort on metabolic syndrome components in a Taiwanese population using partial least squares regression. ( Burley, V; Chien, KL; Gilthorpe, MS; Tu, YK, 2011) |
| "We aimed to investigate whether elevated serum uric acid concentrations are associated with higher risk of metabolic syndrome (MetS) and carotid atherosclerosis in patients with type 2 diabetes." | 3.77 | Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. ( Chen, L; He, M; Hu, R; Huang, Y; Li, Q; Lu, B; Qu, S; Tao, X; Wen, J; Yang, Z; Ye, Z; Zhang, W; Zhang, Z, 2011) |
| " Fructose and non-fructose sugar ordinary consumption was not positively associated with indicators of metabolic syndrome, uric acid and BMI." | 3.77 | Fructose and non-fructose sugar intakes in the US population and their associations with indicators of metabolic syndrome. ( Anderson, GH; Empie, MW; Flickinger, BD; Sun, SZ; Williamson-Hughes, PS, 2011) |
| "The prevalence of albuminuria increases gradually with uric acid elevation." | 3.77 | [The relationship between urinary albumin excretion and serum uric acid in general population]. ( Cai, JF; Fan, XH; Gao, BX; Li, H; Li, JH; Li, XM; Li, XW; Liu, LL; Liu, XJ; Meng, QY; Mou, LJ; Wang, HY; Wu, JX, 2011) |
| "Because approximately 70% of uric acid is excreted from the kidney, hyperuricemia occurs when renal function deteriorates." | 3.77 | Relationship between hyperuricemia and chronic kidney disease. ( Ohno, I, 2011) |
| " In addition, both diets induced hepatic alterations, including variable increases in hepatic TG accumulation and fatty liver, an increase in uric acid content in the liver, as well as an increase in hepatic levels of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha) measured in liver homogenates." | 3.76 | Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver. ( Abdelmalek, M; Johnson, RJ; Lan, HY; Le, M; Mu, W; Nakagawa, T; Reungjui, S; Roncal, C; Sánchez-Lozada, LG; Sautin, YY; Yu, X, 2010) |
| "Little is known about the interrelationships between metabolic syndrome (MS), uric acid, and early carotid atherosclerosis with diet in adolescents." | 3.76 | Carotid intima-media thickness, dietary intake, and cardiovascular phenotypes in adolescents: relation to metabolic syndrome. ( Barth, JD; Croymans, DM; Roberts, CK; Sanchez, A, 2010) |
| "A positive association between serum uric acid and metabolic syndrome has been reported, but little information is available about the association between serum uric acid and metabolic syndrome in Taiwanese adults." | 3.76 | Serum uric acid and metabolic syndrome in Taiwanese adults. ( Chang, TY; Chen, JD; Liu, PW, 2010) |
| " Resistin and uric acid, surrogate plasma markers of metabolic syndrome, were decreased." | 3.76 | Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. ( Alfredo Martinez, J; Bour, S; Carpéné, C; Iffiú-Soltész, Z; Lomba, A; Milagro, FI; Pellati, F; Portillo, MP; Szöko, E; Valet, P; Wanecq, E; Woodley, J, 2010) |
| " The cut-off point varied in subjects with various cardiovascular risk profiles such as serum uric acid level, gender or hypertension." | 3.76 | Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors. ( Ahn, JM; Chae, DW; Chin, HJ; Heo, NJ; Kim, S; Lee, TW; Na, KY, 2010) |
| "A medical history was taken, and FGF21 (measured using an ELISA commercial kit), glucose, uric acid, plasma lipids, total/high-molecular weight (HMW) adiponectin, and retinal-binding protein 4 (RBP4) were measured in 210 individuals with (n=81) and without (n=129) metabolic syndrome." | 3.76 | Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. ( Aguilar-Salinas, CA; Almeda-Valdes, P; Arellano-Campos, O; Cruz-Bautista, I; Cuevas-Ramos, D; Gómez-Pérez, FJ; Meza-Arana, CE; Navarrete-López, M, 2010) |
| " We examined the association between uric acid levels and various clinical parameters, including the components of metabolic syndrome, in essential hypertension." | 3.76 | Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension. ( Anzawa, R; Fujii, T; Seki, S; Tsutsui, K; Yamazaki, K; Yoshimura, M, 2010) |
| "Uric acid (UA) is considered to be a powerful predictor of cardiovascular risk and hyperuricemia might be involved in the metabolic syndrome (MS)." | 3.76 | Relation of uric acid levels to aortic root dilatation in hypertensive patients with and without metabolic syndrome. ( Chen, XF; Du, YX; Fang, CF; Jiang, JJ; Lin, XF; Pu, ZX; Tang, LJ; Wang, JA, 2010) |
| " We enrolled 777 healthy women and women with breast cancer in our nested case-control study to evaluate the association between MS and breast cancer, analyzing anthropometric parameters (weight, height, BMI, waist and hip circumference), blood pressure, serum HDL-C, triglyceride, fasting plasma glucose, insulin, testosterone and uric acid levels and administering a questionnaire about physical activity, food intake, tobacco use, alcohol abuse, personal and familial history of disease." | 3.76 | Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. ( Capasso, I; Cavalcanti, E; Crispo, A; D'Aiuto, G; D'Aiuto, M; De Marco, M; Esposito, E; Esposito, G; Frasci, G; Fucito, A; Giordano, A; Grimaldi, M; Maurea, N; Montella, M; Pedicini, T; Pentimalli, F; Vecchione, A, 2010) |
| " The objective of this study was to analyze the relationships of leptin, C-reactive protein (CRP), adiponectin, insulin, and uric acid to the metabolic syndrome components in lean, overweight, and obese young females." | 3.75 | Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. ( Abdullah, AR; Hasan, HA; Raigangar, VL, 2009) |
| "The aim of the study was to assess the association of serum uric acid levels with microalbuminuria -urinary albumin excretion (UAE)> or = 30mg/24h-." | 3.75 | Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients. ( Costa, JA; González, C; Miralles, A; Moral, D; Pascual, JM; Pérez-Lahiguera, F; Rodilla, E, 2009) |
| "Serum uric acid level has been suggested to be associated with factors that contribute to the metabolic syndrome." | 3.75 | Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. ( Li, Y; Miao, M; Xu, C; Xu, L; Yu, C, 2009) |
| "The aim of this study was to investigate prevalences of hyperuricemia and the metabolic syndrome (MS) in the Hangzhou population, and the relationship between serum uric acid and the MS." | 3.75 | Hyperuricemia and the metabolic syndrome in Hangzhou. ( Cai, Z; Li, D; Wu, X; Xu, X; Zhou, C, 2009) |
| " At moderate or high doses, an effect on any one marker may be absent or even the opposite of that observed at very high or excessive doses; examples include fasting plasma triglyceride, insulin sensitivity, and the putative marker uric acid." | 3.75 | Fructose ingestion: dose-dependent responses in health research. ( Livesey, G, 2009) |
| "The relationship among serum uric acid (SUA), metabolic syndrome, and chronic kidney disease (CKD) is unclear." | 3.75 | Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. ( Chen, HW; Chen, YM; Chuang, FH; Kuo, CF; Li, HY; See, LC; Yu, KH, 2009) |
| "Allopurinol was administered to end-stage renal disease (ESRD) patients with elevated uric acid levels presenting with symptoms of gout and also had risk factors of metabolic syndrome." | 3.75 | The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study. ( Beavers, D; Bowden, RG; Hartman, J; Shelmadine, B; Wilson, RL, 2009) |
| "The relationships between uric acid and metabolic syndrome (MetS) and diabetes, as well as the gender differences in these relationships are controversial." | 3.75 | Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. ( Kawai, R; Oda, E; Sukumaran, V; Watanabe, K, 2009) |
| "Serum uric acid (SUA) level is often elevated in participants with metabolic syndrome (MS), and hyperuricemia appears linked inextricably to the presence of MS." | 3.75 | The relationship between serum uric acid concentration and metabolic syndrome in university freshmen. ( Lin, KP, 2009) |
| "The effects of exercise and serum uric acid on the metabolic syndrome (MetS) were evaluated." | 3.74 | Effects of exercise and serum uric acid on the metabolic syndrome for Japanese workers. ( Amezawa, M; Kawada, T, 2008) |
| "The aim of this study is to investigate the respective associations of alanine aminotransferase (ALT), white blood cell (WBC) count, and uric acid with metabolic syndrome and compare the magnitude in their association with metabolic syndrome, using modified Adult Treatment Panel III (ATP III) and its components." | 3.74 | Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults. ( Kang, YH; Kim, IJ; Kim, YK; Min, HG; Son, SM, 2008) |
| "Perfusion of rat urinary bladder with uric acid (UA) or 1-methyl uric acid (1-MUA) solution was reported to produce features of metabolic syndrome, viz." | 3.74 | Role for the urinary bladder in pathogenesis of metabolic syndrome in Wistar rats. ( Balasubramanian, T, 2008) |
| "Information on plasma homocysteine concentrations and their associated factors in Brazilian subjects with metabolic syndrome (MS) is nonexistent." | 3.74 | Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene. ( Rosa, G; Uehara, SK, 2008) |
| "This post hoc analysis of the GREek Atorvastatin and Coronary heart disease (CHD)." | 3.74 | Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluati ( Athyros, VG; Elisaf, M; Ganotakis, ES; Kakafika, AI; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Papageorgiou, AA; Tziomalos, K, 2007) |
| " Several substances (such as leptin and adiponectin) are secreted from adipocytes, which may contribute to regulate energy homeostasis and the development of cardiovascular diseases." | 3.74 | Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. ( Caliumi, C; Cavallaro, G; Cotesta, D; D' Erasmo, E; De Toma, G; Delfini, E; Diacinti, D; Letizia, C; Mazzuoli, GF; Minisola, S; Panzironi, G; Petramala, L, 2007) |
| "The aim of this project was to study the risk of developing hypertension over a 6-year follow-up in normotensive men with baseline hyperuricemia (serum uric acid >7." | 3.74 | Hyperuricemia and incidence of hypertension among men without metabolic syndrome. ( Krishnan, E; Kuller, L; Kwoh, CK; Schumacher, HR, 2007) |
| "We examined the associations of serum uric acid (UA) with indices of coronary heart disease (CHD) risk, including the 10-year probability of CHD (10y-CHDr), metabolic syndrome (MS), inflammation (C-reactive protein [CRP] and fibrinogen), and the presence and quantity of coronary artery calcium (CAC)." | 3.74 | Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. ( Bielak, LF; Coutinho, Tde A; Kullo, IJ; Peyser, PA; Sheedy, PF; Turner, ST, 2007) |
| "By using data from 8669 participants aged 20 years and more in The Third National Health and Nutrition Examination Survey (1988-1994), we determined the prevalence of the metabolic syndrome at different serum uric acid levels." | 3.74 | Prevalence of the metabolic syndrome in individuals with hyperuricemia. ( Choi, HK; Ford, ES, 2007) |
| "The association between concentrations of uric acid and the metabolic syndrome in children and adolescents remains incompletely understood." | 3.74 | Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. ( Choi, HK; Cook, S; Ford, ES; Li, C, 2007) |
| "This study investigates the impact of uric acid (UA) on the risk factors associated with metabolic syndrome." | 3.74 | Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. ( Chang, HY; Chiou, WK; Lin, JD; Liu, FH; Weng, HF, 2007) |
| "The aim of our investigation was to study the peculiarities of serum uric acid (UA) levels in patients with metabolic syndrome (MS) and without it, also correlations between UA and parameters of MS features." | 3.74 | [Levels of uric acid in serum in patients with metabolic syndrome]. ( Dzhavashvili, LV; Esaliia, NG; Tananashvili, DE; Tetradze, LO; Virsaladze, DK, 2007) |
| " Additionally, serum uric acid is positively associated with metabolic syndrome." | 3.74 | Relationship between hyperuricemia and metabolic syndrome. ( Chen, JH; Chen, LQ; Chen, LY; Chen, ZW; Dai, HL; Fang, LZ; Ren, JJ; Zhu, WH, 2007) |
| "Gout and increased serum uric acid (SUA) levels are often seen in patients with components of the metabolic syndrome." | 3.74 | Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. ( Algra, A; Hjortnaes, J; Huisman, M; Jacobs, J; Olijhoek, J; van der Graaf, Y; Visseren, F, 2007) |
| "The aim of this study was to examine whether serum uric acid (SUA) concentration was related to the metabolic syndrome (MS)." | 3.74 | Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen. ( Katsumata, M; Kawada, T; Otsuka, T; Suzuki, H, 2007) |
| "We investigated the relationship between serum uric acid (SUA) and body fat area, serum lipid level, insulin resistance, and metabolic syndrome in Japanese men." | 3.74 | Relationship between hyperuricemia and body fat distribution. ( Hikita, M; Hosoya, T; Ichida, K; Mori, Y; Ohno, I; Yokose, T, 2007) |
| " Potassium supplementation improves their insulin resistance and hypertension, whereas allopurinol reduces serum levels of uric acid and ameliorates hypertension, hypertriglyceridemia, hyperglycemia, and insulin resistance." | 3.74 | Thiazide diuretics exacerbate fructose-induced metabolic syndrome. ( Johnson, RJ; Mu, W; Nakagawa, T; Reungjui, S; Roncal, CA; Sirivongs, D; Srinivas, TR, 2007) |
| " The risk for metabolic syndrome increased with an increase of body mass index and plasma uric acid level, and decreased with the vigorous physical activity and current alcohol drinking." | 3.74 | Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. ( Chiu, TY; Huang, KC; Lee, LT; Lee, YC; Lin, YC; Yen, SL, 2008) |
| "The link between uric acid levels and metabolic syndrome was investigated." | 3.74 | Comparison of serum uric acid levels between Japanese with and without metabolic syndrome. ( Makino, H; Miyatake, N; Numata, T; Wada, J, 2008) |
| "To assess the association of serum uric acid (UA) with components of metabolic syndrome (MetS) in different ethnic groups." | 3.74 | Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China. ( Alberti, G; Chitson, P; Dong, Y; Gao, W; Nan, H; Pauvaday, V; Qiao, Q; Shaw, J; Söderberg, S; Tuomilehto, J; Uusitalo, U; Zimmet, P, 2008) |
| "To assess the correlation between serum uric acid and insulin resistance in natural population of Beijing." | 3.74 | [Correlation between serum uric acid and insulin resistance]. ( Li, GW; Liu, J; Liu, S; Qin, LP; Wang, M; Wang, W; Zhao, D; Zhou, GH, 2007) |
| "Cross-sectional studies indicate metabolic syndrome is a risk factor for elevated serum uric acid." | 3.74 | Impact of childhood metabolic syndrome components on the risk of elevated uric acid in adulthood: the Bogalusa Heart Study. ( Berenson, G; Chen, W; Menke, A; Muntner, P; Patel, DA; Srinivasan, S, 2008) |
| "Associations between serum uric acid (UA) levels and metabolic syndrome (MetS) have been reported in cross-sectional studies." | 3.74 | Uric acid and the development of metabolic syndrome in women and men. ( Blair, SN; Church, TS; Lobelo, F; Meriwether, RA; Sui, X, 2008) |
| " After adjusting for age, total cholesterol, and smoking status, the odds ratios (95% CI) of sex-specific quartiles of serum uric acid for metabolic syndrome were 1." | 3.73 | Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. ( Ishizaka, N; Ishizaka, Y; Nagai, R; Toda, E; Yamakado, M, 2005) |
| "The levels of the liporegulatory hormone leptin are increased in obesity, which contributes to the metabolic syndrome; the latter is associated with elevated cardiovascular risk and morbidity." | 3.73 | Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans. ( Chraibi, A; Israili, ZH; Lyoussi, B; Mguil, M; Ragala, MA, 2005) |
| " The present study examined a Korean adult population with respect to the relationships between serum uric acid concentrations and hypertension, insulin resistance, and the risk factors of metabolic syndrome." | 3.73 | Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. ( Kang, JH; Keum, DG; Kim, BJ; Kim, BS; Kim, H; Kim, SW; Lee, MH; Lee, WY; Park, JR; Rhee, EJ; Ryu, SH; Shin, HS; Sung, KC; Yoo, TW, 2005) |
| "The worldwide epidemic of metabolic syndrome correlates with an elevation in serum uric acid as well as a marked increase in total fructose intake (in the form of table sugar and high-fructose corn syrup)." | 3.73 | A causal role for uric acid in fructose-induced metabolic syndrome. ( Block, ER; Feig, DI; Glushakova, O; Herrera-Acosta, J; Hu, H; Johnson, RJ; Nakagawa, T; Ouyang, X; Patel, JM; Short, RA; Tuttle, KR; Zharikov, S, 2006) |
| " After adjustment for the degree of obesity, subjects with MS had significantly higher uric acid (6." | 3.73 | Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. ( Gilardini, L; Girola, A; Invitti, C; Maffeis, C; Mazzilli, G; Morabito, F; Pontiggia, B; Sartorio, A; Viberti, GC, 2006) |
| "Hyperuricemia is considered a feature of the metabolic syndrome (MS) despite serum uric acid (SUA) is not considered a diagnostic criterion." | 3.73 | [Serum urate levels and urinary uric acid excretion in subjects with metabolic syndrome]. ( Bascuñana-Quirell, A; Benítez-Rodríguez, E; Elvira-González, J; Escribano-Serrano, J; López-Suárez, A; Michán-Doña, A; Rosal-Obrador, J, 2006) |
| "To study effects of uric acid disbolism in combination with other metabolic disturbances on prevalence and clinical symptoms of arterial hypertension; contribution of uric acid nephropathy to its development." | 3.73 | [Relationships between arterial hypertension, metabolic disturbances and uric acid nephropathy]. ( Balkarov, IM; Britov, AN; Deev, AD; Eliseeva, NA, 2006) |
| "Abdominal obesity is the main determinant of uric acid variance." | 3.73 | Serum uric acid is a determinant of metabolic syndrome in a population-based study. ( Albayrak, S; Hergenç, G; Karabulut, A; Keleş, I; Onat, A; Sari, I; Uyarel, H; Yazici, M, 2006) |
| "0001) differences, and correlated significantly in a beneficial manner to measures of obesity (body mass index, waist circumference, and abdominal height), mean arterial blood pressure, lipoprotein variables (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), measures of glucose homeostasis (insulin, glucose, homeostasis model assessment of insulin resistance [HOMA-IR]), and uric acid, after adjusting for age, race, sex, and cigarette smoking." | 3.73 | Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study. ( Berenson, GS; Chen, W; Patel, DA; Srinivasan, SR; Xu, JH, 2006) |
| "Serum uric acid (UA) level has been suggested to be associated with factors that contribute to the metabolic syndrome." | 3.73 | Association between serum uric acid level and components of the metabolic syndrome. ( Hsu, SR; Lin, SD; Tsai, DH, 2006) |
| " Besides alcohol consumption and the use of antihypertensive therapy, mainly diuretics, serum uric acid is markedly associated with parameters of the metabolic syndrome, in particular serum triglycerides." | 3.72 | Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. ( Bovet, P; Burnier, M; Conen, D; Paccaud, F; Riesen, W; Shamlaye, C; Wietlisbach, V, 2004) |
| "Blood levels of uric acid, cholesterol, triglycerides (TG), high and low density lipoproteins were examined and glucose tolerance test was made in 108 adolescents with arterial hypertension (AH) and different physical constitution (normal, with overweight and obese)." | 3.72 | [Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome]. ( Kazakova, LM; Rovda, EIu; Rovda, IuI; Rovda, TS, 2004) |
| " The aim of this study was to analyse the role of different variables of metabolic syndrome, including leptin, in 74 non-obese children and 68 children with non-syndromal obesity." | 3.71 | Leptin and metabolic syndrome in obese and non-obese children. ( Bueno, M; Fleta, J; Giner, A; Juste, MG; Moreno, LA; Pineda, I; Rodríguez, G; Sarría, A, 2002) |
| "The serum uric acid level has been said to be an independent predictor of cardiovascular disease death, mainly for women, and to be linked with the metabolic Syndrome X of insulin resistance, obesity, hypertension, and dyslipidemia." | 3.71 | Elevated serum leptin concentrations in women with hyperuricemia. ( Chiba, H; Katayose, S; Maruoka, S; Matsubara, M, 2002) |
| " When the cluster of metabolic syndrome was analyzed, SG was inversely related to uric acid levels and to the waist-hip index." | 3.71 | [Glucose effectiveness and components of the metabolic syndrome in recently diagnosed hypertensive patients]. ( Carneado de la Fuente, J; García Morillo, JS; García-Junco, PS; Miranda Guisado, ML; Muñiz Grigalvo, O; Pamies Andreu, E; Vallejo Maroto, I; Villar Ortiz, J, 2002) |
| "The plasma adiponectin levels negatively correlated with BMI, waist-to-hip ratio, fasting plasma glucose, insulin, triglyceride, uric acid levels, hyperinsulinemia, and glucose intolerance in OGTT, but positively with high-density lipoprotein-cholesterol." | 3.71 | Plasma adiponectin levels in overweight and obese Asians. ( Chao, CL; Chen, CL; Chuang, LM; Funahashi, T; Lee, WJ; Matsuzawa, Y; Tai, TY; Tanaka, S; Yang, WS, 2002) |
| "High uric acid concentration is a common finding in subjects with risk factors for cardiovascular disease (CVD), including some characteristics of the metabolic syndrome." | 3.71 | Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. ( Bedini, J; Conget, I; Costa, A; Igualá, I; Quintó, L, 2002) |
| "To examine the relation between fitness and fibrinogen, white blood cell count, uric acid and metabolic syndrome across levels of adiposity in apparently healthy, nonsmoking men." | 3.71 | Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. ( Blair, SN; Church, TS; Earnest, CP; Finley, CE; Gibbons, LW; Kampert, JB, 2002) |
| "So far, to treat hyperuricemia, it has been recommended to use a low-purine diet characterized by limiting protein-containing products." | 3.01 | High-Fructose Diet-Induced Hyperuricemia Accompanying Metabolic Syndrome-Mechanisms and Dietary Therapy Proposals. ( Formanowicz, D; Lubawy, M, 2023) |
| "Psoriasis is a chronic inflammatory dermatosis leading to the development of systemic inflammatory reaction." | 2.78 | [Analysis of the chosen parameters of metabolic status in patients with psoriasis]. ( Kacalak-Rzepka, A; Kiedrowicz, M; Maleszka, R, 2013) |
| " Although blood levels of potassium, hemoglobin A1c and uric acid (UA) significantly increased after 3 months for all of the patients, none of the patients showed serious adverse effects." | 2.77 | Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension. ( Arimura, T; Fujisawa, K; Inoue, A; Kuwano, T; Matsunaga, E; Mitsutake, R; Miura, S; Morii, J; Nagata, I; Norimatsu, K; Saku, K; Shiga, Y; Shimizu, T; Shirotani, T; Uehara, Y, 2012) |
| "Atorvastatin was titrated from 10-80 mg/day aiming at a low density lipoprotein cholesterol (LDL-C) target of <100 mg/dl (group A) or an LDL-C target of <130 mg/dl (group B)." | 2.76 | Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. ( Alexandrides, T; Athyros, VG; Bacharoudis, G; Ganotakis, ES; Karagiannis, A; Liberopoulos, EN; Mikhailidis, DP; Nicolaou, V; Paletas, K; Tziomalos, K, 2011) |
| "Recently, nephrolithiasis has been reported to be involved with renal manifestation of metabolic syndrome." | 2.73 | Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH. ( Inokuchi, T; Ka, T; Kobayashi, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T, 2007) |
| "Obesity is one of the actual problems of modern medicine." | 2.61 | [A role of fructose in urinary stone formation]. ( Golodnikov, II; Kamalov, AA; Nizov, AN; Pavlova, ZS, 2019) |
| "Hyperuricemia has been linked to metabolic syndrome, cardiovascular disease, and chronic kidney disease." | 2.55 | Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus. ( Ahmadieh, H; Azar, S, 2017) |
| "Gout is both an inflammatory and a metabolic disease." | 2.55 | Gout and Metabolic Syndrome: a Tangled Web. ( Krasnokutsky, S; Pillinger, MH; Thottam, GE, 2017) |
| "Nonalcoholic fatty liver disease (NAFLD) is a major, worldwide public health problem." | 2.53 | Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease. ( Braddock, M; Liu, WY; Lu, QD; Shi, KQ; Song, D; Sun, DQ; Wu, SJ; Zheng, MH; Zhu, GQ, 2016) |
| "Nonalcoholic fatty liver disease (NAFLD), tightly linked to the metabolic syndrome (MS), has emerged as a leading cause of chronic liver disease worldwide." | 2.53 | Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD. ( Fargion, S; Lombardi, R; Pisano, G, 2016) |
| "Uric acid stones are a consequence of the excessively acidic urine that results from insulin resistance." | 2.50 | Metabolic syndrome: a multifaceted risk factor for kidney stones. ( Domingos, F; Serra, A, 2014) |
| "Hyperuricemia is linked to gout and features of metabolic syndrome." | 2.48 | The effects of fructose intake on serum uric acid vary among controlled dietary trials. ( Beyene, J; Carleton, AJ; Chiavaroli, L; Cozma, AI; de Souza, RJ; Di Buono, M; Ha, V; Jenkins, AL; Jenkins, DJ; Kendall, CW; Leiter, LA; Mirrahimi, A; Sievenpiper, JL; Wang, DD; Wolever, TM; Yu, ME, 2012) |
| "Hyperuricemia is a specific risk factor for cardiovascular morbidity and mortality." | 2.47 | [Hyperuricemia and uro-nephrological disorders]. ( Hurtes, X; Meria, P, 2011) |
| "Hyperuricemia is a prevalent finding in patients presenting metabolic syndrome, although its clinical meaning is still controversial and often underestimated." | 2.46 | Uric acid as a factor in the metabolic syndrome. ( Batista, MC; Borges, RL; Ribeiro, AB; Zanella, MT, 2010) |
| "Gout and hyperuricemia have long been suspected to be risk factors for cardiovascular disease." | 2.46 | Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? ( Keenan, RT; Shah, A, 2010) |
| "Uric acid has previously been viewed as a benign solute in serum until it exceeds its saturation level." | 2.45 | The role of hyperuricemia in vascular disorders. ( Edwards, NL, 2009) |
| "Allopurinol is an inhibitor of xanthine oxidoreductase (XOR) and inhibits the generation of uric acid (UA) as the final product of purine catabolism, as well as the resulting generation of superoxide (O2(-)), in humans." | 2.45 | Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders? ( Nozaki, S; Onuma, M; Suzuki, I; Yamauchi, T, 2009) |
| "Urolithiasis is a clinically important complication of gout." | 2.44 | [Urolithiasis and nephropathy complicated with gout]. ( Shimizu, T, 2008) |
| "Metabolic syndrome is a cluster of cardiovascular risk factors such as hypertriglyceridemia, hypertension, insulin resistance, based on visceral fat accumulation." | 2.44 | [Relationship between hyperuricemia and metabolic syndrome]. ( Tomita, K; Yamasaki, T, 2008) |
| "Gout is the most common inflammatory arthritis in men, affecting approximately 1-2% of adult men in Western countries." | 2.43 | Recent developments in diet and gout. ( Kavanaugh, A; Lee, SJ; Terkeltaub, RA, 2006) |
| "Hyperuricemia has long been known to be associated with cardiovascular disease, and it is particularly common in people with hypertension, metabolic syndrome, or kidney disease." | 2.43 | Role of uric acid in hypertension, renal disease, and metabolic syndrome. ( Heinig, M; Johnson, RJ, 2006) |
| "Hyperuricemia is perceived as one of the risk factors for developing and progressing cardiovascular disease and metabolic syndrome through various pathological mechanisms." | 1.91 | Effect of Alcohol Consumption Habits on Early Arterial Aging in Subjects with Metabolic Syndrome and Elevated Serum Uric Acid. ( Badarienė, J; Čypienė, A; Gimžauskaitė, S; Jasiūnas, E; Laucevičius, A; Rinkūnienė, E; Ryliškytė, L, 2023) |
| "Low-grade inflammation has been postulated to have a key role in the pathogenesis of MetS and has been linked to insulin resistance (IR)." | 1.72 | Association Between Low-Grade Inflammation and Hyperuricemia in Adults With Metabolic Syndrome in Yucatán, México. ( Avila-Nava, A; Banik, SD; Chim Aké, R; Gutiérrez Solis, AL; Lugo, R, 2022) |
| "Uric acid (UA) is a risk factor associated with cardiometabolic diseases." | 1.72 | Serum Uric Acid Levels and Cardiometabolic Profile in Middle-Aged, Treatment-Naïve Hypertensive Patients. ( Kalaitzidis, RG; Theofilis, P; Tsimihodimos, V; Vordoni, A, 2022) |
| " The dose-response relationship of SUACr and MetS was further assessed by a restricted cubic spline model (RCS)." | 1.72 | Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China. ( Guo, Y; Huang, H; Huang, S; Li, L; Liu, D; Wu, F; Zhong, D, 2022) |
| "Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) are two pathologies that intersect each other." | 1.72 | Non-alcoholic fatty liver disease: correlation with hyperuricemia in a European Mediterranean population. ( Catanzaro, R; He, F; Marotta, F; Sciuto, M; Singh, B, 2022) |
| "Gout was commonly observed in middle-aged men." | 1.62 | A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal. ( Baral, R; Bhochhibhoya, M; Joshi, R; Lama, LD; Nakarmi, S; Vaidya, B, 2021) |
| "Gout is the most common inflammatory arthritis in adults." | 1.62 | Non-alcoholic fatty kidney disease (NAFKD): A novel disease that explains the etiology of hyperuricemia and gout in metabolic syndrome. ( Abrahim, M, 2021) |
| "Uric acid has both antioxidant and pro-oxidant properties in vitro by scavenging and production of reactive oxygen species (ROS)." | 1.62 | Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry. ( Akari, S; Emoto, M; Fukumoto, S; Hirata, K; Imanishi, Y; Ishii, H; Kurajoh, M; Mori, K; Morioka, T; Murase, T; Nagata, Y; Nakamura, T; Yoshida, H; Yoshida, S, 2021) |
| "Anthropometric, clinical biochemical data, and serum samples were collected from patients with MetS, MetS combined with HUA (MetS & HUA) and healthy controls." | 1.62 | NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia. ( Bian, C; Pan, H; Rong, S; Yang, Y; Zhang, H; Zhang, Y, 2021) |
| "Uric acid wGRS was not associated with fasting serum glucose, HbA1C, waist circumference, or BMI." | 1.56 | The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components. ( Biradar, MI; Chiang, KM; Huang, YT; Pan, WH; Yang, HC, 2020) |
| "The prevalence of hyperuricemia has increased substantially in recent decades." | 1.56 | Association between dairy product consumption and hyperuricemia in an elderly population with metabolic syndrome. ( Abete, I; Alonso-Gómez, ÁM; Altozano Rodado, MC; Álvarez-Pérez, J; Arellano, AG; Babio, N; Barragán, R; Becerra-Tomás, N; Bernal, R; Cano-Ibáñez, N; Carmona-González, FJ; Caro, JLL; Casas, R; Corbella, E; Corella, D; Daimiel, L; de la Hera, MG; Díaz-López, A; Estruch, R; Fernández-Carrión, R; Fernández-García, JC; Fitó, M; Gaforio, JJ; Goday, A; Lapetra, J; Lopez-Miranda, J; Martín, M; Martínez, JA; Martínez-González, MÁ; Matía-Martín, P; Mena-Sánchez, G; Morey, M; Palau, A; Pérez-Vega, KA; Pintó, X; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Sureda, A; Toledo, E; Tur, JA; Vaquero-Luna, J; Vázquez, C; Vidal, J; Vioque, J; Wärnberg, J; Zomeño, MD, 2020) |
| "Rosacea is an inflammatory skin disease with a chronic course." | 1.56 | Evaluation of serum uric acid levels in patients with rosacea. ( Karaaslan, E; Karaosmanoglu, N; Ozdemir Cetinkaya, P, 2020) |
| "Uric acid was shown to be the best predictor for MR (sensitivity: 55." | 1.56 | Metabolic risk associated with liver enzymes, uric acid, and hemoglobin in adolescents. ( Andersen, LB; de Mello, ED; de Souza, S; Franke, SIR; Gaya, AR; Lima, RA; Pfeiffer, KA; Renner, JDP; Reuter, CP, 2020) |
| "Hyperuricemia has been associated with metabolic syndrome, and the association with various cardiometabolic risk factors may be affected by sex." | 1.56 | Sex-specific association of hyperuricemia with cardiometabolic abnormalities in a military cohort: The CHIEF study. ( Hoshide, S; Kwon, Y; Lee, JT; Lin, CS; Lin, GM; Lin, YK; Lin, YP; Su, FY; Tsai, KZ; Wu, TJ, 2020) |
| "Hyperuricemia is a risk factor for cardiovascular metabolic diseases." | 1.56 | Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu. ( Cai, L; Huang, G; Liu, H; Wu, J; Xu, J; Yu, X; Zhang, T, 2020) |
| "The prevalence of nonalcoholic fatty liver disease (NAFLD) in the non-obese population has increased and NAFLD is not always recognized in individuals with metabolic syndrome (MS)." | 1.56 | Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome. ( Hirao, A; Kagemoto, K; Kida, Y; Kurihara, T; Nakasono, M; Okahisa, T; Okamoto, K; Okazaki, J; Sogabe, M; Takayama, T; Takehara, M; Tanaka, H; Taniguchi, T; Tomonari, T, 2020) |
| "Metabolic syndrome was more frequent in UA-RSFs (57% vs 39%) but not significant (p = 0." | 1.56 | Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis. ( Croppi, E; Montanari, E; Sciorio, C; Simonelli, G; Trinchieri, A, 2020) |
| "Hyperuricemia has been associated with high blood pressure (BP) values, diabetes mellitus, metabolic syndrome and chronic kidney disease (CKD)." | 1.51 | Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study. ( Bombelli, M; Facchetti, R; Grassi, G; Lurbe, E; Maloberti, A; Mancia, G; Redon, J; Redon, P, 2019) |
| "The uric acid level was strongly associated with incident metabolic syndrome in the multivariable model (adjusted hazard ratio: 1." | 1.51 | Association of Uric Acid with Incident Metabolic Syndrome in a Japanese General Population. ( Imai, K; Kurabayashi, M; Nakamura, T; Ohyama, Y; Saito, Y; Sumiyoshi, H, 2019) |
| "Hyperuricemia is associated with metabolic syndrome, diabetes, hypertension, and kidney and cardiovascular diseases." | 1.48 | Renal Effects of Hyperuricemia. ( Méndez Landa, CE, 2018) |
| "RESULTS Individuals with nephrolithiasis had a significantly higher level of monounsaturated fatty acids (MUFA) and a lower level of polyunsaturated fatty acids (PUFA) versus healthy individuals." | 1.48 | Investigation of Adipose Tissue Fatty Acid Composition in Men with Uronephrolithiasis and Metabolic Syndrome. ( Bikulčienė, I; Hendrixson, V; Kaminskas, A; Kučinskienė, ZA; Vasiliauskaitė, L, 2018) |
| "Treatment with leflunomide was associated with increased levels of carbonyl protein, and lowered levels in TRAP and UA, while the NOx/TRAP ratio further increased." | 1.48 | Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis. ( Alfieri, DF; Costa, NT; de Medeiros, FA; de Sá, MC; Dichi, I; Iriyoda, TMV; Lozovoy, MAB; Maes, M; Micheletti, PL; Reiche, EMV; Scavuzzi, BM; Sekiguchi, BA; Simão, ANC, 2018) |
| "Metabolic syndrome is present in a significant proportion of Egyptian patients with adult SLE." | 1.48 | Metabolic syndrome in systemic lupus erythematosus patients : Relationship to disease activity and neuropsychiatric lupus. ( Hammam, N; Mohamed, AAA; Rashad, SM, 2018) |
| "Although MS and NAFLD were more prevalent in adolescents, young children also demonstrated MS and NAFLD as obesity-related complications." | 1.48 | Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity. ( Cho, J; Kim, JY; Yang, HR, 2018) |
| "Metabolic syndrome was considered a proxy for overall cardiometabolic risk." | 1.48 | Association between serum activin A and metabolic syndrome in older adults: Potential of activin A as a biomarker of cardiometabolic disease. ( Chen, LK; Chou, MY; Kojima, T; Lee, WJ; Liang, CK; Lin, MH; Loh, CH; Peng, LN, 2018) |
| "WIT and post-LT hyperuricemia are associated with the prevalence of PTMS." | 1.48 | Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death. ( Chai, YC; Hu, LS; Jia, A; Lv, Y; Shi, JH; Tian, M; Wang, B; Zhang, C; Zheng, J, 2018) |
| "Hyperuricemia is associated with metabolic syndrome (MetS), but the association is often confounded by the shared background of obesity." | 1.46 | Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. ( Du, T; Li, M; Lin, X; Lu, H; Yu, X; Zhang, S, 2017) |
| "Insulin resistance is characterized by the failure of target cells to respond to normal levels of circulating insulin, and this condition is related to cardiovascular disease." | 1.46 | Insulin resistance and associated factors: a cross-sectional study of bank employees. ( Bissoli, NS; Cattafesta, M; Molina, MDCB; Salaroli, LB; Zandonade, E, 2017) |
| "Hyperuricemia is associated with cardiovascular disease and its prevalence is unknown in black Africans." | 1.46 | Distribution of Serum Uric Acid in Black Africans and Its Association With Cardiovascular Risk Factors. ( Baldo, MP; Capingana, DP; Luchi, WM; Magalhães, P; Mill, JG; Moulin, SR; Souza, JB, 2017) |
| "Hyperuricemia was defined as serum uric acid ≥416 μmol/l in men and ≥357 μmol/l in women." | 1.43 | Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. ( Guo, X; Ou, Q; Sun, Y; Yang, H; Yu, S; Zhang, X; Zheng, L; Zhou, Y, 2016) |
| "Metabolic syndrome was defined according to the Adult Treatment Panel III criteria modified for children and adolescents." | 1.43 | Association of Serum Uric Acid With Cardiometabolic Risk Factors and Metabolic Syndrome in Iranian Adolescents: the CASPIAN-III Study. ( Asayesh, H; Djalalinia, S; Eslami Shahr Babaki, A; Heshmat, R; Kelishadi, R; Motlagh, ME; Qorbani, M; Safari, O; Safiri, S; Tajadini, MH; Tajbakhsh, R, 2016) |
| "Metabolic syndrome was found in 2502 of 18,222 healthy Chinese people (16." | 1.43 | Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome. ( Gao, BL; Su, BY; Tian, CF; Tong, YH; Zhao, XH; Zheng, Y, 2016) |
| "In the present study, 841 NAFLD males (30-75 years) were recruited from a Chinese prospective cohort study (PMMJS) and followed up for five years." | 1.43 | Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males. ( Dong, C; Guo, Z; Liu, C; Qiu, J; Song, K; Wang, Y; Xu, Y; Zhang, B; Zhou, H; Zhou, Z, 2016) |
| "The prevalence rates of NAFLD were 71." | 1.43 | Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. ( Chen, N; He, CM; Li, X; Li, Z; Liu, CQ; Liu, S; Liu, Y; Shi, X; Wang, D; Yan, B; Yang, S; Zeng, X, 2016) |
| "The prevalence of NAFLD in light drinkers was significantly lower than in non-drinkers, and supporting previous reports studying the general population, LAC is one of the significant predictors of a decreased prevalence of NAFLD in men with MS." | 1.42 | Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome. ( Nakasono, M; Okahisa, T; Sogabe, M; Takayama, T; Tanaka, H; Tanaka, T; Taniguchi, T; Tomonari, T, 2015) |
| "Metabolic syndrome was classified according to the Joint Interim Statement, and sleep duration was categorized as very short, short, adequate, and long sleepers (≤ 4, 5-6, 7-8, and ≥ 9 h per night, respectively)." | 1.42 | Contribution of Inflammation, Oxidative Stress, and Antioxidants to the Relationship between Sleep Duration and Cardiometabolic Health. ( Ardern, CI; Kanagasabai, T, 2015) |
| "Metabolic syndrome is characterized by a cluster of atherosclerotic cardiovascular risk factors." | 1.42 | Association of Metabolic Syndrome with the Cardioankle Vascular Index in Asymptomatic Korean Population. ( Kang, SG; Lee, YA; Nam, SH; Rho, JS; Song, SW, 2015) |
| "NAFLD is closely correlated with baPWV, particularly in females." | 1.42 | Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity. ( Chen, JH; Chen, LY; Dai, HL; Fang, LZ; Lu, CR; Qiao, QH; Zhu, WH, 2015) |
| "Hyperuricemia was defined as an SUA level of ≥7." | 1.40 | Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. ( Liu, A; Wang, P; Wu, H; Wuyun, G; You, L, 2014) |
| "Mild hyperuricemia is a strong, independent marker of MS and high cardio-renal risk profile in hypertensive patients under specialist care." | 1.40 | Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. ( Agabiti Rosei, E; Ambrosioni, E; Costa, FV; Deferrari, G; Garneri, D; Gonnella, A; Leoncini, G; Leonetti, G; Muiesan, ML; Pessina, AC; Pontremoli, R; Trimarco, B; Viazzi, F; Volpe, M, 2014) |
| "Insulin resistance is associated with inadequate body composition, in biochemical levels and lifestyle, being the factors associated different in each phase of adolescence." | 1.40 | [Insulin resistance and components of metabolic syndrome, analysis by gender and stage of adolescence]. ( Faria, ER; Faria, FR; Franceschini, Sdo C; Novaes, JF; Peluzio, Mdo C; Priore, SE; Ribeiro, AQ; Ribeiro, SM; Sant Ana, LF, 2014) |
| "Nonalcoholic fatty liver disease (NAFLD) is an emerging health problem worldwide." | 1.39 | Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women. ( Moon, SS, 2013) |
| "In conclusion, weight loss is effective in treating obese children with SDB." | 1.38 | Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid. ( Aerts, P; De Backer, WA; Debode, P; Desager, KN; Franckx, H; Ramet, J; Van Gaal, LF; Van Hoorenbeeck, K; Verhulst, SL; Wouters, K, 2012) |
| "Hyperuricemia was defined as ≥ 6." | 1.38 | Gender distribution of serum uric acid and cardiovascular risk factors: population based study. ( Baldo, MP; Capingana, P; Dantas, EM; Magalhães, P; Mill, JG; Molina, Mdel C; Morelato, RL; Rodrigues, SL; Salaroli, LB, 2012) |
| "Hyperuricemia was defined as SUA ≥70 mg/L in men and ≥60 mg/L in women." | 1.38 | Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. ( Gonçalves, JP; Lopes, C; Oliveira, A; Santos, AC; Severo, M, 2012) |
| "Uric acid (UA) has been frequently reported to be associated with MetS in the general population." | 1.38 | The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder. ( Chen, CH; Chen, PY; Chiu, CC; Huang, MC; Lu, ML; Tsai, CJ, 2012) |
| "Hyperuricemia is common in those subjects and might be considered a potential clinical parameter in the definition of MetS." | 1.38 | Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. ( Cohen, E; Fraser, A; Garty, M; Goldberg, E; Krause, I, 2012) |
| "Insulin sensitivity was estimated using the homeostatic model assessment index (HOMA-B) for beta cell function and HOMA-IR for peripheral tissue IR." | 1.38 | Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions. ( El-Fishawy, HS; Gheita, TA; Hussein, H; Nasrallah, MM, 2012) |
| "Hyperuricemia was defined as UA ≥ 7 mg/dL in men and UA ≥ 6 mg/dL in women." | 1.38 | Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. ( Asefzadeh, S; Esmailzadehha, N; Ghorbani, A; Ziaee, A, 2012) |
| "Hyperuricemia was defined as serum uric acid (SUA) >420 μmol/L for men, >360 μmol/L for women." | 1.37 | Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese. ( Lou, S; Meng, Z; Ren, X; Zhang, Q, 2011) |
| "Uric acid-induced increase in MCP-1 production was blocked by scavenging superoxide or by inhibiting NADPH oxidase and by stimulating peroxisome-proliferator-activated receptor-γ with rosiglitazone." | 1.37 | Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. ( Baldwin, W; Baylis, C; Johnson, RJ; Marek, G; McRae, S; Pannu, V; Sautin, YY; Wymer, D, 2011) |
| "Hyperuricemia was more common in men than in women (51." | 1.37 | Relation of uric acid with components of metabolic syndrome before and after Roux-en-Y gastric bypass in morbidly obese subjects. ( Rossi, FM; Rossi, M; Serpa Neto, A; Teixeira, GK; Valle, LG, 2011) |
| "Hyperuricemia was defined as the values over the mean value plus 2 standard deviations for each age group." | 1.37 | Investigation on hyperuricemia in children with obesity or various pediatric disorders. ( Kubota, M; Nagai, A; Tang, L; Tokuda, M, 2011) |
| "Metabolic syndrome was defined according to the modified National Cholesterol Education Program, using body mass index instead of waist circumference." | 1.36 | Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men. ( Chang, Y; Choi, NK; Kim, I; Lee, WY; Ryu, S; Song, J; Woo, HY; Yoo, SH, 2010) |
| "The metabolic syndrome was defined based on the criteria of the Chinese Diabetes Society (CDS)." | 1.36 | The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. ( Chen, B; Chen, Y; Ni, Z; Xu, W; Yang, D; Ye, B, 2010) |
| "Hyperuricemia was defined as a serum UA value >7." | 1.36 | The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. ( Chiou, WK; Chiu, HT; Huang, DH; Lee, YJ; Lin, JD; Wang, MH, 2010) |
| "Gout is commonly associated with obesity, arterial hypertension, diabetes, and dyslipidemia." | 1.36 | Metabolic syndrome characteristics in gout patients. ( de Miguel, ME; Fraile, JM; Lundelin, KJ; Martínez, P; Puig, JG; Torres, RJ; Vázquez, JJ, 2010) |
| "We documented 1215 new cases of type 2 diabetes." | 1.35 | Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. ( Choi, HK; De Vera, MA; Krishnan, E, 2008) |
| "Hyperuricemia is significantly predicted by anthropometric measure of SFT which is a simple clinical screening method along with creatinine levels." | 1.35 | Hyperuricemia and its related factors in an urban population, Izmir, Turkey. ( Akar, S; Akkoc, N; Birlik, M; Gurler, O; Onen, F; Pakoz, B; Sari, I; Sisman, AR, 2009) |
| "The metabolic syndrome was defined by the original ATP III criteria and the modified ATP III criteria that include a reduced waist circumference." | 1.35 | Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. ( Choi, SJ; Ji, JD; Lee, YH; Rho, YH; Song, GG; Woo, JH, 2008) |
| "Insulin resistance was determined by the homeostasis model assessment (HOMA-IR)." | 1.35 | Uric acid: a surrogate of insulin resistance in older women. ( Chen, LK; Chiou, ST; Hwang, SJ; Lai, HY; Lin, MH, 2008) |
| "Moreover, hyperuricemia is significantly correlated with hypertriglyceridemia, hypertension, and visceral obesity." | 1.35 | Serum uric acid levels and risk of metabolic syndrome in healthy adults. ( Bandarian, F; Ebrahimpour, P; Fakhrzadeh, H; Heshmat, R; Larijani, B, 2008) |
| "Hyperuricemia is postulated to be a risk factor for atherosclerotic diseases, although whether it is independent of classical atherogenic risk factors is controversial." | 1.34 | Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. ( Hashimoto, H; Ishizaka, N; Ishizaka, Y; Nagai, R; Toda, E; Yamakado, M, 2007) |
| "Metabolic syndrome was induced in rats over 8 wk by either a high-fructose diet (60%, F60, n = 7) or by adding fructose to drinking water (10%, F10, n = 7)." | 1.34 | Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. ( Avila-Casado, C; Bautista, P; Cristóbal, M; Franco, M; Herrera-Acosta, J; Jiménez, A; Johnson, RJ; Nakagawa, T; Nepomuceno, T; Sánchez-Lozada, LG; Soto, V; Tapia, E, 2007) |
| "Metabolic syndrome was diagnosed using the WHO criteria." | 1.34 | Serum uric acid level as an independent component of the metabolic syndrome in type 2 diabetic blacks. ( Akande, AA; Akinyinka, OA; Jimoh, AK; Olarinoye, GO, 2007) |
| "Metabolic syndrome is associated with subclinical organ damage in nondiabetic, essential hypertensive patients." | 1.33 | Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. ( Deferrari, G; Falqui, V; Leoncini, G; Parodi, A; Parodi, D; Pontremoli, R; Ratto, E; Tomolillo, C; Vaccaro, V; Viazzi, F, 2005) |
| "In addition, hyperinsulinemia-induced renal magnesium wasting also may be a contributory factor." | 1.33 | Disturbances of phosphate metabolism: another feature of metabolic syndrome. ( Bairaktari, E; Elisaf, M; Kalaitzidis, R; Siamopoulos, KC; Tsimihodimos, V, 2005) |
| "Hyperuricemia is commonly associated with obesity, glucose intolerance, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease." | 1.33 | Is hyperuricemia another facet of the metabolic syndrome? ( Chan, WL; Ho, LT; Hsiao, LC; Hwu, CM; Lin, MW; Liou, TL; Tsai, TT, 2006) |
| "Weight gain is a known side effect of valproate (VPA) therapy, which is associated with hyperinsulinemia and polycystic ovary-like syndrome and unfavorable lipid changes in women." | 1.33 | Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. ( Isojärvi, J; Knip, M; Pakarinen, A; Pylvänen, V, 2006) |
| "Hyperuricemia is prevalent among Thai men and women receiving routine health exams." | 1.33 | Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams. ( Dhanamun, B; Lohsoonthorn, V; Williams, MA, 2006) |
| "Hyperuricemia is part of the "metabolic syndrome"." | 1.32 | Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. ( Debatin, KM; Denzer, C; Heinze, E; Mayer, H; Muche, R; Wabitsch, M, 2003) |
| "Acute hyperinsulinemia was associated with higher urinary pH (6." | 1.32 | The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. ( Abate, N; Cabo-Chan, AV; Chandalia, M; Moe, OW; Sakhaee, K, 2004) |
| "Insulin resistance was determined according to the Homeostasis Model Assessment (HOMA) formula." | 1.32 | Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women. ( Cikim, AS; Molvalilar, S; Orhan, Y; Ozbey, N; Sencer, E, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 152 (23.46) | 29.6817 |
| 2010's | 378 (58.33) | 24.3611 |
| 2020's | 118 (18.21) | 2.80 |
| Authors | Studies |
|---|---|
| Tu, CM | 1 |
| Wei, TE | 1 |
| Tseng, GS | 1 |
| Chen, CC | 1 |
| Liu, CW | 3 |
| Masajtis-Zagajewska, A | 1 |
| Majer, J | 1 |
| Nowicki, M | 1 |
| Andres-Hernando, A | 3 |
| Cicerchi, C | 1 |
| Kuwabara, M | 3 |
| Orlicky, DJ | 1 |
| Sanchez-Lozada, LG | 16 |
| Nakagawa, T | 17 |
| Johnson, RJ | 32 |
| Lanaspa, MA | 10 |
| Tsai, KZ | 2 |
| Su, FY | 2 |
| Cheng, WC | 1 |
| Huang, RY | 1 |
| Lin, YP | 2 |
| Lin, GM | 2 |
| Molla, NH | 1 |
| Kathak, RR | 1 |
| Sumon, AH | 1 |
| Barman, Z | 2 |
| Mou, AD | 2 |
| Hasan, A | 3 |
| Mahmud, F | 1 |
| Fariha, KA | 1 |
| Ali, N | 2 |
| Yazdi, F | 1 |
| Baghaei, MH | 1 |
| Baniasad, A | 1 |
| Naghibzadeh-Tahami, A | 1 |
| Najafipour, H | 1 |
| Gozashti, MH | 1 |
| Cota, BC | 1 |
| Priore, SE | 2 |
| Ribeiro, SAV | 1 |
| Juvanhol, LL | 2 |
| de Faria, ER | 1 |
| de Faria, FR | 1 |
| Pereira, PF | 1 |
| Kimura, Y | 1 |
| Tsukui, D | 1 |
| Kono, H | 1 |
| Kalay Senturk, NG | 1 |
| Dagdeviren Cakir, A | 1 |
| Yildirmak, ZY | 1 |
| Ucar, A | 2 |
| Feitosa, RS | 1 |
| Martins, BP | 1 |
| Almeida, LM | 1 |
| de Oliveira, MB | 1 |
| de Araújo, RMS | 1 |
| de Oliveira, KA | 1 |
| Armborst, D | 1 |
| Bitterlich, N | 1 |
| Alteheld, B | 1 |
| Rösler, D | 1 |
| Metzner, C | 1 |
| Siener, R | 1 |
| Chen, WY | 1 |
| Fu, YP | 1 |
| Zhou, M | 1 |
| Mikolaitytė, J | 2 |
| Badarienė, J | 3 |
| Puronaitė, R | 1 |
| Čypienė, A | 3 |
| Rutkauskienė, I | 1 |
| Dadonienė, J | 2 |
| Laucevičius, A | 3 |
| Laučytė-Cibulskienė, A | 1 |
| Smaliukaitė, M | 1 |
| Ryliškytė, L | 2 |
| Guo, Y | 2 |
| Huang, H | 3 |
| Chen, Y | 6 |
| Shen, C | 1 |
| Xu, C | 4 |
| Biswal, M | 1 |
| M, B | 1 |
| N, R | 1 |
| T, AK | 1 |
| Kulkarni, A | 1 |
| Subhash, N | 1 |
| Zhu, W | 4 |
| Liang, A | 1 |
| Shi, P | 1 |
| Yuan, S | 1 |
| Zhu, Y | 2 |
| Fu, J | 1 |
| Zheng, T | 1 |
| Wen, Z | 1 |
| Wu, X | 3 |
| Banik, SD | 1 |
| Avila-Nava, A | 1 |
| Lugo, R | 1 |
| Chim Aké, R | 1 |
| Gutiérrez Solis, AL | 1 |
| Copur, S | 1 |
| Demiray, A | 1 |
| Kanbay, M | 4 |
| Theofilis, P | 1 |
| Tsimihodimos, V | 2 |
| Vordoni, A | 1 |
| Kalaitzidis, RG | 1 |
| Laso García, I | 1 |
| Gomez Dos Santos, V | 1 |
| Sánchez Herranz, A | 1 |
| Duque Ruiz, G | 1 |
| Arias Fúnez, F | 1 |
| Hevia Palacios, M | 1 |
| Burgos Revilla, FJ | 1 |
| Rajadhyaksha, A | 1 |
| Sarate, N | 1 |
| Raghorte, N | 1 |
| Ingawale, S | 1 |
| Barroso, I | 1 |
| Guimarães, JT | 1 |
| Craveiro, V | 1 |
| Severo, M | 2 |
| Ramos, E | 1 |
| Ou, T | 1 |
| Wang, W | 2 |
| Yong, H | 1 |
| Hao, H | 1 |
| Wang, R | 1 |
| Dai, X | 2 |
| Wang, D | 4 |
| Li, Y | 4 |
| Li, W | 1 |
| Wang, Y | 9 |
| Ouyang, S | 1 |
| Li, M | 6 |
| Liu, R | 2 |
| Zhang, Y | 7 |
| Liu, X | 4 |
| Li, T | 1 |
| Liu, S | 4 |
| Borghi, C | 9 |
| Fogacci, F | 2 |
| Piani, F | 1 |
| Haueisen Sander Diniz, MF | 1 |
| M R Beleigoli, A | 1 |
| Isabel Rodrigues Galvão, A | 1 |
| Weiss Telles, R | 1 |
| Inês Schmidt, M | 1 |
| B Duncan, B | 1 |
| M Benseñor, I | 1 |
| Luiz P Ribeiro, A | 1 |
| Vidigal, PG | 1 |
| Maria Barreto, S | 1 |
| Liu, L | 3 |
| Shao, Y | 2 |
| Li, X | 9 |
| Sun, J | 1 |
| Xing, D | 1 |
| Son, DH | 1 |
| Ha, HS | 1 |
| Park, HM | 1 |
| Kim, HY | 1 |
| Lee, YJ | 3 |
| He, M | 3 |
| Wang, J | 2 |
| Liang, Q | 1 |
| Guo, H | 2 |
| Deji, C | 1 |
| Sui, J | 1 |
| Wang, YW | 1 |
| Liu, Y | 5 |
| Zheng, Y | 2 |
| Qian, B | 1 |
| Chen, H | 2 |
| Ma, M | 1 |
| Su, S | 1 |
| Geng, H | 1 |
| Zhou, WX | 1 |
| Guo, X | 9 |
| Zhu, WZ | 1 |
| Zhang, M | 2 |
| Chen, Z | 4 |
| Rensen, PCN | 1 |
| Hui, CC | 1 |
| Shi, B | 1 |
| Genovesi, S | 2 |
| Tassistro, E | 1 |
| Giussani, M | 2 |
| Lieti, G | 1 |
| Patti, I | 1 |
| Orlando, A | 2 |
| Montemerlo, M | 1 |
| Antolini, L | 1 |
| Parati, G | 6 |
| Michalichen, KC | 1 |
| Weber, VMR | 1 |
| Queiroga, MR | 1 |
| Fernandes, DZ | 1 |
| Carreira, CM | 1 |
| Vieira, ER | 1 |
| Venturini, D | 3 |
| Shih, YL | 1 |
| Lin, Y | 2 |
| Chen, JY | 1 |
| Šebeková, K | 1 |
| Gurecká, R | 1 |
| Repiská, G | 1 |
| Koborová, I | 1 |
| Podracká, Ľ | 1 |
| Raya-Cano, E | 1 |
| Vaquero-Abellán, M | 1 |
| Molina-Luque, R | 1 |
| De Pedro-Jiménez, D | 1 |
| Molina-Recio, G | 1 |
| Romero-Saldaña, M | 1 |
| Yao, S | 1 |
| Zhou, Y | 2 |
| Xu, L | 2 |
| Zhang, Q | 4 |
| Bao, S | 1 |
| Feng, H | 1 |
| Ge, W | 1 |
| Seo, HY | 3 |
| Mun, CY | 3 |
| Park, CY | 4 |
| Bin Choi, S | 3 |
| Hwang, JH | 3 |
| Lee, JH | 3 |
| Yoon, H | 3 |
| El-Eshmawy, MM | 3 |
| Ibrahim, A | 2 |
| Bahriz, R | 2 |
| Shams-Eldin, N | 2 |
| Mahsoub, N | 3 |
| Zhong, D | 1 |
| Liu, D | 1 |
| Li, L | 4 |
| Wu, F | 1 |
| Huang, S | 2 |
| Zheng, J | 2 |
| Miao, Y | 1 |
| Lekpa, FK | 1 |
| Bebey, FS | 1 |
| Bouallo, I | 1 |
| Njonnou, SRS | 1 |
| Luma, HN | 1 |
| Singwe-Ngandeu, M | 1 |
| Choukem, SP | 1 |
| Lubawy, M | 1 |
| Formanowicz, D | 1 |
| Primo, D | 1 |
| Izaola, O | 1 |
| de Luis, D | 1 |
| Tu, YC | 1 |
| Liu, YH | 1 |
| Chen, SC | 1 |
| Su, HM | 1 |
| Mohamad, R | 1 |
| Cakir, AD | 1 |
| Ada, Hİ | 1 |
| Salari, M | 1 |
| Yaghoubi, MA | 1 |
| Miri, M | 1 |
| Mehrad-Majd, H | 1 |
| Hami, M | 1 |
| Konan, V | 1 |
| Swamy, N | 1 |
| Cota E Souza, LA | 1 |
| D'Angelo, GCO | 1 |
| da Silva, GN | 1 |
| Lima, AA | 1 |
| Cao, T | 1 |
| Tong, C | 1 |
| Halengbieke, A | 1 |
| Ni, X | 1 |
| Tang, J | 1 |
| Zheng, D | 1 |
| Yang, X | 8 |
| Chiang, CH | 1 |
| Chang, YJ | 1 |
| He, SR | 1 |
| Chao, JN | 1 |
| Yang, CH | 1 |
| Liu, YT | 1 |
| Protoshchak, VV | 1 |
| Paronnikov, MV | 1 |
| Babkin, PA | 1 |
| Sleptsov, AV | 1 |
| Shen, X | 2 |
| Pan, Q | 2 |
| Huang, Y | 2 |
| You, J | 1 |
| Ding, X | 1 |
| Kim, YK | 2 |
| Yang, YM | 1 |
| Gimžauskaitė, S | 1 |
| Rinkūnienė, E | 1 |
| Jasiūnas, E | 1 |
| Kolahi Ahari, R | 1 |
| Mansoori, A | 1 |
| Sahranavard, T | 1 |
| Miri, MS | 1 |
| Feizi, S | 1 |
| Esmaily, H | 1 |
| Ghayour-Mobarhan, M | 3 |
| Ding, Y | 1 |
| Wang, Z | 3 |
| Niu, H | 1 |
| Deng, Q | 1 |
| Xia, S | 1 |
| Ardekani, AM | 1 |
| Nava, ZH | 1 |
| Zaman, BA | 1 |
| Vahdat, S | 1 |
| Lame-Jouybari, AH | 1 |
| Mivefroshan, A | 1 |
| Wang, C | 3 |
| Sun, W | 1 |
| Dalbeth, N | 1 |
| Wang, X | 3 |
| Ji, X | 1 |
| Xue, X | 1 |
| Han, L | 1 |
| Cui, L | 1 |
| Liu, Z | 2 |
| Ji, A | 1 |
| He, Y | 1 |
| Sun, M | 1 |
| Li, C | 2 |
| Di Sessa, A | 1 |
| Passaro, AP | 1 |
| Colasante, AM | 1 |
| Cioffi, S | 1 |
| Guarino, S | 1 |
| Umano, GR | 1 |
| Papparella, A | 1 |
| Miraglia Del Giudice, E | 1 |
| Marzuillo, P | 1 |
| Yu, X | 4 |
| Sun, F | 1 |
| Ming, J | 1 |
| Liang, S | 2 |
| Zhang, W | 3 |
| Wang, L | 5 |
| Li, Q | 5 |
| Xu, Q | 1 |
| Shi, L | 1 |
| Gao, B | 1 |
| Ji, Q | 1 |
| Maloberti, A | 3 |
| Mengozzi, A | 2 |
| Russo, E | 2 |
| Cicero, AFG | 5 |
| Angeli, F | 1 |
| Agabiti Rosei, E | 2 |
| Barbagallo, CM | 2 |
| Bernardino, B | 1 |
| Bombelli, M | 4 |
| Cappelli, F | 1 |
| Casiglia, E | 3 |
| Cianci, R | 1 |
| Ciccarelli, M | 1 |
| Cirillo, M | 2 |
| Cirillo, P | 6 |
| Desideri, G | 2 |
| D'Elia, L | 2 |
| Dell'Oro, R | 2 |
| Facchetti, R | 3 |
| Ferri, C | 3 |
| Galletti, F | 2 |
| Giannattasio, C | 2 |
| Gesualdo, L | 5 |
| Iaccarino, G | 2 |
| Lippa, L | 2 |
| Mallamaci, F | 2 |
| Masi, S | 2 |
| Masulli, M | 1 |
| Mazza, A | 3 |
| Muiesan, ML | 3 |
| Nazzaro, P | 2 |
| Palatini, P | 2 |
| Pauletto, P | 1 |
| Pontremoli, R | 9 |
| Pugliese, NR | 2 |
| Quarti-Trevano, F | 2 |
| Rattazzi, M | 2 |
| Reboldi, G | 1 |
| Rivasi, G | 2 |
| Salvetti, M | 2 |
| Tikhonoff, V | 3 |
| Tocci, G | 2 |
| Ungar, A | 2 |
| Verdecchia, P | 2 |
| Viazzi, F | 9 |
| Volpe, M | 3 |
| Virdis, A | 2 |
| Grassi, G | 4 |
| Fukuuchi, T | 1 |
| Aoki, Y | 1 |
| Mizuta, E | 1 |
| Ouchi, M | 1 |
| Kurajoh, M | 2 |
| Maruhashi, T | 1 |
| Tanaka, A | 1 |
| Morikawa, N | 1 |
| Nishimiya, K | 1 |
| Akashi, N | 1 |
| Tanaka, Y | 1 |
| Otani, N | 1 |
| Morita, M | 1 |
| Miyata, H | 1 |
| Takada, T | 1 |
| Tsutani, H | 1 |
| Ogino, K | 1 |
| Ichida, K | 3 |
| Hisatome, I | 1 |
| Abe, K | 1 |
| Yang, S | 2 |
| Yu, B | 1 |
| Yu, W | 1 |
| Dai, S | 1 |
| Feng, C | 1 |
| Zhao, X | 2 |
| He, T | 1 |
| Jia, P | 1 |
| Gögebakan, H | 1 |
| Akkececi, NS | 1 |
| Cetin, GY | 1 |
| Wu, SS | 1 |
| Kor, CT | 1 |
| Chen, TY | 1 |
| Liu, KH | 1 |
| Shih, KL | 1 |
| Su, WW | 1 |
| Wu, HM | 1 |
| Biradar, MI | 1 |
| Chiang, KM | 1 |
| Yang, HC | 1 |
| Huang, YT | 1 |
| Pan, WH | 2 |
| Mena-Sánchez, G | 2 |
| Babio, N | 3 |
| Becerra-Tomás, N | 3 |
| Martínez-González, MÁ | 3 |
| Díaz-López, A | 2 |
| Corella, D | 3 |
| Zomeño, MD | 1 |
| Romaguera, D | 2 |
| Vioque, J | 2 |
| Alonso-Gómez, ÁM | 2 |
| Wärnberg, J | 3 |
| Martínez, JA | 3 |
| Serra-Majem, L | 3 |
| Estruch, R | 3 |
| Bernal, R | 1 |
| Lapetra, J | 2 |
| Pintó, X | 2 |
| Tur, JA | 2 |
| Lopez-Miranda, J | 2 |
| Cano-Ibáñez, N | 1 |
| Gaforio, JJ | 2 |
| Matía-Martín, P | 2 |
| Daimiel, L | 2 |
| Caro, JLL | 1 |
| Vidal, J | 2 |
| Vázquez, C | 2 |
| Ros, E | 3 |
| Arellano, AG | 1 |
| Palau, A | 1 |
| Fernández-Carrión, R | 2 |
| Pérez-Vega, KA | 1 |
| Morey, M | 2 |
| de la Hera, MG | 1 |
| Vaquero-Luna, J | 1 |
| Carmona-González, FJ | 1 |
| Abete, I | 2 |
| Álvarez-Pérez, J | 1 |
| Casas, R | 2 |
| Fernández-García, JC | 2 |
| Santos-Lozano, JM | 2 |
| Corbella, E | 2 |
| Sureda, A | 1 |
| Ruiz-Canela, M | 2 |
| Barragán, R | 1 |
| Goday, A | 1 |
| Martín, M | 1 |
| Altozano Rodado, MC | 1 |
| Toledo, E | 1 |
| Fitó, M | 2 |
| Salas-Salvadó, J | 3 |
| Bjelakovic, B | 1 |
| Stefanutti, C | 1 |
| Bonic, D | 1 |
| Vukovic, V | 1 |
| Kavaric, N | 1 |
| Saranac, L | 1 |
| Kocic, G | 1 |
| Klisic, A | 1 |
| Jevtović Stojmenov, T | 1 |
| Lukic, S | 1 |
| Jovic, M | 1 |
| Bjelakovic, M | 1 |
| Jeong, J | 1 |
| Suh, YJ | 1 |
| Kim, HS | 1 |
| Cortese, F | 2 |
| Scicchitano, P | 1 |
| Cortese, AM | 2 |
| Meliota, G | 2 |
| Andriani, A | 1 |
| Truncellito, L | 1 |
| Calculli, G | 1 |
| Giordano, P | 1 |
| Ciccone, MM | 2 |
| Song, Q | 1 |
| Ghazizadeh, H | 2 |
| Rezaei, M | 1 |
| Avan, A | 1 |
| Fazilati, M | 1 |
| Pasdar, A | 1 |
| Tavallaie, S | 2 |
| Kazemi, E | 1 |
| Seyedi, SMR | 1 |
| Ferns, GA | 2 |
| Azimi-Nezhad, M | 1 |
| Chen, F | 2 |
| Ma, G | 1 |
| İnanir, M | 1 |
| Bhardwaj, R | 1 |
| Jain, R | 1 |
| Karaosmanoglu, N | 1 |
| Karaaslan, E | 1 |
| Ozdemir Cetinkaya, P | 1 |
| Zhou, H | 3 |
| Ma, ZF | 1 |
| Lu, Y | 2 |
| Du, Y | 1 |
| Shao, J | 1 |
| Wu, Q | 1 |
| Pan, B | 1 |
| Zhao, Q | 1 |
| Wei, H | 1 |
| Tani, S | 1 |
| Matsuo, R | 1 |
| Imatake, K | 1 |
| Suzuki, Y | 1 |
| Takahashi, A | 1 |
| Yagi, T | 1 |
| Matsumoto, N | 1 |
| Okumura, Y | 1 |
| Vidanapathirana, DM | 1 |
| Samaranayake, D | 1 |
| Wickramasinghe, P | 1 |
| Klongthalay, S | 1 |
| Suriyaprom, K | 1 |
| Li, H | 4 |
| Guo, M | 1 |
| An, Z | 1 |
| Meng, J | 1 |
| Jiang, J | 2 |
| Song, J | 3 |
| Wu, W | 1 |
| de Souza, S | 1 |
| Reuter, CP | 1 |
| Andersen, LB | 1 |
| Lima, RA | 1 |
| Pfeiffer, KA | 1 |
| de Mello, ED | 1 |
| Gaya, AR | 1 |
| Franke, SIR | 1 |
| Renner, JDP | 1 |
| Lin, YK | 1 |
| Lee, JT | 1 |
| Lin, CS | 2 |
| Wu, TJ | 1 |
| Kwon, Y | 1 |
| Hoshide, S | 1 |
| Baygi, F | 1 |
| Herttua, K | 1 |
| Sheidaei, A | 1 |
| Ahmadvand, A | 1 |
| Jensen, OC | 1 |
| Roncal-Jimenez, C | 2 |
| Tolan, DR | 2 |
| Zhang, T | 2 |
| Tang, F | 2 |
| Xue, F | 2 |
| Tao, J | 1 |
| Li, J | 3 |
| Cha, E | 1 |
| Gu, PP | 1 |
| Liu, J | 6 |
| He, LL | 1 |
| Li, GQ | 1 |
| Miah, R | 1 |
| Hasan, M | 1 |
| Hafsa, JM | 1 |
| Trisha, AD | 1 |
| Islam, F | 1 |
| Huang, G | 2 |
| Xu, J | 2 |
| Cai, L | 1 |
| Liu, H | 1 |
| Wu, J | 1 |
| Catanzaro, R | 1 |
| Sciuto, M | 1 |
| He, F | 1 |
| Singh, B | 1 |
| Marotta, F | 1 |
| Mert, H | 1 |
| İrak, K | 1 |
| Çibuk, S | 1 |
| Yıldırım, S | 1 |
| Mert, N | 1 |
| Leoncini, G | 5 |
| Esposito, P | 1 |
| Garibotto, G | 1 |
| Kara, E | 1 |
| Kahraman, E | 1 |
| Dayar, E | 1 |
| Yetik Anacak, G | 1 |
| Demir, O | 1 |
| Gidener, S | 1 |
| Atabey, N | 1 |
| Durmus, N | 1 |
| Fan, Y | 1 |
| Liu, Q | 2 |
| Liu, K | 1 |
| Tang, X | 2 |
| Li, G | 2 |
| Hu, D | 2 |
| Song, G | 1 |
| Peng, J | 1 |
| Tang, Z | 1 |
| Zhang, J | 4 |
| Zhang, L | 3 |
| Agabiti-Rosei, E | 1 |
| Kielstein, JT | 2 |
| Lurbe, E | 2 |
| Mancia, G | 5 |
| Redon, J | 2 |
| Stack, AG | 1 |
| Tsioufis, KP | 1 |
| Peng, B | 1 |
| Li, S | 2 |
| Lian, T | 1 |
| Liu, M | 1 |
| Chen, Q | 2 |
| Vaidya, B | 1 |
| Baral, R | 1 |
| Lama, LD | 1 |
| Joshi, R | 1 |
| Bhochhibhoya, M | 1 |
| Nakarmi, S | 1 |
| Sogabe, M | 3 |
| Okahisa, T | 3 |
| Kurihara, T | 1 |
| Takehara, M | 1 |
| Kagemoto, K | 1 |
| Okazaki, J | 1 |
| Kida, Y | 1 |
| Hirao, A | 1 |
| Tanaka, H | 3 |
| Tomonari, T | 3 |
| Taniguchi, T | 3 |
| Okamoto, K | 1 |
| Nakasono, M | 3 |
| Takayama, T | 3 |
| Gažarová, M | 1 |
| Mečiarová, L | 1 |
| Singh, C | 1 |
| Jain, S | 1 |
| Dhawan, V | 1 |
| Kalra, N | 1 |
| Kumari, S | 1 |
| Adeyanju, OA | 1 |
| Badejogbin, OC | 1 |
| Areola, DE | 1 |
| Olaniyi, KS | 2 |
| Dibia, C | 1 |
| Soetan, OA | 1 |
| Oniyide, AA | 1 |
| Michael, OS | 1 |
| Olatunji, LA | 2 |
| Soladoye, AO | 1 |
| Moulin-Mares, SRA | 1 |
| Oliosa, PR | 1 |
| Faria, ER | 2 |
| Zago-Gomes, MP | 1 |
| Mill, JG | 3 |
| Liu, C | 4 |
| Fu, L | 1 |
| Wang, T | 1 |
| Martins, CC | 1 |
| Bagatini, MD | 1 |
| Simões, JLB | 1 |
| Cardoso, AM | 1 |
| Baldissarelli, J | 1 |
| Dalenogare, DP | 1 |
| Dos Santos, DL | 1 |
| Schetinger, MRC | 1 |
| Morsch, VM | 1 |
| Abrahim, M | 1 |
| Rezazadeh, L | 1 |
| Alipour, B | 1 |
| Jafarabadi, MA | 1 |
| Behrooz, M | 1 |
| Gargari, BP | 1 |
| Asar, M | 1 |
| Elsehely, I | 1 |
| Li, R | 3 |
| Liang, H | 1 |
| Zhu, M | 1 |
| Lai, M | 1 |
| Wang, S | 3 |
| Zhang, H | 7 |
| Ye, H | 1 |
| Zhu, R | 1 |
| Zhang, S | 4 |
| Ma, Z | 1 |
| Tao, L | 1 |
| Han, Y | 1 |
| Eid, BG | 1 |
| Neamatallah, T | 1 |
| Hanafy, A | 1 |
| El-Bassossy, HM | 1 |
| Binmahfouz, L | 1 |
| Aldawsari, HM | 1 |
| El-Aziz, GA | 1 |
| Vemuri, K | 1 |
| Makriyannis, A | 1 |
| Bruno, B | 1 |
| Georgiopoulos, G | 1 |
| Liu, YN | 1 |
| Luo, H | 1 |
| Che, X | 1 |
| Peng, H | 1 |
| Liu, KX | 1 |
| Aztatzi-Aguilar, OG | 1 |
| Sierra-Vargas, MP | 1 |
| Ortega-Romero, M | 1 |
| Jiménez-Corona, AE | 1 |
| Fukumoto, S | 1 |
| Yoshida, S | 1 |
| Akari, S | 1 |
| Murase, T | 1 |
| Nakamura, T | 2 |
| Ishii, H | 2 |
| Yoshida, H | 2 |
| Nagata, Y | 1 |
| Morioka, T | 1 |
| Mori, K | 2 |
| Imanishi, Y | 1 |
| Hirata, K | 1 |
| Emoto, M | 1 |
| Longo, GZ | 2 |
| Silva, DAS | 1 |
| Gabiatti, MP | 1 |
| Martins, PC | 1 |
| Hansen, F | 1 |
| de Magalhães, ELG | 1 |
| da Silva, DCG | 1 |
| Ferreira, FG | 1 |
| Roberto, DMT | 1 |
| Hinnig, PF | 1 |
| Rong, S | 1 |
| Bian, C | 1 |
| Yang, Y | 1 |
| Pan, H | 2 |
| Guler, B | 1 |
| Ertuglu, LA | 1 |
| Dagel, T | 1 |
| Afsar, B | 3 |
| Incir, S | 1 |
| Baygul, A | 1 |
| Covic, A | 2 |
| Jenkins, AJ | 1 |
| Braffett, BH | 1 |
| Basu, A | 1 |
| Bebu, I | 1 |
| Dagogo-Jack, S | 1 |
| Orchard, TJ | 1 |
| Wallia, A | 1 |
| Lopes-Virella, MF | 1 |
| Garvey, WT | 1 |
| Lachin, JM | 1 |
| Lyons, TJ | 1 |
| Lin, Z | 1 |
| Feng, W | 1 |
| Ma, C | 1 |
| Arefan, D | 1 |
| Zhou, D | 1 |
| Cheng, X | 1 |
| Yu, J | 1 |
| Gao, L | 2 |
| Du, L | 1 |
| You, H | 1 |
| Zhu, J | 1 |
| Zhu, D | 1 |
| Wu, S | 1 |
| Qu, S | 2 |
| Du, T | 1 |
| Lu, H | 1 |
| Lin, X | 2 |
| Lu, J | 2 |
| Cao, X | 1 |
| Shi, TT | 1 |
| Feng, JP | 1 |
| Yang, JK | 1 |
| Caliceti, C | 1 |
| Calabria, D | 1 |
| Roda, A | 1 |
| Piscitelli, P | 1 |
| Giorda, C | 2 |
| Ceriello, A | 2 |
| Genovese, S | 1 |
| Russo, G | 1 |
| Guida, P | 1 |
| Fioretto, P | 2 |
| De Cosmo, S | 2 |
| Yilmaz, E | 1 |
| Tamer, E | 1 |
| Artüz, F | 1 |
| Külcü Çakmak, S | 1 |
| Köktürk, F | 1 |
| Salaroli, LB | 2 |
| Cattafesta, M | 1 |
| Molina, MDCB | 1 |
| Zandonade, E | 1 |
| Bissoli, NS | 1 |
| Uzunova, I | 1 |
| Kirilov, G | 1 |
| Zacharieva, S | 1 |
| Zlatareva, N | 1 |
| Kalinov, K | 1 |
| Cheng, YY | 1 |
| Kao, TW | 2 |
| Chang, YW | 1 |
| Wu, CJ | 2 |
| Peng, TC | 1 |
| Wu, LW | 1 |
| Yang, HF | 2 |
| Liaw, FY | 1 |
| Chen, WL | 2 |
| Aldhoon-Hainerová, I | 1 |
| Hainer, V | 1 |
| Zamrazilová, H | 1 |
| Landucci Bonifácio, K | 1 |
| Sabbatini Barbosa, D | 1 |
| Gastaldello Moreira, E | 1 |
| de Farias, CC | 1 |
| Higachi, L | 1 |
| Camargo, AEI | 1 |
| Favaro Soares, J | 1 |
| Odebrecht Vargas, H | 1 |
| Nunes, SOV | 1 |
| Berk, M | 2 |
| Dodd, S | 2 |
| Maes, M | 3 |
| Ahmadieh, H | 1 |
| Azar, S | 1 |
| Borbélyová, V | 1 |
| Domonkos, E | 1 |
| Bábíčková, J | 1 |
| Tóthová, Ľ | 1 |
| Kačmárová, M | 1 |
| Uličná, O | 1 |
| Ostatníková, D | 1 |
| Hodosy, J | 1 |
| Celec, P | 1 |
| Thottam, GE | 1 |
| Krasnokutsky, S | 1 |
| Pillinger, MH | 1 |
| Xu, W | 2 |
| Jia, H | 1 |
| Jialal, I | 1 |
| Pahwa, R | 1 |
| Adams-Huet, B | 1 |
| Siegel, D | 1 |
| Genoni, G | 1 |
| Menegon, V | 1 |
| Secco, GG | 1 |
| Sonzini, M | 1 |
| Martelli, M | 1 |
| Castagno, M | 1 |
| Ricotti, R | 1 |
| Monzani, A | 1 |
| Aronici, M | 1 |
| Grossini, E | 1 |
| Di Mario, C | 1 |
| Bona, G | 1 |
| Bellone, S | 1 |
| Prodam, F | 1 |
| Al-Daghri, NM | 1 |
| Al-Attas, OS | 1 |
| Wani, K | 1 |
| Sabico, S | 1 |
| Alokail, MS | 1 |
| Mahbub, MH | 1 |
| Yamaguchi, N | 1 |
| Takahashi, H | 1 |
| Hase, R | 1 |
| Ishimaru, Y | 1 |
| Sunagawa, H | 1 |
| Amano, H | 1 |
| Kobayashi-Miura, M | 1 |
| Kanda, H | 1 |
| Fujita, Y | 1 |
| Yamamoto, H | 1 |
| Yamamoto, M | 1 |
| Kikuchi, S | 1 |
| Ikeda, A | 1 |
| Kageyama, N | 1 |
| Nakamura, M | 1 |
| Tanabe, T | 1 |
| Chen, YY | 1 |
| Chou, CW | 1 |
| Lai, CH | 1 |
| Sun, YS | 1 |
| Wang, CC | 1 |
| Porchia, LM | 1 |
| Gonzalez-Mejia, ME | 1 |
| Torres-Rasgado, E | 1 |
| Ruiz-Vivanco, G | 1 |
| Pérez-Fuentes, R | 1 |
| Caso, F | 1 |
| Del Puente, A | 1 |
| Oliviero, F | 1 |
| Peluso, R | 1 |
| Girolimetto, N | 1 |
| Bottiglieri, P | 1 |
| Foglia, F | 1 |
| Benigno, C | 1 |
| Tasso, M | 1 |
| Punzi, L | 1 |
| Scarpa, R | 2 |
| Costa, L | 1 |
| Pan, BL | 1 |
| Loke, SS | 1 |
| Méndez Landa, CE | 1 |
| King, C | 1 |
| Jensen, T | 3 |
| Alegría-Díaz, A | 1 |
| Valdez-Ortiz, R | 1 |
| Murguía-Romero, M | 1 |
| Jiménez-Flores, R | 1 |
| Villalobos-Molina, R | 1 |
| Mummidi, S | 1 |
| Duggirala, R | 1 |
| López-Alvarenga, JC | 1 |
| Pérez-Navarro, M | 1 |
| Bikulčienė, I | 1 |
| Vasiliauskaitė, L | 1 |
| Kučinskienė, ZA | 1 |
| Kaminskas, A | 1 |
| Hendrixson, V | 1 |
| Mao, Z | 1 |
| Zhang, X | 5 |
| Yang, K | 1 |
| Qian, X | 1 |
| Zhang, G | 1 |
| De Pergola, G | 1 |
| Termine, G | 1 |
| Carbonara, R | 1 |
| Masiello, M | 1 |
| Silvestris, F | 1 |
| Caccavo, D | 1 |
| Kawamoto, R | 5 |
| Ninomiya, D | 2 |
| Kasai, Y | 2 |
| Senzaki, K | 1 |
| Kusunoki, T | 4 |
| Ohtsuka, N | 4 |
| Kumagi, T | 2 |
| Spatola, L | 2 |
| Ferraro, PM | 1 |
| Gambaro, G | 2 |
| Badalamenti, S | 2 |
| Dauriz, M | 1 |
| Tadic, M | 1 |
| Cuspidi, C | 1 |
| Wang, LX | 1 |
| Filipp, SL | 1 |
| Urbina, EM | 1 |
| Gurka, MJ | 5 |
| DeBoer, MD | 5 |
| Pirro, M | 1 |
| Bianconi, V | 1 |
| Schiaroli, E | 1 |
| Francisci, D | 1 |
| Mannarino, MR | 1 |
| Bagaglia, F | 1 |
| Sahebkar, A | 1 |
| Merriman, T | 2 |
| Baldelli, F | 1 |
| Marin, M | 1 |
| Maalouf, NM | 3 |
| Srećković, B | 1 |
| Soldatovic, I | 1 |
| Colak, E | 1 |
| Mrdovic, I | 1 |
| Sumarac-Dumanovic, M | 1 |
| Janeski, H | 1 |
| Janeski, N | 1 |
| Gacic, J | 1 |
| Dimitrijevic-Sreckovic, V | 1 |
| Ahmadnezhad, M | 1 |
| Arefhosseini, SR | 1 |
| Parizadeh, MR | 1 |
| Tayefi, M | 1 |
| Darroudi, S | 1 |
| Moohebati, M | 1 |
| Ebrahimi, M | 1 |
| Heidari-Bakavoli, A | 1 |
| Azarpajouh, MR | 1 |
| Mogharebzadeh, V | 1 |
| Costa, NT | 1 |
| Scavuzzi, BM | 1 |
| Iriyoda, TMV | 1 |
| Lozovoy, MAB | 1 |
| Alfieri, DF | 1 |
| de Medeiros, FA | 1 |
| de Sá, MC | 1 |
| Micheletti, PL | 1 |
| Sekiguchi, BA | 1 |
| Reiche, EMV | 1 |
| Simão, ANC | 1 |
| Dichi, I | 6 |
| Hammam, N | 2 |
| Rashad, SM | 1 |
| Mohamed, AAA | 2 |
| Kim, JY | 1 |
| Cho, J | 1 |
| Yang, HR | 1 |
| Ramirez, AJ | 1 |
| Christen, AI | 1 |
| Sanchez, RA | 1 |
| El-Fawal, R | 1 |
| El Fayoumi, HM | 1 |
| Mahmoud, MF | 1 |
| Song, YM | 2 |
| Lee, K | 2 |
| Battelli, MG | 2 |
| Bortolotti, M | 1 |
| Polito, L | 2 |
| Bolognesi, A | 2 |
| Ren, P | 1 |
| Gao, M | 1 |
| Chang, WC | 2 |
| Lee, CC | 1 |
| Chen, KH | 2 |
| Wu, YW | 2 |
| Hwang, JJ | 2 |
| Wójcik, M | 1 |
| Ruszała, A | 1 |
| Szczudlik, E | 1 |
| Janus, D | 1 |
| Sztefko, K | 1 |
| Starzyk, JB | 1 |
| Yamamoto, T | 2 |
| Xie, J | 1 |
| Li, Z | 5 |
| Field, C | 1 |
| Block, C | 1 |
| Taylor, T | 1 |
| Petrikova, J | 1 |
| Janicko, M | 1 |
| Fedacko, J | 1 |
| Drazilova, S | 1 |
| Madarasova Geckova, A | 1 |
| Marekova, M | 1 |
| Pella, D | 1 |
| Jarcuska, P | 1 |
| Giovannini, M | 1 |
| Grandi, E | 1 |
| Rosticci, M | 2 |
| D'Addato, S | 2 |
| Peng, LN | 1 |
| Chou, MY | 1 |
| Liang, CK | 1 |
| Lee, WJ | 2 |
| Kojima, T | 2 |
| Lin, MH | 2 |
| Loh, CH | 1 |
| Chen, LK | 2 |
| Redon, P | 1 |
| Yan, D | 1 |
| Xu, M | 2 |
| Li, F | 1 |
| Ren, M | 1 |
| Wu, M | 1 |
| Ferreira, TDS | 1 |
| Fernandes, JFR | 1 |
| Araújo, LDS | 1 |
| Nogueira, LP | 1 |
| Leal, PM | 1 |
| Antunes, VP | 1 |
| Rodrigues, MLG | 1 |
| Valença, DCT | 1 |
| Kaiser, SE | 1 |
| Klein, MRST | 1 |
| Perez-Pozo, SE | 4 |
| Lillo, JL | 2 |
| Grases, F | 1 |
| Schold, JD | 1 |
| Sato, Y | 1 |
| Hernando, AA | 1 |
| Garcia, G | 1 |
| Rivard, C | 2 |
| Roncal, C | 5 |
| Russo, GT | 1 |
| Shimizu, T | 3 |
| Hori, H | 1 |
| Umeyama, M | 1 |
| Shimizu, K | 1 |
| Hu, LS | 1 |
| Chai, YC | 1 |
| Shi, JH | 1 |
| Zhang, C | 2 |
| Tian, M | 1 |
| Lv, Y | 1 |
| Wang, B | 1 |
| Jia, A | 1 |
| Troisi, J | 1 |
| Belmonte, F | 1 |
| Bisogno, A | 1 |
| Lausi, O | 1 |
| Marciano, F | 1 |
| Cavallo, P | 1 |
| Guercio Nuzio, S | 1 |
| Landolfi, A | 1 |
| Pierri, L | 1 |
| Vajro, P | 1 |
| Tseng, CK | 1 |
| Chen, J | 1 |
| Feng, J | 1 |
| Wilson, I | 1 |
| Jones, A | 1 |
| Tan, Y | 1 |
| Yang, F | 2 |
| Huang, XF | 1 |
| Harada, PH | 1 |
| Benseñor, IM | 1 |
| Bittencourt, MS | 1 |
| Nasir, K | 3 |
| Blaha, MJ | 2 |
| Jones, SR | 1 |
| Toth, PP | 1 |
| Lotufo, PA | 1 |
| Akase, T | 1 |
| Kikuchi, A | 1 |
| El Zohri, MH | 1 |
| Gheita, TA | 2 |
| Kocak, MZ | 1 |
| Aktas, G | 1 |
| Erkus, E | 1 |
| Sincer, I | 1 |
| Atak, B | 1 |
| Duman, T | 1 |
| Özalp Kızılay, D | 1 |
| Şen, S | 1 |
| Ersoy, B | 1 |
| Shibata, Y | 1 |
| Inoue, S | 1 |
| Watanabe, M | 1 |
| Serrano, N | 1 |
| Ojeda, CA | 1 |
| Gamboa Delgado, E | 1 |
| Colmenares Mejia, CC | 1 |
| Quintero Lesmes, DC | 1 |
| Lee, J | 1 |
| Hong, YS | 1 |
| Park, SH | 2 |
| Kang, KY | 1 |
| Yu, TY | 2 |
| Jin, SM | 2 |
| Jee, JH | 2 |
| Bae, JC | 2 |
| Lee, MK | 2 |
| Kim, JH | 5 |
| Cheng, J | 1 |
| Huangfu, N | 1 |
| Zhao, R | 1 |
| Xu, Z | 1 |
| Zhang, F | 1 |
| Zheng, W | 1 |
| Zhang, D | 3 |
| Trinchieri, A | 1 |
| Croppi, E | 1 |
| Simonelli, G | 1 |
| Sciorio, C | 1 |
| Montanari, E | 1 |
| Battaglino, MG | 1 |
| Nava, E | 1 |
| Pavlova, ZS | 1 |
| Golodnikov, II | 1 |
| Kamalov, AA | 1 |
| Nizov, AN | 1 |
| Sumiyoshi, H | 1 |
| Ohyama, Y | 2 |
| Imai, K | 2 |
| Kurabayashi, M | 2 |
| Saito, Y | 1 |
| Freixer, G | 1 |
| Bueno-Cavanillas, A | 1 |
| Martín-Sánchez, V | 1 |
| Razquin, C | 1 |
| Abellán Cano, I | 1 |
| Sorli, JV | 1 |
| Torres, L | 1 |
| Navarrete-Muñoz, EM | 1 |
| Tojal Sierra, L | 1 |
| Crespo-Oliva, E | 1 |
| Zulet, MÁ | 2 |
| Sanchez-Villegas, A | 1 |
| Bernal-Lopez, MR | 1 |
| Del Mar Bibiloni, M | 1 |
| Quifer, M | 1 |
| Prieto, RM | 1 |
| Fernandez-Brufal, N | 1 |
| Salaverria Lete, I | 1 |
| Cenoz, JC | 1 |
| Llimona, R | 1 |
| Tang, ZH | 1 |
| Fang, Z | 1 |
| Zeng, F | 1 |
| Zhou, L | 2 |
| Moon, SS | 1 |
| Kohjimoto, Y | 2 |
| Sasaki, Y | 2 |
| Iguchi, M | 1 |
| Matsumura, N | 1 |
| Inagaki, T | 1 |
| Hara, I | 2 |
| Ishiro, M | 1 |
| Takaya, R | 1 |
| Mori, Y | 2 |
| Takitani, K | 1 |
| Kono, Y | 1 |
| Okasora, K | 1 |
| Kasahara, T | 1 |
| Tamai, H | 1 |
| Tabara, Y | 1 |
| Kohara, K | 1 |
| Miki, T | 1 |
| Takayama, S | 2 |
| Abe, M | 2 |
| Katoh, T | 1 |
| Soltani, Z | 1 |
| Rasheed, K | 1 |
| Kapusta, DR | 1 |
| Reisin, E | 1 |
| Stanhope, KL | 1 |
| Schwarz, JM | 1 |
| Havel, PJ | 1 |
| Rizzo, M | 1 |
| Obradovic, M | 1 |
| Labudovic-Borovic, M | 1 |
| Nikolic, D | 1 |
| Montalto, G | 1 |
| Rizvi, AA | 1 |
| Mikhailidis, DP | 10 |
| Isenovic, ER | 1 |
| Katsiki, N | 4 |
| Athyros, VG | 6 |
| Karagiannis, A | 5 |
| Liu, RT | 1 |
| Chung, MS | 1 |
| Wang, PW | 1 |
| Chen, CD | 1 |
| Lee, JJ | 1 |
| Lee, WC | 1 |
| Chancellor, MB | 1 |
| Yang, KD | 1 |
| Chuang, YC | 1 |
| Zhou, T | 1 |
| Watts, K | 1 |
| Agalliu, I | 1 |
| DiVito, J | 1 |
| Hoenig, DM | 1 |
| Hosoya, T | 2 |
| Ohno, I | 3 |
| Li, WC | 1 |
| Lee, YY | 1 |
| Chen, IC | 1 |
| Sun, C | 1 |
| Chiu, FH | 1 |
| Chuang, CH | 1 |
| Liu, PJ | 2 |
| Ma, F | 2 |
| Lou, HP | 2 |
| Zhu, YN | 2 |
| Oda, E | 3 |
| Yuan, J | 1 |
| Yao, P | 1 |
| Yang, B | 1 |
| Gui, L | 1 |
| Chen, W | 4 |
| Wei, S | 1 |
| Miao, X | 1 |
| Min, X | 1 |
| Yang, H | 7 |
| Fang, W | 1 |
| Liang, Y | 1 |
| Hu, FB | 1 |
| Wu, T | 1 |
| Bian, S | 1 |
| Gao, Y | 3 |
| Liu, W | 1 |
| Sun, K | 1 |
| Su, T | 1 |
| Xu, B | 1 |
| Bi, Y | 1 |
| Ning, G | 2 |
| Kawada, T | 8 |
| Otsuka, T | 2 |
| Onat, A | 3 |
| Can, G | 2 |
| Örnek, E | 1 |
| Altay, S | 1 |
| Yüksel, M | 2 |
| Ademoğlu, E | 1 |
| Xie, Y | 1 |
| Wang, M | 2 |
| Tan, A | 2 |
| Liang, Z | 1 |
| Shi, D | 2 |
| Huang, Z | 1 |
| Lu, Z | 2 |
| Wu, C | 2 |
| Liao, M | 1 |
| Sun, Y | 6 |
| Qin, X | 1 |
| Hu, Y | 2 |
| Peng, T | 1 |
| Mo, Z | 2 |
| Mavlianov, IR | 1 |
| Abdullaev, AK | 1 |
| de la Iglesia, R | 1 |
| Lopez-Legarrea, P | 1 |
| Bondia-Pons, I | 1 |
| Navas-Carretero, S | 1 |
| Forga, L | 1 |
| Sun, N | 1 |
| Tian, JL | 1 |
| Wang, H | 5 |
| Tu, YK | 2 |
| D'Aiuto, F | 1 |
| Lin, HJ | 1 |
| Chen, YW | 1 |
| Chien, KL | 3 |
| Jaipakdee, J | 1 |
| Jiamjarasrangsri, W | 1 |
| Lohsoonthorn, V | 2 |
| Lertmaharit, S | 1 |
| Shafiu, M | 3 |
| Sundaram, S | 1 |
| Le, M | 3 |
| Ishimoto, T | 2 |
| Sautin, YY | 7 |
| Uysal, Y | 1 |
| Wolters, B | 1 |
| Knop, C | 1 |
| Reinehr, T | 1 |
| Gisondi, P | 1 |
| Targher, G | 3 |
| Cagalli, A | 1 |
| Girolomoni, G | 1 |
| Altuğ Çakmak, H | 1 |
| Köroğlu, B | 1 |
| Yüksel, H | 1 |
| Cicero, AF | 1 |
| Salvi, P | 1 |
| Cai, W | 1 |
| Zhang, B | 2 |
| Miao, L | 1 |
| Sun, YP | 1 |
| Zou, Y | 1 |
| Yao, H | 1 |
| Ayyavoo, A | 1 |
| Derraik, JG | 1 |
| Hofman, PL | 1 |
| Cutfield, WS | 1 |
| Zhang, HW | 1 |
| Jiang, S | 1 |
| Xu, YC | 1 |
| You, L | 1 |
| Liu, A | 2 |
| Wuyun, G | 1 |
| Wu, H | 1 |
| Wang, P | 1 |
| Chang, HT | 1 |
| Shen, HC | 1 |
| Hu, YC | 1 |
| Chen, YF | 1 |
| Tung, TH | 1 |
| Sheikhbahaei, S | 1 |
| Fotouhi, A | 1 |
| Hafezi-Nejad, N | 1 |
| Nakhjavani, M | 1 |
| Esteghamati, A | 1 |
| Takahara, M | 1 |
| Katakami, N | 1 |
| Kaneto, H | 1 |
| Noguchi, M | 1 |
| Shimomura, I | 1 |
| Sakhaee, K | 4 |
| Hsieh, CH | 3 |
| Lin, JD | 5 |
| Wu, CZ | 3 |
| Hsu, CH | 2 |
| Pei, D | 5 |
| Liang, YJ | 2 |
| Chen, YL | 5 |
| Qin, L | 1 |
| Yang, Z | 4 |
| Gu, H | 1 |
| Lu, S | 2 |
| Shi, Q | 1 |
| Xing, Y | 2 |
| Su, Q | 1 |
| Bonakdaran, S | 1 |
| Kharaqani, B | 1 |
| Chen, S | 3 |
| Shao, X | 1 |
| Guo, J | 1 |
| Li, B | 1 |
| Deng, K | 1 |
| Holthöfer, H | 1 |
| Zou, H | 1 |
| Yin, X | 1 |
| Zhou, J | 1 |
| Yu, D | 1 |
| Dong, X | 1 |
| Zheng, F | 1 |
| Garneri, D | 1 |
| Gonnella, A | 1 |
| Ambrosioni, E | 2 |
| Costa, FV | 1 |
| Leonetti, G | 1 |
| Pessina, AC | 2 |
| Trimarco, B | 1 |
| Deferrari, G | 3 |
| Mulè, G | 1 |
| Riccobene, R | 1 |
| Castiglia, A | 1 |
| D'Ignoto, F | 1 |
| Ajello, E | 1 |
| Geraci, G | 1 |
| Guarino, L | 1 |
| Nardi, E | 1 |
| Vaccaro, F | 1 |
| Cerasola, G | 1 |
| Cottone, S | 1 |
| Domingos, F | 1 |
| Serra, A | 1 |
| Sarmento, PL | 1 |
| Plavnik, FL | 1 |
| Scaciota, A | 1 |
| Lima, JO | 1 |
| Miranda, RB | 1 |
| Ajzen, SA | 1 |
| Vallianou, NG | 1 |
| Evangelopoulos, AA | 1 |
| Bountziouka, V | 1 |
| Bonou, MS | 1 |
| Katsagoni, C | 1 |
| Vogiatzakis, ED | 1 |
| Avgerinos, PC | 1 |
| Barbetseas, J | 1 |
| Panagiotakos, DB | 2 |
| Jia, G | 1 |
| Aroor, AR | 1 |
| Whaley-Connell, AT | 1 |
| Sowers, JR | 1 |
| Stibůrková, B | 1 |
| Pavlíková, M | 1 |
| Sokolová, J | 1 |
| Kožich, V | 1 |
| Stelmach, MJ | 2 |
| Wasilewska, N | 2 |
| Wicklund-Liland, LI | 1 |
| Wasilewska, A | 2 |
| Ciarla, S | 1 |
| Struglia, M | 1 |
| Giorgini, P | 1 |
| Striuli, R | 1 |
| Necozione, S | 1 |
| Properzi, G | 1 |
| Kacalak-Rzepka, A | 1 |
| Kiedrowicz, M | 1 |
| Maleszka, R | 1 |
| Ferrara, LA | 1 |
| Umans, JG | 1 |
| Franceschini, N | 1 |
| Jolly, S | 1 |
| Lee, ET | 1 |
| Yeh, J | 1 |
| Devereux, RB | 1 |
| Howard, BV | 1 |
| de Simone, G | 1 |
| DeBosch, BJ | 1 |
| Kluth, O | 1 |
| Fujiwara, H | 1 |
| Schürmann, A | 1 |
| Moley, K | 1 |
| Valle, M | 1 |
| Martos, R | 1 |
| Cañete, MD | 1 |
| Valle, R | 1 |
| van Donkelaar, EL | 1 |
| Bermudo, F | 1 |
| Cañete, R | 1 |
| Gawron-Skarbek, A | 1 |
| Chrzczanowicz, J | 1 |
| Kostka, J | 1 |
| Nowak, D | 1 |
| Drygas, W | 1 |
| Jegier, A | 1 |
| Kostka, T | 1 |
| Zhao, Y | 1 |
| Catena, C | 1 |
| Colussi, G | 1 |
| Capobianco, F | 1 |
| Brosolo, G | 1 |
| Sechi, LA | 1 |
| Mahmoud, AA | 1 |
| Elshazly, SM | 1 |
| Faria, FR | 1 |
| Franceschini, Sdo C | 1 |
| Peluzio, Mdo C | 1 |
| Sant Ana, LF | 1 |
| Novaes, JF | 1 |
| Ribeiro, SM | 1 |
| Ribeiro, AQ | 1 |
| Cho, S | 1 |
| Kim, SR | 1 |
| Zhang, MC | 1 |
| Mao, JF | 1 |
| Yi, LD | 1 |
| de Oliveira, A | 1 |
| Hermsdorff, HHM | 1 |
| Guedes Cocate, P | 1 |
| Bressan, J | 1 |
| Azevedo Novello, A | 1 |
| Cardoso dos Santos, E | 1 |
| José Natali, A | 1 |
| Andrade, JA | 1 |
| Kang, HC | 1 |
| Greffin, S | 1 |
| Garcia Rosa, ML | 1 |
| Lugon, JR | 1 |
| Sun, D | 1 |
| Fernandez, C | 1 |
| Srinivasan, SR | 2 |
| Berenson, GS | 2 |
| Nagahama, K | 1 |
| Inoue, T | 2 |
| Kohagura, K | 1 |
| Kinjo, K | 1 |
| Ohya, Y | 1 |
| Marotta, T | 1 |
| Liccardo, M | 1 |
| Schettini, F | 1 |
| Verde, F | 1 |
| Ferrara, AL | 1 |
| Ohno, M | 1 |
| Deguchi, F | 1 |
| Izumi, K | 1 |
| Ishigaki, H | 1 |
| Sarui, H | 1 |
| Sasaki, A | 1 |
| Segawa, T | 1 |
| Yamaki, T | 1 |
| Ohashi, H | 1 |
| Li, LX | 1 |
| Dong, XH | 1 |
| Li, MF | 1 |
| Zhang, R | 1 |
| Li, TT | 1 |
| Shen, J | 3 |
| Bao, YQ | 1 |
| Jia, WP | 1 |
| Zhang, JJ | 1 |
| Wu, ZB | 1 |
| Cai, YJ | 1 |
| Ke, B | 1 |
| Huang, YJ | 1 |
| Qiu, CP | 1 |
| Yang, YB | 1 |
| Shi, LY | 1 |
| Qin, J | 1 |
| Tanaka, T | 2 |
| Lee, JK | 1 |
| Ryoo, JH | 1 |
| Choi, JM | 1 |
| Park, SK | 1 |
| Juárez-Reyes, K | 1 |
| Brindis, F | 1 |
| Medina-Campos, ON | 1 |
| Pedraza-Chaverri, J | 1 |
| Bye, R | 1 |
| Linares, E | 1 |
| Mata, R | 1 |
| Recondo, J | 1 |
| Ortega-Calvo, M | 1 |
| Basora, J | 1 |
| Szczerbinski, L | 1 |
| Protas, P | 1 |
| Yamanishi, H | 1 |
| Ibrahim, SM | 1 |
| El-Denshary, ES | 1 |
| Abdallah, DM | 1 |
| Gradillas-García, A | 1 |
| Álvarez, J | 1 |
| Rubio, JA | 1 |
| de Abajo, FJ | 1 |
| Jaeschke, L | 1 |
| Steinbrecher, A | 1 |
| Pischon, T | 1 |
| Andou, T | 1 |
| Fukumitsu, M | 1 |
| Zelber-Sagi, S | 1 |
| Ben-Assuli, O | 1 |
| Rabinowich, L | 1 |
| Goldstein, A | 1 |
| Magid, A | 1 |
| Shalev, V | 1 |
| Shibolet, O | 1 |
| Chodick, G | 1 |
| Bortolasci, CC | 1 |
| Vargas, HO | 1 |
| Vargas Nunes, SO | 1 |
| de Melo, LG | 1 |
| de Castro, MR | 1 |
| Moreira, EG | 1 |
| Barbosa, DS | 3 |
| Chen, L | 3 |
| Mai, L | 1 |
| Fang, L | 1 |
| Ying, K | 1 |
| Chen, D | 1 |
| Yao, Z | 1 |
| Jiang, Y | 1 |
| Rivard, CJ | 1 |
| Bjornstad, PS | 1 |
| Sundborn, G | 1 |
| Donderski, R | 1 |
| Miśkowiec-Wiśniewska, I | 1 |
| Kretowicz, M | 1 |
| Grajewska, M | 1 |
| Manitius, J | 2 |
| Kamińska, A | 1 |
| Junik, R | 1 |
| Siódmiak, J | 1 |
| Stefańska, A | 1 |
| Odrowąż-Sypniewska, G | 1 |
| Pluta, A | 1 |
| Lanaspa, M | 1 |
| Yadav, D | 1 |
| Lee, ES | 1 |
| Kim, HM | 1 |
| Choi, E | 1 |
| Lee, EY | 1 |
| Lim, JS | 1 |
| Ahn, SV | 1 |
| Koh, SB | 1 |
| Chung, CH | 1 |
| Seetho, IW | 1 |
| Parker, RJ | 1 |
| Craig, S | 1 |
| Duffy, N | 1 |
| Hardy, KJ | 1 |
| Wilding, JP | 1 |
| Goodson, NJ | 1 |
| Ságodi, L | 1 |
| Fehér, V | 1 |
| Kiss-Tóth, E | 1 |
| Almási, A | 1 |
| Barkai, L | 1 |
| Nakamura, Y | 1 |
| Ueshima, H | 1 |
| Okuda, N | 1 |
| Miura, K | 1 |
| Kita, Y | 1 |
| Miyagawa, N | 1 |
| Yoshita, K | 1 |
| Nakagawa, H | 1 |
| Sakata, K | 1 |
| Saitoh, S | 1 |
| Okamura, T | 1 |
| Okayama, A | 1 |
| Choudhry, SR | 1 |
| Rodriguez, B | 1 |
| Masaki, KH | 1 |
| Chan, Q | 1 |
| Elliott, P | 1 |
| Stamler, J | 1 |
| Lima, WG | 1 |
| Martins-Santos, ME | 1 |
| Chaves, VE | 1 |
| Papavasileiou, MV | 1 |
| Karamanou, AG | 1 |
| Kalogeropoulos, P | 1 |
| Moustakas, G | 1 |
| Patsianis, S | 1 |
| Pittaras, A | 1 |
| Rosei, EA | 1 |
| Bardin, T | 1 |
| Dawson, J | 1 |
| Dominiczak, A | 1 |
| Manolis, AJ | 1 |
| Perez-Ruiz, F | 1 |
| Yu, S | 5 |
| Tian, Y | 1 |
| Chen, K | 1 |
| Xie, Z | 1 |
| Fang, Y | 1 |
| Nie, Y | 1 |
| Mu, Y | 1 |
| Jiang, M | 1 |
| Sun, G | 2 |
| Kargiotis, K | 1 |
| Giouleme, O | 1 |
| Katsiki, E | 1 |
| Anagnostis, P | 2 |
| Boutari, C | 1 |
| Doumas, M | 1 |
| Obokata, M | 1 |
| Negishi, K | 1 |
| Okada, H | 1 |
| Uslu, S | 1 |
| Ozcelik, E | 1 |
| Kebapci, N | 1 |
| Temel, HE | 1 |
| Demirci, F | 1 |
| Ergun, B | 1 |
| Demirustu, C | 1 |
| Kanagasabai, T | 1 |
| Ardern, CI | 1 |
| Simão, AN | 5 |
| Wei, CY | 1 |
| Sun, CC | 1 |
| Wei, JC | 1 |
| Tai, HC | 1 |
| Sun, CA | 2 |
| Chung, CF | 1 |
| Chou, YC | 2 |
| Lin, PL | 2 |
| Yang, T | 2 |
| Nam, SH | 1 |
| Kang, SG | 1 |
| Lee, YA | 1 |
| Song, SW | 1 |
| Rho, JS | 1 |
| Ou, Q | 1 |
| Zheng, L | 2 |
| Yuan, H | 2 |
| Yu, C | 2 |
| Sun, L | 1 |
| Zhu, X | 1 |
| Zhao, C | 1 |
| Zhang, Z | 3 |
| Castejon, R | 1 |
| Jimenez-Ortiz, C | 1 |
| Rosado, S | 1 |
| Tutor-Ureta, P | 1 |
| Mellor-Pita, S | 1 |
| Yebra-Bango, M | 1 |
| Que, S | 1 |
| Zheng, S | 1 |
| Zhu, WH | 2 |
| Fang, LZ | 2 |
| Lu, CR | 1 |
| Dai, HL | 2 |
| Chen, JH | 3 |
| Qiao, QH | 1 |
| Chen, LY | 2 |
| Sun, DQ | 1 |
| Wu, SJ | 1 |
| Liu, WY | 1 |
| Lu, QD | 1 |
| Zhu, GQ | 1 |
| Shi, KQ | 1 |
| Braddock, M | 1 |
| Song, D | 1 |
| Zheng, MH | 1 |
| Rubio-Guerra, AF | 1 |
| Morales-López, H | 1 |
| Garro-Almendaro, AK | 1 |
| Vargas-Ayala, G | 1 |
| Durán-Salgado, MB | 1 |
| Huerta-Ramírez, S | 1 |
| Lozano-Nuevo, JJ | 1 |
| Kim, HJ | 1 |
| Kim, JE | 1 |
| Jung, JH | 2 |
| Kim, ER | 1 |
| Hong, SN | 1 |
| Chang, DK | 1 |
| Son, HJ | 1 |
| Rhee, PL | 1 |
| Kim, JJ | 1 |
| Kim, YH | 1 |
| Rajan, S | 1 |
| Zalpuri, I | 1 |
| Harrington, A | 1 |
| Cimpeanu, C | 1 |
| Song, X | 2 |
| Fan, X | 1 |
| Sun, HL | 1 |
| Lue, KH | 1 |
| Zurlo, A | 1 |
| Veronese, N | 1 |
| Giantin, V | 1 |
| Maselli, M | 1 |
| Zambon, S | 1 |
| Maggi, S | 1 |
| Musacchio, E | 1 |
| Toffanello, ED | 1 |
| Sartori, L | 1 |
| Perissinotto, E | 1 |
| Crepaldi, G | 1 |
| Manzato, E | 1 |
| Sergi, G | 1 |
| Lai, YC | 1 |
| Yew, YW | 1 |
| Solak, Y | 1 |
| Bertoli, S | 1 |
| Leone, A | 1 |
| Vignati, L | 1 |
| Spadafranca, A | 1 |
| Bedogni, G | 1 |
| Vanzulli, A | 1 |
| Rodeschini, E | 1 |
| Battezzati, A | 1 |
| Zhao, L | 1 |
| Wang, O | 1 |
| Zhou, F | 1 |
| Ji, B | 1 |
| Lee, JW | 1 |
| Im, JP | 1 |
| Kastorini, CM | 1 |
| Georgousopoulou, EN | 1 |
| Laskaris, A | 1 |
| Skourlis, N | 1 |
| Zana, A | 1 |
| Chatzinikolaou, C | 1 |
| Chrysohoou, C | 1 |
| Puddu, PE | 1 |
| Tousoulis, D | 1 |
| Stefanadis, C | 1 |
| Pitsavos, C | 1 |
| Ortega-Cortes, R | 1 |
| Trujillo, X | 1 |
| Hurtado López, EF | 1 |
| López Beltrán, AL | 1 |
| Colunga Rodríguez, C | 1 |
| Barrera-de Leon, JC | 1 |
| Tlacuilo-Parra, A | 1 |
| Alemzadeh, R | 1 |
| Kichler, J | 1 |
| Kerimi, A | 1 |
| Williamson, G | 1 |
| Fukuno, H | 1 |
| Muguruma, N | 1 |
| Aibibula, Z | 1 |
| Ailixiding, M | 1 |
| Iwata, M | 1 |
| Piao, J | 1 |
| Hara, Y | 1 |
| Okawa, A | 1 |
| Asou, Y | 1 |
| Baek, JH | 1 |
| Guo, Q | 1 |
| Luo, W | 1 |
| Yin, DS | 1 |
| Jia, CY | 1 |
| Lombardi, R | 1 |
| Pisano, G | 1 |
| Fargion, S | 1 |
| Xiao, J | 1 |
| Zhang, P | 1 |
| Chen, X | 1 |
| Bartoli, F | 1 |
| Crocamo, C | 1 |
| Gennaro, GM | 1 |
| Castagna, G | 1 |
| Trotta, G | 1 |
| Clerici, M | 1 |
| Carrà, G | 1 |
| Harada, M | 1 |
| Izawa, A | 1 |
| Hidaka, H | 1 |
| Nakanishi, K | 1 |
| Terasawa, F | 1 |
| Motoki, H | 1 |
| Yazaki, Y | 1 |
| Ikeda, U | 1 |
| Hongo, M | 1 |
| Norvik, JV | 1 |
| Storhaug, HM | 1 |
| Ytrehus, K | 1 |
| Jenssen, TG | 1 |
| Zykova, SN | 1 |
| Eriksen, BO | 1 |
| Solbu, MD | 1 |
| Castaldo, G | 1 |
| Monaco, L | 1 |
| Castaldo, L | 1 |
| Galdo, G | 1 |
| Cereda, E | 1 |
| Safiri, S | 1 |
| Qorbani, M | 1 |
| Heshmat, R | 2 |
| Tajbakhsh, R | 1 |
| Eslami Shahr Babaki, A | 1 |
| Djalalinia, S | 1 |
| Motlagh, ME | 1 |
| Tajadini, MH | 1 |
| Asayesh, H | 1 |
| Safari, O | 1 |
| Kelishadi, R | 1 |
| Sung, J | 1 |
| Qi, J | 1 |
| Dai, H | 1 |
| Lu, M | 1 |
| Chen, R | 1 |
| Yang, P | 1 |
| Moulin, SR | 1 |
| Baldo, MP | 2 |
| Souza, JB | 1 |
| Luchi, WM | 1 |
| Capingana, DP | 1 |
| Magalhães, P | 2 |
| Gugliucci, A | 2 |
| Li, YY | 1 |
| Yu, Y | 1 |
| Wang, F | 1 |
| Zhang, HQ | 1 |
| Zhao, M | 1 |
| Zhao, JJ | 1 |
| He, SJ | 1 |
| Chan, C | 1 |
| Xie, ZD | 1 |
| Hu, XB | 1 |
| Li, HY | 2 |
| Wang, MZ | 1 |
| Bai, YN | 1 |
| Sánchez-Rodríguez, MA | 1 |
| Zacarías-Flores, M | 1 |
| Castrejón-Delgado, L | 1 |
| Ruiz-Rodríguez, AK | 1 |
| Mendoza-Núñez, VM | 1 |
| Krajcoviechova, A | 2 |
| Tremblay, J | 2 |
| Wohlfahrt, P | 2 |
| Bruthans, J | 2 |
| Tahir, MR | 2 |
| Hamet, P | 2 |
| Cifkova, R | 2 |
| Gradinaru, D | 1 |
| Margina, D | 1 |
| Borsa, C | 1 |
| Ionescu, C | 1 |
| Ilie, M | 1 |
| Costache, M | 1 |
| Dinischiotu, A | 1 |
| Prada, GI | 1 |
| Su, BY | 1 |
| Tian, CF | 1 |
| Gao, BL | 1 |
| Tong, YH | 1 |
| Zhao, XH | 1 |
| Song, GG | 2 |
| Ji, JD | 2 |
| Lee, YH | 2 |
| Seo, YH | 1 |
| Choi, SJ | 2 |
| Meng, Z | 2 |
| Guo, C | 1 |
| Mostafa, DK | 1 |
| Nasra, RA | 1 |
| Zahran, N | 1 |
| Ghoneim, MT | 1 |
| Liu, JS | 1 |
| Chuang, TJ | 1 |
| Chang, HW | 1 |
| Huang, CL | 1 |
| Li, PF | 1 |
| Zhou, Z | 1 |
| Song, K | 1 |
| Qiu, J | 1 |
| Xu, Y | 2 |
| Guo, Z | 1 |
| Dong, C | 1 |
| Kelany, ME | 1 |
| Hakami, TM | 1 |
| Omar, AH | 1 |
| Angelini, C | 1 |
| Maringhini, S | 1 |
| Liu, CQ | 1 |
| He, CM | 1 |
| Chen, N | 1 |
| Shi, X | 1 |
| Zeng, X | 1 |
| Yan, B | 1 |
| Luciano, R | 1 |
| Shashaj, B | 1 |
| Spreghini, M | 1 |
| Del Fattore, A | 1 |
| Rustico, C | 1 |
| Wietrzykowska Sforza, R | 1 |
| Morino, GS | 1 |
| Dallapiccola, B | 1 |
| Manco, M | 1 |
| Kushiyama, A | 1 |
| Nakatsu, Y | 1 |
| Matsunaga, Y | 1 |
| Yamamotoya, T | 1 |
| Ueda, K | 1 |
| Inoue, Y | 1 |
| Sakoda, H | 1 |
| Fujishiro, M | 1 |
| Ono, H | 1 |
| Asano, T | 1 |
| Tsuda, K | 1 |
| Bernardes, N | 1 |
| Ayyappan, P | 1 |
| De Angelis, K | 1 |
| Bagchi, A | 1 |
| Akolkar, G | 1 |
| da Silva Dias, D | 1 |
| Belló-Klein, A | 1 |
| Singal, PK | 1 |
| Chang, JB | 1 |
| Hung, YJ | 1 |
| Lee, CH | 3 |
| Lin, CM | 1 |
| Fu, YQ | 1 |
| Zheng, JS | 1 |
| Zeng, XY | 1 |
| Zeng, W | 1 |
| Fan, ZF | 1 |
| Chen, M | 1 |
| Li, D | 2 |
| Cibičková, Ľ | 1 |
| Langová, K | 1 |
| Vaverková, H | 1 |
| Kubíčková, V | 1 |
| Karásek, D | 1 |
| Lee, AM | 1 |
| Amezawa, M | 1 |
| Puig, JG | 3 |
| Martínez, MA | 1 |
| Mora, M | 1 |
| Fraile, JM | 3 |
| Montoya, F | 1 |
| Torres, RJ | 3 |
| Oliver, WJ | 1 |
| Mu, W | 5 |
| Gabriela Sanchez-Lozada, L | 1 |
| Rodriguez-Iturbe, B | 1 |
| Benner, SA | 1 |
| Choi, HK | 4 |
| De Vera, MA | 1 |
| Krishnan, E | 2 |
| Kang, YH | 1 |
| Min, HG | 1 |
| Kim, IJ | 1 |
| Son, SM | 1 |
| Balasubramanian, T | 1 |
| Lam, CW | 1 |
| Kong, AP | 2 |
| Tsui, TK | 1 |
| Ozaki, R | 2 |
| Chan, HM | 1 |
| Tong, SF | 1 |
| Siu, TS | 1 |
| Tam, S | 1 |
| Chan, JC | 2 |
| Feig, DI | 4 |
| Kang, DH | 3 |
| Pacifico, L | 1 |
| Cantisani, V | 1 |
| Anania, C | 1 |
| Bonaiuto, E | 1 |
| Martino, F | 1 |
| Pascone, R | 1 |
| Chiesa, C | 1 |
| Abdullah, AR | 1 |
| Hasan, HA | 1 |
| Raigangar, VL | 1 |
| Navaneethan, SD | 1 |
| Beddhu, S | 1 |
| Sari, I | 2 |
| Akar, S | 1 |
| Pakoz, B | 1 |
| Sisman, AR | 1 |
| Gurler, O | 1 |
| Birlik, M | 1 |
| Onen, F | 1 |
| Akkoc, N | 1 |
| Uehara, SK | 1 |
| Rosa, G | 1 |
| Park, W | 1 |
| Kim, BS | 2 |
| Lee, JE | 1 |
| Huh, JK | 1 |
| Kim, BJ | 2 |
| Sung, KC | 2 |
| Kang, JH | 2 |
| Lee, MH | 2 |
| Park, JR | 2 |
| Rhee, EJ | 2 |
| Oh, KW | 1 |
| Lee, WY | 3 |
| Park, SW | 1 |
| Kim, SW | 2 |
| Hermida, RC | 1 |
| Chayán, L | 1 |
| Ayala, DE | 1 |
| Mojón, A | 1 |
| Domínguez, MJ | 1 |
| Fontao, MJ | 1 |
| Soler, R | 1 |
| Alonso, I | 1 |
| Fernández, JR | 1 |
| Segal, M | 1 |
| Glassock, RJ | 1 |
| Shimada, M | 1 |
| Gersch, MS | 2 |
| Scherer, PM | 1 |
| Kim, KM | 1 |
| Henderson, GN | 1 |
| Rodilla, E | 1 |
| Pérez-Lahiguera, F | 1 |
| Costa, JA | 1 |
| González, C | 1 |
| Miralles, A | 1 |
| Moral, D | 1 |
| Pascual, JM | 1 |
| Kanellis, J | 1 |
| Yang, LL | 1 |
| Hua, Q | 1 |
| Liu, RK | 1 |
| Miao, M | 1 |
| Cai, Z | 1 |
| Xu, X | 1 |
| Zhou, C | 1 |
| Edwards, NL | 1 |
| Marasini, B | 1 |
| Massarotti, M | 1 |
| Livesey, G | 1 |
| Samara, A | 1 |
| Herbeth, B | 1 |
| Aubert, R | 1 |
| Berrahmoune, H | 1 |
| Fumeron, F | 1 |
| Siest, G | 1 |
| Visvikis-Siest, S | 1 |
| Tziomalos, K | 3 |
| Kawai, R | 2 |
| Korpachev, VV | 1 |
| Hurina, NM | 2 |
| Korpacheva, TI | 1 |
| Shuprovych, AA | 2 |
| Mosendz, IO | 1 |
| See, LC | 1 |
| Kuo, CF | 1 |
| Chuang, FH | 1 |
| Chen, YM | 2 |
| Chen, HW | 1 |
| Yu, KH | 1 |
| Suzuki, I | 1 |
| Yamauchi, T | 1 |
| Onuma, M | 1 |
| Nozaki, S | 1 |
| Hu, QH | 1 |
| Li, JM | 1 |
| Zhang, DM | 1 |
| Kong, LD | 1 |
| Abdelmalek, M | 1 |
| Reungjui, S | 3 |
| Lan, HY | 1 |
| Kawasaki, N | 1 |
| Takashima, T | 1 |
| Sagawa, K | 1 |
| Yamada, H | 1 |
| Shindo, K | 1 |
| Kakehi, K | 1 |
| Riches, PL | 1 |
| Wright, AF | 2 |
| Ralston, SH | 1 |
| Shelmadine, B | 1 |
| Bowden, RG | 1 |
| Wilson, RL | 1 |
| Beavers, D | 1 |
| Hartman, J | 1 |
| Sukumaran, V | 1 |
| Watanabe, K | 1 |
| Croymans, DM | 1 |
| Sanchez, A | 1 |
| Barth, JD | 1 |
| Roberts, CK | 1 |
| Ryu, S | 1 |
| Chang, Y | 1 |
| Woo, HY | 1 |
| Yoo, SH | 1 |
| Choi, NK | 1 |
| Kim, I | 1 |
| Grimaldi, S | 1 |
| Englund, A | 1 |
| Partonen, T | 1 |
| Haukka, J | 1 |
| Pirkola, S | 1 |
| Reunanen, A | 1 |
| Aromaa, A | 1 |
| Lönnqvist, J | 1 |
| Lin, KP | 1 |
| Indraratna, PL | 1 |
| Williams, KM | 1 |
| Graham, GG | 1 |
| Day, RO | 1 |
| Sachs, L | 1 |
| Batra, KL | 1 |
| Zimmermann, B | 1 |
| Macić-Dzanković, A | 1 |
| Dzanković, F | 1 |
| Pojskić, B | 1 |
| Velija-Asimi, Z | 1 |
| Simmons, D | 1 |
| Joshi, S | 1 |
| Shaw, J | 2 |
| Chang, CH | 1 |
| Chuang, YW | 1 |
| Liao, SC | 1 |
| Tang, YJ | 1 |
| Sheu, WH | 2 |
| Chen, DY | 1 |
| Liu, PW | 1 |
| Chang, TY | 1 |
| Chen, JD | 1 |
| Schold, J | 1 |
| Iffiú-Soltész, Z | 1 |
| Wanecq, E | 1 |
| Lomba, A | 1 |
| Portillo, MP | 1 |
| Pellati, F | 1 |
| Szöko, E | 1 |
| Bour, S | 1 |
| Woodley, J | 1 |
| Milagro, FI | 1 |
| Alfredo Martinez, J | 1 |
| Valet, P | 1 |
| Carpéné, C | 1 |
| Akin, F | 1 |
| Turgut, S | 1 |
| Bastemir, M | 1 |
| Turgut, G | 1 |
| Kursunluoglu, R | 1 |
| Karasu, U | 1 |
| Guclu, A | 1 |
| Ferguson, TF | 1 |
| Funkhouser, E | 1 |
| Roseman, J | 1 |
| Yoo, HG | 1 |
| Lee, SI | 1 |
| Chae, HJ | 1 |
| Park, SJ | 1 |
| Lee, YC | 2 |
| Yoo, WH | 1 |
| Chen, B | 1 |
| Yang, D | 1 |
| Ye, B | 1 |
| Ni, Z | 1 |
| Ogbera, A | 1 |
| Fasanmade, O | 1 |
| Kalra, S | 1 |
| Kirilmaz, B | 1 |
| Asgun, F | 1 |
| Alioglu, E | 1 |
| Ercan, E | 1 |
| Tengiz, I | 1 |
| Turk, U | 1 |
| Saygi, S | 1 |
| Ozerkan, F | 1 |
| Galli-Tsinopoulou, A | 1 |
| Grammatikopoulou, MG | 1 |
| Stylianou, C | 1 |
| Emmanouilidou, E | 1 |
| Kokka, P | 1 |
| Antonini-Canterin, F | 1 |
| La Carrubba, S | 1 |
| Gullace, G | 1 |
| Zito, C | 1 |
| Di Bello, V | 1 |
| Di Salvo, G | 1 |
| Benedetto, F | 1 |
| Novo, S | 1 |
| Pezzano, A | 1 |
| Perticone, F | 1 |
| Balbarini, A | 1 |
| Carerj, S | 1 |
| Chiou, WK | 3 |
| Wang, MH | 1 |
| Huang, DH | 1 |
| Chiu, HT | 1 |
| McKeigue, PM | 1 |
| Campbell, H | 1 |
| Wild, S | 1 |
| Vitart, V | 1 |
| Hayward, C | 1 |
| Rudan, I | 1 |
| Wilson, JF | 1 |
| Hermans, MP | 1 |
| Ahn, SA | 1 |
| Rousseau, MF | 1 |
| Heo, NJ | 1 |
| Ahn, JM | 1 |
| Lee, TW | 1 |
| Chin, HJ | 1 |
| Na, KY | 1 |
| Chae, DW | 1 |
| Kim, S | 1 |
| Borges, RL | 1 |
| Ribeiro, AB | 1 |
| Zanella, MT | 1 |
| Batista, MC | 1 |
| Shah, A | 1 |
| Keenan, RT | 1 |
| Inagaki, H | 1 |
| Wakayama, Y | 1 |
| Katsumata, M | 2 |
| Yamaoka-Tojo, M | 1 |
| Tojo, T | 1 |
| Takahira, N | 1 |
| Matsunaga, A | 1 |
| Aoyama, N | 1 |
| Masuda, T | 1 |
| Izumi, T | 1 |
| Loomba, R | 1 |
| Rao, F | 1 |
| Khandrika, S | 1 |
| Ziegler, MG | 1 |
| Brenner, DA | 1 |
| O'Connor, DT | 1 |
| Yiğiner, O | 1 |
| Ozçelik, F | 1 |
| Aparci, M | 1 |
| Işilak, Z | 1 |
| Uz, O | 1 |
| Lee, HJ | 1 |
| Park, HT | 1 |
| Cho, GJ | 1 |
| Yi, KW | 1 |
| Ahn, KH | 1 |
| Shin, JH | 1 |
| Kim, T | 1 |
| Kim, YT | 1 |
| Hur, JY | 1 |
| Kim, SH | 1 |
| de Miguel, ME | 1 |
| Martínez, P | 2 |
| Lundelin, KJ | 1 |
| Vázquez, JJ | 2 |
| de Miguel, E | 1 |
| Cuevas-Ramos, D | 1 |
| Almeda-Valdes, P | 1 |
| Gómez-Pérez, FJ | 1 |
| Meza-Arana, CE | 1 |
| Cruz-Bautista, I | 1 |
| Arellano-Campos, O | 1 |
| Navarrete-López, M | 1 |
| Aguilar-Salinas, CA | 1 |
| Johri, N | 1 |
| Cooper, B | 1 |
| Robertson, W | 1 |
| Choong, S | 1 |
| Rickards, D | 1 |
| Unwin, R | 1 |
| Seki, S | 1 |
| Tsutsui, K | 1 |
| Fujii, T | 1 |
| Yamazaki, K | 1 |
| Anzawa, R | 1 |
| Yoshimura, M | 1 |
| Wiernsperger, N | 1 |
| Geloen, A | 1 |
| Rapin, JR | 1 |
| Tang, LJ | 1 |
| Jiang, JJ | 1 |
| Chen, XF | 1 |
| Wang, JA | 1 |
| Lin, XF | 1 |
| Du, YX | 1 |
| Fang, CF | 1 |
| Pu, ZX | 1 |
| Capasso, I | 1 |
| Esposito, E | 1 |
| Pentimalli, F | 1 |
| Crispo, A | 1 |
| Montella, M | 1 |
| Grimaldi, M | 1 |
| De Marco, M | 1 |
| Cavalcanti, E | 1 |
| D'Aiuto, M | 1 |
| Fucito, A | 1 |
| Frasci, G | 1 |
| Maurea, N | 1 |
| Esposito, G | 1 |
| Pedicini, T | 1 |
| Vecchione, A | 1 |
| D'Aiuto, G | 1 |
| Giordano, A | 1 |
| Madero, M | 2 |
| Jalal, D | 1 |
| Krzystek-Korpacka, M | 1 |
| Patryn, E | 1 |
| Kustrzeba-Wojcicka, I | 1 |
| Chrzanowska, J | 1 |
| Gamian, A | 1 |
| Noczynska, A | 1 |
| Meshkani, R | 1 |
| Zargari, M | 1 |
| Larijani, B | 2 |
| Nguyen, S | 1 |
| Lustig, RH | 1 |
| Harris, DJ | 1 |
| Brodov, Y | 1 |
| Behar, S | 1 |
| Boyko, V | 1 |
| Chouraqui, P | 1 |
| Lou, S | 1 |
| Ren, X | 1 |
| Barbosa, MC | 1 |
| Brandão, AA | 1 |
| Pozzan, R | 1 |
| Magalhães, ME | 1 |
| Campana, EM | 1 |
| Fonseca, FL | 1 |
| Pizzi, OL | 1 |
| Freitas, EV | 1 |
| Brandão, AP | 1 |
| Hu, YF | 1 |
| Chen, SA | 1 |
| Yeh, HI | 1 |
| Iba, A | 1 |
| Baldwin, W | 1 |
| McRae, S | 1 |
| Marek, G | 1 |
| Wymer, D | 1 |
| Pannu, V | 1 |
| Baylis, C | 1 |
| Serpa Neto, A | 1 |
| Rossi, FM | 1 |
| Valle, LG | 1 |
| Teixeira, GK | 1 |
| Rossi, M | 1 |
| Tomiyama, H | 1 |
| Higashi, Y | 1 |
| Takase, B | 1 |
| Node, K | 1 |
| Sata, M | 1 |
| Ishibashi, Y | 1 |
| Ueda, S | 1 |
| Shimada, K | 1 |
| Yamashina, A | 1 |
| Korpacheva-Zinych, OV | 1 |
| Zapolski, T | 1 |
| Waciński, P | 1 |
| Kondracki, B | 1 |
| Rychta, E | 1 |
| Buraczyńska, MJ | 1 |
| Wysokiński, A | 1 |
| Myśliwiec, M | 1 |
| Kim, SY | 1 |
| Jung, ES | 1 |
| Jung, SW | 1 |
| Koo, JS | 1 |
| Yeon, JE | 1 |
| Kwon, SY | 1 |
| Lee, SW | 1 |
| Byun, KS | 1 |
| Jang, WC | 1 |
| Nam, YH | 1 |
| Ahn, YC | 1 |
| Park, SM | 1 |
| Yoon, IK | 1 |
| Choe, JY | 1 |
| Her, M | 1 |
| Kim, SK | 1 |
| Burley, V | 1 |
| Gilthorpe, MS | 1 |
| Lozovoy, MA | 3 |
| Simão, TN | 2 |
| Dichi, JB | 1 |
| Matsuo, T | 1 |
| Cecchini, R | 2 |
| Lai, X | 1 |
| Chen, G | 1 |
| Huang, B | 1 |
| Wu, Y | 1 |
| Yao, L | 1 |
| Lin, F | 1 |
| Qiao, Y | 1 |
| Zhu, S | 1 |
| Wen, J | 2 |
| Hurtes, X | 1 |
| Meria, P | 1 |
| Ganotakis, ES | 2 |
| Paletas, K | 1 |
| Nicolaou, V | 1 |
| Bacharoudis, G | 1 |
| Alexandrides, T | 1 |
| Liberopoulos, EN | 3 |
| Elisaf, M | 3 |
| Lu, B | 1 |
| Ye, Z | 1 |
| Tao, X | 1 |
| Hu, R | 1 |
| Stellato, D | 1 |
| Morrone, LF | 1 |
| Di Giorgio, C | 1 |
| Hara, S | 1 |
| Tsuji, H | 1 |
| Ohmoto, Y | 1 |
| Amakawa, K | 1 |
| Hsieh, SD | 1 |
| Arase, Y | 1 |
| Nakajima, H | 2 |
| Strohmaier, WL | 1 |
| Wrobel, BM | 1 |
| Schubert, G | 1 |
| Hohmann, MS | 1 |
| Morimoto, HK | 1 |
| Reiche, EM | 1 |
| Sun, SZ | 1 |
| Anderson, GH | 1 |
| Flickinger, BD | 1 |
| Williamson-Hughes, PS | 1 |
| Empie, MW | 1 |
| Alvarez-Lario, B | 1 |
| Macarrón-Vicente, J | 1 |
| Van Hoorenbeeck, K | 1 |
| Franckx, H | 1 |
| Debode, P | 1 |
| Aerts, P | 1 |
| Wouters, K | 1 |
| Ramet, J | 1 |
| Van Gaal, LF | 1 |
| Desager, KN | 1 |
| De Backer, WA | 1 |
| Verhulst, SL | 1 |
| Yamaguchi, S | 1 |
| Dong, L | 1 |
| Gaucher, EA | 1 |
| Rho, YH | 2 |
| Bian, L | 1 |
| Choi, Y | 1 |
| Fan, XH | 1 |
| Cai, JF | 1 |
| Gao, BX | 1 |
| Mou, LJ | 1 |
| Li, JH | 1 |
| Liu, XJ | 1 |
| Wu, JX | 1 |
| Meng, QY | 1 |
| Wang, HY | 1 |
| Liu, LL | 1 |
| Li, XM | 2 |
| Li, XW | 1 |
| Al-Meshaweh, AF | 1 |
| Jafar, Y | 1 |
| Asem, M | 1 |
| Akanji, AO | 1 |
| Kubota, M | 1 |
| Nagai, A | 1 |
| Tang, L | 1 |
| Tokuda, M | 1 |
| Rodrigues, SL | 1 |
| Capingana, P | 1 |
| Dantas, EM | 1 |
| Molina, Mdel C | 1 |
| Morelato, RL | 1 |
| Chu, CH | 1 |
| Bai, CH | 1 |
| You, SL | 1 |
| Chou, WY | 1 |
| Hwang, LC | 1 |
| Su, TC | 1 |
| Tseng, CH | 1 |
| Jin, M | 1 |
| Yang, I | 1 |
| Yin, Y | 1 |
| Luo, JJ | 1 |
| Yang, XF | 1 |
| Kitagawa, A | 1 |
| Ohta, Y | 1 |
| Ohashi, K | 1 |
| Onji, M | 1 |
| Panero, F | 1 |
| Gruden, G | 1 |
| Perotto, M | 1 |
| Fornengo, P | 1 |
| Barutta, F | 1 |
| Greco, E | 1 |
| Runzo, C | 1 |
| Ghezzo, G | 1 |
| Cavallo-Perin, P | 1 |
| Bruno, G | 1 |
| Hasegawa, M | 1 |
| Gonçalves, JP | 1 |
| Oliveira, A | 1 |
| Santos, AC | 1 |
| Lopes, C | 1 |
| Pasalic, D | 1 |
| Marinkovic, N | 1 |
| Feher-Turkovic, L | 1 |
| Moreno, JA | 1 |
| Hong, E | 1 |
| Shiga, Y | 1 |
| Miura, S | 1 |
| Mitsutake, R | 1 |
| Norimatsu, K | 1 |
| Nagata, I | 1 |
| Arimura, T | 1 |
| Morii, J | 1 |
| Kuwano, T | 1 |
| Uehara, Y | 1 |
| Inoue, A | 1 |
| Shirotani, T | 1 |
| Fujisawa, K | 1 |
| Matsunaga, E | 1 |
| Saku, K | 1 |
| Santos, RD | 3 |
| Wang, DD | 1 |
| Sievenpiper, JL | 1 |
| de Souza, RJ | 1 |
| Chiavaroli, L | 1 |
| Ha, V | 1 |
| Cozma, AI | 1 |
| Mirrahimi, A | 1 |
| Yu, ME | 1 |
| Carleton, AJ | 1 |
| Di Buono, M | 1 |
| Jenkins, AL | 1 |
| Leiter, LA | 1 |
| Wolever, TM | 1 |
| Beyene, J | 1 |
| Kendall, CW | 1 |
| Jenkins, DJ | 1 |
| Wang, JY | 1 |
| Tang, SH | 1 |
| Bagul, PK | 1 |
| Middela, H | 1 |
| Matapally, S | 1 |
| Padiya, R | 1 |
| Bastia, T | 1 |
| Madhusudana, K | 1 |
| Reddy, BR | 1 |
| Chakravarty, S | 1 |
| Banerjee, SK | 1 |
| Kushnarenko, NN | 1 |
| Govorin, AV | 1 |
| Shcherbakova, OA | 1 |
| Sotnikova, SG | 1 |
| Ivanitskaia, OV | 1 |
| Lin, H | 1 |
| Meng, W | 1 |
| Zhu, Z | 1 |
| Turner, ST | 2 |
| Langaee, T | 1 |
| Gong, Y | 1 |
| Chapman, AB | 1 |
| Gums, JG | 1 |
| Johnson, JA | 1 |
| Kunitskaia, NA | 1 |
| Ar'ev, AL | 1 |
| Zhou, K | 1 |
| Kumar, U | 1 |
| Yuen, VG | 1 |
| McNeill, JH | 1 |
| Kadlec, AO | 1 |
| Greco, K | 1 |
| Fridirici, ZC | 1 |
| Hart, ST | 1 |
| Vellos, T | 1 |
| Turk, TM | 1 |
| Moreto, F | 2 |
| de Oliveira, EP | 2 |
| Manda, RM | 1 |
| Torezan, GA | 1 |
| Teixeira, O | 1 |
| Michelin, E | 1 |
| Burini, RC | 2 |
| Lin, WT | 1 |
| Huang, HL | 1 |
| Huang, MC | 2 |
| Chan, TF | 1 |
| Ciou, SY | 1 |
| Lee, CY | 1 |
| Chiu, YW | 1 |
| Duh, TH | 1 |
| Wang, TN | 1 |
| Liu, TY | 1 |
| Chiu, CC | 1 |
| Chen, CH | 1 |
| Chen, PY | 1 |
| Tsai, CJ | 1 |
| Lu, ML | 1 |
| Keenan, T | 1 |
| Silverman, MG | 1 |
| Tota-Maharaj, R | 1 |
| Carvalho, JA | 2 |
| Conceição, RD | 1 |
| Blumenthal, RS | 2 |
| Cabrera-Rode, E | 1 |
| Orlandi, N | 1 |
| Padrón, Y | 1 |
| Arranz, C | 1 |
| Olano, R | 1 |
| Machado, M | 1 |
| Hernández-Yero, A | 1 |
| Calderín, R | 1 |
| Domínguez, E | 1 |
| Xia, MF | 1 |
| Lin, HD | 1 |
| Yan, HM | 1 |
| Bian, H | 1 |
| Chang, XX | 1 |
| He, WY | 1 |
| Jeekel, J | 1 |
| Hofman, A | 1 |
| Gao, X | 1 |
| Cho, ST | 1 |
| Jung, SI | 1 |
| Myung, SC | 1 |
| Kim, TH | 1 |
| Sirota, JC | 1 |
| McFann, K | 1 |
| Chonchol, M | 1 |
| Jalal, DI | 1 |
| Ice, CL | 1 |
| Sun, SS | 1 |
| Choi, KC | 1 |
| Ho, CS | 1 |
| Chan, MH | 1 |
| Chan, CW | 1 |
| Cohen, E | 1 |
| Krause, I | 1 |
| Fraser, A | 1 |
| Goldberg, E | 1 |
| Garty, M | 1 |
| El-Fishawy, HS | 1 |
| Nasrallah, MM | 1 |
| Hussein, H | 1 |
| Papanas, N | 1 |
| Fonseca, VA | 1 |
| Maltezos, E | 1 |
| Ziaee, A | 1 |
| Esmailzadehha, N | 1 |
| Ghorbani, A | 1 |
| Asefzadeh, S | 1 |
| Tapia, E | 2 |
| Cristóbal, M | 2 |
| García-Arroyo, FE | 1 |
| Soto, V | 2 |
| Monroy-Sánchez, F | 1 |
| Pacheco, U | 1 |
| Roncal-Jiménez, CA | 1 |
| Cruz-Robles, D | 1 |
| Silveira, LV | 1 |
| Osgood, K | 1 |
| Krakoff, J | 1 |
| Thearle, M | 1 |
| Mangge, H | 2 |
| Zelzer, S | 1 |
| Puerstner, P | 1 |
| Schnedl, WJ | 1 |
| Reeves, G | 1 |
| Postolache, TT | 1 |
| Weghuber, D | 1 |
| Nakanishi, N | 2 |
| Sato, M | 1 |
| Shirai, K | 1 |
| Nakajima, K | 1 |
| Murakami, S | 1 |
| Takatorige, T | 1 |
| Suzuki, K | 2 |
| Tatara, K | 2 |
| Moreno, LA | 2 |
| Pineda, I | 2 |
| Rodríguez, G | 1 |
| Fleta, J | 1 |
| Giner, A | 1 |
| Juste, MG | 1 |
| Sarría, A | 1 |
| Bueno, M | 2 |
| Matsubara, M | 2 |
| Chiba, H | 1 |
| Maruoka, S | 1 |
| Katayose, S | 2 |
| García Morillo, JS | 1 |
| García-Junco, PS | 1 |
| Miranda Guisado, ML | 1 |
| Vallejo Maroto, I | 1 |
| Pamies Andreu, E | 1 |
| Muñiz Grigalvo, O | 1 |
| Carneado de la Fuente, J | 1 |
| Villar Ortiz, J | 1 |
| Yang, WS | 1 |
| Funahashi, T | 1 |
| Tanaka, S | 1 |
| Matsuzawa, Y | 1 |
| Chao, CL | 1 |
| Chen, CL | 1 |
| Tai, TY | 1 |
| Chuang, LM | 1 |
| Ben-Noun, L | 1 |
| Laor, A | 1 |
| Namioka, K | 1 |
| Yokoyama, H | 2 |
| Moriya, S | 2 |
| Homma, Y | 1 |
| Ogawa, T | 1 |
| Hirose, H | 1 |
| Saito, I | 1 |
| Kahn, HS | 1 |
| Valdez, R | 1 |
| Aronson, D | 1 |
| Bartha, P | 1 |
| Zinder, O | 1 |
| Kerner, A | 1 |
| Shitman, E | 1 |
| Markiewicz, W | 1 |
| Brook, GJ | 1 |
| Levy, Y | 1 |
| Denzer, C | 1 |
| Muche, R | 1 |
| Mayer, H | 1 |
| Heinze, E | 1 |
| Debatin, KM | 1 |
| Wabitsch, M | 1 |
| Abate, N | 1 |
| Chandalia, M | 1 |
| Cabo-Chan, AV | 1 |
| Moe, OW | 1 |
| Hepburn, AL | 1 |
| Feher, MD | 1 |
| Nishina, K | 1 |
| Okamoto, M | 1 |
| Matsuo, Y | 1 |
| Conen, D | 1 |
| Wietlisbach, V | 1 |
| Bovet, P | 1 |
| Shamlaye, C | 1 |
| Riesen, W | 1 |
| Paccaud, F | 1 |
| Burnier, M | 1 |
| Bieber, JD | 1 |
| Terkeltaub, RA | 2 |
| Invitti, C | 4 |
| Gilardini, L | 4 |
| Viberti, G | 1 |
| Weng, HF | 2 |
| Fang, JT | 1 |
| Liu, TH | 1 |
| Rovda, IuI | 1 |
| Kazakova, LM | 1 |
| Rovda, TS | 1 |
| Rovda, EIu | 1 |
| Ishizaka, N | 2 |
| Ishizaka, Y | 2 |
| Toda, E | 2 |
| Nagai, R | 2 |
| Yamakado, M | 2 |
| Ratto, E | 2 |
| Vaccaro, V | 2 |
| Parodi, D | 1 |
| Parodi, A | 2 |
| Falqui, V | 2 |
| Tomolillo, C | 2 |
| Kalaitzidis, R | 1 |
| Bairaktari, E | 1 |
| Siamopoulos, KC | 1 |
| Al-Shaer, MH | 1 |
| Lyoussi, B | 1 |
| Ragala, MA | 1 |
| Mguil, M | 1 |
| Chraibi, A | 1 |
| Israili, ZH | 1 |
| Milionis, HJ | 2 |
| Rizos, E | 1 |
| Goudevenos, J | 1 |
| Seferiadis, K | 2 |
| Elisaf, MS | 3 |
| Yoo, TW | 1 |
| Shin, HS | 1 |
| Kim, H | 1 |
| Ryu, SH | 1 |
| Keum, DG | 1 |
| Kniazewska, MH | 1 |
| Zmudzińska-Kitczak, J | 1 |
| Urban, K | 1 |
| Obuchowicz, AK | 1 |
| Niwińska-Faryna, B | 1 |
| Pietrzak, JA | 1 |
| Swietochowska-Chechlińska, AA | 1 |
| Głowacki, JG | 1 |
| Tresaco, B | 1 |
| Bueno, G | 1 |
| Garagorri, JM | 1 |
| Hu, H | 1 |
| Zharikov, S | 1 |
| Tuttle, KR | 1 |
| Short, RA | 2 |
| Glushakova, O | 1 |
| Ouyang, X | 1 |
| Block, ER | 1 |
| Herrera-Acosta, J | 2 |
| Patel, JM | 1 |
| Kalantzi, KJ | 1 |
| Goudevenos, JA | 1 |
| Cikim, AS | 1 |
| Ozbey, N | 1 |
| Sencer, E | 1 |
| Molvalilar, S | 1 |
| Orhan, Y | 1 |
| McTernan, PG | 1 |
| Girola, A | 2 |
| da Silva, NF | 1 |
| Alberti, L | 1 |
| Kumar, S | 1 |
| Zanolin, ME | 1 |
| Tosi, F | 1 |
| Zoppini, G | 1 |
| Castello, R | 1 |
| Spiazzi, G | 1 |
| Dorizzi, R | 1 |
| Muggeo, M | 1 |
| Moghetti, P | 1 |
| Lee, SJ | 1 |
| Kavanaugh, A | 1 |
| Tang, W | 1 |
| Hong, Y | 1 |
| Province, MA | 1 |
| Rich, SS | 1 |
| Hopkins, PN | 1 |
| Arnett, DK | 1 |
| Pankow, JS | 1 |
| Miller, MB | 1 |
| Eckfeldt, JH | 1 |
| Maffeis, C | 1 |
| Pontiggia, B | 2 |
| Mazzilli, G | 2 |
| Sartorio, A | 2 |
| Morabito, F | 1 |
| Viberti, GC | 1 |
| Tseng, YH | 1 |
| Liou, TL | 1 |
| Lin, MW | 1 |
| Hsiao, LC | 1 |
| Tsai, TT | 1 |
| Chan, WL | 1 |
| Ho, LT | 1 |
| Hwu, CM | 1 |
| Pylvänen, V | 1 |
| Pakarinen, A | 1 |
| Knip, M | 1 |
| Isojärvi, J | 1 |
| Ghironzi, G | 1 |
| Andriani, E | 1 |
| Marinelli, L | 1 |
| Valentini, M | 1 |
| Tessari, F | 1 |
| López-Suárez, A | 1 |
| Elvira-González, J | 1 |
| Bascuñana-Quirell, A | 1 |
| Rosal-Obrador, J | 1 |
| Michán-Doña, A | 1 |
| Escribano-Serrano, J | 1 |
| Benítez-Rodríguez, E | 1 |
| Hashimoto, H | 1 |
| Tomita, H | 1 |
| Oka, Y | 1 |
| Britov, AN | 1 |
| Eliseeva, NA | 1 |
| Deev, AD | 1 |
| Balkarov, IM | 1 |
| Jiménez, A | 1 |
| Bautista, P | 1 |
| Nepomuceno, T | 1 |
| Avila-Casado, C | 1 |
| Franco, M | 1 |
| Dhanamun, B | 1 |
| Williams, MA | 1 |
| Tsouli, SG | 1 |
| Pływaczewski, R | 1 |
| Bednarek, M | 1 |
| Jonczak, L | 1 |
| Górecka, D | 1 |
| Sliwińiski, P | 1 |
| Kakafika, AI | 1 |
| Papageorgiou, AA | 1 |
| Uyarel, H | 1 |
| Hergenç, G | 1 |
| Karabulut, A | 1 |
| Albayrak, S | 1 |
| Yazici, M | 1 |
| Keleş, I | 1 |
| Patel, DA | 2 |
| Xu, JH | 1 |
| Wei, YD | 1 |
| Hu, DY | 1 |
| Zhang, RF | 1 |
| Zheng, LQ | 1 |
| Yu, JM | 1 |
| Toprak, O | 1 |
| Cirit, M | 1 |
| Yesil, M | 1 |
| Bayata, S | 1 |
| Tanrisev, M | 1 |
| Varol, U | 1 |
| Ersoy, R | 1 |
| Esi, E | 1 |
| Lin, SD | 1 |
| Tsai, DH | 1 |
| Hsu, SR | 1 |
| Sato, W | 2 |
| Heinig, M | 2 |
| Gersch, M | 2 |
| Sautin, Y | 3 |
| Delfini, E | 1 |
| Petramala, L | 1 |
| Caliumi, C | 1 |
| Cotesta, D | 1 |
| De Toma, G | 1 |
| Cavallaro, G | 1 |
| Panzironi, G | 1 |
| Diacinti, D | 1 |
| Minisola, S | 1 |
| D' Erasmo, E | 1 |
| Mazzuoli, GF | 1 |
| Letizia, C | 1 |
| Kwoh, CK | 1 |
| Schumacher, HR | 1 |
| Kuller, L | 1 |
| Orakzai, R | 1 |
| Meneghelo, RS | 1 |
| Coutinho, Tde A | 1 |
| Peyser, PA | 1 |
| Bielak, LF | 1 |
| Sheedy, PF | 1 |
| Kullo, IJ | 1 |
| Pascual, E | 1 |
| Sivera, F | 1 |
| Mukuddem-Petersen, J | 1 |
| Stonehouse Oosthuizen, W | 1 |
| Jerling, JC | 1 |
| Hanekom, SM | 1 |
| White, Z | 1 |
| Bianchi, C | 1 |
| Penno, G | 1 |
| Malloggi, L | 1 |
| Barontini, R | 1 |
| Corfini, M | 1 |
| Giovannitti, MG | 1 |
| Di Cianni, G | 1 |
| Del Prato, S | 1 |
| Miccoli, R | 1 |
| Kaneshi, T | 1 |
| Yoshida, T | 1 |
| Ohshiro, T | 1 |
| Nagasaki, H | 1 |
| Asato, Y | 1 |
| Ohta, T | 1 |
| Ford, ES | 2 |
| Cook, S | 1 |
| Rathmann, W | 1 |
| Haastert, B | 1 |
| Icks, A | 1 |
| Giani, G | 1 |
| Roseman, JM | 1 |
| Chang, HY | 1 |
| Liu, FH | 1 |
| Conti, N | 1 |
| Zamboni, S | 1 |
| Cuppini, S | 1 |
| Zennaro, R | 1 |
| Virsaladze, DK | 1 |
| Tetradze, LO | 1 |
| Dzhavashvili, LV | 1 |
| Esaliia, NG | 1 |
| Tananashvili, DE | 1 |
| Takahashi, S | 1 |
| Inokuchi, T | 1 |
| Kobayashi, T | 1 |
| Ka, T | 1 |
| Tsutsumi, Z | 1 |
| Moriwaki, Y | 1 |
| Chen, ZW | 1 |
| Ren, JJ | 1 |
| Chen, LQ | 1 |
| Hjortnaes, J | 1 |
| Algra, A | 1 |
| Olijhoek, J | 1 |
| Huisman, M | 1 |
| Jacobs, J | 1 |
| van der Graaf, Y | 1 |
| Visseren, F | 1 |
| Lee, MS | 1 |
| Wahlqvist, ML | 1 |
| Yu, HL | 1 |
| Suzuki, H | 1 |
| Hikita, M | 1 |
| Yokose, T | 1 |
| Roncal, CA | 1 |
| Srinivas, TR | 1 |
| Sirivongs, D | 1 |
| Akande, AA | 1 |
| Jimoh, AK | 1 |
| Akinyinka, OA | 1 |
| Olarinoye, GO | 1 |
| Segal, MS | 1 |
| Benner, S | 1 |
| Yen, SL | 1 |
| Chiu, TY | 1 |
| Lin, YC | 1 |
| Lee, LT | 1 |
| Huang, KC | 1 |
| Tetradze, L | 1 |
| Virsaladze, D | 1 |
| Javashvili, L | 1 |
| Kilasonia, L | 1 |
| Tananashvili, D | 1 |
| Palmer, IM | 1 |
| Schutte, AE | 1 |
| Huisman, HW | 1 |
| Van Rooyen, JM | 1 |
| Schutte, R | 1 |
| Malan, L | 1 |
| Malan, NT | 1 |
| Stejskal, D | 1 |
| Karpísek, M | 1 |
| Reutová, H | 1 |
| Stejskal, P | 1 |
| Kotolová, H | 1 |
| Kollár, P | 1 |
| Woo, JH | 1 |
| Lai, HY | 1 |
| Hwang, SJ | 1 |
| Chiou, ST | 1 |
| Numata, T | 1 |
| Miyatake, N | 1 |
| Wada, J | 1 |
| Makino, H | 1 |
| Lippi, G | 1 |
| Montagnana, M | 1 |
| Franchini, M | 1 |
| Favaloro, EJ | 1 |
| Nan, H | 1 |
| Qiao, Q | 1 |
| Söderberg, S | 1 |
| Gao, W | 1 |
| Zimmet, P | 1 |
| Alberti, G | 1 |
| Dong, Y | 1 |
| Uusitalo, U | 1 |
| Pauvaday, V | 1 |
| Chitson, P | 1 |
| Tuomilehto, J | 1 |
| Pilz, S | 1 |
| Haj-Yahya, S | 1 |
| Almer, G | 1 |
| Zhao, D | 1 |
| Li, GW | 1 |
| Qin, LP | 1 |
| Zhou, GH | 1 |
| Stark, K | 1 |
| Reinhard, W | 1 |
| Neureuther, K | 1 |
| Wiedmann, S | 1 |
| Sedlacek, K | 1 |
| Baessler, A | 1 |
| Fischer, M | 1 |
| Weber, S | 1 |
| Kaess, B | 1 |
| Erdmann, J | 1 |
| Schunkert, H | 1 |
| Hengstenberg, C | 1 |
| Bozbaş, H | 1 |
| Yildirir, A | 1 |
| Pirat, B | 1 |
| Eroğlu, S | 1 |
| Korkmaz, ME | 1 |
| Atar, I | 1 |
| Ulus, T | 1 |
| Aydinalp, A | 1 |
| Ozin, B | 1 |
| Müderrisoğlu, H | 1 |
| Yamasaki, T | 1 |
| Tomita, K | 1 |
| Gianotti, TF | 1 |
| Sookoian, S | 1 |
| Dieuzeide, G | 1 |
| García, SI | 1 |
| Gemma, C | 1 |
| González, CD | 1 |
| Pirola, CJ | 1 |
| Ebrahimpour, P | 1 |
| Fakhrzadeh, H | 1 |
| Bandarian, F | 1 |
| Muntner, P | 1 |
| Srinivasan, S | 1 |
| Menke, A | 1 |
| Berenson, G | 1 |
| Sui, X | 1 |
| Church, TS | 2 |
| Meriwether, RA | 1 |
| Lobelo, F | 1 |
| Blair, SN | 2 |
| Costa, A | 1 |
| Igualá, I | 1 |
| Bedini, J | 1 |
| Quintó, L | 1 |
| Conget, I | 1 |
| Fernández-Andrade, C | 1 |
| Finley, CE | 1 |
| Earnest, CP | 1 |
| Kampert, JB | 1 |
| Gibbons, LW | 1 |
| Ota, T | 1 |
| Takamura, T | 1 |
| Hirai, N | 1 |
| Kobayashi, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Dose-response Effect of Serum Uric Acid on the Prevalence and Electrocardiographic Left Ventricular Hypertrophy in the Apparently Healthy Individuals[NCT03473951] | 18,000 participants (Anticipated) | Observational | 2018-03-26 | Recruiting | |||
| Losartan and Eprosartan Induce a Similar Effect on Oral Fructose-induced Rise in Serum Uric Acid Concentration in Patients With Metabolic Syndrome[NCT04954560] | 16 participants (Actual) | Interventional | 2008-01-01 | Completed | |||
| An Intervention Study of Intermittent Fasting and Low Carbon Diet in Patients With Metabolic Syndrome[NCT04475822] | 169 participants (Actual) | Interventional | 2020-07-12 | Completed | |||
| Diabetes Control and Complications Trial (DCCT)[NCT00360815] | 1,441 participants | Interventional | 1983-08-31 | Completed | |||
| Epidemiology of Diabetes Interventions and Complications (EDIC)[NCT00360893] | 1,441 participants (Actual) | Observational | 1994-04-30 | Active, not recruiting | |||
| Data-driven Clustering for Metabolic Classification of Obesity Using Machine Learning[NCT04282837] | 2,495 participants (Actual) | Observational | 2020-03-01 | Completed | |||
| The Bogalusa Heart Study[NCT00005129] | 11,737 participants (Actual) | Observational | 1972-06-30 | Active, not recruiting | |||
| Effects of Pharmacological Reversal of Hyperuricemia on Features of the Metabolic Syndrome[NCT01654276] | Phase 4 | 24 participants (Actual) | Interventional | 2012-05-31 | Completed | ||
| Phase 2 Study to Determine if Allopurinol Blocks Features of Metabolic Syndrome Induced by Fructose Ingestion[NCT00639756] | Phase 2 | 60 participants (Anticipated) | Interventional | 2008-06-30 | Completed | ||
| Paediatric Obesity and Cardiovascular Dysfunction: Searching for Early Markers of Damage[NCT03169257] | 100 participants (Actual) | Interventional | 2015-01-15 | Completed | |||
| The Effect of Acute Fructose Load in Patients With Chronic Kidney Disease and Patients With Type 2 Diabetes Compared to Healthy Subjects[NCT03157960] | 20 participants (Actual) | Interventional | 2012-02-01 | Completed | |||
| Adverse Metabolic Effects of Dietary Sugar: Ad Libitum vs Energy-balanced Diets[NCT02548767] | 36 participants (Actual) | Interventional | 2016-02-29 | Completed | |||
| Non-alcoholic Fatty Liver Disease (NAFLD) in Overweight and Obese People Under Nutritional and Lifestyle Follow-up: a Randomized Controlled Trial[NCT03183193] | 120 participants (Anticipated) | Interventional | 2016-06-30 | Recruiting | |||
| Genetic-specific Effects of Fructose on Liver Lipogenesis[NCT03783195] | 15 participants (Actual) | Interventional | 2019-01-25 | Completed | |||
| "Evaluation of the Intervention Program Obeldicks for Obese Children and Adolescents"[NCT00435734] | 4,000 participants (Actual) | Observational | 1999-07-31 | Active, not recruiting | |||
| A Population Based Cohort Study on Metabolic Syndrome Complications, and Mortality; (MetSCoM) Study[NCT02958579] | 10,000 participants (Anticipated) | Observational | 2005-01-31 | Recruiting | |||
| The Oral Fructose Load Test and Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease With Comparison With Healthy Controls.[NCT01332526] | 70 participants (Anticipated) | Observational | 2011-05-31 | Not yet recruiting | |||
| Allopurinol Versus Febuxostat: A New Approach for Management of Hepatic Steatosis in Metabolic-Associated Fatty Liver Disease[NCT05474560] | Phase 4 | 90 participants (Actual) | Interventional | 2022-01-01 | Completed | ||
| A Single-arm Trial to Evaluate the Efficacy of an Aggressive Weight Loss Program With a Ketogenic Induction Phase for the Treatment of Chronic Plaque Psoriasis[NCT03531528] | 37 participants (Actual) | Interventional | 2018-05-21 | Completed | |||
| Effects of Allopurinol on Inflammatory Markers and Morphostructural Changes Evidenced by Musculoskeletal Ultrasound in Individuals With Asymptomatic Hyperuricemia. A Proof of Concept[NCT04012294] | Phase 3 | 200 participants (Anticipated) | Interventional | 2019-08-30 | Recruiting | ||
| Comparison of Serum Concentrations, Physical and Psychological Well-being in Patients Having Chronic Musculoskeletal Pain With and Without Metabolic Syndrome[NCT03338868] | 100 participants (Anticipated) | Observational [Patient Registry] | 2015-08-01 | Recruiting | |||
| [NCT02797028] | Phase 4 | 320 participants (Anticipated) | Interventional | 2015-01-31 | Recruiting | ||
| Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)[NCT04073719] | 50 participants (Anticipated) | Interventional | 2019-09-01 | Not yet recruiting | |||
| Study on the Effect of Hyperuricaemia on Chronic Renal Disease and Intervention[NCT03425708] | Phase 4 | 400 participants (Anticipated) | Interventional | 2017-01-01 | Recruiting | ||
| Effects of the Glucocorticoid Antagonist, Mifepristone, on Glucose Intolerance in Obese and Overweight Individuals[NCT01419535] | Phase 1/Phase 2 | 19 participants (Actual) | Interventional | 2011-11-29 | Completed | ||
| Vascular Health and Risk Factors in Children With Down Syndrome[NCT04735874] | 55 participants (Actual) | Observational | 2021-02-02 | Completed | |||
| Changes in Serum Fibroblast Growth Factor 21 (FGF21) Levels After a Cardiorespiratory Exercise Program[NCT01512368] | 82 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)[NCT00416741] | 2,000 participants (Actual) | Observational | 2005-02-28 | Completed | |||
| Effect of Important Food Sources of Fructose-containing Sugars on Cardiometabolic Risk Factors: A Series of Systematic Reviews and Meta-analyses of Controlled Trials to Inform Dietary Guidelines, Public Health Policy, and Future Trial Design[NCT02716870] | 1 participants (Anticipated) | Observational | 2015-06-30 | Active, not recruiting | |||
| Effect of Fructose on Metabolic Control in Humans: A Series of Systematic Reviews and Meta-analyses to Provide Evidence-based Guidance for Nutrition Guidelines Development[NCT01363791] | 1 participants (Anticipated) | Observational | 2009-05-31 | Active, not recruiting | |||
| Effect of Fructose-containing Sugar Sweetened Beverages (SSBs) on Body Weight: A Systematic Review and Meta-analysis of Controlled Feeding Trials to Provide Evidence-based Guidance for Nutrition Guidelines Development[NCT01608607] | 1 participants (Actual) | Observational | 2012-05-31 | Active, not recruiting | |||
| The Relation of Total and Individual Fructose-containing Sugars With Incident Cardiometabolic Diseases: A Series of Systematic Reviews and Meta-analyses of Prospective Observational Studies[NCT01608620] | 1 participants (Anticipated) | Observational | 2012-05-31 | Active, not recruiting | |||
| Study for the Investigation of New Individual Risk Profiles and Therapeutic Strategies in Obesity Related Cardiovascular and Metabolic Disorders.[NCT00482924] | 1,500 participants (Anticipated) | Observational | 2003-01-31 | Recruiting | |||
| Monitoring of Metabolic Adverse Events of Second Generation Antipsychotics in a Naive Pediatric Population Followed in Mental Health Outpatient and Inpatient Clinical Settings (MEMAS Prospective Study)[NCT04395326] | 120 participants (Anticipated) | Observational | 2017-01-01 | Recruiting | |||
| Association Between Walnut Consumption and Diabetes Risk in NHANES May be Gender Sex Specific[NCT03224533] | 34,121 participants (Actual) | Observational | 2015-06-01 | Completed | |||
| Uric Acid and Hypertension in African Americans[NCT00241839] | Phase 3 | 150 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| Influence of Food Liking of Adding Spices to Replace Dietary Sugar Using Sequential Monadic CLT Methodology[NCT03139552] | 150 participants (Actual) | Interventional | 2016-10-17 | Completed | |||
| Influence on Food Liking of Adding Spices to Replace Dietary Sugar[NCT03134079] | 160 participants (Actual) | Interventional | 2015-09-10 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Diastolic BP by ambulatory blood pressure monitor. (NCT01654276)
Timeframe: 6 months
| Intervention | mmHg (Mean) |
|---|---|
| Gout and Hyperuricemia | 75 |
Systolic BP by ambulatory blood pressure monitor. (NCT01654276)
Timeframe: 6 months
| Intervention | mmHg (Mean) |
|---|---|
| Gout and Hyperuricemia | 126 |
(NCT01654276)
Timeframe: 6 months
| Intervention | kg/m^2 (Mean) |
|---|---|
| Gout and Hyperuricemia | 33.4 |
(NCT01654276)
Timeframe: 6 months
| Intervention | % of serum uric acid excreted in urine (Mean) |
|---|---|
| Gout and Hyperuricemia | 0.04 |
(NCT01654276)
Timeframe: 6 months
| Intervention | Homeostatic model assessment for Insulin (Mean) |
|---|---|
| Gout and Hyperuricemia | 1.86 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 0.98 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 107 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 49 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mU/L (Mean) |
|---|---|
| Gout and Hyperuricemia | 14 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 175 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 4.4 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 196 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 1332 |
(NCT01654276)
Timeframe: 6 months
| Intervention | pH (Mean) |
|---|---|
| Gout and Hyperuricemia | 5.58 |
(NCT01654276)
Timeframe: 6 months
| Intervention | mg/dl (Mean) |
|---|---|
| Gout and Hyperuricemia | 208 |
The adipose tissue insulin resistance index (Adipo-IR), a surrogate measure for fasting adipose-tissue insulin resistance, was calculated as the product of fasting insulin and fasting free fatty acids (FFA) (NCT01419535)
Timeframe: 9 days
| Intervention | mmol/l·μU/l (Mean) |
|---|---|
| Post-mifepristone | 49.9 |
| Post-placebo | 65.5 |
The Adipo-SI was calculated as ratio of the slope of the linear decrease in natural log transformed FFA [Ln (FFA) slope] during the first 90 minutes of the FSIVGTT and the area under the curve (AUC) of insulin during that 90-minute period (AUC Insulin 0-90 min). (NCT01419535)
Timeframe: 9 days
| Intervention | ln(mmol /uU/mL*min)*10^8 (Mean) |
|---|---|
| Post-mifepristone | 61.7 |
| Post-placebo | 42.8 |
Fasting insulin after study agent administration compared to baseline (NCT01419535)
Timeframe: 9 days
| Intervention | pmol/L (Mean) |
|---|---|
| Post-mifepristone | 95.6 |
| Post-placebo | 142.8 |
fasting plasma glucose after study agent compared to baseline (NCT01419535)
Timeframe: Nine days
| Intervention | mg/dL (Mean) |
|---|---|
| Post-mifepristone | 100.4 |
| Post-placebo | 107.8 |
insulin sensitivity index based on the effect of insulin on glucose during frequently sampled intravenous glucose tolerance test (FSIVGTT) (NCT01419535)
Timeframe: Nine days
| Intervention | min-1·μU·ml-1 (Mean) |
|---|---|
| Post-mifepristone | 1.49 |
| Post-placebo | 1.41 |
HOMA-IR is an index of insulin resistance, measured as glucose in mmol/L x insulin in mIU/mL)/22.5. HOMA-IR > 2.5 indicates insulin resistance. (NCT01419535)
Timeframe: 9 days
| Intervention | units on a scale (Mean) |
|---|---|
| Post-mifepristone | 3.58 |
| Post-placebo | 5.78 |
Serum measurement of epinephrine was done at baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise. (NCT01512368)
Timeframe: Baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise
| Intervention | pg/mL (Median) | |
|---|---|---|
| Baseline | Final (at 2 weeks) | |
| Supervised Exercising | 9.2 | 15.5 |
Serum measurement of glucose was done at baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise (NCT01512368)
Timeframe: Baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise
| Intervention | mg/dL (Mean) | |
|---|---|---|
| Baseline Glucose | Final Glucose (at 2 weeks) | |
| Supervised Exercising | 86.0 | 86.3 |
Serum measurement of FGF21 using human ELISA kit was done at baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise. (NCT01512368)
Timeframe: Baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise
| Intervention | ng/L (Median) | |
|---|---|---|
| Baseline | Final (after 2 weeks) | |
| Supervised Exercising | 276.8 | 460.8 |
Serum measurement of free fatty acids (FFAs) was done at baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise. (NCT01512368)
Timeframe: Baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise
| Intervention | mg/dL (Median) | |
|---|---|---|
| Baseline | Final (after 2 weeks) | |
| Supervised Exercising | 0.36 | 0.54 |
Serum measurement of leptin was done at baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise (NCT01512368)
Timeframe: Baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise
| Intervention | ng/mL (Median) | |
|---|---|---|
| Baseline | Final (at 2 weeks) | |
| Supervised Exercising | 13.1 | 12.4 |
Serum measurement of total adiponectin was done at baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise (NCT01512368)
Timeframe: Baseline, 1hr and 4 hr after a bout of exercise, and repeated after two weeks of daily supervised exercise
| Intervention | ng/mL (Median) | |
|---|---|---|
| Baseline | Final (at 2 weeks) | |
| Supervised Exercising | 10.1 | 10.5 |
"The Diastolic BP was taken at Baseline and after 8-10 weeks of treatment or placebo while on chlorthalidone and potassium chloride. The blood pressure was measured according to Shared Care protocol: 15 minutes of quiet, undisturbed rest with three BP measurements obtained subsequently at 5 minute intervals.~The mean of the second and third reading was the value used for analysis for both the Baseline measurement and the measurement after 8 - 10 weeks of treatment. The dependent variable is baseline value minus ending value.~Measures are in millimeters of mercury (mm hg)" (NCT00241839)
Timeframe: Measured at 8-10 weeks on allopurinol / placebo
| Intervention | mm Hg (Mean) |
|---|---|
| A (Allopurinol) | 3.44 |
| B (Placebo) | -0.83 |
Subjects had 24 hr blood pressure monitoring (ABPM) at baseline and treatment end. The readings were averaged and the changes from baseline to treatment end were compared. (NCT00241839)
Timeframe: Baseline and end of treatment (8-10 weeks on allopurinol / placebo)
| Intervention | mm Hg (Mean) |
|---|---|
| A (Allopurinol) | -5.9 |
| B (Placebo) | 0.90 |
"The systolic BP was taken at Baseline and after 8-10 weeks of treatment on placebo, while on chlorthalidone and potassium chloride. The blood pressure was measured according to Shared Care protocol: 15 minutes of quiet, undisturbed rest with three BP measurements obtained subsequently at 5 minute intervals.~The mean of the second and third reading was the value used for analysis for both the Baseline measurement and the measurement after 8 - 10 weeks of treatment. The dependent variable is baseline value minus ending value.~Measures are in millimeters of mercury (mm hg)" (NCT00241839)
Timeframe: Measured at 8-10 weeks on allopurinol or placebo
| Intervention | mm Hg (Mean) |
|---|---|
| A (Allopurinol) | 0.21 |
| B (Placebo) | -0.95 |
Subjects on allopurinol are expected to lower their uric acid levels relative to placebo. (NCT00241839)
Timeframe: Baseline UA levels compared to end of treatment levels (8-10 weeks on allopurinol / placebo)
| Intervention | mg/dl (Mean) |
|---|---|
| A (Allopurinol) | 2.29 |
| B (Placebo) | 0.14 |
Overall liking of apple crisp with a 9-point hedonic rating scale instrument (whereby 0 = dislike extremely and 9 = like extremely ) (NCT03139552)
Timeframe: Day of taste testing
| Intervention | score on likert rating scale (Mean) |
|---|---|
| Full Sugar Recipe | 7.31 |
| Reduced Sugar Recipe | 6.83 |
| Reduced Sugar Plus Spice Recipe | 7.22 |
Overall liking of oatmeal with a 9-point hedonic rating scale instrument (whereby 0 = dislike extremely and 9 = like extremely ) (NCT03139552)
Timeframe: day of taste testing
| Intervention | score on a likert rating scale (Mean) |
|---|---|
| Full Sugar Recipe | 6.84 |
| Reduced Sugar Recipe | 5.70 |
| Reduced Sugar Plus Spice Recipe | 6.15 |
Overall liking of tea with a 9-point hedonic rating scale instrument (whereby 0 = dislike extremely and 9 = like extremely ) (NCT03139552)
Timeframe: day of taste testing
| Intervention | score on a likert rating scale (Mean) |
|---|---|
| Full Sugar Recipe | 6.00 |
| Reduced Sugar Recipe | 5.62 |
| Reduced Sugar Plus Spice Recipe | 5.85 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 54 |
| Second Place Ranking | 63 |
| Third Place Ranking | 33 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 88 |
| Second Place Ranking | 39 |
| Third Place Ranking | 21 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 66 |
| Second Place Ranking | 41 |
| Third Place Ranking | 42 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 48 |
| Second Place Ranking | 60 |
| Third Place Ranking | 40 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 63 |
| Second Place Ranking | 44 |
| Third Place Ranking | 43 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 49 |
| Second Place Ranking | 50 |
| Third Place Ranking | 50 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 33 |
| Second Place Ranking | 43 |
| Third Place Ranking | 74 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: day of taste testing
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 12 |
| Second Place Ranking | 49 |
| Third Place Ranking | 87 |
Subjects ranked each recipe in order of likability as first, second or third. (NCT03139552)
Timeframe: Day of taste testings
| Intervention | Participants (Count of Participants) |
|---|---|
| First Place Ranking | 34 |
| Second Place Ranking | 58 |
| Third Place Ranking | 57 |
96 reviews available for uric acid and Metabolic Syndrome
| Article | Year |
|---|---|
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
Topics: Animals; Atherosclerosis; Comorbidity; Diabetes Mellitus, Type 2; Gout; Humans; Hypertension; Hyperu | 2021 |
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Topics: Cardiovascular Diseases; Gout; Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2022 |
New markers in metabolic syndrome.
Topics: Adipokines; Alkaline Phosphatase; Biomarkers; Diabetes Mellitus, Type 2; Humans; Inflammation; Insul | 2022 |
Association between metabolic syndrome and uric acid: a systematic review and meta-analysis.
Topics: Biomarkers; Female; Humans; Male; Metabolic Syndrome; Uric Acid | 2022 |
High-Fructose Diet-Induced Hyperuricemia Accompanying Metabolic Syndrome-Mechanisms and Dietary Therapy Proposals.
Topics: Diet; Fructose; Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2023 |
The Results of the URRAH (Uric Acid Right for Heart Health) Project: A Focus on Hyperuricemia in Relation to Cardiovascular and Kidney Disease and its Role in Metabolic Dysregulation.
Topics: Acute Coronary Syndrome; Humans; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; Risk Factors; U | 2023 |
Exploring the Multifaceted Nexus of Uric Acid and Health: A Review of Recent Studies on Diverse Diseases.
Topics: Diet; Gout; Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2023 |
Uric Acid in Metabolic and Cerebrovascular Disorders: A Review.
Topics: Animals; Biomarkers; Blood Glucose; Cardiometabolic Risk Factors; Cerebrovascular Disorders; Diabete | 2020 |
Fructose Production and Metabolism in the Kidney.
Topics: Animals; Cardiomegaly; Diabetic Nephropathies; Dietary Sugars; Energy Metabolism; Fatty Acids; Fruct | 2020 |
Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age.
Topics: Cardiovascular Diseases; Child; Diabetes Mellitus; Fructose; Humans; Hypertension; Insulin Resistanc | 2020 |
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
Topics: Diabetes Mellitus, Type 2; Gout; Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2020 |
Uric acid metabolism in polycystic ovary syndrome.
Topics: Female; Humans; Hyperuricemia; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Ur | 2021 |
Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.
Topics: Cardiovascular Diseases; Diet; Feeding Behavior; Female; Fructose; Humans; Hyperuricemia; Male; Meta | 2017 |
Effects of Sodium Glucose Cotransporter-2 Inhibitors on Serum Uric Acid in Type 2 Diabetes Mellitus.
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hyperglycemia; Hyperuricemia; Hypoglyc | 2017 |
Gout and Metabolic Syndrome: a Tangled Web.
Topics: Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Gout; Humans; Hyperlipide | 2017 |
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study.
Topics: Arthritis, Psoriatic; Blood Glucose; Humans; Lipids; Metabolic Syndrome; Risk Factors; Skin; Uric Ac | 2018 |
Uric Acid as a Cause of the Metabolic Syndrome.
Topics: AMP Deaminase; Animals; Diabetes Mellitus; Dietary Sugars; Fatty Liver; Fructose; Humans; Hypertensi | 2018 |
Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus.
Topics: Humans; Insulin Resistance; Metabolic Syndrome; Nephrolithiasis; Prevalence; Risk Factors; Uric Acid | 2018 |
The role of xanthine oxidoreductase and uric acid in metabolic syndrome.
Topics: Adipocytes; Adipogenesis; Animals; Cell Differentiation; Endothelium, Vascular; Humans; Hypertension | 2018 |
Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals.
Topics: Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dyslipidemias; Humans; Hypertension; | 2019 |
Impact of reduced pulmonary function in the Japanese general population: Lessons from the Yamagata-Takahata study.
Topics: Adiponectin; Asian People; Atrial Fibrillation; Biomarkers; Cigarette Smoking; Comorbidity; Diabetes | 2019 |
Hyperuricemia and Cardiovascular Disease.
Topics: Cardiovascular Diseases; Gout; Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2019 |
Prevention of Cardiovascular Diseases in Children and Adolescents.
Topics: Adolescent; Age of Onset; Arterial Pressure; Biomarkers; Blood Glucose; Cardiovascular Diseases; Chi | 2019 |
[A role of fructose in urinary stone formation].
Topics: Animals; Fructose; Humans; Kidney Calculi; Metabolic Syndrome; Obesity; Uric Acid | 2019 |
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
Topics: Animals; Cardiovascular Diseases; Humans; Hypertension; Kidney; Kidney Diseases; Metabolic Syndrome; | 2013 |
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
Topics: Animals; Cardiovascular Diseases; Humans; Hypertension; Kidney; Kidney Diseases; Metabolic Syndrome; | 2013 |
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
Topics: Animals; Cardiovascular Diseases; Humans; Hypertension; Kidney; Kidney Diseases; Metabolic Syndrome; | 2013 |
Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?
Topics: Animals; Cardiovascular Diseases; Humans; Hypertension; Kidney; Kidney Diseases; Metabolic Syndrome; | 2013 |
Adverse metabolic effects of dietary fructose: results from the recent epidemiological, clinical, and mechanistic studies.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Child; Clinical Trials as Topic; Diabetes Mellitus, | 2013 |
Uric acid metabolism in pre-hypertension and the metabolic syndrome.
Topics: Animals; Glucose Transport Proteins, Facilitative; Humans; Hyperuricemia; Metabolic Syndrome; Organi | 2014 |
Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.
Topics: Endothelium, Vascular; Female; Humans; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; L | 2014 |
[Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment. Topics: I. Pathophysiology, diagnosis and treatment; 8. Asymptomatic hyperuricemia].
Topics: Cardiovascular Diseases; Diabetes Mellitus; Humans; Hyperuricemia; Metabolic Syndrome; Renal Insuffi | 2013 |
[Pathogenetic significance of hyperuricemia in the formation and development of pathological processes associated with metabolic syndrome].
Topics: Global Health; Humans; Hyperuricemia; Incidence; Metabolic Syndrome; Risk Factors; Uric Acid | 2013 |
Sugar, uric acid, and the etiology of diabetes and obesity.
Topics: Animals; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Sucrose; Disease Models, Animal | 2013 |
Epidemiology and clinical pathophysiology of uric acid kidney stones.
Topics: Ammonium Compounds; Animals; Comorbidity; Crystallization; Diabetes Mellitus, Type 2; Humans; Hydrog | 2014 |
Association of serum uric acid and metabolic syndrome in type 2 diabetes.
Topics: Adult; Atherosclerosis; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Cross-Section | 2014 |
Metabolic syndrome: a multifaceted risk factor for kidney stones.
Topics: Humans; Kidney Calculi; Metabolic Syndrome; Oxidative Stress; Risk Factors; Uric Acid | 2014 |
Fructose and uric acid: is there a role in endothelial function?
Topics: Cardio-Renal Syndrome; Endothelium, Vascular; Female; Fructose; Humans; Insulin Resistance; Male; Me | 2014 |
Xanthine oxidoreductase in atherosclerosis pathogenesis: not only oxidative stress.
Topics: Adipocytes; Animals; Atherosclerosis; Cardiovascular Diseases; Cell Differentiation; Cell Movement; | 2014 |
[Relationship between spot urine pH and number of metabolic syndrome features].
Topics: Cholesterol, HDL; Humans; Hydrogen-Ion Concentration; Metabolic Syndrome; Predictive Value of Tests; | 2014 |
Fat storage syndrome in Pacific peoples: a combination of environment and genetics?
Topics: Cultural Characteristics; Diabetes Mellitus, Type 2; Diet; Dietary Carbohydrates; Dietary Sucrose; E | 2014 |
Uric acid as a modulator of glucose and lipid metabolism.
Topics: Animals; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Liver; Metabolic Syndrome; Uric Acid | 2015 |
Serum uric acid and the risk of cardiovascular and renal disease.
Topics: Cardiovascular Diseases; Gout Suppressants; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; | 2015 |
Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Male; Metabolic Syndrome; Middle | 2015 |
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies.
Topics: Adult; Aged; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fat | 2015 |
Why focus on uric acid?
Topics: Animals; Gout; Gout Suppressants; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Risk Fact | 2015 |
Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.
Topics: Animals; Drug Design; Humans; Hyperuricemia; Inflammasomes; Insulin Resistance; Metabolic Syndrome; | 2016 |
Uric acid in metabolic syndrome: From an innocent bystander to a central player.
Topics: Diabetes Mellitus; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Non-alcoholic Fatty Live | 2016 |
At the interface of antioxidant signalling and cellular function: Key polyphenol effects.
Topics: Animals; Antioxidants; Diet; Endothelial Cells; Endothelium, Vascular; Flavonoids; Humans; Inflammat | 2016 |
Role of Serum Uric Acid and Ferritin in the Development and Progression of NAFLD.
Topics: Disease Progression; Ferritins; Humans; Liver Cirrhosis; Metabolic Syndrome; Non-alcoholic Fatty Liv | 2016 |
Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences.
Topics: Diabetes Mellitus; Humans; Hydrogen-Ion Concentration; Kidney Calculi; Metabolic Syndrome; Obesity; | 2017 |
Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis.
Topics: Animals; Atherosclerosis; Disease Progression; Free Radicals; Heart Failure; Humans; Inflammasomes; | 2016 |
Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.
Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Glycat | 2017 |
Excessive consumption of fructose causes cardiometabolic dysfunctions through oxidative stress and inflammation.
Topics: Animals; Blood Pressure; Dietary Sugars; Fructose; Healthy Lifestyle; Humans; Hypertension; Hyperuri | 2017 |
Lessons from comparative physiology: could uric acid represent a physiologic alarm signal gone awry in western society?
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Pressure; Evolution, Molecular; Fasting; Fructose; Gout; | 2009 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Uric acid and cardiovascular risk.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2008 |
Recent advances in the pathophysiology of nephrolithiasis.
Topics: Animals; Calcium Oxalate; Humans; Kidney Calculi; Kidney Tubules; Metabolic Syndrome; Nephrolithiasi | 2009 |
Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?
Topics: Animals; Diabetes Mellitus, Type 2; Dietary Sucrose; Fructose; Humans; Metabolic Syndrome; Sweetenin | 2009 |
Systemic inflammation, metabolic syndrome and progressive renal disease.
Topics: C-Reactive Protein; Chemokine CCL2; Disease Progression; Fructose; Humans; Inflammation; Kidney Dise | 2009 |
The role of hyperuricemia in vascular disorders.
Topics: Animals; Biological Evolution; Cardiovascular Diseases; Disease Models, Animal; Humans; Hypertension | 2009 |
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipokines; Birth Weight; Blood Coagulation Disorders; | 2009 |
Allopurinol, an inhibitor of uric acid synthesis--can it be used for the treatment of metabolic syndrome and related disorders?
Topics: Allopurinol; Enzyme Inhibitors; Fatty Liver; Humans; Liver Diseases; Metabolic Syndrome; Mucositis; | 2009 |
Recent insights into the pathogenesis of hyperuricaemia and gout.
Topics: Animals; Genetic Predisposition to Disease; Genome-Wide Association Study; Gout; Humans; Hyperuricem | 2009 |
Medical implications of hyperuricemia.
Topics: Animals; Cardiovascular Diseases; Gout; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabo | 2009 |
Uric acid as a factor in the metabolic syndrome.
Topics: Biomarkers; Brazil; Cardiovascular Diseases; Female; Global Health; Humans; Hyperuricemia; Insulin R | 2010 |
Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
Topics: Animals; Antioxidants; Cardiovascular Diseases; Cells, Cultured; Clinical Trials as Topic; Comorbidi | 2010 |
An update and practical guide to renal stone management.
Topics: Age of Onset; Calcium Oxalate; Calcium Phosphates; Cross-Sectional Studies; Cystine; Diabetes Mellit | 2010 |
Fructose and cardiometabolic disorders: the controversy will, and must, continue.
Topics: Diet; Fructose; Humans; Hypertriglyceridemia; Liver; Metabolic Syndrome; Risk Factors; Sweetening Ag | 2010 |
Dietary fructose and hypertension.
Topics: Animals; Blood Pressure; Disease Models, Animal; Endothelium, Vascular; Fructose; Humans; Hypertensi | 2011 |
The effect of fructose on renal biology and disease.
Topics: Diabetes Mellitus; Diet; Dietary Carbohydrates; Fatty Liver; Female; Fructose; Humans; Hypertension; | 2010 |
[Hyperuricemia and metabolic syndrome].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Fructose; Humans; Hyperuricemia; Insulin Resistance | 2010 |
Metabolic syndrome and the genesis of uric acid stones.
Topics: Humans; Kidney; Metabolic Syndrome; Nephrolithiasis; Uric Acid | 2011 |
Uric acid as a cardiometabolic risk factor: to be or not to be.
Topics: Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metabolic Syndrome; R | 2011 |
[Hyperuricemia and uro-nephrological disorders].
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diagnosis, Differential; Humans; Hypertension; H | 2011 |
Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage?
Topics: Biomarkers; Cardiovascular Diseases; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Progno | 2012 |
Is there anything good in uric acid?
Topics: Age Factors; Brain Diseases; Cardiovascular Diseases; Female; Gout; Humans; Hypertension; Hyperurice | 2011 |
[Relationship between metabolic syndrome and urinary stone disease].
Topics: Animals; Female; Humans; Insulin Resistance; Intra-Abdominal Fat; Life Style; Male; Metabolic Syndro | 2011 |
The epidemiology of uric acid and fructose.
Topics: Adult; Aged; Aged, 80 and over; Beverages; Diabetes Mellitus; Female; Fructose; Gout; Humans; Hyperu | 2011 |
[Lozartan potential in hyperuricemia correction].
Topics: Antihypertensive Agents; Humans; Hypertension; Hyperuricemia; Losartan; Metabolic Syndrome; Uric Aci | 2011 |
Uric acid, hyperuricemia and vascular diseases.
Topics: Coronary Disease; Gout; Humans; Hypertension; Hyperuricemia; Inflammasomes; Inflammation; Metabolic | 2012 |
Cardiovascular and renal effects of hyperuricaemia and gout.
Topics: Biomarkers; Cardiovascular Diseases; Diabetes Complications; Disease Progression; Evidence-Based Med | 2012 |
Uric acid as one of the important factors in multifactorial disorders--facts and controversies.
Topics: Biomarkers; Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Uric A | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The effects of fructose intake on serum uric acid vary among controlled dietary trials.
Topics: Clinical Trials as Topic; Diet, Diabetic; Energy Metabolism; Fructose; Humans; Hyperuricemia; Metabo | 2012 |
The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome.
Topics: Animals; Endothelium, Vascular; Humans; Hypertension; Hyperuricemia; Inflammation; Metabolic Syndrom | 2012 |
Uric acid and diabetes: Is there a link?
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies | 2013 |
Gout: on the brink of novel therapeutic options for an ancient disease.
Topics: Acute Disease; Benzothiadiazines; Diuretics; Female; Gout; Humans; Hypertension; Hyperuricemia; Kidn | 2004 |
[Hyperuricemia as a unique marker for metabolic syndrome].
Topics: Adipose Tissue; Arteriosclerosis; Biomarkers; Humans; Hyperuricemia; Insulin Resistance; Life Style; | 2005 |
Recent developments in diet and gout.
Topics: Beer; Feeding Behavior; Female; Food, Formulated; Gout; Humans; Insulin Resistance; Male; Metabolic | 2006 |
Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?
Topics: Animals; Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2006 |
Uric acid, the metabolic syndrome, and renal disease.
Topics: Animals; Disease Models, Animal; Disease Progression; Fructose; Humans; Kidney Diseases; Metabolic S | 2006 |
Role of uric acid in hypertension, renal disease, and metabolic syndrome.
Topics: Biomarkers; Blood Pressure; Fructose; Humans; Hypertension; Hyperuricemia; Kidney Diseases; Metaboli | 2006 |
Therapeutic advances in gout.
Topics: Allopurinol; Feeding Behavior; Gout; Humans; Metabolic Syndrome; Risk Reduction Behavior; Uric Acid; | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus, Type 2; Fructose; Genetic Predispo | 2007 |
The conundrum of hyperuricemia, metabolic syndrome, and renal disease.
Topics: Animals; Humans; Hypertension; Hyperuricemia; Insulin Resistance; Kidney; Metabolic Syndrome; Renal | 2008 |
The paradoxical relationship between serum uric acid and cardiovascular disease.
Topics: Animals; Antioxidants; Cardiovascular Diseases; Heart Failure; Humans; Hypertension; Hyperuricemia; | 2008 |
Metabolic syndrome and uric acid nephrolithiasis.
Topics: Humans; Hydrogen-Ion Concentration; Metabolic Syndrome; Nephrolithiasis; Uric Acid | 2008 |
[Urolithiasis and nephropathy complicated with gout].
Topics: Gout; Humans; Hydrogen-Ion Concentration; Metabolic Syndrome; Renal Insufficiency; Uric Acid; Urolit | 2008 |
[Relationship between hyperuricemia and metabolic syndrome].
Topics: Adipocytes; Cardiovascular Diseases; Cell Differentiation; Humans; Hyperuricemia; Metabolic Syndrome | 2008 |
[Renal markers and predictors, and renal and cardiovascular risk factors].
Topics: Age Factors; Alcohol Drinking; Biomarkers; Blood Pressure; Cardiovascular Diseases; Fatty Acids; Hum | 2002 |
30 trials available for uric acid and Metabolic Syndrome
| Article | Year |
|---|---|
Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
Topics: Acrylates; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihyp | 2021 |
Coping Strategies Influence Cardiometabolic Risk Factors in Chronic Psychological Stress: A Post Hoc Analysis of A Randomized Pilot Study.
Topics: Adaptation, Psychological; Adult; C-Reactive Protein; Cardiometabolic Risk Factors; Chronic Disease; | 2021 |
Liraglutide Plus Dapagliflozin for High Uric Acid and Microalbuminuria in Diabetes Mellitus Complicated With Metabolic Syndrome.
Topics: Benzhydryl Compounds; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucosides; Glycolipids; Humans; | 2022 |
Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial.
Topics: Blood Glucose; Body Weight; Diet, Carbohydrate-Restricted; Dyslipidemias; Humans; Intra-Abdominal Fa | 2022 |
Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study.
Topics: C-Reactive Protein; Citrates; Citric Acid; Gout; Humans; Male; Metabolic Syndrome; Prospective Studi | 2023 |
Association of Serum Uric Acid with Metabolic Syndrome and Its Components: A Mendelian Randomization Analysis.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucose Transport Proteins, Facilitative; Humans; Mendelian | 2020 |
Daily consumption effects of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 on oxidative stress in metabolic syndrome patients.
Topics: Bifidobacterium; Bifidobacterium animalis; Female; Humans; Lactobacillus acidophilus; Male; Metaboli | 2021 |
Serum urate and cardiovascular events in the DCCT/EDIC study.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Heart Disease Risk Factors; Human | 2021 |
Serum urate and cardiovascular events in the DCCT/EDIC study.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Heart Disease Risk Factors; Human | 2021 |
Serum urate and cardiovascular events in the DCCT/EDIC study.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Heart Disease Risk Factors; Human | 2021 |
Serum urate and cardiovascular events in the DCCT/EDIC study.
Topics: Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Heart Disease Risk Factors; Human | 2021 |
Does Vitamin D Status Correlate with Cardiometabolic Risk Factors in Adults with Growth Hormone Deficiency?
Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Blood Glucose; C-Reacti | 2017 |
Effects of pharmacological reversal of hyperuricemia on features of the metabolic syndrome in patients with gouty arthritis.
Topics: Arthritis, Gouty; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diastole; Fe | 2018 |
Interaction Between Lactate and Uric Acid is Associated With a Higher Prevalence of Metabolic Syndrome: A Community-Based Study.
Topics: Adult; C-Reactive Protein; China; Cross-Sectional Studies; Female; Humans; Insulin Resistance; Lacti | 2019 |
Fructose increases risk for kidney stones: potential role in metabolic syndrome and heat stress.
Topics: Adult; Aged; Calcium Oxalate; Fructose; Heat-Shock Response; Humans; Kidney Calculi; Male; Metabolic | 2018 |
A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project.
Topics: Adipose Tissue; American Heart Association; Biomarkers; Blood Glucose; Body Composition; Body Mass I | 2014 |
[Analysis of the chosen parameters of metabolic status in patients with psoriasis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Chole | 2013 |
Cardiovascular risk factors and total serum antioxidant capacity in healthy men and in men with coronary heart disease.
Topics: Adult; Aged; Antioxidants; Biomarkers; Comorbidity; Coronary Artery Disease; Humans; Incidence; Men; | 2014 |
L-carnitine ameliorated fasting-induced fatigue, hunger, and metabolic abnormalities in patients with metabolic syndrome: a randomized controlled study.
Topics: Administration, Intravenous; Adult; Alanine Transaminase; Blood Glucose; Blood Pressure; Body Mass I | 2014 |
Measurement of waist and hip circumference with a body surface scanner: feasibility, validity, reliability, and correlations with markers of the metabolic syndrome.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Cholesterol, HDL; Cross-Sectional Studies; Female; Glycated | 2015 |
The fructose tolerance test in patients with chronic kidney disease and metabolic syndrome in comparison to healthy controls.
Topics: Adult; Aged; Body Mass Index; Disease Progression; Female; Fructose; Glomerular Filtration Rate; Hum | 2015 |
Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.
Topics: Adult; Biomarkers; Biopsy; Blood Glucose; Female; Greece; Humans; Hydroxymethylglutaryl-CoA Reductas | 2015 |
Effects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome.
Topics: Blood Glucose; Blood Pressure; Cholesterol, HDL; Double-Blind Method; Estradiol; Female; Glutathione | 2016 |
Evaluation of risk markers fluctuation during an initial therapy with rosiglitazon in patients suffering from metabolic syndrome.
Topics: Biomarkers; C-Reactive Protein; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Fibrino | 2009 |
Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response.
Topics: Adult; Aged; Allopurinol; Antimetabolites; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, | 2010 |
Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
Topics: Aged; Bezafibrate; Blood Glucose; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; | 2010 |
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Disease-Free Survival; Female; Glomer | 2011 |
Efficacy and safety of a single-pill fixed-dose combination of high-dose telmisartan/hydrochlorothiazide in patients with uncontrolled hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; B | 2012 |
Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension.
Topics: Adolescent; Adult; Aged; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Obesit | 2012 |
Effect of Diamel in patients with metabolic syndrome: a randomized double-blind placebo-controlled study.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Dietary Supplements; Double-Blind Method; Female; Human | 2013 |
Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial.
Topics: Adult; Anacardium; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive Protein; Diet; Female; Fruc | 2007 |
Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH.
Topics: Bezafibrate; Biomarkers; Body Mass Index; Fenofibrate; Gout; Humans; Hydrogen-Ion Concentration; Hyp | 2007 |
[Relation of serum uric acid levels with basic metabolic parameters in patients with metabolic syndrome during insulin-sensitizing therapy].
Topics: Adult; Female; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Rosiglitazone; Thia | 2007 |
522 other studies available for uric acid and Metabolic Syndrome
| Article | Year |
|---|---|
Serum uric acid is associated with incident metabolic syndrome independent of body shape index and body roundness index in healthy individuals.
Topics: Adult; Biomarkers; Body Mass Index; Female; Humans; Hyperuricemia; Incidence; Male; Metabolic Syndro | 2021 |
Umami-induced obesity and metabolic syndrome is mediated by nucleotide degradation and uric acid generation.
Topics: Animals; Energy Intake; Metabolic Syndrome; Mice; Nucleotides; Obesity; Sodium Glutamate; Taste; Uri | 2021 |
Associations between metabolic biomarkers and localized stage II/III periodontitis in young adults: The CHIEF Oral Health study.
Topics: Biomarkers; Blood Glucose; Humans; Metabolic Syndrome; Oral Health; Periodontitis; Risk Factors; Tri | 2021 |
Assessment of the relationship between serum uric acid levels and liver enzymes activity in Bangladeshi adults.
Topics: Adult; Aged; Alanine Transaminase; Bangladesh; Biomarkers; Cross-Sectional Studies; Female; gamma-Gl | 2021 |
Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome.
Topics: Cholesterol, HDL; Cross-Sectional Studies; Humans; Lipoproteins, HDL; Metabolic Syndrome; Uric Acid | 2022 |
Cardiometabolic risk in adolescents with normal weight obesity.
Topics: Adolescent; Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Male; | 2022 |
Assessment of Serum Spexin Levels in Obese Adolescents with Metabolic Syndrome Antecedents: Preliminary Results.
Topics: Adolescent; Child; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Pediatric Obesity; Uric | 2021 |
Serum uric acid is independently associated with metabolic syndrome and systemic hypertension in women from northeast Brazil.
Topics: Brazil; Cross-Sectional Studies; Female; Humans; Hypertension; Metabolic Syndrome; Risk Factors; Uri | 2022 |
The bidirectional relationship between metabolic syndrome and hyperuricemia in China: A longitudinal study from CHARLS.
Topics: Adult; China; Female; Follow-Up Studies; Humans; Hyperuricemia; Incidence; Longitudinal Studies; Mal | 2022 |
Which Clusters of Metabolic Syndrome Are the Most Associated with Serum Uric Acid?
Topics: Adult; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged | 2022 |
Inflammaging and Vascular Function in Metabolic Syndrome: The Role of Hyperuricemia.
Topics: Adult; Carotid Arteries; Carotid Intima-Media Thickness; Female; Humans; Hyperuricemia; Male; Metabo | 2022 |
Association between circulating cystatin C and hyperuricemia: a cross-sectional study.
Topics: Aged; Cross-Sectional Studies; Cystatin C; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; | 2022 |
Comparison of Serum Uric Acid Levels Among Men and Women with Metabolic Syndrome - A Study.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Obesity; Ri | 2022 |
Study of Serum Uric Acid Levels in Patients of Metabolic Syndrome in a Tertiary Care Centre in South India.
Topics: Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Prevalence; Tertiary Care Centers; Uric Aci | 2022 |
Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels.
Topics: Body Mass Index; China; Cholesterol; Cholesterol, LDL; Humans; Lipids; Metabolic Syndrome; Non-alcoh | 2022 |
Association Between Low-Grade Inflammation and Hyperuricemia in Adults With Metabolic Syndrome in Yucatán, México.
Topics: Adult; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; H | 2022 |
Serum Uric Acid Levels and Cardiometabolic Profile in Middle-Aged, Treatment-Naïve Hypertensive Patients.
Topics: Adult; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Meta | 2022 |
Metabolic syndrome in calcium oxalate stones: Is it so important in this type of lithiasis?
Topics: Calcium Oxalate; Estradiol; Female; Glucose; Humans; Hypertension; Lithiasis; Male; Metabolic Syndro | 2022 |
A Clinical Profile of Patients with Hyperuricemia and the Relationship between Hyperuricemia and Metabolic Syndrome: A Cross-sectional Study at a Tertiary Hospital in the Indian Population.
Topics: Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Hypertriglyceridemia; Hyperuricemi | 2022 |
How the metabolic phenotype in adulthood is affected by long-lasting immunological trajectories since adolescence.
Topics: Adolescent; Adult; Body Mass Index; Humans; Metabolic Syndrome; Phenotype; Uric Acid; Waist Circumfe | 2022 |
Association Between Serum Uric Acid Level and Carotid Atherosclerosis and Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus.
Topics: Carotid Artery Diseases; Carotid Intima-Media Thickness; Cross-Sectional Studies; Diabetes Mellitus, | 2022 |
Not all the eggs and the chickens are the same: The case of uric acid and metabolic syndrome.
Topics: Animals; Chickens; Eggs; Humans; Metabolic Syndrome; Uric Acid | 2022 |
Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA - Brasil).
Topics: Adult; Biomarkers; Brazil; Humans; Hyperuricemia; Longitudinal Studies; Metabolic Syndrome; Obesity; | 2022 |
Individual and combined relationship of serum uric acid and alanine aminotransferase on metabolic syndrome in adults in Qingdao, China.
Topics: Adult; Alanine Transaminase; China; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrom | 2022 |
Association of obesity phenotypes with left ventricular mass index and left ventricular hypertrophy in children and adolescents.
Topics: Child; Female; Humans; Hypertrophy, Left Ventricular; Hyperuricemia; Insulin Resistance; Male; Metab | 2022 |
Impacts of food consumption on biochemical markers and anthropometric variables of women with metabolic syndrome.
Topics: Aged; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholesterol, | 2022 |
The Association between High-Sensitivity C-Reactive Protein and Metabolic Syndrome in an Elderly Population Aged 50 and Older in a Community Receiving Primary Health Care in Taiwan.
Topics: Adult; Aged; C-Reactive Protein; Cross-Sectional Studies; Humans; Metabolic Syndrome; Middle Aged; P | 2022 |
The Presence of Hyperhomocysteinemia Does Not Aggravate the Cardiometabolic Risk Imposed by Hyperuricemia in Young Individuals: A Retrospective Analysis of a Cross-Sectional Study.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Hom | 2022 |
Association between hyperuricemia and metabolic syndrome: A cross-sectional study in Tibetan adults on the Tibetan plateau.
Topics: Adult; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Tibet; Uric | 2022 |
The relationship between hyperuricemia and anemia and metabolic syndrome in Korean adults: The Korea National Health and Nutrition Examination Survey 2019.
Topics: Adult; Anemia; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Nutrition Surveys; Republic | 2023 |
The relationship between hyperuricemia and anemia and metabolic syndrome in Korean adults: The Korea National Health and Nutrition Examination Survey 2019.
Topics: Adult; Anemia; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Nutrition Surveys; Republic | 2023 |
The relationship between hyperuricemia and anemia and metabolic syndrome in Korean adults: The Korea National Health and Nutrition Examination Survey 2019.
Topics: Adult; Anemia; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Nutrition Surveys; Republic | 2023 |
The relationship between hyperuricemia and anemia and metabolic syndrome in Korean adults: The Korea National Health and Nutrition Examination Survey 2019.
Topics: Adult; Anemia; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Nutrition Surveys; Republic | 2023 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Association of the serum uric acid to creatinine ratio with metabolic syndrome in the middle age and older population in China.
Topics: Aged; Creatinine; Cross-Sectional Studies; Female; Humans; Hypertension; Metabolic Syndrome; Middle | 2022 |
Hyperuricemia as an effect modifier of the association between metabolic phenotypes and nonalcoholic fatty liver disease in Chinese population.
Topics: Body Mass Index; East Asian People; Humans; Hyperuricemia; Metabolic Syndrome; Non-alcoholic Fatty L | 2023 |
Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study.
Topics: Aged; Cameroon; Female; Gout; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Obesity; | 2022 |
Resistin/uric acid index as a marker of metabolic syndrome in females with obesity.
Topics: Adolescent; Body Mass Index; Cross-Sectional Studies; Female; Glucose; Humans; Insulin; Insulin Resi | 2023 |
Metabolic Syndrome and Its Components Are Associated with New-Onset Hyperuricemia in a Large Taiwanese Population Follow-Up Study.
Topics: Adult; Female; Follow-Up Studies; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Obes | 2023 |
Comparative analyses of surrogates of metabolic syndrome in children and adolescents with metabolically healthy obesity vs. metabolically unhealthy obesity according to Damanhoury's criteria.
Topics: Body Mass Index; Child; Female; Humans; Hyperuricemia; Metabolic Syndrome; Obesity, Metabolically Be | 2023 |
Association of Metabolic Syndrome and Hyperuricemia in the Recipients of Kidney Transplants: A Single-Center Study.
Topics: Cross-Sectional Studies; Humans; Hyperuricemia; Kidney Transplantation; Metabolic Syndrome; Tacrolim | 2023 |
Endocrinology.
Topics: Body Mass Index; C-Peptide; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Mellitus, Typ | 2023 |
Uric acid level in climacteric women and its association with clinical and metabolic parameters.
Topics: Anthropometry; Blood Pressure; Female; Humans; Menopause; Metabolic Syndrome; Uric Acid | 2023 |
Serum uric acid to creatinine ratio and metabolic syndrome in middle-aged and elderly population: Based on the 2015 CHARLS.
Topics: Aged; China; Creatinine; Female; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged | 2023 |
Association of 25(OH)-Vitamin D and metabolic factors with colorectal polyps.
Topics: Adenomatous Polyps; Adult; Colonic Polyps; Cross-Sectional Studies; Female; Humans; Hyperglycemia; M | 2023 |
[Prevention of urolithiasis using febuxostat in patients with metabolic syndrome].
Topics: Febuxostat; Humans; Metabolic Syndrome; Uric Acid; Urinary Calculi; Urolithiasis | 2023 |
Metabolic Syndrome Predicts Uric Acid Stones in the Upper Urinary Tract: Development and Validation of a Nomogram Model.
Topics: Calcium; Humans; Metabolic Syndrome; Nephrolithiasis; Nomograms; Potassium; Retrospective Studies; U | 2023 |
An analysis of the associations of high-sensitivity C-reactive protein and uric acid with metabolic syndrome components in Korean adults by sex: a cross-sectional study using the Korea national health and nutrition examination survey 2016-2018.
Topics: Adult; C-Reactive Protein; Cross-Sectional Studies; Female; Humans; Hypertension; Hypertriglyceridem | 2023 |
Effect of Alcohol Consumption Habits on Early Arterial Aging in Subjects with Metabolic Syndrome and Elevated Serum Uric Acid.
Topics: Aging; Alcohol Drinking; Female; Habits; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Age | 2023 |
Serum uric acid to high-density lipoprotein ratio as a novel indicator of inflammation is correlated with the presence and severity of metabolic syndrome: A large-scale study.
Topics: Cohort Studies; Cross-Sectional Studies; Humans; Inflammation; Lipoproteins, HDL; Metabolic Syndrome | 2023 |
FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning.
Topics: Cross-Sectional Studies; Elasticity Imaging Techniques; Humans; Liver Cirrhosis; Metabolic Syndrome; | 2023 |
The association between lipid profile, oxidized LDL and the components of metabolic syndrome with serum mineral status and kidney function in individuals with obesity.
Topics: Adult; Albumins; Cholesterol, LDL; Humans; Iron; Kidney; Magnesium; Metabolic Syndrome; Minerals; Ob | 2023 |
Kidney damage predictors in children with metabolically healthy and metabolically unhealthy obesity phenotype.
Topics: Adolescent; Adult; Body Mass Index; Child; Humans; Kidney; Kidney Diseases; Metabolic Syndrome; Obes | 2023 |
Serum uric acid to high-density lipoprotein cholesterol ratio is a promising marker for identifying metabolic syndrome in nondiabetic Chinese men.
Topics: Adult; Cholesterol, HDL; Diabetes Mellitus; East Asian People; Female; Humans; Male; Metabolic Syndr | 2023 |
Development and validation of an age-sex-ethnicity-specific metabolic syndrome score in the Chinese adults.
Topics: Adult; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; East | 2023 |
Relationship between Metabolic Syndrome and Uric Acid Levels in Patients with Familial Mediterranean Fever.
Topics: Adult; Biomarkers; Body Mass Index; Cross-Sectional Studies; Familial Mediterranean Fever; Female; H | 2019 |
Relationships between Serum Uric Acid, Malondialdehyde Levels, and Carotid Intima-Media Thickness in the Patients with Metabolic Syndrome.
Topics: Antioxidants; Biomarkers; C-Reactive Protein; Carotid Intima-Media Thickness; Female; Humans; Linear | 2019 |
The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components.
Topics: Adult; Blood Pressure; Cholesterol, HDL; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Mi | 2020 |
Association between dairy product consumption and hyperuricemia in an elderly population with metabolic syndrome.
Topics: Age Factors; Aged; Biomarkers; Cross-Sectional Studies; Dairy Products; Diet, Fat-Restricted; Diet, | 2020 |
Serum uric acid and left ventricular geometry pattern in obese children.
Topics: Adolescent; Case-Control Studies; Child; Cross-Sectional Studies; Female; Humans; Hypertrophy, Left | 2019 |
Association between Serum Uric Acid and Metabolic Syndrome in Koreans.
Topics: Adult; Aged; Area Under Curve; Female; Humans; Logistic Models; Male; Metabolic Syndrome; Middle Age | 2019 |
Serum Uric Acid and Metabolic Syndrome: a Retrospective Cohort Study.
Topics: Biomarkers; Humans; Metabolic Syndrome; Retrospective Studies; Risk Factors; Uric Acid | 2019 |
Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; China; Diabetes | 2019 |
Association between serum cell adhesion molecules with hs-CRP, uric acid and VEGF genetic polymorphisms in subjects with metabolic syndrome.
Topics: Adult; Biomarkers; C-Reactive Protein; Cell Adhesion Molecules; Cholesterol; Cross-Sectional Studies | 2020 |
Measurement of the Combined Levels of Serum Uric Acid and Alanine Aminotransferase and the Risk of Metabolic Syndrome in a Population Aged 60 Years or More in Northeastern China.
Topics: Aged; Aged, 80 and over; Alanine Transaminase; China; Female; Humans; Male; Metabolic Syndrome; Midd | 2020 |
Serum uric acid (SUA) in morbidly obese patients and its relationship with metabolic syndrome.
Topics: Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Obesity, Morbid; Triglycerides; Uric Acid | 2020 |
Association between Serum Uric Acid Levels and Metabolic Syndrome.
Topics: Biomarkers; Cross-Sectional Studies; Humans; Metabolic Syndrome; Risk Factors; Uric Acid | 2020 |
Evaluation of serum uric acid levels in patients with rosacea.
Topics: Adolescent; Adult; Aged; Body Mass Index; C-Reactive Protein; Disease Progression; Female; Humans; M | 2020 |
Elevated serum uric acid, hyperuricaemia and dietary patterns among adolescents in mainland China.
Topics: Adolescent; Child; China; Cross-Sectional Studies; Diet; Female; Follow-Up Studies; Humans; Hyperuri | 2020 |
The serum uric acid level in females may be a better indicator of metabolic syndrome and its components than in males in a Japanese population .
Topics: Adult; Asian People; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Sex | 2020 |
Association of Serum Uric acid and Gamma-glutamyltransferase with Obesity Related Metabolic Derangements in a Cohort of Children with Obesity in Sri Lanka
Topics: Adolescent; Biomarkers; Body Mass Index; Child; Child, Preschool; Cohort Studies; Cross-Sectional St | 2019 |
Increased Uric Acid and Life Style Factors Associated with Metabolic Syndrome in Thais.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Exercise; Female; Humans; Life Style; Male; | 2020 |
Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; China; Cross-Sectional Studies; Fatty Liver; Female; He | 2020 |
Metabolic risk associated with liver enzymes, uric acid, and hemoglobin in adolescents.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Brazil; Cardiorespiratory Fitness; Ch | 2020 |
Sex-specific association of hyperuricemia with cardiometabolic abnormalities in a military cohort: The CHIEF study.
Topics: Adolescent; Adult; Cross-Sectional Studies; Female; Humans; Hypertension; Hypertriglyceridemia; Hype | 2020 |
Association of Serum Uric Acid with cardio-metabolic risk factors and metabolic syndrome in seafarers working on tankers.
Topics: Adult; Cross-Sectional Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Military Personnel; N | 2020 |
Serum uric acid to creatinine ratio and metabolic syndrome in postmenopausal Chinese women.
Topics: Aged; Body Mass Index; China; Creatinine; Female; Humans; Logistic Models; Male; Metabolic Syndrome; | 2020 |
Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults.
Topics: Adult; Bangladesh; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Male; Metabolic Sy | 2020 |
Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu.
Topics: Aged, 80 and over; Blood Glucose; China; Cholesterol, HDL; Cross-Sectional Studies; Female; Humans; | 2020 |
Non-alcoholic fatty liver disease: correlation with hyperuricemia in a European Mediterranean population.
Topics: Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Non-alcoholic Fatt | 2022 |
The effect of evening primrose oil (
Topics: Adiponectin; Animals; Antioxidants; Cholesterol, LDL; Fructose; Glucose; Insulins; Interleukin-6; Me | 2022 |
The role of resistin on metabolic syndrome-induced erectile dysfunction and the possible therapeutic effect of Boldine.
Topics: Animals; Antioxidants; Aporphines; Blood Glucose; Blood Pressure; Disease Models, Animal; Erectile D | 2020 |
Sex-specific association of serum uric acid dynamics with the incidence of metabolic syndrome in a health check-up Chinese population: a prospective cohort study.
Topics: Adult; Asian People; Cohort Studies; Female; Humans; Linear Models; Longitudinal Studies; Male; Meta | 2020 |
[Association of serum uric acid/creatinine ratio and metabolic syndrome in euthyroid population].
Topics: Creatinine; Cross-Sectional Studies; Humans; Metabolic Syndrome; Prevalence; Risk Factors; Uric Acid | 2020 |
Distinguish different Chinese medicine types of metabolic syndrome by combining body mass index and uric acid.
Topics: Body Mass Index; China; Humans; Medicine, Chinese Traditional; Metabolic Syndrome; Retrospective Stu | 2020 |
A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal.
Topics: Adult; Cross-Sectional Studies; Female; Gout; Humans; Male; Metabolic Syndrome; Middle Aged; Nepal; | 2021 |
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Body Mass Index; Cholesterol, HDL; Cholesterol, L | 2020 |
Uric acid alterations by consumption of gluten-free bakery products in relation to cardiovascular and metabolic syndrome risk factors.
Topics: Adult; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diet, Gluten-Free; Female; Human | 2020 |
Uric acid as a predictor of endothelial dysfunction in patients with metabolic syndrome.
Topics: Brachial Artery; Endothelium, Vascular; Humans; Metabolic Syndrome; Uric Acid; Vasodilation | 2021 |
Sodium butyrate arrests pancreato-hepatic synchronous uric acid and lipid dysmetabolism in high fat diet fed Wistar rats.
Topics: Animals; Blood Glucose; Butyric Acid; Diet, High-Fat; Disease Models, Animal; Dyslipidemias; Female; | 2021 |
Association of uric acid with cardiovascular risk in Brazilian children and adolescents.
Topics: Adolescent; Age Factors; Biomarkers; Brazil; Cardiometabolic Risk Factors; Cardiovascular Diseases; | 2021 |
The association of serum uric acid with metabolic syndrome and its components-From a single-clinical centre in China.
Topics: China; Female; Humans; Male; Metabolic Syndrome; Retrospective Studies; Risk Factors; Uric Acid | 2021 |
Increased oxidative stress and inflammatory markers contrasting with the activation of the cholinergic anti-inflammatory pathway in patients with metabolic syndrome.
Topics: Acetylcholinesterase; Adult; Aged; Antioxidants; Biomarkers; C-Reactive Protein; Female; Follow-Up S | 2021 |
Non-alcoholic fatty kidney disease (NAFKD): A novel disease that explains the etiology of hyperuricemia and gout in metabolic syndrome.
Topics: Adult; Female; Gout; Humans; Hyperuricemia; Kidney Diseases; Male; Metabolic Syndrome; Uric Acid | 2021 |
Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity.
Topics: Adult; Bilirubin; Body Mass Index; Cardiometabolic Risk Factors; Cardiovascular Diseases; Case-Contr | 2022 |
Electrochemical dual signal sensing platform for the simultaneous determination of dopamine, uric acid and glucose based on copper and cerium bimetallic carbon nanocomposites.
Topics: Biomarkers; Biosensing Techniques; Blood Glucose; Cerium; Copper; Dopamine; Electrochemical Techniqu | 2021 |
Dose-response relationship between distinct serum uric acid trajectories and metabolic syndrome risk: A 5-year prospective cohort study.
Topics: Adult; Biomarkers; Cardiometabolic Risk Factors; China; Female; Humans; Hyperuricemia; Longitudinal | 2021 |
Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome.
Topics: Animals; Cytoprotection; Fibrosis; Inflammation; Kidney; Male; Metabolic Syndrome; Morpholines; Pyra | 2021 |
The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk.
Topics: Biomarkers; Cardiovascular Diseases; Cause of Death; Female; Follow-Up Studies; Humans; Italy; Male; | 2021 |
Osteopontin's relationship with malnutrition and oxidative stress in adolescents. A pilot study.
Topics: Adolescent; Aryldialkylphosphatase; Biomarkers; Blood Glucose; Body Mass Index; Catalase; Female; Hu | 2021 |
Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry.
Topics: Aged; Antioxidants; Cross-Sectional Studies; Female; Health Status; Humans; Japan; Male; Metabolic S | 2021 |
Phase angle association with metabolic profile in adults: A population-based study.
Topics: Blood Glucose; Body Mass Index; Cholesterol, HDL; Cross-Sectional Studies; Female; Humans; Insulin R | 2021 |
Uric acid: A new marker for metabolic syndrome? Results of a population-based study with adults.
Topics: Adult; Biomarkers; Brazil; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Male; Metabolic S | 2021 |
NMR spectroscopy based metabolomics confirms the aggravation of metabolic disorder in metabolic syndrome combined with hyperuricemia.
Topics: Adult; Biomarkers; Case-Control Studies; Disease Progression; Energy Metabolism; Humans; Hyperuricem | 2021 |
The Speed of Ingestion of a Sugary Beverage Has an Effect on the Acute Metabolic Response to Fructose.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 2; Eating; Female; Fibroblast Growth Factors; Fructose | 2021 |
Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study.
Topics: Adult; Blood Glucose; Body Mass Index; China; Comorbidity; Female; Glucose Tolerance Test; Humans; H | 2021 |
Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia.
Topics: Adult; Aged; China; Cohort Studies; Cross-Sectional Studies; Female; Humans; Hypertriglyceridemia; H | 2017 |
An Increase in Normal SUA Level Within the Normal Range Predicts Risk of Metabolic Syndrome, Especially in Women: A Cross-Sectional Study.
Topics: Adult; Aged; Case-Control Studies; Cross-Sectional Studies; Demography; Female; Humans; Logistic Mod | 2017 |
Serum Uric Acid and Cardiometabolic Disease: Another Brick in the Wall?
Topics: Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2017 |
Metabolic syndrome, serum uric acid and renal risk in patients with T2D.
Topics: Acute Kidney Injury; Aged; Albuminuria; Blood Pressure; Body Mass Index; Cholesterol, HDL; Databases | 2017 |
Evaluation of serum uric acid levels in psoriasis vulgaris.
Topics: Adult; Arthritis, Psoriatic; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Midd | 2017 |
Insulin resistance and associated factors: a cross-sectional study of bank employees.
Topics: Adult; Blood Pressure; Brazil; C-Reactive Protein; Cross-Sectional Studies; Female; Humans; Insulin; | 2017 |
Examining the gender difference in the association between metabolic syndrome and the mean leukocyte telomere length.
Topics: Adult; Aged; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Female; Human | 2017 |
Impact of dietary intake, lifestyle and biochemical factors on metabolic health in obese adolescents.
Topics: Adolescent; Alanine Transaminase; Biomarkers; C-Reactive Protein; Czech Republic; Diet; Diet, Health | 2017 |
Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers.
Topics: Adult; Biomarkers; Bipolar Disorder; Blood Glucose; Body Mass Index; C-Reactive Protein; Cross-Secti | 2017 |
Does long-term androgen deficiency lead to metabolic syndrome in middle-aged rats?
Topics: Age Factors; Andropause; Animals; Aromatase Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; C | 2017 |
Sex difference in the association of serum uric acid with metabolic syndrome and its components: a cross-sectional study in a Chinese Yi population.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Asian People; Blood Pressure; Body Mass Ind | 2017 |
Normal uric acid levels in nascent metabolic syndrome patients residing in northern California.
Topics: Adult; California; Case-Control Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Pilo | 2017 |
Insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity.
Topics: Adolescent; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Child; Female; Humans; Insuli | 2017 |
Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients.
Topics: Adult; Biomarkers; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Female; Humans; Male; Met | 2017 |
Association of plasma free amino acids with hyperuricemia in relation to diabetes mellitus, dyslipidemia, hypertension and metabolic syndrome.
Topics: Adult; Aged; Amino Acids; Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus; Dyslipidemi | 2017 |
The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study.
Topics: Adult; Age Factors; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Hypertension; Longit | 2018 |
Low serum uric acid concentration augments insulin effects on the prevalence of metabolic syndrome.
Topics: Adult; Cross-Sectional Studies; Female; Follow-Up Studies; Humans; Hyperinsulinism; Hyperuricemia; I | 2018 |
Chronic kidney disease associated with decreased bone mineral density, uric acid and metabolic syndrome.
Topics: Bone Density; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Progno | 2018 |
Renal Effects of Hyperuricemia.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Glomerular Filtration Rate; Humans; Hypertensi | 2018 |
Clinical Significance of Serum Uric Acid Levels in Mexican Young Adults.
Topics: Adolescent; Adult; Cholesterol, LDL; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hu | 2018 |
Investigation of Adipose Tissue Fatty Acid Composition in Men with Uronephrolithiasis and Metabolic Syndrome.
Topics: Adipose Tissue; Case-Control Studies; Fatty Acids; Fatty Acids, Unsaturated; Gas Chromatography-Mass | 2018 |
Sex-specific associations of serum uric acid with metabolic syndrome in Chinese rural population: The RuralDiab study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; China; Female; Humans; Male; Meta-Analysis as Topic; Met | 2018 |
Uric Acid, Metabolic Syndrome and Atherosclerosis: The Chicken or the Egg, Which Comes First?
Topics: Adult; Atherosclerosis; Biomarkers; Carotid Intima-Media Thickness; Female; Humans; Insulin; Leptin; | 2018 |
Baseline and changes in serum uric acid independently predict 11-year incidence of metabolic syndrome among community-dwelling women.
Topics: Aged; Biomarkers; Female; Follow-Up Studies; Humans; Hyperuricemia; Incidence; Japan; Metabolic Synd | 2018 |
Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol, HDL; Diabetes Mellitus; Fasting; Female; Humans; | 2018 |
Longitudinal Associations of Metabolic Syndrome Severity Between Childhood and Young Adulthood: The Bogalusa Heart Study.
Topics: Adolescent; Adult; Aging; Alabama; Black People; Cardiovascular Diseases; Child; Cross-Sectional Stu | 2018 |
Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Biomarkers; Body Mass Index; Brachial Artery; Cr | 2018 |
Homocysteine is the confounding factor of metabolic syndrome-confirmed by siMS score.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Confounding Factors, Epidem | 2018 |
Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cholest | 2018 |
Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.
Topics: Adolescent; Adult; Advanced Oxidation Protein Products; Aged; Antirheumatic Agents; Arthritis, Rheum | 2018 |
Metabolic syndrome in systemic lupus erythematosus patients : Relationship to disease activity and neuropsychiatric lupus.
Topics: Adolescent; Adult; Aged; Cross-Sectional Studies; Egypt; Female; Humans; Lupus Erythematosus, System | 2018 |
Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity.
Topics: Adolescent; Age of Onset; Anthropometry; Blood Pressure; Child; Child, Preschool; Cholesterol; Femal | 2018 |
Serum Uric Acid Elevation is Associated to Arterial Stiffness in Hypertensive Patients with Metabolic Disturbances.
Topics: Arterial Pressure; Biomarkers; Blood Glucose; Cross-Sectional Studies; Essential Hypertension; Femal | 2018 |
Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: Effect on oxidative stress and low grade inflammation.
Topics: Animals; Blood Glucose; Blood Pressure; Carotenoids; Diosmin; Drug Therapy, Combination; Glycation E | 2018 |
Genetic and Environmental Influences on the Associations Between Uric Acid Levels and Metabolic Syndrome Over Time.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cholesterol, HDL; Cohort Studies; Environment; Feeding B | 2018 |
Association Between Metabolic Syndrome and the Serum Uric Acid: a Cohort Study.
Topics: Adult; Asian People; China; Cohort Studies; Female; Follow-Up Studies; Humans; Incidence; Male; Meta | 2018 |
Hyperuricemia Is Associated With a Higher Prevalence of Metabolic Syndrome in Military Individuals.
Topics: Adult; Cohort Studies; Female; Humans; Hyperuricemia; Logistic Models; Male; Metabolic Syndrome; Mil | 2018 |
Shall we diagnose metabolic syndrome in adolescents?
Topics: Adolescent; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Female; Humans; Insulin Re | 2018 |
Effect of Uric Acid Control on Serum Creatinine.
Topics: Aged; Allopurinol; Antimetabolites; Comorbidity; Correlation of Data; Creatinine; Disease Progressio | 2019 |
Serum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables.
Topics: Adolescent; Adult; Cohort Studies; Europe; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Od | 2018 |
Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study.
Topics: Aged; Aged, 80 and over; Female; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; Predictiv | 2018 |
Association between serum activin A and metabolic syndrome in older adults: Potential of activin A as a biomarker of cardiometabolic disease.
Topics: Absorptiometry, Photon; Activins; Aged; Aged, 80 and over; Aging; Biomarkers; Body Mass Index; C-Rea | 2018 |
Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study.
Topics: Aged; Blood Pressure; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Europe, Eastern; Fema | 2019 |
Serum Uric Acid Levels are Associated with Cardiometabolic Risk Factors in Healthy Young and Middle-Aged Adults.
Topics: Adiposity; Adult; Blood Pressure; C-Reactive Protein; Cholesterol; Cross-Sectional Studies; Diet Sur | 2018 |
Characteristics of gout patients according to the laterality of nephrolithiasis: A cross-sectional study using helical computed tomography.
Topics: Adult; Aged; Biomarkers; Creatinine; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Go | 2019 |
Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death.
Topics: Adult; Biomarkers; Donor Selection; End Stage Liver Disease; Female; Follow-Up Studies; Humans; Hype | 2018 |
Salivary markers of hepato-metabolic comorbidities in pediatric obesity.
Topics: Adolescent; Biomarkers; Child; Comorbidity; Female; Glucose; Homeostasis; Humans; Insulin; Insulin R | 2019 |
The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals.
Topics: Adult; Biomarkers; Electrocardiography; Female; Humans; Hypertrophy, Left Ventricular; Hyperuricemia | 2019 |
Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder.
Topics: Adult; Bipolar Disorder; China; Comorbidity; Correlation of Data; Diagnostic and Statistical Manual | 2018 |
Composite acute phase glycoproteins with coronary artery calcification depends on metabolic syndrome presence - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Topics: Acute-Phase Proteins; Adult; Biomarkers; Brazil; C-Reactive Protein; Coronary Artery Disease; Corona | 2019 |
Serum Uric Acid to Creatinine Ratio Independently Predicts Incident Metabolic Syndrome Among Community-Dwelling Persons.
Topics: Age Factors; Aged; Aged, 80 and over; Cohort Studies; Creatinine; Female; Follow-Up Studies; Glomeru | 2019 |
Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features.
Topics: Adult; Blood Cell Count; Blood Sedimentation; Cholesterol; Echocardiography, Doppler; Female; Heart; | 2019 |
Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus.
Topics: Biomarkers; Cholesterol; Diabetes Mellitus, Type 2; Female; Humans; Male; Metabolic Syndrome; Middle | 2019 |
Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children
Topics: Adolescent; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Female; Follow-Up Studies; | 2019 |
[Uric acid and its association with the components of the metabolic syndrome in Colombian adolescents].
Topics: Adolescent; Age Factors; Body Mass Index; Colombia; Cross-Sectional Studies; Female; Humans; Male; M | 2019 |
High serum uric acid level is associated with greater handgrip strength in the aged population.
Topics: Adult; Age Factors; Aged; Cross-Sectional Studies; Female; Hand Strength; Humans; Male; Metabolic Sy | 2019 |
The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome.
Topics: Adult; Aged; Antioxidants; Body Mass Index; Female; Follow-Up Studies; Humans; Hyperuricemia; Incide | 2019 |
Anthropometric variables, physical activity and dietary intakes of patients with uric acid nephrolithiasis.
Topics: Aged; Aged, 80 and over; Blood Pressure; Body Mass Index; Case-Control Studies; Dietary Carbohydrate | 2020 |
Glutamine confers renoprotection by normalizing lipid and glutathione content in insulin-resistant pregnant rats.
Topics: Adenosine Deaminase; Animals; Female; Fructose; Glutamine; Glutathione; Insulin Resistance; Lipids; | 2019 |
Association of Uric Acid with Incident Metabolic Syndrome in a Japanese General Population.
Topics: Biomarkers; Female; Humans; Incidence; Japan; Male; Metabolic Syndrome; Middle Aged; Population Surv | 2019 |
Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study.
Topics: Aged; Cross-Sectional Studies; Fabaceae; Humans; Hyperuricemia; Metabolic Syndrome; Prevalence; Risk | 2020 |
Association and interaction analysis of metabolic syndrome and serum uric acid on diastolic heart failure.
Topics: Adult; Aged; Female; Heart Failure, Diastolic; Humans; Logistic Models; Male; Metabolic Syndrome; Mi | 2013 |
Relationship between serum uric acid level and nonalcoholic fatty liver disease in pre- and postmenopausal women.
Topics: Adult; Alanine Transaminase; Asian People; Aspartate Aminotransferases; Body Mass Index; Cholesterol | 2013 |
Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Topics: Adult; Aged; Body Mass Index; Citrates; Citric Acid; Cross-Sectional Studies; Female; Humans; Hyperc | 2013 |
Association of uric acid with obesity and endothelial dysfunction in children and early adolescents.
Topics: Adolescent; Area Under Curve; Asian People; Biomarkers; Blood Pressure; Body Composition; Body Mass | 2013 |
Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Diagnostic Techniques, Endocrine; Female; Humans | 2013 |
The prevalence and predictors of androgen deficiency in Taiwanese men with type 2 diabetes.
Topics: Age Factors; Aged; Body Mass Index; C-Reactive Protein; Cholesterol; Cross-Sectional Studies; Diabet | 2013 |
Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy.
Topics: Female; Humans; Intra-Abdominal Fat; Kidney Calculi; Male; Metabolic Syndrome; Middle Aged; Nephrost | 2013 |
Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age.
Topics: Adult; Age Distribution; Age Factors; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Cr | 2013 |
Relationship between serum uric acid levels and metabolic syndrome in Chinese postmenopausal women.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Biomarkers; Blood Pressure; China; Cholesterol; Choles | 2014 |
Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population.
Topics: Adult; Asian People; Biomarkers; Chi-Square Distribution; Female; Humans; Hyperuricemia; Incidence; | 2014 |
Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population.
Topics: Age Factors; Aged; Aged, 80 and over; Alleles; Asian People; China; Cross-Sectional Studies; Female; | 2013 |
Dietary nutrient intake and metabolic syndrome risk in Chinese adults: a case-control study.
Topics: Adult; Aged; Anthropometry; Antioxidants; Asian People; Biomarkers; Case-Control Studies; China; Cho | 2013 |
Serum potassium level is associated with metabolic syndrome: a population-based study.
Topics: Aged; Asian People; Blood Glucose; Body Mass Index; China; Cholesterol, HDL; Cholesterol, LDL; Cross | 2014 |
Effect of shift work on the development of metabolic syndrome after 3 years in Japanese male workers.
Topics: Adult; Follow-Up Studies; Humans; Insulin; Japan; Life Style; Male; Metabolic Syndrome; Middle Aged; | 2014 |
Elevated serum uric acid in nondiabetic people mark pro-inflammatory state and HDL dysfunction and independently predicts coronary disease.
Topics: Apolipoproteins B; Biomarkers; Cholesterol, HDL; Cohort Studies; Coronary Disease; Diabetes Mellitus | 2013 |
Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men.
Topics: Adult; Aged; Asian People; China; Confidence Intervals; Diabetes Mellitus; Fatty Liver; Humans; Line | 2013 |
Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components.
Topics: Aged; Aged, 80 and over; Body Mass Index; Brachial Artery; Cholesterol, HDL; Female; Humans; Insulin | 2013 |
Relationship between metabolic syndrome and diagnoses of periodontal diseases among participants in a large Taiwanese cohort.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cohort Studies; Creatin | 2013 |
Prevalence of metabolic syndrome and its association with serum uric acid levels in Bangkok Thailand.
Topics: Adult; Blood Pressure; Body Weights and Measures; Cross-Sectional Studies; Female; Humans; Hyperuric | 2013 |
Components of the metabolic syndrome are negative predictors of weight loss in obese children with lifestyle intervention.
Topics: Adolescent; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Female; | 2014 |
Hyperuricemia in patients with chronic plaque psoriasis.
Topics: Adult; Aged; Arthritis, Psoriatic; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Hy | 2014 |
Serum total and high-density lipoprotein phospholipids: independent predictive value for cardiometabolic risk.
Topics: Apolipoproteins; Cardiovascular Diseases; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Follo | 2014 |
Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study.
Topics: Adult; Atherosclerosis; Female; Humans; Hypertension; Italy; Male; Metabolic Syndrome; Middle Aged; | 2014 |
Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China.
Topics: Adult; Body Mass Index; China; Fatty Liver; Feeding Behavior; Female; Humans; Hyperuricemia; Life St | 2013 |
Postterm births: are prolonged pregnancies too long?
Topics: Body Composition; Body Mass Index; Cerebral Palsy; Child Behavior Disorders; Child, Preschool; Diabe | 2014 |
[A cross-sectional study on serum uric acid level and the distribution of metabolic syndrome among Uigur, Han and Kazak prediabetic groups in Xinjiang].
Topics: Adult; Aged; Aged, 80 and over; China; Cross-Sectional Studies; Female; Humans; Male; Metabolic Synd | 2013 |
Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Incidence; M | 2014 |
Clinical investigation of metabolic syndrome in the female elderly occupational population.
Topics: Aged; Aged, 80 and over; Body Mass Index; Female; Humans; Metabolic Syndrome; Obesity; Prevalence; R | 2014 |
Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephrop | 2014 |
Contribution of visceral fat accumulation and adiponectin to the clustering of metabolic abnormalities in a Japanese population.
Topics: Adiponectin; Adult; Alanine Transaminase; Blood Glucose; Cholesterol, HDL; Cluster Analysis; Female; | 2014 |
Is lower uric acid level better? A combined cross-sectional and longitudinal study in the elderly.
Topics: Aged; Blood Glucose; Blood Pressure; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Inciden | 2014 |
Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals.
Topics: Age Factors; Aged; Asian People; Biomarkers; Cardiovascular Diseases; China; Cross-Sectional Studies | 2014 |
Association of uric acid with metabolic syndrome in men, premenopausal women and postmenopausal women.
Topics: Adult; Aged; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Postmen | 2014 |
[The correlation between serum uric acid level and abdominal obesity or metabolic syndrome].
Topics: Adult; Aged; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Risk Factors | 2014 |
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study.
Topics: Aged; Albuminuria; Biomarkers; Body Mass Index; Cardiovascular Diseases; Cohort Studies; Cross-Secti | 2014 |
Relationships between mild hyperuricaemia and aortic stiffness in untreated hypertensive patients.
Topics: Adult; Albuminuria; Aorta; Body Mass Index; Cross-Sectional Studies; Female; Humans; Hypertension; H | 2014 |
Relationship between cardiovascular risk factors and the echogenicity and pattern of the carotid intima-media complex in men.
Topics: Adult; Atherosclerosis; C-Reactive Protein; Cardiovascular Diseases; Carotid Artery, Common; Carotid | 2014 |
Association of butyrylcholinesterase with cardiometabolic risk factors among apparently healthy adults.
Topics: Adult; Biomarkers; Blood Glucose; Body Mass Index; Butyrylcholinesterase; Cross-Sectional Studies; D | 2014 |
Metabolic syndrome, alcohol consumption and genetic factors are associated with serum uric acid concentration.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; ATP Binding Cassette Transporter, Subfamily G, Member 2; | 2014 |
Blood lipid profile and BMI-Z-score in adolescents with hyperuricemia.
Topics: Adolescent; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hypertension; Hyper | 2015 |
Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
Topics: Adult; Aged; Blood Pressure; Body Mass Index; China; Cross-Sectional Studies; Diabetes Mellitus, Typ | 2014 |
Serum uric acid levels and metabolic syndrome.
Topics: Adolescent; Adult; Aged; Female; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; | 2014 |
Serum uric acid does not predict incident metabolic syndrome in a population with high prevalence of obesity.
Topics: Aged; Body Composition; Body Mass Index; Cohort Studies; Female; Humans; Hypertension; Indians, Nort | 2014 |
Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9.
Topics: Allopurinol; Animals; Body Composition; Calorimetry; Echocardiography; Enterocytes; Glucose Transpor | 2014 |
Association of serum uric acid levels to inflammation biomarkers and endothelial dysfunction in obese prepubertal children.
Topics: Biomarkers; Body Mass Index; C-Reactive Protein; Child; Cross-Sectional Studies; Endothelium, Vascul | 2015 |
The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease.
Topics: Adult; Anthropometry; Case-Control Studies; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Ass | 2014 |
Uricaemia and left ventricular mass in hypertensive patients.
Topics: Blood Glucose; Cross-Sectional Studies; Echocardiography; Female; Humans; Hypertension; Hypertrophy, | 2014 |
Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Fenofibrate; Fructose; Glutathione | 2014 |
[Insulin resistance and components of metabolic syndrome, analysis by gender and stage of adolescence].
Topics: Adipose Tissue; Adolescent; Age Factors; Blood Glucose; Body Mass Index; Child; Cholesterol; Dyslipi | 2014 |
A possible role of serum uric acid as a marker of metabolic syndrome.
Topics: Adult; Asian People; Biomarkers; Body Mass Index; Cohort Studies; Healthy Volunteers; Humans; Hyperu | 2014 |
[Relationship between serum uric acid level and metabolic syndrome in Uygur children and adolescents with overweight or obesity].
Topics: Adolescent; Body Mass Index; Child; China; Female; Humans; Linear Models; Male; Metabolic Syndrome; | 2014 |
The impact of serum uric acid on the diagnostic of metabolic syndrome in apparently healthy brazilian middle-aged men.
Topics: Brazil; Cardiovascular Diseases; Cross-Sectional Studies; Humans; Male; Metabolic Syndrome; Middle A | 2014 |
Serum uric acid and disorders of glucose metabolism: the role of glycosuria.
Topics: Adult; Age Factors; Blood Glucose; Brazil; Community Health Services; Comorbidity; Cross-Sectional S | 2014 |
Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study.
Topics: Adult; Body Mass Index; Child; Female; Humans; Louisiana; Male; Metabolic Syndrome; Middle Aged; Odd | 2014 |
Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study.
Topics: Adult; Body Mass Index; Child; Female; Humans; Louisiana; Male; Metabolic Syndrome; Middle Aged; Odd | 2014 |
Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study.
Topics: Adult; Body Mass Index; Child; Female; Humans; Louisiana; Male; Metabolic Syndrome; Middle Aged; Odd | 2014 |
Uric acid is associated with metabolic syndrome in children and adults in a community: the Bogalusa Heart Study.
Topics: Adult; Body Mass Index; Child; Female; Humans; Louisiana; Male; Metabolic Syndrome; Middle Aged; Odd | 2014 |
Associations between serum uric acid levels and the incidence of hypertension and metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan.
Topics: Adult; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Humans; Hypertension; Incidence; Japan | 2015 |
Association of hyperuricemia with conventional cardiovascular risk factors in elderly patients.
Topics: Age Factors; Aged; Cardiovascular Diseases; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; | 2015 |
Correlation between renal function and common risk factors for chronic kidney disease in a healthy middle-aged population: a prospective observational 2-year study.
Topics: Adult; Age Factors; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Cholesterol, LDL; F | 2014 |
Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes.
Topics: Aged; Asian People; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cross- | 2015 |
Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome.
Topics: Abdomen; Adult; Aged; Alanine Transaminase; Alcohol Drinking; Asian People; Aspartate Aminotransfera | 2015 |
Serum uric acid level and the incidence of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study.
Topics: Adult; Cohort Studies; Follow-Up Studies; Humans; Incidence; Male; Metabolic Syndrome; Middle Aged; | 2014 |
Hypoglycemic, antihyperglycemic, and antioxidant effects of the edible plant Anoda cristata.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Flavones; Flavonoids; Free Ra | 2015 |
Associations between serum uric acid concentrations and metabolic syndrome and its components in the PREDIMED study.
Topics: Aged; Aged, 80 and over; Asian People; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; C | 2015 |
Hematological parameters in adolescents with hyperuricemia.
Topics: Adolescent; Body Mass Index; Female; Hematologic Tests; Humans; Hyperuricemia; Male; Metabolic Syndr | 2014 |
Geraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status.
Topics: Acyclic Monoterpenes; Adiponectin; Adipose Tissue; Adiposity; Animals; Blood Pressure; Body Weight; | 2015 |
[Relationship between vitamin D deficiency and metabolic syndrome in adult population of the Community of Madrid].
Topics: Adult; Aged; Anthropometry; Blood Glucose; Cross-Sectional Studies; Diet; Disease Susceptibility; Fe | 2015 |
Metabolic syndrome showed significant relationship with carotid atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Dis | 2016 |
The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.
Topics: Adult; Alanine Transaminase; Biomarkers; Body Mass Index; Cross-Sectional Studies; Databases, Factua | 2015 |
Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.
Topics: Adolescent; Adult; Aged; Atherosclerosis; Biomarkers; Bipolar Disorder; Blood Glucose; Body Mass Ind | 2015 |
The association of metabolic syndrome and its components with brachial-ankle pulse wave velocity in south China.
Topics: Adolescent; Adult; Aged; Ankle Brachial Index; Biomarkers; Blood Glucose; Blood Pressure; Cardiovasc | 2015 |
Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome: Results from Fangchenggang Area Male Health and Examination Survey in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Blood Pressure; Body Mass Index; China | 2015 |
Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort.
Topics: Adult; Aged; Biomarkers; Blood Pressure; Female; Follow-Up Studies; Health Status Disparities; Human | 2015 |
Serum urate and obstructive sleep apnoea in severe obesity.
Topics: Adult; Blood Pressure; C-Reactive Protein; Continuous Positive Airway Pressure; Female; Follow-Up St | 2015 |
[Metabolic complications of obesity during adolescence, particularly regarding elevated uric acid levels].
Topics: Adolescent; Biomarkers; Blood Pressure; Body Mass Index; Case-Control Studies; Child; Cross-Sectiona | 2015 |
Relationship of three different types of low-carbohydrate diet to cardiometabolic risk factors in a Japanese population: the INTERMAP/INTERLIPID Study.
Topics: Adult; Asian People; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; | 2016 |
Uric acid blood levels and relationship with the components of metabolic syndrome in hypertensive patients.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein B-100; Biomarkers; Blood Glucose; Blood Pressure; Ch | 2016 |
Combination of hyperuricemia and metabolic syndrome is an independent and powerful predictor for left ventricular hypertrophy in rural Chinese.
Topics: Adult; Aged; Anthropometry; Asian People; Body Mass Index; China; Cross-Sectional Studies; Female; H | 2015 |
The association between serum uric acid levels, metabolic syndrome and cardiovascular disease in middle aged and elderly Chinese: results from the DYSlipidemia International Study.
Topics: Aged; Cardiovascular Diseases; China; Cohort Studies; Coronary Disease; Dyslipidemias; Female; Human | 2015 |
Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
Topics: Adult; Age Factors; Aged; Alanine Transaminase; Blood Pressure; Body Mass Index; Cardiovascular Dise | 2015 |
A Risk Score with Additional Four Independent Factors to Predict the Incidence and Recovery from Metabolic Syndrome: Development and Validation in Large Japanese Cohorts.
Topics: Asian People; Cohort Studies; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Incidenc | 2015 |
Effects of serum uric acid levels on the arginase pathway in women with metabolic syndrome.
Topics: Adult; Arginase; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Chol | 2016 |
Contribution of Inflammation, Oxidative Stress, and Antioxidants to the Relationship between Sleep Duration and Cardiometabolic Health.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Blood Pressure; C-Reactive Protein; Cardiovascular Physiol | 2015 |
Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation.
Topics: Adult; Advanced Oxidation Protein Products; Antioxidants; Biomarkers; Blood Glucose; C-Reactive Prot | 2015 |
Association between Hyperuricemia and Metabolic Syndrome: An Epidemiological Study of a Labor Force Population in Taiwan.
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol, HDL; Cross-Sectional Studies; Employment; Epidemi | 2015 |
Association of Metabolic Syndrome with the Cardioankle Vascular Index in Asymptomatic Korean Population.
Topics: Alanine Transaminase; Ankle; Aspartate Aminotransferases; Blood Glucose; Blood Pressure; Blood Urea | 2015 |
Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities.
Topics: Adult; Aged; Aged, 80 and over; China; Comorbidity; Dyslipidemias; Female; Humans; Hypertension; Hyp | 2016 |
Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus.
Topics: Adult; Aged; Arteries; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies | 2016 |
Hyperuricemia is independently associated with left ventricular hypertrophy in post-menopausal women but not in pre-menopausal women in rural Northeast China.
Topics: Adult; Age Factors; Aged; Body Mass Index; China; Diabetes Mellitus; Dyslipidemias; Female; Humans; | 2015 |
Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Topics: Adult; Aged; Ankle Brachial Index; Biomarkers; Blood Glucose; Blood Pressure; Chi-Square Distributio | 2015 |
Circulating Levels of Uric Acid and Risk for Metabolic Syndrome.
Topics: Adult; Female; Humans; Hyperuricemia; Insulin Resistance; Male; Metabolic Syndrome; Mexico; Poverty; | 2017 |
Uric Acid Is a Risk Indicator for Metabolic Syndrome-related Colorectal Adenoma: Results in a Korean Population Receiving Screening Colonoscopy.
Topics: Adenoma; Adult; Asian People; Blood Glucose; Blood Pressure; Colonoscopy; Colorectal Neoplasms; Cros | 2015 |
Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiovascular Diseases; Cross-Sectional Stu | 2016 |
Uric Acid Levels Can Predict Metabolic Syndrome and Hypertension in Adolescents: A 10-Year Longitudinal Study.
Topics: Adolescent; Child; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Longitudinal Studies; Ma | 2015 |
High serum uric acid levels increase the risk of metabolic syndrome in elderly women: The PRO.V.A study.
Topics: Age Factors; Aged; Aged, 80 and over; Biomarkers; Female; Follow-Up Studies; Humans; Hyperuricemia; | 2016 |
Psoriasis and uric acid: a population-based cross-sectional study.
Topics: Adult; Case-Control Studies; Cross-Sectional Studies; Female; Gout; Humans; Hyperuricemia; Logistic | 2016 |
Metabolic correlates of subcutaneous and visceral abdominal fat measured by ultrasonography: a comparison with waist circumference.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Blood Pressure; Body Mass Index; Body Weight; Cholest | 2016 |
Fructose and glucose combined with free fatty acids induce metabolic disorders in HepG2 cell: A new model to study the impacts of high-fructose/sucrose and high-fat diets in vitro.
Topics: Cell Cycle; Cholesterol; Diet, High-Fat; Fatty Acids, Nonesterified; Fructokinases; Fructose; Glucos | 2016 |
[Hyperuricemia as a Novel Risk Factor for Colorectal Adenomatous Polyp].
Topics: Adenoma; Colorectal Neoplasms; Female; Humans; Male; Metabolic Syndrome; Uric Acid | 2015 |
Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Mass Index; Body Wei | 2016 |
Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients.
Topics: Adolescent; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Child; Cross-Sectional Studies; | 2016 |
Uric Acid-Induced Inflammation Is Mediated by the Parathyroid Hormone:25-Hydroxyvitamin D Ratio in Obese Adolescents.
Topics: Adolescent; Female; Humans; Inflammation; Male; Metabolic Syndrome; Parathyroid Hormone; Pediatric O | 2016 |
Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.
Topics: Alanine Transaminase; Alcohol Drinking; Blood Glucose; Blood Pressure; Body Mass Index; Female; Huma | 2016 |
Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis.
Topics: Adipose Tissue; Animals; Apoptosis; Carrier Proteins; Chondrocytes; Diet, High-Fat; Enzyme Activatio | 2016 |
Cross-sectional and longitudinal study on the association between serum uric acid and metabolic syndrome.
Topics: Cross-Sectional Studies; Humans; Hyperuricemia; Longitudinal Studies; Metabolic Syndrome; Uric Acid | 2016 |
Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition.
Topics: Aging; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Female; Follow-Up Studies; | 2016 |
[Clinical Significance of Urinary Microalbumin to Creatinine Ratio in Physical Examinations].
Topics: Albuminuria; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Body Mass Index; China; Cholesterol | 2016 |
[Association between serum direct bilirubin with metabolic syndrome and its components based on a longitudinal health check-up study].
Topics: Adult; Bilirubin; Biomarkers; Cohort Studies; Female; gamma-Glutamyltransferase; Humans; Longitudina | 2016 |
Exploring the association between bipolar disorder and uric acid: A mediation analysis.
Topics: Adult; Bipolar Disorder; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle A | 2016 |
Importance of cystatin C and uric acid levels in the association of cardiometabolic risk factors in Japanese junior high school students.
Topics: Adolescent; Biomarkers; Cardiovascular Diseases; Child; Cholesterol, HDL; Creatinine; Cystatin C; Fe | 2017 |
Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study.
Topics: Aged; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; Chi-Square Distribution; Female; H | 2016 |
An observational study of sequential protein-sparing, very low-calorie ketogenic diet (Oloproteic diet) and hypocaloric Mediterranean-like diet for the treatment of obesity.
Topics: Adult; Blood Glucose; Blood Urea Nitrogen; Caloric Restriction; Cardiovascular Diseases; Creatinine; | 2016 |
Association of Serum Uric Acid With Cardiometabolic Risk Factors and Metabolic Syndrome in Iranian Adolescents: the CASPIAN-III Study.
Topics: Adolescent; Body Mass Index; Cardiovascular Diseases; Case-Control Studies; Child; Cross-Sectional S | 2016 |
Genetic and environmental influences on the associations between change in kidney function and changes in cardiometabolic factors in Koreans.
Topics: Adult; Asian People; Biomarkers; Blood Glucose; Chi-Square Distribution; Female; Gene-Environment In | 2017 |
Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
Topics: Adolescent; Alanine Transaminase; Blood Glucose; Body Mass Index; Case-Control Studies; Child; Chole | 2016 |
Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients.
Topics: Cross-Sectional Studies; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged; Preval | 2016 |
Distribution of Serum Uric Acid in Black Africans and Its Association With Cardiovascular Risk Factors.
Topics: Adult; Aged; Angola; Black People; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; | 2017 |
Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
Topics: Adenosine Monophosphate; Adenylate Kinase; Allosteric Site; AMP-Activated Protein Kinases; Animals; | 2016 |
[Investigation of metabolic disorders in patients with familial fatty liver disease and their first-degree relatives].
Topics: Blood Glucose; Body Mass Index; China; Family; Fatty Liver; Humans; Hyperglycemia; Metabolic Syndrom | 2016 |
The relationship between serum uric acid and metabolic syndrome in premenopausal and postmenopausal women in the Jinchang Cohort.
Topics: Adult; China; Cohort Studies; Female; Humans; Metabolic Syndrome; Middle Aged; Postmenopause; Premen | 2017 |
Association between Serum Uric Acid and Elevated Alanine Aminotransferase in the General Population.
Topics: Adult; Alanine; Alanine Transaminase; Asian People; China; Cross-Sectional Studies; Female; Humans; | 2016 |
The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.
Topics: Adiposity; Adult; Albuminuria; Biomarkers; Blood Pressure; Chi-Square Distribution; Creatinine; Cros | 2016 |
Adiponectin: possible link between metabolic stress and oxidative stress in the elderly.
Topics: Adiponectin; Aged; Aging; Biomarkers; Case-Control Studies; Cholesterol, HDL; Female; Humans; Insuli | 2017 |
Correlation of the leucocyte count with traditional and non-traditional components of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; China; Female; Fibrinogen; Humans; Hy | 2016 |
Metabolic syndrome: prevalence and risk factors in Korean gout patients.
Topics: Adult; Aged; Female; Gout; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Preval | 2018 |
Protodioscin ameliorates fructose-induced renal injury via inhibition of the mitogen activated protein kinase pathway.
Topics: Animals; Diet; Dietary Carbohydrates; Dioscorea; Diosgenin; Extracellular Signal-Regulated MAP Kinas | 2016 |
Pleiotropic protective effects of Vitamin D against high fat diet-induced metabolic syndrome in rats: One for all.
Topics: Animals; Biomarkers; Body Weight; Calcium; Cytoprotection; Diet, High-Fat; Drug Interactions; Hypert | 2016 |
The Power of Serum Uric Acid in Predicting Metabolic Syndrome Diminishes With Age in an Elderly Chinese Population.
Topics: Aged; Aged, 80 and over; Aging; Asian People; Cross-Sectional Studies; Female; Humans; Longitudinal | 2016 |
Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.
Topics: Adult; Aged; Asian People; China; Comorbidity; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertens | 2016 |
Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Catalase; Cholesterol; Curcumin; Fructose; Hepa | 2017 |
Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults.
Topics: Aged; Biomarkers; China; Disease Susceptibility; Female; Humans; Insulin Resistance; Life Style; Mal | 2016 |
Percentiles of serum uric acid and cardiometabolic abnormalities in obese Italian children and adolescents.
Topics: Adolescent; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Child, Preschool; Cross-Sec | 2017 |
Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in the Obesity.
Topics: Adiposity; Adult; Albuminuria; Blood Pressure; Humans; Metabolic Syndrome; Obesity; Oxidative Stress | 2017 |
Response to Letter to the Editor entitled Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in Obesity.
Topics: Adiposity; Adult; Albuminuria; Blood Pressure; Humans; Metabolic Syndrome; Obesity; Oxidative Stress | 2017 |
The Role of Uric Acid for Predicting Future Metabolic Syndrome and Type 2 Diabetes in Older People.
Topics: Aged; Aged, 80 and over; Aging; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; | 2017 |
Positive association between metabolic syndrome and serum uric acid in Wuhan.
Topics: Adult; Age Factors; Body Mass Index; China; Cholesterol, LDL; Cross-Sectional Studies; Female; Human | 2017 |
Correlation of uric acid levels and parameters of metabolic syndrome.
Topics: Adult; Biomarkers; Cholesterol, HDL; Cross-Sectional Studies; Dyslipidemias; Female; Humans; Male; M | 2017 |
Correlation of metabolic syndrome severity with cardiovascular health markers in adolescents.
Topics: Adolescent; Apolipoproteins B; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Child; Cross | 2017 |
Effects of exercise and serum uric acid on the metabolic syndrome for Japanese workers.
Topics: Adult; Blood Glucose; Blood Pressure; Cholesterol, HDL; Exercise; Humans; Japan; Male; Metabolic Syn | 2008 |
Serum urate, metabolic syndrome, and cardiovascular risk factors. A population-based study.
Topics: Adult; Aged; C-Reactive Protein; Cardiovascular Diseases; Female; Humans; Male; Metabolic Syndrome; | 2008 |
Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile.
Topics: Adult; Body Mass Index; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Epidemiologic Meth | 2008 |
Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: a study of Korean adults.
Topics: Adult; Aged; Alanine Transaminase; Blood Glucose; Blood Pressure; Female; Humans; Insulin Resistance | 2008 |
Role for the urinary bladder in pathogenesis of metabolic syndrome in Wistar rats.
Topics: Animals; Blood Glucose; Glucose; Insulin; Insulin Resistance; Metabolic Syndrome; Perfusion; Rats; R | 2008 |
A novel mutation of SLC22A12 gene causing primary renal hypouricemia in a patient with metabolic syndrome.
Topics: Adult; Aged; Creatinine; Diabetes Mellitus, Type 2; DNA Mutational Analysis; Family; Female; Humans; | 2008 |
Serum uric acid and its association with metabolic syndrome and carotid atherosclerosis in obese children.
Topics: Alanine Transaminase; Blood Glucose; Blood Pressure; Carotid Artery Diseases; Child; Cholesterol; Co | 2009 |
Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Topics: Adiponectin; Adolescent; Adult; Biomarkers; Body Mass Index; C-Reactive Protein; Cross-Sectional Stu | 2009 |
Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.
Topics: Cardiovascular Diseases; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Proportional Hazards | 2009 |
Hyperuricemia and its related factors in an urban population, Izmir, Turkey.
Topics: Adult; Blood Glucose; Body Composition; Creatinine; Diabetes Mellitus; Female; Gout; Humans; Hyperte | 2009 |
Association of homocysteinemia with high concentrations of serum insulin and uric acid in Brazilian subjects with metabolic syndrome genotyped for C677T polymorphism in the methylenetetrahydrofolate reductase gene.
Topics: Adult; Body Mass Index; Brazil; Cross-Sectional Studies; Female; Folic Acid Deficiency; Genotype; Ho | 2008 |
Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword.
Topics: Adult; Body Mass Index; Calcium; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Female; Hum | 2009 |
Association of metabolic syndrome and blood pressure nondipping profile in untreated hypertension.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Creatine; Cross-Sect | 2009 |
Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells.
Topics: Adenosine Triphosphate; Animals; Base Sequence; Cell Line; Chemokine CCL2; DNA Primers; Fructokinase | 2009 |
Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.
Topics: Adult; Aged; Albuminuria; Cross-Sectional Studies; Female; Humans; Hypertension; Male; Metabolic Syn | 2009 |
Association between two common polymorphisms of PPARgamma gene and metabolic syndrome families in a Chinese population.
Topics: Adult; Aged; Alleles; China; Cholesterol, HDL; Creatinine; Female; Gene Frequency; Genetic Predispos | 2009 |
Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.
Topics: Adult; Biomarkers; China; Cross-Sectional Studies; Fatty Liver; Female; Humans; Male; Metabolic Synd | 2009 |
Hyperuricemia and the metabolic syndrome in Hangzhou.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Body Mass Index; China; Cross-Sectional Studies; Fem | 2009 |
What rheumatologists should know about gout and cardiovascular disease.
Topics: Cardiovascular Diseases; Gout; Humans; Metabolic Syndrome; Physicians; Rheumatology; Uric Acid | 2009 |
Fructose ingestion: dose-dependent responses in health research.
Topics: Blood Glucose; Body Weight; Coronary Disease; Diabetes Mellitus, Type 2; Diet; Dose-Response Relatio | 2009 |
Sex-dependent associations of leptin with metabolic syndrome-related variables: the Stanislas study.
Topics: Adiposity; Adult; Analysis of Variance; Biomarkers; Blood Glucose; Blood Pressure; Body Mass Index; | 2010 |
Significance of heart rate in the prevalence of metabolic syndrome and its related risk factors in Japanese.
Topics: Adult; Asian People; Body Mass Index; Cholesterol, HDL; Female; Heart Rate; Humans; Male; Metabolic | 2009 |
[Peculiarities of uric acid balance disorders in patients with type 2 diabetes and metabolic syndrome].
Topics: Abdominal Fat; Aged; Diabetes Insipidus, Nephrogenic; Female; Humans; Hyperuricemia; Insulin Resista | 2009 |
Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
Topics: Adult; Female; Glomerular Filtration Rate; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle A | 2009 |
Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement.
Topics: Allopurinol; Animals; Antioxidants; Dietary Carbohydrates; Dinoprostone; Fructose; Hyperuricemia; Ki | 2009 |
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver.
Topics: Animals; Body Fat Distribution; Chemokine CCL2; Dietary Carbohydrates; Dietary Sucrose; Energy Intak | 2010 |
[Survey of relationship between measurement of abdominal circumference and metabolic syndrome on new health check in university].
Topics: Adult; Blood Cell Count; Female; gamma-Glutamyltransferase; Hematocrit; Hematopoiesis; Humans; Liver | 2009 |
The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.
Topics: Adult; Allopurinol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Gout Supp | 2009 |
Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus; Female; Humans; Male; Metabolic Syndr | 2009 |
Carotid intima-media thickness, dietary intake, and cardiovascular phenotypes in adolescents: relation to metabolic syndrome.
Topics: Adolescent; Body Mass Index; Cardiovascular Diseases; Carotid Arteries; Diet; Female; Humans; Male; | 2010 |
Longitudinal increase in gamma-glutamyltransferase within the reference interval predicts metabolic syndrome in middle-aged Korean men.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Glucose; C-Reactive Protein; Cholest | 2010 |
Experienced poor lighting contributes to the seasonal fluctuations in weight and appetite that relate to the metabolic syndrome.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Alcohol-Related Disorders; Anxiety Disorders; Appe | 2009 |
The relationship between serum uric acid concentration and metabolic syndrome in university freshmen.
Topics: Adult; Cross-Sectional Studies; Humans; Hyperuricemia; Metabolic Syndrome; Students; Universities; U | 2009 |
Hyperuricemia, cardiovascular disease, and the metabolic syndrome.
Topics: Angiotensin II; Cardiovascular Diseases; Humans; Hypertension; Hyperuricemia; Metabolic Syndrome; Ob | 2009 |
Hypomagnesaemia is associated with diabetes: Not pre-diabetes, obesity or the metabolic syndrome.
Topics: Adult; Aged; Australia; Creatinine; Diabetes Mellitus; Female; Health Status; Humans; Magnesium; Mag | 2010 |
Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly men.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Biomarkers; Cholesterol, HDL; Creatinine; Homes for the Age | 2009 |
Serum uric acid and metabolic syndrome in Taiwanese adults.
Topics: Age Factors; Alcohol Drinking; Cross-Sectional Studies; Electric Impedance; Exercise; Feeding Behavi | 2010 |
Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice.
Topics: Adipocytes; Administration, Oral; Animals; Aorta; Benzylamines; Blood Glucose; Cholesterol; Hydrogen | 2010 |
Angiotensin-converting enzyme gene polymorphism in overweight and obese Turkish patients with insulin resistance.
Topics: Adipose Tissue; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Fe | 2010 |
Factor analysis of metabolic syndrome components in the Coronary Artery Risk Development in Young Adults (CARDIA) study: examination of factors by race-sex groups and across time.
Topics: Adolescent; Adult; Black or African American; Blood Glucose; Body Mass Index; Cholesterol; Coronary | 2010 |
Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis.
Topics: Adiposity; Adult; Aged; Arthritis, Gouty; Case-Control Studies; Female; Humans; Insulin Resistance; | 2011 |
The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Blood Pressure; | 2010 |
Menopausal symptoms and the metabolic syndrome in Nigerian women with type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Arthralgia; Body Mass Index; Cholesterol, HDL; Cross-Sectional Studi | 2011 |
High inflammatory activity related to the number of metabolic syndrome components.
Topics: Blood Cell Count; Body Mass Index; C-Reactive Protein; Case-Control Studies; Female; Fibrinogen; Hum | 2010 |
Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese.
Topics: Adolescent; Child; Child, Preschool; Diabetes Complications; Female; Humans; Hypertension; Male; Met | 2010 |
Association between carotid atherosclerosis and metabolic syndrome: results from the ISMIR study.
Topics: Aged; Blood Glucose; Carotid Artery Diseases; Creatinine; Cross-Sectional Studies; Female; Fibrinoge | 2010 |
The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers; Female; Humans; Hyperuricemia; | 2010 |
Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Biomarkers; Causality; Female; Genotype; | 2010 |
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemia.
Topics: Aged; Atrial Natriuretic Factor; Biomarkers; Blood Glucose; Cross-Sectional Studies; Diabetes Mellit | 2009 |
Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
Topics: Adult; Albuminuria; Cardiovascular Diseases; Chronic Disease; Cohort Studies; Creatinine; Cross-Sect | 2010 |
Serum insulin is significantly related to components of the metabolic syndrome in Japanese working men.
Topics: Adult; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Cross-Sectional Studies; Employ | 2010 |
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cardiovascular Diseases; Chi-Square Distribution; Cholestero | 2010 |
Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins.
Topics: Adult; Biomarkers; Blood Pressure; California; Cross-Sectional Studies; Dyslipidemias; Fatty Liver; | 2010 |
The beneficial effects of allopurinol in cardiology practice: decrease in uric acid and vascular oxidative stress/ the effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot stu
Topics: Allopurinol; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Metabolic Syndrome; Oxidative | 2010 |
Relationship between uric acid and metabolic syndrome according to menopausal status.
Topics: Adult; Aged; Blood Pressure; Cross-Sectional Studies; Female; Health Status; Humans; Hyperuricemia; | 2011 |
Metabolic syndrome characteristics in gout patients.
Topics: Aged; Blood Glucose; Blood Pressure; Female; Gout; Humans; Hyperuricemia; Male; Metabolic Syndrome; | 2010 |
Uric acid metabolism in patients with primary gout and the metabolic syndrome.
Topics: Female; Gout; Humans; Male; Metabolic Syndrome; Middle Aged; Uric Acid | 2010 |
Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
Topics: Adult; Blood Glucose; Body Mass Index; Cohort Studies; Cross-Sectional Studies; Fasting; Female; Fib | 2010 |
Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension.
Topics: Adult; Age Factors; Aged; Biomarkers; Blood Glucose; Blood Pressure; Chronic Disease; Creatinine; Fe | 2010 |
Relation of uric acid levels to aortic root dilatation in hypertensive patients with and without metabolic syndrome.
Topics: Aged; Aortic Diseases; Blood Pressure; Cardiovascular Diseases; Dilatation, Pathologic; Echocardiogr | 2010 |
Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006.
Topics: Adolescent; Blood Glucose; Blood Pressure; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, | 2010 |
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.
Topics: Adult; Aged; Alcoholism; Blood Glucose; Blood Pressure; Body Height; Body Mass Index; Body Size; Bod | 2010 |
Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity.
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Male; Metabolic Syndrome; Obesity; Poland; Risk | 2011 |
The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Female; Glucose Tolerance Test; Humans; | 2011 |
Just a spoonful of sugar helps the blood pressure go up.
Topics: Animals; Blood Glucose; Blood Pressure; Fructose; Humans; Hypertension; Metabolic Syndrome; Risk Fac | 2010 |
Is metabolic syndrome related to uric acid metabolism in gout patients?
Topics: Gout; Humans; Metabolic Syndrome; Prevalence; Uric Acid | 2010 |
Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese.
Topics: Adult; Aging; Asian People; Body Mass Index; China; Cross-Sectional Studies; Female; Humans; Hyperur | 2011 |
Association between uric acid and cardiovascular risk variables in a non-hospitalized population.
Topics: Adult; Age Factors; Biomarkers; Blood Pressure; Body Mass Index; Brazil; Cardiovascular Diseases; Cr | 2011 |
Metabolic syndrome does not impose greater atrial fibrillation risk in elderly hypertensive patients.
Topics: Age Factors; Aged; Atrial Fibrillation; Creatinine; Diuretics; Female; Humans; Hypertension; Hypertr | 2010 |
[Metabolic syndrome and nephrolithiasis].
Topics: Animals; Calcium; Humans; Hydrogen-Ion Concentration; Insulin Resistance; Metabolic Syndrome; Nephro | 2011 |
Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome.
Topics: 3T3-L1 Cells; Adipocytes; Adiponectin; Adipose Tissue; Animals; Cells, Cultured; Chemokine CCL2; Hum | 2011 |
Relation of uric acid with components of metabolic syndrome before and after Roux-en-Y gastric bypass in morbidly obese subjects.
Topics: Adolescent; Adult; Epidemiologic Methods; Female; Gastric Bypass; Humans; Hyperuricemia; Male; Metab | 2011 |
Relationships among hyperuricemia, metabolic syndrome, and endothelial function.
Topics: Adult; Brachial Artery; Cross-Sectional Studies; Endothelium, Vascular; Humans; Hyperuricemia; Japan | 2011 |
[Disorders of uric acid metabolism in rats with fructose-induced experimental insulin resistance syndrome].
Topics: 5'-Nucleotidase; Adenosine Deaminase; Animals; Blood Glucose; Disease Models, Animal; Female; Fructo | 2011 |
Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Topics: Aged; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Female; Humans; Hyperuricemia; Inflamm | 2011 |
[Restriction of fructose intake can prevent hyperuricemia, glomerular filtration and cardiovascular diseases].
Topics: Coronary Artery Disease; Female; Humans; Kidney Diseases; Male; Metabolic Syndrome; Uric Acid | 2011 |
Carotid intima-media thickness is increased not only in non-alcoholic fatty liver disease patients but also in alcoholic fatty liver patients.
Topics: Adult; Alanine Transaminase; Alcohol Drinking; Analysis of Variance; Aspartate Aminotransferases; Bi | 2011 |
G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome.
Topics: Adult; Asian People; Biomarkers; Chi-Square Distribution; Chromatography, High Pressure Liquid; Cros | 2012 |
Unravelling the effects of age, period and cohort on metabolic syndrome components in a Taiwanese population using partial least squares regression.
Topics: Adult; Age Factors; Blood Glucose; Blood Pressure; Body Mass Index; Cohort Effect; Female; Humans; L | 2011 |
Immunological and biochemical parameters of patients with metabolic syndrome and the participation of oxidative and nitroactive stress.
Topics: Adiponectin; Adult; Antioxidants; Biomarkers; Body Mass Index; C-Reactive Protein; Case-Control Stud | 2011 |
Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China.
Topics: Adult; Aged; Blood Flow Velocity; Blood Pressure; Cardiovascular Diseases; China; Female; Humans; Hy | 2012 |
Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease.
Topics: Atorvastatin; Cholesterol, LDL; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxy | 2011 |
Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Carotid Arteries; Carotid Artery Diseases; Carotid Steno | 2011 |
High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Cohort Studies; Cross-Sectional Studies; Diagnostic Te | 2012 |
Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis.
Topics: Aged; Blood Pressure; Diabetes Mellitus; Humans; Hydrogen-Ion Concentration; Hypertension; Insulin R | 2012 |
Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
Topics: Acute-Phase Proteins; Adult; Biomarkers; C-Reactive Protein; Comorbidity; Female; Humans; Inflammati | 2011 |
Fructose and non-fructose sugar intakes in the US population and their associations with indicators of metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Diet; Dietary Carbohydrates; Fructose; Humans; Me | 2011 |
Weight loss and sleep-disordered breathing in childhood obesity: effects on inflammation and uric acid.
Topics: Adenoidectomy; Adolescent; Belgium; Biomarkers; Child; Female; Follow-Up Studies; Humans; Inflammati | 2012 |
Racial/ethnic and sex differences in the relationship between uric acid and metabolic syndrome in adolescents: an analysis of National Health and Nutrition Survey 1999-2006.
Topics: Adolescent; Anthropometry; Black or African American; Blood Glucose; Blood Pressure; Child; Choleste | 2012 |
Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations.
Topics: Animals; Biological Evolution; Cardio-Renal Syndrome; Humans; Metabolic Syndrome; Mutation; Obesity; | 2011 |
Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men.
Topics: Atherosclerosis; Biomarkers; Body Mass Index; Calcinosis; Carotid Intima-Media Thickness; Coronary A | 2012 |
[The relationship between urinary albumin excretion and serum uric acid in general population].
Topics: Adult; Aged; Albuminuria; Creatinine; Female; Humans; Kidney Diseases; Lipids; Logistic Models; Male | 2011 |
Determinants of blood uric acid levels in a dyslipidemic Arab population.
Topics: Adult; Arabs; Body Mass Index; Chi-Square Distribution; Coronary Artery Disease; Cross-Sectional Stu | 2012 |
Relationship between hyperuricemia and chronic kidney disease.
Topics: Glomerulonephritis, IGA; Humans; Hypertension; Hyperuricemia; Kidney; Kidney Failure, Chronic; Kidne | 2011 |
Investigation on hyperuricemia in children with obesity or various pediatric disorders.
Topics: Adolescent; Age Distribution; Child; Child, Preschool; Female; Humans; Hyperuricemia; Infant; Japan; | 2011 |
Gender distribution of serum uric acid and cardiovascular risk factors: population based study.
Topics: Adult; Biomarkers; Body Mass Index; Brazil; Epidemiologic Methods; Female; Humans; Hypertension; Hyp | 2012 |
Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study.
Topics: Adult; Analysis of Variance; Biomarkers; Chi-Square Distribution; Female; Humans; Hyperuricemia; Inc | 2012 |
Melatonin improves metabolic syndrome induced by high fructose intake in rats.
Topics: Adipokines; Analysis of Variance; Animals; Antioxidants; Blood Glucose; Body Weight; Cholesterol; Di | 2012 |
Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Asian People; Biomarkers; Carotid Artery Diseases; Caro | 2012 |
Uric acid is not an independent predictor of cardiovascular mortality in type 2 diabetes: a population-based study.
Topics: Aged; Biomarkers; Cardiovascular Diseases; Cause of Death; Chi-Square Distribution; Diabetes Complic | 2012 |
Metabolic syndrome: new targets for an old problem.
Topics: Animals; Endothelial Cells; Humans; Inflammation; Metabolic Syndrome; Oxidative Stress; Uric Acid | 2012 |
Predictive ability of serum high-molecular-weight adiponectin in combination with serum insulin and serum C-reactive protein for the presence of metabolic syndrome.
Topics: Adiponectin; Adult; Alanine Transaminase; Biomarkers; C-Reactive Protein; gamma-Glutamyltransferase; | 2012 |
Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Confounding Factors, Epidemiologic; Cros | 2012 |
Predictors of the development of metabolic syndrome in male workers: a 3-year follow-up study.
Topics: Adult; Age Factors; Alcohol Drinking; Cholesterol, HDL; Confidence Intervals; Exercise; Follow-Up St | 2012 |
A single oral dose of fructose induces some features of metabolic syndrome in rats: role of oxidative stress.
Topics: Administration, Oral; Animals; Blood Glucose; Blood Pressure; Dose-Response Relationship, Drug; Fruc | 2013 |
Elevated uric acid, the metabolic syndrome and cardiovascular disease: cause, consequence, or just a not so innocent bystander?
Topics: Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Uric Acid | 2012 |
Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents.
Topics: Adolescent; Blood Pressure; Humans; Male; Metabolic Syndrome; Risk Factors; ROC Curve; Triglycerides | 2012 |
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats.
Topics: Animals; Ascorbic Acid; Blood Glucose; Body Weight; Catalase; Eating; Fructose; Glucose Tolerance Te | 2012 |
[Clinical significance of insulin resistance syndrome in development of endothelial dysfunction in patients with primary gout].
Topics: Adult; Atherosclerosis; Blood Glucose; Brachial Artery; Carbohydrate Metabolism; Disease Progression | 2012 |
A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Biomarkers; China; Humans; Longitudinal Studies; Male; | 2012 |
[Characteristics of carbohydrate metabolism changes in elderly patients with gout and metabolic syndrome].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Carbohydrate Metabolism; Dyslipidemias; | 2012 |
The effects of phentolamine on fructose-fed rats.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Disease Models | 2012 |
Metabolic syndrome and urinary stone composition: what factors matter most?
Topics: Adult; Aged; Calcium Oxalate; Calcium Phosphates; Diabetes Complications; Dyslipidemias; Female; Hum | 2012 |
Pathological and behavioral risk factors for higher serum C-reactive protein concentrations in free-living adults--a Brazilian community-based study.
Topics: Abdominal Fat; Adult; Aged; Aged, 80 and over; Anthropometry; Blood Glucose; Body Mass Index; Brazil | 2013 |
Effects on uric acid, body mass index and blood pressure in adolescents of consuming beverages sweetened with high-fructose corn syrup.
Topics: Adolescent; Anthropometry; Beverages; Blood Pressure; Body Mass Index; Child; Dietary Sucrose; Drink | 2013 |
The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder.
Topics: Adult; Cholesterol, HDL; Cross-Sectional Studies; Female; Humans; Hypertension; Hypertriglyceridemia | 2012 |
Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Fatty Liver; Femal | 2012 |
Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese population.
Topics: Aged; Asian People; Cohort Studies; Cross-Sectional Studies; Fatty Liver; Female; Glomerular Filtrat | 2012 |
Correlation of metabolic syndrome with urinary stone composition.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Body Mass Index; Calcium Oxalate; Case-Control Stu | 2013 |
Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.
Topics: Adult; Aged; Aspartate Aminotransferases; Cholesterol, HDL; Cross-Sectional Studies; Fatty Liver; Fe | 2013 |
A confirmatory factor analysis of the metabolic syndrome in adolescents: an examination of sex and racial/ethnic differences.
Topics: Adolescent; Age Factors; Area Under Curve; Biomarkers; Black or African American; C-Reactive Protein | 2012 |
Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents.
Topics: Adolescent; Biomarkers; Body Mass Index; Cardiovascular Diseases; Child; Cross-Sectional Studies; Fe | 2013 |
Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Hyperuricemia; Insulin Resistance | 2012 |
Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions.
Topics: Adult; Biomarkers; Case-Control Studies; Gout; Humans; Insulin; Insulin Resistance; Male; Metabolic | 2012 |
Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran.
Topics: Adult; Aged; Biomarkers; Comorbidity; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Iran; | 2012 |
Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Female; Humans; H | 2013 |
Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats.
Topics: Animals; Beverages; Fatty Liver; Fructokinases; Fructose; Glucose; Hypertrophy; Hyperuricemia; Insul | 2013 |
Dietary, anthropometric, and biochemical determinants of uric acid in free-living adults.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Blood Pressure; Body Composition; Body Ma | 2013 |
Serum uric acid predicts both current and future components of the metabolic syndrome.
Topics: Adolescent; Adult; Black or African American; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fe | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
Topics: Adiponectin; Adiposity; Adolescent; Adult; Age Factors; Cardiovascular Diseases; Case-Control Studie | 2013 |
Associations between white blood cell count and features of the metabolic syndrome in Japanese male office workers.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Cross-Sectional Studies; Humans; | 2002 |
Leptin and metabolic syndrome in obese and non-obese children.
Topics: Blood Glucose; Blood Pressure; Body Height; Body Weight; Child; Cholesterol, HDL; Factor Analysis, S | 2002 |
Elevated serum leptin concentrations in women with hyperuricemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Blood Glucose; Body Mass Index; Choles | 2002 |
[Glucose effectiveness and components of the metabolic syndrome in recently diagnosed hypertensive patients].
Topics: Adult; Aged; Cholesterol, VLDL; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glucose; | 2002 |
Plasma adiponectin levels in overweight and obese Asians.
Topics: Adiponectin; Blood Glucose; Blood Pressure; Body Constitution; Body Mass Index; Cholesterol, HDL; Fa | 2002 |
Relationship of neck circumference to cardiovascular risk factors.
Topics: Adolescent; Adult; Blood Glucose; Body Constitution; Body Mass Index; Cardiovascular Diseases; Chole | 2003 |
Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation.
Topics: Adiponectin; Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Biomarkers; Body Mass Ind | 2003 |
Association between gamma-glutamyl transpeptidase activity and status of disorders constituting insulin resistance syndrome.
Topics: Adult; Aged; Body Mass Index; Cholesterol; Cholesterol, HDL; Comorbidity; Cross-Sectional Studies; g | 2003 |
Correlation between insulin resistance and gamma-glutamyl transpeptidase sensitivity in light drinkers.
Topics: Adult; Alcohol Drinking; Alcoholism; Blood Glucose; Body Mass Index; Cholesterol, HDL; Dose-Response | 2003 |
Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoproteins B; Blood Glucose; Blood Pressure; Body C | 2003 |
Association between fasting glucose and C-reactive protein in middle-aged subjects.
Topics: Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cross-Sectional Studies; Diabe | 2004 |
Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome.
Topics: Adolescent; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Child; Cholesterol, HDL; Cohor | 2003 |
The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
Topics: Acids; Adult; Female; Humans; Hydrogen-Ion Concentration; Hyperinsulinism; Insulin Resistance; Kidne | 2004 |
Gout.
Topics: Coronary Disease; Fenofibrate; Gout; Humans; Hypolipidemic Agents; Metabolic Syndrome; Risk Factors; | 2004 |
Clustering of components of the metabolic syndrome and risk for development of type 2 diabetes in Japanese male office workers.
Topics: Adult; Analysis of Variance; Blood Glucose; Body Mass Index; Cholesterol, LDL; Cluster Analysis; Dia | 2004 |
Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.
Topics: Adult; Age Distribution; Alcohol Drinking; Blood Pressure; Body Height; Body Mass Index; Cardiovascu | 2004 |
Obesity and the metabolic syndrome in children and adolescents.
Topics: Adolescent; Biomarkers; C-Reactive Protein; Child; Humans; Metabolic Syndrome; Obesity; Uric Acid | 2004 |
Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anthropometry; Blood Glucose; Body Composition; Body Constitution; B | 2004 |
[Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome].
Topics: Adolescent; Body Mass Index; Body Weights and Measures; Child; Cholesterol; Female; Glucose Toleranc | 2004 |
Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Bilirubin; Carotid Artery Diseases; Cross-Sectional St | 2005 |
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients.
Topics: Albuminuria; Analysis of Variance; Blood Glucose; Body Mass Index; Cardiovascular Diseases; Carotid | 2005 |
Disturbances of phosphate metabolism: another feature of metabolic syndrome.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, LDL; Creatinine; Electrolytes; F | 2005 |
Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome?
Topics: Drug Combinations; Humans; Lovastatin; Metabolic Syndrome; Niacin; Uric Acid | 2005 |
Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
Topics: Aged; Blood Glucose; Blood Pressure; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Female; | 2005 |
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects.
Topics: Aged; Apolipoprotein A-I; Brain Ischemia; Case-Control Studies; Cholesterol; Cholesterol, HDL; Diabe | 2005 |
Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Female; Humans; Hypertension; Insulin Resistance; Male; | 2005 |
[Characteristics of metabolic syndrome in children and adolescents with arterial hypertension].
Topics: Adolescent; Body Mass Index; Child; Cholesterol, HDL; Cholesterol, LDL; Female; Glucose Intolerance; | 2005 |
Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children.
Topics: Adolescent; Anthropometry; Blood Glucose; Blood Pressure; Body Composition; Body Height; Body Mass I | 2005 |
A causal role for uric acid in fructose-induced metabolic syndrome.
Topics: Animals; Fructose; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Triglycerides; Uric Acid | 2006 |
Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects.
Topics: Aged; Body Mass Index; Brain Ischemia; Case-Control Studies; Female; Humans; Hypertension; Lipids; M | 2005 |
Associations among sex hormone binding globulin concentrations and characteristics of the metabolic syndrome in obese women.
Topics: Adult; Age Factors; Androstenedione; Blood Glucose; Blood Pressure; Body Mass Index; Case-Control St | 2004 |
Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents.
Topics: Adiponectin; Adolescent; Biomarkers; C-Reactive Protein; Child; Female; Humans; Insulin; Interleukin | 2006 |
Clustering of cardiovascular risk factors associated with the insulin resistance syndrome: assessment by principal component analysis in young hyperandrogenic women.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cholesterol, HDL; Fe | 2006 |
Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study.
Topics: Adult; Body Mass Index; C-Reactive Protein; Cholesterol, HDL; Cluster Analysis; Family Health; Femal | 2006 |
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors.
Topics: Adolescent; Albuminuria; Blood Glucose; Cardiovascular Diseases; Child; Female; Glucose Tolerance Te | 2006 |
Uric acid: an additional component of metabolic syndrome?
Topics: Cardiovascular Diseases; Humans; Hyperuricemia; Metabolic Syndrome; Uric Acid | 2006 |
Is hyperuricemia another facet of the metabolic syndrome?
Topics: Alanine Transaminase; Body Mass Index; Cholesterol, HDL; Humans; Hyperuricemia; Male; Metabolic Synd | 2006 |
Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
Topics: Adult; Anticonvulsants; Body Mass Index; Epilepsy; Female; Humans; Hyperinsulinism; Insulin; Lipopro | 2006 |
Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study.
Topics: Adult; Age Distribution; Aged; Anthropometry; Awareness; Blood Glucose; Blood Pressure; Cholesterol; | 2006 |
[Serum urate levels and urinary uric acid excretion in subjects with metabolic syndrome].
Topics: Aged; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Uric Acid | 2006 |
Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals.
Topics: Aged; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Artery Diseases; Elasticity; Femal | 2007 |
Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis.
Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Carotid Artery, Common; Female; Humans; Incidence; | 2006 |
[Relationships between arterial hypertension, metabolic disturbances and uric acid nephropathy].
Topics: Adult; Female; Follow-Up Studies; Heart Rate; Humans; Hypertension; Hyperuricemia; Insulin; Kidney D | 2006 |
Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats.
Topics: Animals; Body Weight; Capillaries; Drinking; Eating; Fructose; Hypertension, Renal; Kidney; Kidney G | 2007 |
Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, HDL; Female; Humans; Hyper | 2006 |
[Hyperuricaemia in males with obstructive sleep apnoea (osa)].
Topics: Body Mass Index; Comorbidity; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Obesity; | 2005 |
Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluati
Topics: Aged; Atorvastatin; Coronary Disease; Cost-Benefit Analysis; Creatinine; Female; Glomerular Filtrati | 2007 |
Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Topics: Abdominal Fat; Adult; Aged; Biomarkers; Coronary Disease; Cross-Sectional Studies; Disease Susceptib | 2006 |
Reviewer's perspective of the role of uric acid.
Topics: Adult; Aged; Biomarkers; Coronary Disease; Cross-Sectional Studies; Disease Susceptibility; Female; | 2006 |
Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Topics: Adiponectin; Adiposity; Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cardiovascular Diseas | 2006 |
[Metabolic syndrome complicated by peripheral arterial disease: clinical study of 2115 cases].
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Blood Glucose; Blood Urea Nitrogen; Body Mass Index | 2006 |
Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Blood Glucose; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabetes Mellitus | 2007 |
Association between serum uric acid level and components of the metabolic syndrome.
Topics: Adult; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Female; Humans; | 2006 |
Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Pressure; Body Mass Index; Calcium | 2007 |
Hyperuricemia and incidence of hypertension among men without metabolic syndrome.
Topics: Adult; Blood Pressure; Follow-Up Studies; Humans; Hypertension; Hyperuricemia; Incidence; Male; Meta | 2007 |
Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome.
Topics: Brazil; Coronary Artery Disease; Cross-Sectional Studies; Humans; Male; Metabolic Syndrome; Middle A | 2007 |
Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis.
Topics: Aged; Biomarkers; C-Reactive Protein; Calcinosis; Coronary Artery Disease; Coronary Disease; Coronar | 2007 |
Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
Topics: Aged; Atherosclerosis; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease | 2008 |
Birthweight and risk factors for cardiovascular diseases in Japanese schoolchildren.
Topics: Adiponectin; Birth Weight; Child; Coronary Artery Disease; Female; Humans; Infant, Newborn; Japan; M | 2007 |
Prevalence of the metabolic syndrome in individuals with hyperuricemia.
Topics: Adult; Body Mass Index; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Multiv | 2007 |
Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents.
Topics: Adolescent; Anthropometry; Area Under Curve; Biomarkers; Blood Glucose; Blood Pressure; C-Reactive P | 2007 |
Ten-year change in serum uric acid and its relation to changes in other metabolic risk factors in young black and white adults: the CARDIA study.
Topics: Adolescent; Adult; Alcohol Drinking; Biomarkers; Black or African American; Blood Pressure; Body Mas | 2007 |
Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.
Topics: Adult; Aged; Body Mass Index; Female; Humans; Insulin Resistance; Leptin; Lipoproteins, HDL; Male; M | 2007 |
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension.
Topics: Albuminuria; Arteries; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Cardiovascular Dis | 2007 |
Pulse hypertension: a new component of the metabolic syndrome in elderly women?
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Blood Glucose; Blood Pressure; Coronary Disease; Cr | 2007 |
[Levels of uric acid in serum in patients with metabolic syndrome].
Topics: Adult; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Uric Acid | 2007 |
Relationship between hyperuricemia and metabolic syndrome.
Topics: Adult; Female; Humans; Hyperuricemia; Male; Metabolic Syndrome; Risk Factors; Sex Characteristics; U | 2007 |
Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Coronary Artery Disease; Female; Humans; Ma | 2007 |
Hyperuricemia and metabolic syndrome in Taiwanese children.
Topics: Age Factors; Blood Glucose; Blood Pressure; Body Mass Index; Child; Cholesterol; Demography; Female; | 2007 |
Serum uric acid is significantly related to the components of the metabolic syndrome in Japanese workingmen.
Topics: Adult; Biomarkers; Blood Glucose; C-Reactive Protein; Cross-Sectional Studies; Dyslipidemias; Employ | 2007 |
Relationship between hyperuricemia and body fat distribution.
Topics: Adipose Tissue; Adult; Body Fat Distribution; Humans; Hyperuricemia; Insulin Resistance; Lipids; Mal | 2007 |
Thiazide diuretics exacerbate fructose-induced metabolic syndrome.
Topics: Allopurinol; Animals; Blood Pressure; Body Weight; Diuretics; Fructose; Gout Suppressants; Hydrochlo | 2007 |
Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity.
Topics: Adolescent; Albuminuria; Aldosterone; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Ma | 2008 |
Serum uric acid level as an independent component of the metabolic syndrome in type 2 diabetic blacks.
Topics: Adult; Aged; Black People; Diabetes Mellitus, Type 2; Epidemiologic Studies; Female; Humans; Hypertr | 2007 |
Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen.
Topics: Adolescent; Adult; Alcohol Drinking; Body Mass Index; Epidemiologic Methods; Exercise; Female; Hepat | 2008 |
A comparison of uric acid levels in Black African vs Caucasian women from South Africa: the POWIRS study.
Topics: Adult; Black People; Blood Pressure; Blood Pressure Determination; Diet Surveys; Female; Humans; Met | 2007 |
Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA.
Topics: Aged; Blood Glucose; Creatinine; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Metabolic | 2008 |
Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Cross-Sectional Studies; Female; Humans; Hype | 2008 |
Uric acid: a surrogate of insulin resistance in older women.
Topics: Body Mass Index; Chronic Disease; Female; Glomerular Filtration Rate; Humans; Insulin Resistance; Ki | 2008 |
Comparison of serum uric acid levels between Japanese with and without metabolic syndrome.
Topics: Abdominal Fat; Adult; Aged; Alcohol Drinking; Asian People; Dyslipidemias; Female; Humans; Male; Met | 2008 |
Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China.
Topics: Adult; Aged; Blood Pressure; China; Cohort Studies; Diabetes Mellitus; Female; Humans; India; Lipids | 2008 |
Uric acid indicates a high cardiovascular risk profile but is not closely associated with insulin resistance in obese adolescents.
Topics: Adolescent; Cardiovascular Diseases; Humans; Insulin Resistance; Metabolic Syndrome; Obesity; Risk F | 2008 |
[Correlation between serum uric acid and insulin resistance].
Topics: Adult; Blood Glucose; China; Female; Humans; Insulin; Insulin Resistance; Male; Metabolic Syndrome; | 2007 |
Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Coronary Artery Disease; Female; Genetic Predi | 2008 |
Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
Topics: C-Reactive Protein; Case-Control Studies; Coronary Artery Disease; Cross-Sectional Studies; Female; | 2008 |
A decreased mitochondrial DNA content is related to insulin resistance in adolescents.
Topics: Adolescent; Blood Glucose; Cross-Sectional Studies; DNA-Binding Proteins; DNA, Mitochondrial; Down-R | 2008 |
Serum uric acid levels and risk of metabolic syndrome in healthy adults.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Female; Humans; Hypertension; Hypertriglyceridemia; Hype | 2008 |
Impact of childhood metabolic syndrome components on the risk of elevated uric acid in adulthood: the Bogalusa Heart Study.
Topics: Adolescent; Child; Child, Preschool; Cholesterol, HDL; Cross-Sectional Studies; Female; Gout; Humans | 2008 |
Uric acid and the development of metabolic syndrome in women and men.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Prospective S | 2008 |
Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome.
Topics: Adult; Blood Glucose; Blood Pressure; Body Mass Index; Chemistry; Colorimetry; Diabetes Mellitus, Ty | 2002 |
Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome.
Topics: Adipose Tissue; Adult; Body Composition; Body Constitution; Body Mass Index; Cross-Sectional Studies | 2002 |
Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese.
Topics: Adult; Asian People; Biomarkers; Blood Glucose; Body Mass Index; Cholesterol, HDL; Cross-Sectional S | 2002 |